"mrcuis"|"str"
C0444499|"0/5"
C0450319|"1051"
C1520273|"10Q21"
C0442766|"1/24"
C0135262|"1-(2-(4-AMINOPHENYL)ETHYL)-4-(3-TRIFLUOROMETHYLPHENYL)PIPERAZINE (PAPP)"
C1520470|"12P12"
C1520474|"12P13"
C0090388|"14-3-3 PROTEIN"
C1552130|"16S"
C1520768|"17Q21"
C1520846|"19P13.12"
C1520855|"19Q13"
C1520865|"19Q13.32"
C1553633|"1A"
C0914069|"1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE"
C0740116|+2
C0000325|"20-METHYLCHOLANTHRENE"
C1521104|"22Q11.2"
C0045511|"2,4-DINITROPHENOL (DNP)"
C0000343|"25-HYDROXY ERGOCALCIFEROL"
C0535968|"25-HYDROXYVITAMIN D"
C0286330|"26S ATP-DEPENDENT PROTEASOME"
C4319602|"27"
C0172934|"27-HYDROXYCHOLESTEROL"
C1553619|"28P"
C1553667|"29A"
C0046196|"2-HYDROXYESTRADIOL"
C1552116|"2S"
C0442757|"3/4"
C0442759|"3/6"
C1442459|"3 DAYS"
C0000399|"3-DEAZAURIDINE"
C2975999|"3-HYDROXY-3-METHYLGLUTARYL-COENZYME A REDUCTASE"
C0047472|"3-HYDROXYKYNURENINE"
C0332060|"3M PHARMACEUTICALS"
C0047645|"3-NITROTYROSINE"
C0600600|"3' UNTRANSLATED REGION"
C0439509|/40
C0048865|"5,11-METHENYLTETRAHYDROHOMOFOLATE (MTHF)"
C1455498|"5,6-DIHYDROXYINDOLE-2-CARBOXYLIC ACID OXIDASE"
C2350345|"5'-AMP-ACTIVATED PROTEIN KINASE"
C1531433|"5-HYDROXYTRYPTAMINE RECEPTOR 2A"
C0049308|"5-METHYLCYTOSINE"
C1826478|"5'-NUCLEOTIDASE, CYTOSOLIC IIIB"
C1521452|"5P"
C0600493|"5' UNTRANSLATED REGION"
C0442748|"6/4"
C1521535|"6P21.1"
C1521551|"6P25"
C1419129|"6-PYRUVOYLTETRAHYDROPTERIN SYNTHASE"
C0049865|"7 DEHYDROCHOLESTEROL"
C1414040|"7-DEHYDROCHOLESTEROL REDUCTASE"
C0049866|"7-DEHYDROCHOLESTEROL REDUCTASE"
C1521639|"7Q21"
C0050078|"8-HYDROXY-DEOXYGUANOSINE"
C0295541|"8-ISOPROSTANE"
C1515502|"9P21.3"
C1300813|ABDOMINAL CIRCUMFERENCE
C1510714|ABERRANT DNA METHYLATION
C0085732|ABILITY
C0562734|ABILITY TO PERFORM PERSONAL CARE ACTIVITY
C0262361|ABNORMAL GROWTH
C1704258|ABNORMALITY
C0423571|ABNORMAL SENSATION
C0935542|ABORIGINES
C0000833|ABSCESS MORPHOLOGY
C0000849|ABSENTEEISM
C4285220|ABSORBABLE MODIFIED POLYMER HEMOSTATIC POWDER
C0233642|ABSTRACT THINKING
C1510747|ACADEMIA
C0700132|ACADEMIC ACHIEVEMENT
C0542560|ACADEMIC DEGREE
C0000876|ACADEMY
C0050393|ACARBOSE-CONTAINING PRODUCT
C0178951|ACCELEROMETERS
C3645535|ACCEPTABILITY
C0000901|ACCEPTORS
C0151736|ACCIDENTAL INJURY
C0728853|ACCIDENT DUE TO WEATHER EXPOSURE
C0000924|ACCIDENTS AND FALLS
C0000934|ACCLIMATIZATION
C0000938|ACCOUNTING
C4055506|ACCUMULATION
C0443131|ACCURATE
C0000966|ACETALDEHYDE
C0000975|ACETATE
C0001028|ACETATE-COA LIGASE
C0001038|ACETYLATION
C0001041|ACETYLCHOLINE PREPARATION
C0001044|ACETYLCHOLINESTERASE
C0001046|ACETYLCHOLINESTERASE INHIBITORS
C0001026|ACETYLCOENZYME A
C0001022|ACETYL COENZYME A CARBOXYLASE
C0001040|ACETYL-L-CARNITINE
C2000891|ACID CERAMIDASE
C1447285|ACIDIC LEUCINE-RICH NUCLEAR PHOSPHOPROTEIN 32 FAMILY MEMBER A
C0001109|ACID PHOSPHATASE
C0001128|ACIDS
C0599122|ACID SPHINGOMYELINASE
C0439661|ACQUIRED
C1706701|ACQUISITION
C1171301|ACTIGRAPHY
C0001271|ACTIN
C0001246|ACTINIUM, NOS
C3266814|ACTION ATTRIBUTE
C0730452|ACTION THERAPY
C1570167|ACTIVATING TRANSCRIPTION FACTOR 7-INTERACTING PROTEIN 1
C1879547|ACTIVATION
C0001282|ACTIVATION ANALYSIS
C0596035|ACTIVATION PRODUCT
C1412886|ACTIVATOR OF HSP90 ATPASE ACTIVITY 1
C1704532|ACTIVE METHOD
C1531698|ACTIVE MONITORING
C0205177|ACTIVE (QUALIFIER VALUE)
C0441655|ACTIVITY
C0683317|ACTIVITY LEVEL
C1412501|ACTIVITY-REGULATED CYTOSKELETON-ASSOCIATED PROTEIN
C0237400|ACTUAL
C0001302|ACUPUNCTURE POINTS
C0394664|ACUPUNCTURE THERAPY
C0679878|ACUTE CARE
C1285577|ACUTE CONFUSIONAL STATE
C0948089|ACUTE CORONARY SYNDROME
C0001314|ACUTE DISEASES
C1290838|ACUTE HEART DISEASE
C0342301|ACUTE HYPERGLYCEMIA
C0348776|ACUTE PARALYTIC POLIOMYELITIS, UNSPECIFIED
C0001347|ACUTE PHASE REACTANTS
C0001367|ACYCLOVIR-CONTAINING PRODUCT
C0368608|ACYL CARNITINE
C1539289|ACYL-COA WAX ALCOHOL ACYLTRANSFERASE 2
C0001374|ACYL COENZYME A
C0026452|ACYLGLYCEROL LIPASE
C2937289|ADAPT
C0392673|ADAPTATION, NOS
C1451465|ADAPTER MOLECULE CRK
C0231193|ADAPTIVE
C1412442|ADAPTOR RELATED PROTEIN COMPLEX 2 SUBUNIT ALPHA 2
C0442796|ADDITIVES
C0596040|ADDUCT
C0001407|ADENINE
C1412217|ADENOSINE DEAMINASE RNA SPECIFIC B2 (INACTIVE)
C0001413|ADENOSINE PHOSPHATE
C0001443|ADENOSINE PRODUCT
C0815050|ADENOSINE RECEPTOR ANTAGONIST
C0101589|ADENOVIRUS E4 PROTEIN
C1510800|ADENOVIRUS VECTOR
C1412228|ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE 1
C0001492|ADENYL CYCLASE
C0001465|ADENYLIC ACID
C1510802|ADHERENCE
C0389071|ADIPONECTIN
C1540187|ADIPOQ GENE
C1540188|ADIPOR1 GENE
C1563743|ADIPOSITY
C1412181|A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 10
C1412207|A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 9
C0456081|ADJUSTMENTS
C0677850|ADJUVANT THERAPY
C0001554|ADMINISTRATION, MANAGEMENT
C0085751|ADMINISTRATOR
C0809949|ADMISSION
C0001593|ADOPTION, NOS
C0678209|ADOPTIVE IMMUNITY
C0523452|ADP
C0034783|ADRENERGIC RECEPTOR SITE
C0184591|ADULT DAY CENTER
C0277562|ADULT DISEASE, NOS
C0700597|ADULTHOOD
C0001675|ADULT HUMAN (21+)
C0683572|ADULT OFFSPRING
C0725066|ADVANCE
C0600371|ADVANCE CARE PLANNING
C0162574|ADVANCED GLYCATION END PRODUCTS
C3812151|ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR
C0877373|ADVANCED MALIGNANT NEOPLASM
C0205179|ADVANCED PHASE
C0877248|ADVERSE EVENT (AE)
C0559546|ADVERSE REACTIONS
C0850410|ADVICE/EDUCATION;NUTRITIONAL
C0001701|AEROBIC EXERCISES
C0392760|AFFECTING
C1510827|AFFINITY
C0814630|AFFORDABILITY
C0027567|AFRICAN RACE
C0338657|AGE-ASSOCIATED MEMORY IMPAIRMENT
C0699810|AGE DIFFERENCES
C1510828|AGE-MONTHS
C0450442|AGENT
C0206132|AGE OF ONSET
C0236848|AGE-RELATED COGNITIVE DECLINE
C0001787|AGE-RELATED OSTEOPOROSIS
C1510829|AGE-YEARS
C0001804|AGGLUTININS
C0205418|AGGREGATE
C0332621|AGGREGATION, NOS
C1510835|AGING-RELATED PROCESS
C0304518|AGLYCONE, NOS
C0001814|AGMATINE
C0242186|AGRAMMATISM
C0051028|AICA-RIBOTIDE
C1421876|AICDA GENE
C0740830|AIDS DEFINING ILLNESS
C1510837|AIRBORNE PARTICULATE MATTER
C0683901|AIRPLANE
C0001869|AIR POLLUTANTS
C0001873|AIR--POLLUTION
C0085623|AKINESIA
C1428707|AKT1 SUBSTRATE 1, PROLINE-RICH
C1515844|AKT SIGNALING PATHWAY
C0051078|ALA-ALA
C0051083|ALANYLPROLINE
C0702172|ALAR
C0336648|ALARMS
C0001924|ALBUMINS
C0001925|ALBUMINURIA
C0678478|ALCOHOL AND TOBACCO
C1412236|ALCOHOL DEHYDROGENASE 1B, CLASS I, BETA POLYPEPTIDE
C0001942|ALCOHOL DEHYDROGENASES
C0678361|ALCOHOL IMPAIRMENT
C0683723|ALCOHOL POLICY
C0001956|ALCOHOL USE DISORDER
C0684287|ALDEHYDE DEHYDROGENASE
C0001992|ALDEHYDES
C1412335|ALDH2 GENE
C1436327|ALDOSE REDUCTASE
C0002006|ALDOSTERONE PREPARATION
C0102118|ALENDRONATE
C0771311|ALENDRONIC ACID-CONTAINING PRODUCT
C0002028|ALGAE, NOS
C1706765|ALIGNMENT
C0281666|ALITRETINOIN-CONTAINING PRODUCT
C0002059|ALKALINE PHOSPHATASE (ALP)
C0002062|ALKALOIDS
C1412284|ALKYLGLYCERONE-PHOSPHATE SYNTHASE
C0102190|ALKYLGLYCEROPHOSPHOETHANOLAMINE PHOSPHODIESTERASE
C1424945|ALLANTOICASE
C1527304|ALLERGIC RESPONSE
C1412299|ALLOGRAFT INFLAMMATORY FACTOR 1
C1555794|ALLOPATHIC & OSTEOPATHIC PHYSICIANS; ORTHOPAEDIC SURGERY
C0002144|ALLOPURINOL-CONTAINING PRODUCT
C1720882|ALLOSTASIS
C0002151|ALLOXANUM / ALLOXAN
C0002190|ALPHA1 ANTICHYMOTRYPSIN
C1412376|ALPHA-1-MICROGLOBULIN/BIKUNIN PRECURSOR
C0391398|ALPHA-2A-ADRENERGIC RECEPTOR
C1412046|ALPHA-2-MACROGLOBULIN
C0002198|ALPHA2 MACROGLOBULIN
C1879648|ALPHA2 SIGNIFICANCE
C0051318|ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID (AMPA)
C0001641|ALPHA-BLOCKER
C1291208|ALPHA-KETOGLUTARATE
C0002287|ALPHA-LACTALBUMIN
C0002318|ALPHA-TUBULIN
C1515926|ALTERATION
C0332270|ALTERNATING
C1523987|ALTERNATIVE
C1527378|ALTERNATIVE MEDICINES
C0002345|ALTERNATIVE SPLICING
C0949216|ALTERNATIVE THERAPY
C0102840|ALUMINUM CHLORIDE-CONTAINING PRODUCT
C0206103|ALUMINUM COMPOUNDS
C0002371|ALUMINUM HYDROXIDE PRODUCT
C0473223|ALUMINUM INTOXICATION
C0202311|ALUMINUM MEASUREMENT, NOS
C0002367|ALUMINUM, NOS
C0051522|ALUMINUM SULPHATE
C1456623|ALZHEIMER'S CAREGIVERS
C3539026|ALZHEIMER'S DISEASE ASSESSMENT SCALE-COGNITIVE CDISC VERSION QUESTIONNAIRE
C3641947|ALZHEIMER'S DISEASE COOPERATIVE STUDY ACTIVITIES OF DAILY LIVING INVENTORY QUESTIONNAIRE
C0002403|AMANTADINE-CONTAINING PRODUCT
C0002421|AMBROXOL-CONTAINING PRODUCT
C0945826|AMBULATION
C0242876|AMBULATORY BLOOD PRESSURE MONITORING
C0430799|AMBULATORY EEG
C1704563|AMERICAN ACADEMY OF OSTEOPATHY
C0596070|AMERICAN ETHNICITY
C0002460|AMERICAN INDIANS
C0063517|A METHYLTRYPTAMINE
C0002482|AMIDES
C0002508|AMINES
C0002520|AMINO ACIDS
C1510863|AMINO-ARGININE
C0596072|AMINO GROUP
C1413031|AMINOPEPTIDASE O (PUTATIVE)
C0002570|AMINOPEPTIDASES
C0238622|AMISH
C0103045|AMISULPRIDE-CONTAINING PRODUCT
C0051696|AMLODIPINE-CONTAINING PRODUCT
C0002607|AMMONIA, NOS
C0002615|AMMONIUM CHLORIDE-CONTAINING PRODUCT
C1705760|AMORPHOUS, EOSINOPHILIC, AND ACELLULAR DEPOSIT
C0002644|AMOXAPINE-CONTAINING PRODUCT
C0072899|AMPA RECEPTOR
C0002680|AMPICILLIN-CONTAINING PRODUCT
C0051767|AMSONIC ACID
C1562561|AMYLIN ANALOG
C0002716|AMYLOID
C0169424|AMYLOID BETA 42 PEPTIDE
C0611285|AMYLOID BETA A4 PROTEIN
C1412467|AMYLOID BETA PRECURSOR LIKE PROTEIN 2
C1412460|AMYLOID BETA PRECURSOR PROTEIN BINDING FAMILY B MEMBER 2
C0078939|AMYLOID BETA-PROTEIN
C0475316|AMYLOID FIBRES
C1706803|AMYLOIDOGENESIS
C0002721|AMYLOID P COMPONENT
C0085151|AMYLOID PRECURSOR PROTEIN
C1456454|AMYLOID PROTEIN
C1098268|AN-1792
C0018149|ANAEROBIC GRAM-NEGATIVE BACTERIA
C0948482|ANALGESIC EFFECT
C0243071|ANALOG
C0936012|ANALYSIS
C0443354|ANALYTE
C0923870|ANATOMICAL LOCATION (PROPERTY)
C1515974|ANATOMIC SITE
C0887872|ANCHORING JUNCTION
C0814908|ANCOVA
C0085805|ANDROGEN-BINDING PROTEINS
C0279493|ANDROGEN THERAPY
C0002871|ANEMIA, UNSPECIFIED
C0002903|ANESTHESIA PROCEDURES
C0002930|ANESTHETICS
C0002976|ANGIOGENESIS FACTOR
C0302600|ANGIOGENIC PROCESS
C0051844|ANGIOGENIN
C1452534|ANGIOTENSIN-CONVERTING ENZYME
C0960880|ANGIOTENSIN-CONVERTING ENZYME 2
C0003015|ANGIOTENSIN-CONVERTING ENZYME INHIBITORS
C1422064|ANGIOTENSIN I-CONVERTING ENZYME 2
C0003009|ANGIOTENSIN II-CONTAINING PRODUCT
C0003012|ANGIOTENSIN III
C2713666|ANGIOTENSINOGEN
C0003017|ANGIOTENSINOGEN
C1439284|ANGIOTENSIN RECEPTOR 1
C0815017|ANGIOTENSIN RECEPTOR ANTAGONIST
C0034787|ANGIOTENSIN RECEPTOR SITE
C0003018|ANGIOTENSINS
C0599779|ANIMAL MODELS
C0440447|ANIMAL PROTEINS
C0003048|ANIMAL RESEARCH
C0683949|ANIMAL STUDY
C0229982|ANIMAL TISSUE, NOS
C1293089|ANIMAL TRIALS
C0003075|ANIONS
C0221278|ANISOCYTOSIS, RED CELLS
C0085406|ANISOTROPY
C1328319|ANKLE BRACHIAL PRESSURE INDEX
C1412404|ANKYRIN 3
C1412417|ANNEXIN A1
C0003123|ANOREXIA
C0234507|ANOSOGNOSIA
C0003134|ANSERINE
C1706817|ANSWER
C0003138|ANTACIDS
C0175190|ANTERIOR CINGULATE GYRUS
C0233795|ANTEROGRADE AMNESIA
C0003161|ANTHOCYANINS
C0003188|ANTHROPOMETRY
C0279492|ANTIANDROGEN THERAPY
C1624602|ANTIANTIBODY
C0051989|ANTIARRHYTHMIC PEPTIDE (AAP)
C0282556|ANTIASTHMATICS
C0279516|ANTIBACTERIAL DRUGS
C0003238|ANTIBIOTIC COMBINATIONS
C0003237|ANTIBIOTICS
C0003232|ANTIBIOTICS
C0201278|ANTIBODY MEASUREMENT, NOS
C0003241|ANTIBODY, NOS
C0003261|ANTIBODY PRODUCTION
C0474643|ANTIBODY TITRE
C0383429|ANTI-CD52 MONOCLONAL ANTIBODY
C0242896|ANTICHOLINERGICS
C0003281|ANTICOAGULATION TREATMENT
C0003286|ANTICONVULSIVE DRUGS
C1096649|ANTIDEPRESSANT THERAPY
C0003289|ANTIDEPRESSIVE AGENT
C0935929|ANTIDIABETIC AGENTS
C0003299|ANTIEPILEPTICS
C1148575|ANTIGEN BINDING
C0206431|ANTIGEN PRESENTATION
C0003315|ANTIGEN PRESENTING CELLS
C0585941|ANTIHYPERTENSIVE THERAPY
C0003242|ANTI-IDIOTYPIC ANTIBODIES
C0051979|ANTI-IMMUNOGLOBULIN G ANTIBODY
C0051980|ANTI-IMMUNOGLOBULIN M ANTIBODY
C0003209|ANTI-INFLAMMATORY DRUGS
C1096024|ANTIINFLAMMATORY THERAPY
C0003374|ANTIMALARIALS
C4084937|ANTIMICROBIAL PEPTIDE
C1412384|ANTI-MULLERIAN HORMONE
C1148564|ANTIOXIDANT ACTIVITY
C0003402|ANTIOXIDANTS
C0003405|ANTIPARKINSONISM DRUGS
C0701858|ANTIPERSPIRANTS
C0162595|ANTIPHOSPHOLIPID ANTIBODY
C0085826|ANTIPLATELET DRUG
C1096021|ANTIPLATELET THERAPY
C1548819|ANTIPSYCHOTIC MEDICATIONS
C0079925|ANTISENSE OLIGONUCLEOTIDES
C0080124|ANTISENSE-RNA
C0078977|ANTITRUST LAW
C0281481|ANTI-TUMOR NECROSIS FACTOR THERAPY
C0003451|ANTIVIRALS
C0718606|ANX
C0150135|ANXIETY REDUCTION
C0860603|ANXIETY SYMPTOMS
C0162871|AORTA ABDOMINALIS; ANEURYSM
C0085828|AP1 PROTEIN
C0489438|APACHE II SCORE
C1412457|APBA2 GENE
C1332100|APC REGULATOR OF WNT SIGNALING PATHWAY 2
C1332101|APEH GENE
C1538913|APH-1 HOMOLOG A, GAMMA-SECRETASE SUBUNIT
C0234461|APHASIC
C1181031|APICAL RAMUS OF TRUNK OF POSTERIOR SEGMENTAL ARTERY
C0912024|APIGENIN
C0201534|APLAB
C1861696|APOCRINE GLAND SECRETION, VARIATION IN
C3642141|APOE*4 ALLELE
C3642142|APOE GENE PRODUCT
C0003592|APOLIPOPROTEIN A
C4553379|APOLIPOPROTEIN(A)
C0085201|APOLIPOPROTEIN A-I
C1412469|APOLIPOPROTEIN A-II
C0855604|APOLIPOPROTEIN A-I INCREASED
C0003593|APOLIPOPROTEIN B
C0205666|APOLIPOPROTEIN B-100
C0052189|APOLIPOPROTEIN C-I
C0052191|APOLIPOPROTEIN C-III
C1412480|APOLIPOPROTEIN D
C0052193|APOLIPOPROTEIN D (APO-D)
C0003595|APOLIPOPROTEIN E
C0052198|APOLIPOPROTEIN E 2
C0052199|APOLIPOPROTEIN E3
C1412481|APOLIPOPROTEIN E GENE
C0443526|APOLIPOPROTEIN E ISOFORM
C1445865|APOLIPOPROTEIN GENE
C1412484|APOLIPOPROTEIN H
C0003591|APOLIPOPROTEINS
C0003601|APOPROTEIN
C0052190|APOPROTEIN C-II
C0219474|APOPTOSIS REGULATOR BAX
C1516044|APOPTOTIC
C0243111|APPARATUS
C0750489|APPARENT
C1364818|APP GENE
C1095830|APPLES
C1706839|APPLICABLE
C1947919|APPLICATION
C4281677|APPLICATION CONTEXT
C0185125|APPLICATION PROCEDURE
C2698172|APPLICATION PROGRAM INTERFACE
C1533134|APPLICATION - UNIT OF PRODUCT USAGE
C1705543|APP WT ALLELE
C0599013|APTAMER
C0003646|APTITUDE
C1332102|APURINIC/APYRIMIDINIC ENDODEOXYRIBONUCLEASE 1
C0109329|AQUAPORIN-1
C1412494|AQUAPORIN 4
C0292777|AQUAPORIN-4
C0282540|ARABS
C0733521|ARA-C
C0178485|ARACHIDONATE
C1412361|ARACHIDONATE 5-LIPOXYGENASE
C0003693|ARACHIDONATE 5-LIPOXYGENASE
C0003695|ARACHIDONIC ACID
C0001857|ARC
C0003737|ARCHITECTURE
C1551706|ARCTIC
C0205146|AREA
C0376690|AREA UNDER THE CURVE (AUC)
C0003753|ARECOLINE
C1412511|ARF6 GENE
C1367578|AR GENE
C0523503|ARGININE TEST
C0003779|ARGIPRESSIN
C0299792|ARIPIPRAZOLE-CONTAINING PRODUCT
C0001280|ARMED MACROPHAGE
C0772162|AROMATIC
C0301713|AROMATIC AMINO ACID, NOS
C0003808|AROUSAL
C1510941|ARRAY
C1706388|ARRAY FEATURE
C0172217|ARSENAL
C0003818|ARSENIC, NOS
C0052430|ARTEMISININ
C0429856|ARTERIAL FLOW
C0398345|ARTERIAL PERFUSION
C0599949|ARTERIAL STIFFNESS
C0878486|ARTERIOLOSCLEROSIS, NOS
C0003483|ARTERY, AORTA
C0002940|ARTERY; DILATATION
C1706852|ARTICLE
C0282379|ARUBA
C1427198|ARYLFORMAMIDASE
C1412544|ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR-LIKE PROTEIN
C0003942|ARYL SULFOTRANSFERASE
C0003940|ARYLSULPHATASES
C0003947|ASBESTOS, NOS
C0521059|ASCOMA
C0178487|ASCORBATE
C0337704|ASHKENAZI JEWISH RELIGION
C0003988|ASIAN AMERICANS
C0052506|ASIATICOSIDE
C0003944|'AS IF' PERSONALITY
C1826350|ASPARAGINYL-TRNA SYNTHETASE 2, MITOCHONDRIAL
C0085845|ASPARTATE (ASP)
C2239905|ASPARTIC PEPTIDASE, RETROVIRAL-LIKE 1
C0078989|ASPARTYL PROTEASE
C1879746|ASPECT
C0004057|ASPIRIN-CONTAINING PRODUCT
C1422219|ASPSCR1 TETHER FOR SLC2A4, UBX DOMAIN CONTAINING
C1510438|ASSAY TECHNIQUE
C1516048|ASSESSMENT
C1269765|ASSISTS
C1292726|ASSOCIATED DISORDER
C0521989|ASSOCIATED SYMPTOM
C0332281|ASSOCIATED WITH
C0596129|ASSOCIATION CORTEX
C2346866|ASSORTMENT
C0052565|ASTAXANTHINE
C0004093|ASTHENIA
C0004112|ASTROCYTES
C0521395|ASTROCYTIC
C0004114|ASTROCYTOMAS
C3887640|ASTROCYTOSIS
C0242688|ASTRONAUTS
C1424691|ASTROTACTIN 2
C0067385|ASYMMETRIC DIMETHYLARGININE
C1145759|ATAZANAVIR-CONTAINING PRODUCT
C1850554|ATELOSTEOGENESIS, TYPE II
C1412615|ATF1 GENE
C1412617|ATF4 GENE
C1412622|ATF6 GENE
C0238703|ATHLETES
C0919524|ATM SERINE/THREONINE KINASE
C0242849|ATOMIC FORCE MICROSCOPY
C0567415|ATOMS
C0002103|ATOPIC RHINITIS
C0286651|ATORVASTATIN-CONTAINING PRODUCT
C0001473|ATPASE
C1412689|ATPASE, CU(2+)-TRANSPORTING, BETA POLYPEPTIDE
C1412677|ATPASE H+ TRANSPORTING V1 SUBUNIT E1
C1412058|ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 1
C1412061|ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 2
C1412064|ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 5
C1412066|ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 7
C1412083|ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 9
C1412096|ATP-BINDING CASSETTE, SUBFAMILY G, MEMBER 1
C1332002|ATP BINDING CASSETTE SUBFAMILY G MEMBER 2 (JUNIOR BLOOD GROUP)
C1422254|ATP-BINDING CASSETTE, SUBFAMILY G, MEMBER 4
C0242738|ATP-BINDING CASSETTE TRANSPORTERS
C1433276|ATP-DEPENDENT DNA HELICASE Q4
C1423571|AT-RICH INTERACTION DOMAIN-CONTAINING PROTEIN 4B
C1337094|AT-RICH INTERACTIVE DOMAIN-CONTAINING PROTEIN 4B
C0333641|ATROPHY, NOS
C1332120|ATR SERINE/THREONINE KINASE
C1261512|ATTACK BEHAVIOR
C0052657|ATTAPULGITE
C0730261|ATTENDING CLINIC
C0004268|ATTENTION, NOS
C0599946|ATTENUATION
C1538298|ATXN1 GENE
C1538299|ATXN2 GENE
C0027481|A-TYPE NATRIURETIC PEPTIDE
C3537043|ATYPICAL ANTIPSYCHOTIC
C1276996|ATYPICAL ANTIPSYCHOTIC
C4055429|ATYPICALITY SCALE
C1266129|ATYPICAL LIPOMATOUS TUMOR
C0004302|AUDITORY PROJECTION AREA STRUCTURE
C0238711|AUSTRALIAN
C1510586|AUTISM SPECTRUM DISORDERS
C0004358|AUTOANTIBODY
C1272321|AUTOANTIBODY TEST
C0004359|AUTOANTIGEN
C0544711|AUTOFLUORESCENCE
C0443146|AUTOIMMUNE REACTIONS
C0004366|AUTOIMMUNE RESPONSE
C0004368|AUTOIMMUNITY
C0456979|AUTOMATED ENDODONTIC TECHNIQUE
C0518003|AUTONOMIC FUNCTION
C0544966|AUTOPHAGIC VACUOLE
C3887595|AUTOPHAGOSOME
C1825497|AUTOPHAGY RELATED 5
C0870182|AUTOSOME DISORDERS
C0596142|AUTOSOMES
C0470187|AVAILABILITY OF
C1510992|AVERAGE
C0330230|AVOCADO
C0870186|AVOIDANCE
C0234422|AWAKE
C1720052|AWAKENING
C3538806|AXIAL R
C0004461|AXON STRUCTURE
C0004462|AXOPLASMIC TRANSPORT, NOS
C0004475|AZACITIDINE-CONTAINING PRODUCT
C0004599|BACITRACIN, NOS
C0004610|BACTERIA IN THE BLOOD
C0003321|BACTERIAL ANTIGENS
C0085238|BACTERIAL GENOMES
C0004651|BACTERIOPHAGES
C0560184|BALANCE
C0452410|BALANCED DIET
C1563149|BALANCED LIGAMENTOUS TENSION TECHNIQUE
C0179199|BALANCES
C0025919|BALB/C MOUSE
C0442712|BALKE PROTOCOL
C1706910|BALL DEVICE
C0175723|BAND
C0422784|BANGLADESHI
C2698328|BAPINEUZUMAB
C0337728|BAPTIST RELIGION
C0949843|BARBERRY
C0206162|BAROREFLEXES
C1706912|BARRIER DEVICE
C1849718|BARTSOCAS-PAPAS SYNDROME
C0596155|BASAL CELL
C2331620|BASAL FOREBRAIN
C1705938|BASE
C0002055|BASE
C1158530|BASE EXCISION REPAIR
C0168634|BASELINE
C1442488|BASELINE
C0600436|BASE PAIR
C0337796|BASQUES
C0150141|BATHS
C3203003|BAYS
C1332371|BCL2-ASSOCIATED ATHANOGENE 1
C0812198|BCL2-ASSOCIATED X PROTEIN
C0376515|BCL2 GENE
C1332397|BCL2-LIKE 1
C4042483|BCL-2 PROTEIN
C1412761|BCL2-RELATED PROTEIN A1
C0812238|BCL3 TRANSCRIPTION COACTIVATOR
C3853697|BDNF/NT-3 GROWTH FACTORS RECEPTOR
C2987476|BE
C0004896|BEANS
C0451022|BECK DEPRESSION INVENTORY
C1453431|BECLIN-1
C0085281|BEHAVIOR ADDICTIVE
C0001807|BEHAVIOR AGGRESSIVE
C0004941|BEHAVIORAL SYMPTOMS
C0149623|BEHAVIOR DISTURBANCE
C4050216|BEHAVIOR RATING INVENTORY OF EXECUTIVE FUNCTION (BRIEF)
C0683444|BEHAVIOR TEST
C0004930|BEHAVIOUR DISORDER
C0004933|BEHAVIOUR MODIFICATION TECHNIQUE
C0337797|BELGIANS
C0814225|BENEFIT
C0770932|BENSERAZIDE HYDROCHLORIDE
C0005035|BENZBROMARONE-CONTAINING PRODUCT
C0005052|BENZO[A]PYRENE
C4048284|BENZODIAZEPINE, NOS
C0005064|BENZODIAZEPINES
C0205923|BENZODIAZEPINES--RECEPTORS
C0005068|BENZOFURAN
C0053258|BENZOYLECGONINE
C0053339|BERGENIN
C0005135|BERRY, NOS
C1826421|BESTROPHIN 1
C3888198|BESTROPHINOPATHY, AUTOSOMAL RECESSIVE
C0053358|BETA-2 GLYCOPROTEIN 1
C2827504|BETA AMYLOID 42 MEASUREMENT
C2825879|BETA AMYLOID MEASUREMENT
C0001645|BETA BLOCKING AGENTS
C0053396|BETA-CAROTENE PRODUCT
C0105770|BETA CATENIN
C0053407|BETADEX
C0005220|BETA-GALACTOSIDASE-CONTAINING PRODUCT
C0005304|BETAINE-CONTAINING PRODUCT
C0053518|BETAINE-HOMOCYSTEINE METHYLTRANSFERASE
C3899952|BETA ISOMER OF C-TERMINAL TELOPEPTIDE OF TYPE I COLLAGEN
C0005248|BETA-LACTOGLOBULIN
C1454853|BETA SECRETASE
C1569775|BETA-SECRETASE 1
C0162806|BETA SHEET
C1412727|BETA-SITE AMYLOID BETA A4 PRECURSOR PROTEIN-CLEAVING ENZYME 1
C1412728|BETA-SITE AMYLOID BETA A4 PRECURSOR PROTEIN-CLEAVING ENZYME 2
C0106127|BETA-SITOSTEROL
C0005290|BETA-TUBULIN
C0796392|BEVACIZUMAB-CONTAINING PRODUCT
C0005329|BEVERAGES
C0765273|BEXAROTENE-CONTAINING PRODUCT
C1101725|BEXTRA
C0004684|BHR
C1332410|BID GENE
C0936049|BILBERRY
C0005390|BILE ACIDS
C0005437|BILIRUBIN, TOTAL
C0166479|BILOBALIDE
C0179302|BINDERS
C0333909|BINUCLEATED CELL
C0005508|BIOAVAILABILITY
C0806069|BIOAVAILABLE ESTRADIOL
C0205474|BIOCHEMICAL
C0678659|BIOCHEMICAL MECHANISM
C1511130|BIOCHEMICAL PROCESS
C1511131|BIOCHEMICAL REACTIONS
C0430027|BIOCHEMICAL TEST
C0872110|BIOCHIP
C0005486|BIOENERGETICS
C0005492|BIOFLAVONOIDS
C2347023|BIOLOGICAL ABSORPTION
C0005507|BIOLOGICAL ASSAY
C2985526|BIOLOGICAL PROFILE
C0700276|BIOLOGICAL STRUCTURE
C1531518|BIOLOGICAL TREATMENT
C0005532|BIOLOGY
C0596177|BIOMATERIAL COMPATIBILITY
C0005537|BIOMECHANICS
C0005540|BIOMEDICAL RESEARCH
C0005553|BIOPHYSICS
C0005558|BIOPSY, NOS
C0677862|BIOPSY SPECIMEN
C0600364|BIOSENSORS
C2347026|BIOSPECIMEN
C0205184|BIPHASIC
C0005632|BISACODYL, NOS
C0178515|BISEXUAL
C0053800|BISPHENOL A-CONTAINING PRODUCT
C0453277|BLACKCURRANTS
C0005680|BLACKS
C0741548|BLADDER SYMPTOMS
C0179323|BLADES
C0335532|BLAST FURNACEMAN (ORE SMELTING)
C0078140|BLEOMYCIN/METHOTREXATE/VINCRISTINE
C0456909|BLIND VISION
C0229665|BLOOD, ARTERIAL
C0005854|BLOOD-BRAIN BARRIER
C1305865|BLOOD-BRAIN BARRIER
C0855915|BLOOD CAFFEINE
C0234562|BLOOD-CEREBROSPINAL FLUID BARRIER
C0005811|BLOOD FUNCTION
C0432616|BLOOD GROUP ANTIBODY A, NOS
C0596192|BLOOD LIPIDS
C0678863|BLOOD PRESSURE REGULATION
C0005832|BLOOD PROTEINS
C0178913|BLOOD SPECIMEN
C0005802|BLOOD SUGAR
C0003280|BLOOD THINNERS
C0005810|BLOOD TYPE
C0413399|BLOW
C0527443|BMP-2
C1155364|BMP RECEPTOR SIGNALING PATHWAY
C0005126|BMU
C1412812|BNIP3 GENE
C0972401|BOARDS
C0678854|BODY BALANCE
C0005885|BODY COMPOSITION
C0518026|BODY FAT PERCENTAGE
C0518010|BODY MASS
C0005893|BODY MASS INDEX (BMI)
C1305855|BODY MASS INDEX, NOS
C0005955|BONE MARROW CELLS
C1511246|BONE MARROW STEM CELL
C1412830|BONE MARROW STROMAL CELL ANTIGEN 1
C1612225|BONE MORPHOGENETIC PROTEIN 6
C0053932|BONE MORPHOGENETIC PROTEINS
C0450131|BONE MORPHOGENIC PROTEIN
C0005974|BONE RESORPTION, NOS
C0391978|BONY TISSUE, NOS
C0006002|BOOKS
C0020975|BOOSTER VACCINATION
C4049706|BORG CATEGORY-RATIO 10 PERCEIVED EXERTION SCORE 3
C0006024|BORNA DISEASE VIRUS
C0006034|BORRELIA BURGDORFERI
C1456557|BOTANICAL
C4085865|BOTHERED BY FORGETFULNESS
C0443158|BRAIN ACTIVITY
C0002708|BRAIN, AMYGDALOID BODY
C4551584|BRAIN; ATROPHY
C0740294|BRAIN BIOPSY
C0596208|BRAIN CELL
C1161311|BRAIN CIRCULATION
C0006110|BRAIN DEATH
C1332408|BRAIN-DERIVED NEUROTROPHIC FACTOR
C3486709|BRAIN-DERIVED NEUROTROPHIC FACTOR
C0107103|BRAIN DERIVED NEUROTROPHIC FACTOR (BDNF)
C1160340|BRAIN DEVELOPMENT
C0678908|BRAIN FUNCTION
C0751955|BRAIN INFARCTION
C0596215|BRAIN METABOLISM
C1113650|BRAIN MORPHOLOGY
C0006119|BRAIN PATHOLOGY
C1273723|BRAIN REGION
C0006121|BRAINSTEM STRUCTURE
C0870227|BRAIN STIMULATION
C0459385|BRAIN TISSUE STRUCTURE
C1113695|BRAIN VOLUME
C0002521|BRANCHED CHAIN AMINO ACIDS
C1412751|BRANCHED-CHAIN AMINOTRANSFERASE 1
C1253959|BRANCH OF
C0054028|BRASSICASTEROL
C0006137|BRAZIL
C0238815|BRAZILIAN
C0598034|BRCA2 GENE
C0443161|BREAKING DOWN
C0105421|BREAKPOINT CLUSTER REGION PROTEIN
C0376571|BREAST CANCER 1 GENE
C1843354|BREAST CANCER- AND SALIVARY GLAND-EXPRESSED GENE
C1451357|BREAST CANCER ANTI-ESTROGEN RESISTANCE PROTEIN 1
C0281189|BREAST CANCER PREVENTION
C0006147|BREAST FEEDING, NOS
C1332412|BRIDGING INTEGRATOR 1
C4085652|BRISTOL STOOL TYPE 2
C0596227|BRITISH
C0006217|BROMELIN
C0006222|BROMIDE SALT, NOS
C0282359|BROMSULPHALEIN (BSP)
C0997158|BROMUS SECALINUS WHOLE
C0004096|BRONCHITIC ASTHMA
C0337527|BROTHERS
C0452710|BROWN RICE
C1412828|BSG GENE
C0442010|BUCCAL
C0330394|BUCKWHEAT - CEREAL
C0006347|BUDGETS
C0718687|BUFFERED ASPIRIN-CONTAINING PRODUCT
C2986569|BUILDUP
C2828008|BURDEN
C0178525|BUTYROLACTONE
C1412756|BUTYRYLCHOLINESTERASE
C1704763|B VITAMIN
C0006041|BWA
C1846978|C1D NUCLEAR RECEPTOR COREPRESSOR
C4284286|C2 WT ALLELE
C0694598|CA1 FIELD
C0330498|CABBAGE
C0006628|CACODYLIC ACID
C0006632|CADMIUM, NOS
C0054433|CAFFEIC ACID
C0565793|CAFFEINATED COFFEE
C0948365|CAFFEINE CONSUMPTION
C0054444|CALBINDIN
C1413080|CALBINDIN 1
C1611184|CALCIFICATION OF CORONARY ARTERY
C1858663|CALCINEURIN-BINDING PROTEIN 1
C1562036|CALCINEURIN INHIBITORS
C1511479|CALCINEURIN SUBUNIT B TYPE 1
C0006669|CALCITONIN GENE RELATED PEPTIDE (CGRP)
C1367551|CALCITONIN RELATED POLYPEPTIDE ALPHA
C0006674|CALCITRIOL PREPARATION
C0006681|CALCIUM CARBONATE-CONTAINING PRODUCT
C0006684|CALCIUM CHANNEL BLOCKING AGENT, NOS
C0006685|CALCIUM CHANNELS
C0175895|CALCIUM DEPOSIT
C0596233|CALCIUM FLUX
C1539418|CALCIUM HOMEOSTASIS MODULATOR 1
C0489458|CALCIUM INTAKE
C0249742|CALCIUM RECEPTORS
C1413136|CALCIUM-SENSING RECEPTOR
C0600431|CALCIUM SIGNALING
C1096745|CALCIUM SUPPLEMENT THERAPY
C1456413|CALCIUM VOLTAGE-GATED CHANNEL SUBUNIT ALPHA1 A
C0002045|CALCULATED
C0870240|CALCULATOR
C1516147|CALENDAR
C1366910|CALMODULIN
C1425365|CALMODULIN-LIKE 5
C0006779|CALORIMETRY
C0006784|CALPAIN
C0054533|CALPAIN INHIBITOR
C3711669|CALRETININ
C0949852|CAMELLIA SINENSIS
C0452802|CAMEMBERT CHEESE
C0179533|CAMERAS
C0054560|CAMPESTEROL
C0238884|CANADIAN
C1516188|CANCER CONTROL
C0919437|CANCER GENES
C1516211|CANCER MODEL
C1516213|CANCER PATIENT
C0596244|CANCER RISK
C1516231|CANCER SURVIVOR
C0920425|CANCER TREATMENT
C4527371|CANDIDATE
C1332838|CANDIDATE DISEASE GENE
C0006863|CANNABIDIOL-CONTAINING PRODUCT
C1413555|CANNABINOID RECEPTOR 2
C0054594|CANNABINOID RECEPTORS
C0006864|CANNABINOIDS
C0936079|CANNABIS, NOS
C2698977|CAPABILITY
C1516240|CAPACITYQUANTITY
C1413109|CAPN1 GENE
C0006931|CAPSAICIN-CONTAINING PRODUCT
C3210186|CAPSAICIN (TOPICAL)
C1136102|CAPSID PROTEIN
C0006938|CAPTOPRIL-CONTAINING PRODUCT
C0006949|CARBAMAZEPINE PRODUCT
C0368836|CARBAMOYLPHOSPHATE SYNTHETASE
C0006961|CARBAMOYL PHOSPHATE SYNTHETASE 1
C0006972|CARBAZOCHROME-CONTAINING PRODUCT
C0006982|CARBIDOPA-CONTAINING PRODUCT
C0054696|CARBOHYDRATE DEFICIENT TRANSFERRIN (CDT)
C0489461|CARBOHYDRATE INTAKE
C1568156|CARBON C 11 PITTSBURGH COMPOUND B
C0007012|CARBON DIOXIDE, NOS
C1413052|CARBONIC ANHYDRASE IX
C0007018|CARBON MONOXIDE
C0007009|CARBON, NOS
C0178528|CARBOXYLATE
C1413336|CARBOXYL-ESTER LIPASE
C0007066|CARBOXYLIC ACIDS
C1707271|CARBOXY-TERMINAL AMINO ACID
C1335071|CARBOXY-TERMINAL DOMAIN RNA POLYMERASE II POLYPEPTIDE A SMALL PHOSPHATASE 2
C0596263|CARCINOGENESIS
C0678222|CARCINOMA OF BREAST
C1522601|CARDIAC
C0741923|CARDIAC EVENT
C0150496|CARDIAC MONITORING, NOS
C0262402|CARDIAC PROBLEM
C1096316|CARDIAC TROPONIN
C0428776|CARDIDX
C0315056|CARDIOBACTERIUM HOMINIS
C1531624|CARDIOEMBOLIC STROKE
C0007188|CARDIOLIPIN
C0175906|CARDIOLOGISTS
C2981722|CARDIORESPIRATORY FITNESS
C1320716|CARDIOVASCULAR EVENT
C0007220|CARDIOVASCULAR MEDICATIONS
C1301700|CARDIOVASCULAR MORBIDITY
C0741949|CARDIOVASCULAR PATHOLOGY
C0007227|CARDIOVASCULAR PHYSIOLOGY
C0587038|CARDIOVASCULAR THERAPY
C0007165|CARDOUT
C1947933|CARE
C0178534|CAREER
C1321223|CAREGIVER BEHAVIOR
C0870252|CAREGIVER BURDEN
C0516893|CAREGIVER EMOTIONAL HEALTH STATUS
C0085537|CAREGIVERS
C0250336|CARE PROTOCOL
C0729338|CARE PROVISION REGIMES
C1305660|CARER
C0333519|CARIES, NOS
C0150499|CARING
C0007258|CARNITINE
C0007267|CARNOSINE
C3495555|CARNOSINEMIA
C0007269|CAROTENES
C0741968|CAROTID
C0751633|CAROTID ARTERY PLAQUE
C0007272|CAROTID ARTERY STRUCTURE
C0577631|CAROTID ATHEROSCLEROTIC DISEASE
C0007271|CAROTINOID
C0449439|CARRIER STATUS
C0206243|CARRYING
C1707310|CASCADE DEVICE
C0007328|CASE-CONTROL STUDY
C0054845|CASEIN HYDROLYSATE
C0868928|CASES
C0534519|CASPASE-1
C1413131|CASPASE 14, APOPTOSIS-RELATED CYSTEINE PROTEASE
C0291573|CASPASE-3
C1437927|CASPASE-4
C1366513|CASPASE 4, APOPTOSIS-RELATED CYSTEINE PROTEASE
C0537969|CASPASE-7
C1332666|CASPASE 7, APOPTOSIS-RELATED CYSTEINE PROTEASE
C1567180|CASPASE-9
C1159825|CASPASE ACTIVATION
C1707312|CASPASE-DEPENDENT APOPTOSIS
C1516312|CASPASE INHIBITOR
C1151515|CATALASE ACTIVITY
C1553362|CATALONIAN
C0007382|CATALYSIS
C0175921|CATALYSTS
C0162594|CATALYTIC ANTIBODY
C0007413|CATECHOL
C3850446|CATECHOL O-METHYLTRANSFERASE
C0007407|CATECHOL-O-METHYLTRANSFERASE (COMT)
C0595267|CATECHOL-O-METHYLTRANSFERASE INHIBITOR-CONTAINING PRODUCT
C1564904|CATENINS
C0007428|CATHEPSIN
C0699919|CATHEPSIN B
C0007427|CATHEPSIN D
C0162563|CATHETER ABLATION
C0547070|CATHETER ABLATION
C0007447|CATIONS
C0015127|CAUSE
C1419916|CAVEOLAE-ASSOCIATED PROTEIN 2
C0887901|CAVEOLIN
C1527865|CAVEOLIN-1
C1510420|CAVITY, NOS
C1413154|CBR1 GENE
C1428360|CCAAT/ENHANCER-BINDING PROTEIN, ZETA
C0282552|CC CHEMOKINE
C1449159|C-C MOTIF CHEMOKINE 2
C0674299|C-C MOTIF CHEMOKINE 22
C1429582|C-C MOTIF CHEMOKINE 4
C1332708|CD22 MOLECULE
C1439292|CD33 MOLECULE
C3538723|CD34 MEASUREMENT
C1366645|CD36 MOLECULE
C3715135|CD38 EXPRESSING CELL COUNT
C1332712|CD44 MOLECULE (INDIAN BLOOD GROUP)
C1332714|CD4 MOLECULE
C0694872|CDH1 GENE
C1337110|CDH3 GENE
C1425696|CDK5 REGULATORY SUBUNIT-ASSOCIATED PROTEIN 2
C0751608|CDNA LIBRARY
C0887808|CDNA MICROARRAYS
C0919242|CDT
C0538927|CELECOXIB-CONTAINING PRODUCT
C0162610|C ELEGANS
C1326120|CELL ACTIVATION
C0007578|CELL ADHESION MOLECULES (CAM)
C0007585|CELL CULTURE PROCEDURE
C0007586|CELL CYCLE PATHWAY
C0243021|CELL CYCLE PROTEIN
C1155872|CELL CYCLE REGULATION PROCESS
C1824234|CELL CYCLE REGULATOR OF NONHOMOLOGOUS END JOINING
C0007587|CELL DEATH PROCESS
C0007589|CELL DIFFERENTIATION PROCESS
C0007590|CELL DIVISION PROCESS
C0007625|CELL-FREE SYSTEM
C0599732|CELL INJURY
C0007582|CELL INTERACTION
C0599733|CELL KILLING
C1611701|CELL MARKER
C1318444|CELL PHENOTYPE
C0882846|CELL POSITIVE FOR CD33 ANTIGEN
C0596290|CELL PROLIFERATION
C0007584|CELLS
C0007581|CELL SENESCENCE
C0007616|CELL SORTING
C0034800|CELL SURFACE RECEPTOR
C0040682|CELL TRANSFORMATION
C0007577|CELLULAR ADHESION
C0079613|CELLULAR ADOPTIVE IMMUNOTHERAPY
C0020966|CELLULAR IMMUNITY
C0085304|CELLULAR POLARITY
C0282636|CELLULAR RESPIRATION
C3825288|CELLULAR SIGNAL TRANSDUCTION
C1516373|CELLULAR STRESS
C0243092|CELLULAR STRUCTURES
C0302189|CELLULAR THERAPY
C0146283|CELLULAR TUMOR ANTIGEN P53
C0007620|CELL VIABILITY
C0007667|CENTENARIANS
C0935444|CENTERING
C0007670|CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC)
C0007673|CENTRAL AFRICAN REPUBLIC
C0004303|CENTRAL AUDITORY DYSFUNCTION
C0333763|CENTRAL CORES
C0594440|CENTRALLY ACTING ACETYLCHOLINESTERASE INHIBITOR-CONTAINING PRODUCT
C0683212|CENTRAL NERVOUS SYSTEM FUNCTION
C0444755|CENTRIFUGAL PUMP
C0007745|CERAMIDES
C0007758|CEREBELLAR ATAXIA, NOS
C0742034|CEREBELLAR FUNCTION
C0007763|CEREBELLAR NUCLEUS
C0007765|CEREBELLUM, NOS
C0085220|CEREBRAL AMYLOID ANGIOPATHY
C1861735|CEREBRAL AMYLOID ANGIOPATHY, ITM2B-RELATED, 2
C0235946|CEREBRAL ATROPHY
C0751587|CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY
C0428714|CEREBRAL BLOOD FLOW
C0007818|CEREBRAL CIRCULATION
C0234387|CEREBRAL DISORDER, NOS
C0456144|CEREBRAL DYSGENESIS
C0234386|CEREBRAL FUNCTION, NOS
C0007784|CEREBRAL HEMISPHERE HEMORRHAGE
C0354532|CEREBRAL VASODILATORS
C0055108|CEREBROLYSIN
C0394552|CEREBROSPINAL FLUID COLLECTION
C1278276|CEREBROSPINAL FLUID LACTATE MEASUREMENT
C1292530|CEREBROSPINAL FLUID SAMPLE
C0225992|CEREBROVASCULAR SYSTEM STRUCTURE
C0228174|CEREBRUM
C0528023|CERIVASTATIN-CONTAINING PRODUCT
C0062609|CEROTIC ACID
C0205423|CERTAINTY
C0007836|CERTIFIED
C0093437|CEVIMELINE-CONTAINING PRODUCT
C1413357|CFLAR GENE
C0085940|C-FOS GENE
C0805586|CHALLENGE
C0474414|CHALLENGING BEHAVIOUR
C0935616|CHAMBER
C0542299|CHANGE IN BEHAVIOR
C0870261|CHANNEL BLOCKERS
C0109272|CHAPERONIN 60
C0558269|CHAPLAINS
C0007952|CHARACTER
C1521970|CHARACTERISTIC
C1706211|CHARGE
C1424448|CHEK2 GENE
C0007974|CHELATING AGENTS
C0007090|CHEMICAL CARCINOGEN
C3272558|CHEMICAL OR TEXTUAL REFERENCE TO ACTUAL TEST OR PARAMETER
C2347609|CHEMICAL PROBE
C1320374|CHEMICAL RESTRAINT
C0596322|CHEMICAL STABILITY
C0220806|CHEMICAL SUBSTANCE
C0007991|CHEMICAL WARFARE AGENTS
C1337092|CHEMOKINE, CC MOTIF, LIGAND 2
C0282554|CHEMOKINES
C0008018|CHEMOTAXIS, NOS
C0003392|CHEMOTHERAPEUTICS
C0936039|CHERRY
C0742343|CHEST SYNDROME ACUTE
C1720589|CHI
C0264408|CHILDHOOD; ASTHMA
C0870268|CHILD MOLESTATION
C0008059|CHILDREN
C0008083|CHILDREN--MORTALITY
C4039583|CHIMERIC ANTIGEN RECEPTOR
C0008121|CHINESE AMERICANS
C1273412|CHINESE HERBAL MEDICINE
C0152035|CHINESE PEOPLE
C0008145|CHITINASE
C1413387|CHITINASE 3-LIKE 1
C0008107|CHL
C1413393|CHL1, MOUSE, HOMOLOG OF
C0085504|CHLAMYDOPHILA PNEUMONIAE
C0008190|CHLORELLA
C0008203|CHLORIDE SALT, NOS
C0008240|CHLOROGENIC ACID
C0008266|CHLOROPLASTS
C0008269|CHLOROQUINE-CONTAINING PRODUCT
C0008286|CHLORPROMAZINES
C1538456|CHMP FAMILY, MEMBER 2B
C1538460|CHMP FAMILY, MEMBER 5
C0085080|CHO CELLS
C0008299|CHOCOLATE
C0682100|CHOCTAW
C0008301|CHOKING
C0008356|CHOLERA TOXIN
C0008377|CHOLESTEROL
C1861617|CHOLESTEROL CRYSTALLIZATION INHIBITOR
C1261104|CHOLESTEROL CRYSTALS
C0008387|CHOLESTEROL ESTERS
C0055538|CHOLESTEROL ESTER TRANSFER PROTEIN
C0003277|CHOLESTEROL-LOWERING DRUG
C1156530|CHOLESTEROL METABOLISM
C0008381|CHOLESTEROL SIDE-CHAIN CLEAVAGE ENZYME, MITOCHONDRIAL
C1159709|CHOLESTEROL TRANSPORT
C4050214|CHOLESTERYL ESTER TRANSFER PROTEIN MEASUREMENT
C1413353|CHOLESTERYL ESTER TRANSFER PROTEIN, PLASMA
C0008407|CHOLINE ACETYLTRANSFERASE
C1538452|CHOLINE DEHYDROGENASE
C3542407|CHOLINE DEHYDROGENASE, MITOCHONDRIAL
C4082365|CHOLINE O-ACETYLTRANSFERASE
C1413376|CHOLINE O-ACETYLTRANSFERASE
C0008405|CHOLINE PREPARATION
C0599668|CHOLINERGIC
C2333949|CHOLINERGIC NEURON
C0034792|CHOLINERGIC RECEPTOR SITE
C0242893|CHOLINERGICS
C0684164|CHOLINERGIC SYSTEM
C0008425|CHOLINESTERASE INHIBITORS
C0556089|CHOLINE SUPPLEMENTATION
C0008466|CHONDROITIN SULPHATE
C2945739|CHOP
C0262212|CHOROIDAL FISSURE
C0600518|CHOROIDAL NEOVASCULARIZATION
C1328856|CHROMATIN IMMUNOPRECIPITATION
C1332742|CHROMATIN LICENSING AND DNA REPLICATION FACTOR 1
C1516509|CHROMATIN LOOP
C1156210|CHROMATIN REMODELING
C1295114|CHROMOGRANIN A MEASUREMENT
C1257806|CHROMOSOMAL INSTABILITY
C1327882|CHROMOSOME 1Q
C1428691|CHROMOSOME 9 OPEN READING FRAME 72
C0376628|CHROMOSOME BREAKAGE
C0333677|CHROMOSOME MOSAICISM
C0008651|CHROMOSOME PAIR 1
C0008652|CHROMOSOME PAIR 10
C0008653|CHROMOSOME PAIR 11
C0008658|CHROMOSOME PAIR 16
C0008660|CHROMOSOME PAIR 18
C0008661|CHROMOSOME PAIR 19
C0008662|CHROMOSOME PAIR 2
C0008664|CHROMOSOME PAIR 21
C0008666|CHROMOSOME PAIR 3
C0008670|CHROMOSOME PAIR 7
C0008633|CHROMOSOMES
C0598175|CHROMOSOME SEGREGATION
C1824833|CHROMOSOME X OPEN READING FRAME 56
C0205191|CHRONIC
C0751813|CHRONIC BRAIN INJURY
C0265116|CHRONIC CEREBRAL ISCHEMIA
C1290386|CHRONIC HEART DISEASE
C0342300|CHRONIC HYPERGLYCEMIA
C0008679|CHRONIC ILLNESS
C0151317|CHRONIC INFECTIOUS DISEASE
C1290886|CHRONIC INFLAMMATORY DISORDER
C0751249|CHRONIC INSOMNIA
C1263722|CHRONIC METABOLIC DISORDER
C0221388|CHRONIC NONALCOHOLIC LIVER DISEASE, NOS
C0221764|CHRONIC PSYCHOSIS
C0264220|CHRONIC RESPIRATORY DISEASE, NOS
C1510527|CHRONIC STRESS
C4082769|CHRONIC TRAUMATIC ENCEPHALOPATHY
C1135993|CHRONIC WASTING DISEASE
C0008717|CHRONOLOGY
C0443616|CHYLOMICRON REMNANTS
C0008742|CHYMOTRYPSIN PRODUCT
C0967376|CIALIS
C0007404|CIANIDANOL
C0239059|CIGARETTE SMOKE
C0700219|CIGARETTE SMOKING
C0694535|CIGARETTE USE
C0055729|CILOSTAZOL-CONTAINING PRODUCT
C0598179|CINGULATE CORTEX
C0008802|CINNAMON
C0813142|CIRCADIAN RHYTHM DISORDER
C0008810|CIRCADIAN RHYTHMS
C1551714|CIRCLE TRIBE
C4055233|CIRCULATING MICRORNA
C0005775|CIRCULATION
C3540512|CIRCUMFERENTIAL SUPRACRESTAL FIBEROTOMY
C1268666|CIRCUMSCRIBED LESION
C0055782|CIRCUMSPOROZOITE PROTEIN
C0233649|CIRCUMSTANTIALITY
C0072916|CISAPRIDE-CONTAINING PRODUCT
C1969088|CISD2 GENE
C0008845|CITALOPRAM-CONTAINING PRODUCT
C0552371|CITATION
C0682134|CITIZEN
C1413745|CITRATE SYNTHASE, MITOCHONDRIAL
C0008865|CITRUS, NOS
C0680413|CIVILIAN
C2986669|CLARIFY
C0005595|CLASS AVES
C0456387|CLASSES
C0009547|CLASSICAL COMPLEMENT PATHWAY
C0008902|CLASSIFIED
C4291659|CLASSIFIER
C0008905|CLATHRIN
C1413460|CLAUDIN 1
C1413469|CLAUDIN 2
C0815172|CLIENT CHARACTERISTICS
C0008942|CLIENTS
C0205210|CLINICAL
C0683325|CLINICAL ASPECTS
C4684590|CLINICAL BENEFIT
C4553154|CLINICAL INVESTIGATION
C1516615|CLINICAL MANAGEMENT
C4553328|CLINICAL OUTCOME ASSESSMENT (COA)
C0030667|CLINICAL PATHOLOGY
C0237412|CLINICAL PSYCHOLOGISTS
C0205563|CLINICAL STAGING
C0008972|CLINICAL STUDY
C1516634|CLINICAL TESTING
C1516635|CLINICAL TREATMENT
C0008976|CLINICAL TRIALS
C0871685|CLINICIANS
C0442592|CLINIC - WALK IN, OTHER
C1413503|CLOCK GENE
C1516671|CLONAL HEMATOPOIETIC STEM CELL
C0009013|CLONING
C0070166|CLOPIDOGREL-CONTAINING PRODUCT
C0185010|CLOSURE BY CLIP
C0009073|CLOTIAZEPAM
C0009079|CLOZAPINE-CONTAINING PRODUCT
C0221096|CLUB DEVICE
C1704332|CLUSTER
C0009085|CLUSTER ANALYSIS
C1413514|CLUSTERIN
C1453673|CLUSTERIN
C0383881|CLUSTER OF DIFFERENTIATION ANTIGEN (WORKSHOP) 17
C0079068|C-MYC
C1824763|CNBP GENE
C0007680|CNS AFFECTING DRUGS
C0742468|CNS LESION
C0876909|COACHES
C0006675|COAGULATION FACTOR IV
C1414498|COAGULATION FACTOR XI
C0441509|COAGULATION THERAPY
C0009137|COAL TAR PRODUCT
C0003492|COARCTATION OF THE AORTA
C0719394|COATED ASPIRIN
C0598180|COATED PIT
C0086024|COBALAMIN PREPARATION, NOS
C0009170|COCAINE PRODUCT
C0056060|COCONUT OIL
C0009210|COCOS NUCIFERA
C0009219|CODING
C0009221|CODON
C1707429|*COEFFICIENT
C0009235|COENZYMES
C0178555|COFACTOR
C0556160|COFFEE INTAKE
C0009237|COFFEE, NOS
C0265338|COFFIN-SIRIS SYNDROME
C0945984|COGNITION:BEHAVIOR
C0009240|COGNITIONS
C0945985|COGNITION:STATUS
C1516691|COGNITIVE
C0870300|COGNITIVE ASSESSMENT
C0679035|COGNITIVE DEVELOPMENT
C0004448|COGNITIVE FUNCTION: AWARENESS
C3899527|COGNITIVE INTERVENTION
C0683267|COGNITIVE LEARNING
C0871689|COGNITIVE PROCESSES
C0870302|COGNITIVE PROCESSING SPEED
C0150174|COGNITIVE STIMULATION
C0525041|COGNITIVE SYMPTOMS
C0599755|COHORT
C1824586|COILED-COIL DOMAIN-CONTAINING PROTEIN 62: CCDC62
C1413568|COILIN
C1449705|CO-IMMUNOPRECIPITATION
C0282116|COLLABORATION
C1567335|COLLAGENASE 3
C0009325|COLLAGEN PRODUCT
C1948058|COLLATERAL
C1423911|COLLECTIN SUBFAMILY MEMBER 12
C0557806|COLLEGES
C0337196|COLLISION
C3245499|COLOMBIA
C1553372|COLOMBIAN
C0009407|COLORIMETRY
C0009413|COLOSTRUM
C0009393|COLOURS
C1185738|COLUMN STRUCTURE
C0241845|COMBATIVE
C1331418|COMFORT
C0947611|COMMENT
C0870312|COMMITMENT
C0162859|COMMON CAROTID ARTERY STRUCTURE
C1521917|COMMON DATA ELEMENT (CDE)
C0009452|COMMUNICATION
C1705415|COMMUNICATION CONTACT
C0009462|COMMUNITY
C0587907|COMMUNITY CLINIC
C1275743|COMORBID CONDITIONS
C0009488|COMORBIDITY
C0009490|COMOROS ISLANDS
C0683941|COMPARATIVE ANALYSIS
C1707455|COMPARISON
C0242270|COMPASSION
C0152057|COMPENSATION (DEFENSE MECHANISM)
C0231186|COMPENSATORY
C0086035|COMPETENT
C0679932|COMPETITION
C0009546|COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY, NOS
C0006556|COMPLEMENTARY DNA (CDNA)
C0936077|COMPLEMENTARY THERAPY
C1571455|COMPLEMENT C3
C1538975|COMPLEMENT COMPONENT 1, Q SUBCOMPONENT-LIKE 1
C1412938|COMPLEMENT COMPONENT 2
C1412999|COMPLEMENT COMPONENT 4A
C1824180|COMPLEMENT COMPONENT 5A RECEPTOR 1
C0009499|COMPLEMENT COMPONENT C1, NOS
C0009506|COMPLEMENT COMPONENT C3, NOS
C0009517|COMPLEMENT COMPONENT C4A
C0009516|COMPLEMENT COMPONENT C4, NOS
C0301986|COMPLEMENT COMPONENT C5A
C0009519|COMPLEMENT COMPONENT C5, NOS
C0312743|COMPLEMENT COMPONENT, NOS
C1305959|COMPLEMENT FACTOR
C1538440|COMPLEMENT FACTOR H
C0009528|COMPLEMENT PATHWAY REGULATION
C0009498|COMPLEMENT PROTEIN
C0034793|COMPLEMENT RECEPTOR SITE
C0009552|COMPLEMENT RECEPTOR TYPE 1
C0312770|COMPLEMENT REGULATOR, NOS
C0301847|COMPLETE ANTIBODY
C0852733|COMPLETED SUICIDE
C1704241|COMPLEX
C0439855|COMPLEX
C1413670|COMPLEXIN 1
C1413671|COMPLEXIN 2
C0449432|COMPONENT
C0486616|COMPOSITION (PROPERTY)
C1880156|COMPREHENSIVE
C4050363|COMPREHENSIVE SCORE FOR FINANCIAL TOXICITY
C0728907|COMPRESSION
C2945640|COMPROMISE
C1880157|COMPUTATION
C1704861|COMPUTER PROGRAMMING OBJECT
C1135159|COMT GENE
C0009629|CONALBUMIN
C0004927|CONATION
C2985113|CONCENTRATED DISADVANTAGE
C3541951|CONCEPT MODEL DOMAIN
C0178566|CONCEPTS
C0006107|CONCUSSION, UNSPECIFIED
C0008855|CONDENSING ENZYME
C0034936|CONDITIONED RESPONSES
C4041558|CONE-ROD SYNAPTIC DISORDER, CONGENITAL NONPROGRESSIVE
C0233800|CONFABULATION
C0086047|CONFERENCE
C0009667|CONFIDENCE INTERVALS
C0558095|CONFIDENT
C1456348|CONFIRMATORY TECHNIQUE
C0750484|CONFIRMED
C0009671|CONFLICT (PSYCHOLOGY)
C0242842|CONFOCAL MICROSCOPY
C0009742|CONGO RED STAIN
C1136013|CONJUGATED ESTROGENS (EQUINE)
C1257880|CONJUGATED LINOLEIC ACIDS
C0449379|CONNECTION
C1707489|CONNECTIVITY
C0110611|CONNEXIN
C1266852|CONSANGUINITY
C0009789|CONSANGUINITY
C0870341|CONSCIENTIOUSNESS
C0234421|CONSCIOUS STATE
C1707491|CONSECUTIVE
C1554192|CONSENT
C0459914|CONSERVATIVE THERAPY
C0750591|CONSIDER
C0332290|CONSISTENT WITH
C1547014|*CONSTANT
C0729650|CONSTITUENTS
C0009813|CONSTRICTION
C2827421|CONSTRUCT
C0403066|CONSTRUCTION WORKERS
C0009818|CONSULTING WITH
C1707496|CONSUMER/CONCERNED CITIZEN
C0009830|CONSUMPTION OF GOODS
C0238690|CONTACT EXPOSURE TO ARSENIC
C0337246|CONTACT WITH MACHINERY, NOS
C0456205|CONTENTS
C0013626|CONTINUING EDUCATION
C0199451|CONTINUOUS POSITIVE AIRWAYS PRESSURE
C1140999|CONTRACTION, NOS
C1444657|CONTRAINDICATED
C0009928|CONTRAST SENSITIVITY
C0491298|CONTROL, HEMOGLOBIN
C2587213|CONTROLLING
C0680243|CONTROVERSY
C0750971|CONTUSION OF CEREBRUM
C0150095|CONVENIENCE SAMPLING
C2700387|CONVERGENCE
C0439836|CONVERSIONS
C0596382|COOPERATIVE STUDY
C0700114|COORDINATION
C1711307|COORDINATOR
C0086059|COPING SKILLS
C0860194|COPPER HIGH
C0009968|COPPER SUPPLEMENT
C1948062|COPY
C0444669|CORE
C1539125|CORIN, SERINE PEPTIDASE
C0737244|CORONA RADIATA
C0085532|CORONARY ANGIOGRAPHY, NOS
C0006629|CORPSE
C0175754|CORPUS CALLOSUM, AGENESIS OF
C0010097|CORPUS STRIATUM STRUCTURE
C1707520|CORRELATION
C0393570|CORTICOBASAL DEGENERATION
C0010124|CORTICOSTERONE
C0529997|CORTICOTROPIN-RELEASING FACTOR RECEPTOR 1
C0010132|CORTICOTROPIN-RELEASING HORMONE
C0010148|CORYNEBACTERIUM, NOS
C0010186|COST
C0010181|COST EFFECTIVENESS
C0162698|COST OF ILLNESS
C0010194|COTININE
C0814472|CO-TREATMENT
C0010197|COTTON SEED
C0010206|COUMARINIC ANHYDRIDE
C0679947|COUNSELLING;INDIVIDUAL
C0740209|COUNSELLING, UNSPECIFIED
C0750480|COUNT
C0454664|COUNTRY
C0079170|COUNTY
C1948027|COUPLE
C0010222|COUPLES
C0750729|COURSES
C0337580|COUSINS
C0180153|COVERS
C0007452|COW
C3827022|COWAT
C0056912|CPG DINUCLEOTIDE
C0282523|CPG ISLANDS
C1413694|CR1 GENE
C0998265|CRAB
C4048285|C-REACTIVE PROTEIN
C0006560|C-REACTIVE PROTEIN (CRP)
C0010286|CREATINE
C0010294|CREATININE
C0056471|CREATINOLFOSFATE
C1413702|CREB1 GENE
C1530423|CREB-BINDING PROTEIN
C0010306|CRETE
C1413709|CRHR1 GENE
C0010182|CRI
C0010317|CRIB
C0010331|CRIPPLED
C0231224|CRISIS, NOS
C0243161|CRITERION
C0010357|CROSS REACTION
C0562506|CROSSROADS
C0552389|CROSS-SECTION
C0010362|CROSS-SECTIONAL STUDY
C0427896|CRYSTAL - HUMAN MATERIAL
C0444626|CRYSTAL STRUCTURE
C0879468|CSF1R GENE
C0007809|CSF PRESSURE
C1536105|CT ANGIOGRAPHY
C1332804|CTSB GENE
C0412585|CT SCAN OF BRAIN
C1332805|CTSD GENE
C1413814|CTSG GENE
C1550244|CUFF
C0010453|CULTURE (ANTHROPOLOGICAL)
C0007635|CULTURED CELLS
C0007600|CULTURED CELLS
C1257811|CULTURED MILK
C0056301|CUPRIC SULFATE
C2347872|CUPROUS
C0180231|CUPS
C1273390|CURATIVE TREATMENT
C4086228|CURCUMINOID
C0010467|CURCUMIN STAIN
C2981734|CUSTOMER
C0543460|CUTTLEFISH, NOS
C0751956|CVA NOS ACUTE
C1332814|C-X3-C MOTIF CHEMOKINE LIGAND 1
C3812195|CXCL10
C1308752|C-X-C MOTIF CHEMOKINE 10
C1334126|CXCR2 GENE
C1332823|CXCR4 GENE
C0056650|CYANIDIN
C1047211|CYANOPHYTA
C4522312|CYCLASE-ASSOCIATED ACTIN CYTOSKELETON REGULATORY PROTEIN 1
C0001455|CYCLIC AMP
C0056695|CYCLIC AMP RESPONSE ELEMENT BINDING PROTEIN (CREB)
C0596399|CYCLIC COMPOUND
C0030957|CYCLIC PEPTIDES
C0079185|CYCLIN B
C1565306|CYCLIN-DEPENDENT KINASE 5
C0243045|CYCLIN-DEPENDENT KINASES
C1511572|CYCLING
C0079183|CYCLINS
C0010558|CYCLODEXTRINS
C0010572|CYCLOHEXIMIDE
C0389003|CYCLOOXYGENASE 1
C0387583|CYCLOOXYGENASE-2
C1257954|CYCLOOXYGENASE-2 INHIBITOR
C0085387|CYCLOOXYGENASE INHIBITORS
C0055162|CYCLOPHOSPHAMIDE/FLUOROURACIL/PREDNISONE
C0003805|CYP19
C0056849|CYPERMETHRIN
C0887457|CYSTAMINE DIHYDROCHLORIDE
C0010640|CYSTATHIONINE
C0071744|CYSTATIN C
C0010646|CYSTATINS
C0010656|CYSTEINE ENDOPEPTIDASE
C0010658|CYSTEINE PROTEINASES--INHIBITORS
C0675175|CYSTEINYL-LEUKOTRIENE
C0056889|CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) PROTEIN
C0149523|CYSTITIS; ACUTE
C0068899|CYTARABINE/MITOXANTRONE
C0069290|CYTARABINE/PREDNISONE/VINCRISTINE
C0010725|CYTIDINE DIPHOSPHATE CHOLINE
C1413844|CYTOCHROME B(-245), BETA SUBUNIT
C0010749|CYTOCHROME C
C4284184|CYTOCHROME C OXIDASE SUBUNIT 1
C1426584|CYTOCHROME C, SOMATIC
C0010760|CYTOCHROME OXIDASE
C1142644|CYTOCHROME P450 3A4
C0070319|CYTOCHROME P450 CYP2B1 ENZYME
C0057223|CYTOCHROME P450 CYP2D6 ENZYME
C3714798|CYTOCHROME P450 CYP3A4 ENZYME
C0010762|CYTOCHROME P450 ENZYME SYSTEM
C1413858|CYTOCHROME P450, FAMILY 17, SUBFAMILY A, POLYPEPTIDE 1
C1413861|CYTOCHROME P450, FAMILY 21, SUBFAMILY A, POLYPEPTIDE 2
C1413885|CYTOCHROME P450, FAMILY 46, SUBFAMILY A, POLYPEPTIDE 1
C1332828|CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19
C1332830|CYTOCHROME P450, SUBFAMILY IID, POLYPEPTIDE 6
C1413864|CYTOCHROME P450, SUBFAMILY XXVIIA, POLYPEPTIDE 1
C1325304|CYTOCHROMES
C0010798|CYTOCHROMES
C0008625|CYTOGENETIC ABNORMALITY
C1511612|CYTOKERATIN-14 STAINING METHOD
C1333196|CYTOKINE GENE
C1332762|CYTOKINE-INDUCIBLE SH2-CONTAINING PROTEIN
C1742862|CYTOKINE-INDUCIBLE SH2-CONTAINING PROTEIN
C0206552|CYTOKINE RECEPTOR
C1449195|CYTOKINE RECEPTOR COMMON SUBUNIT BETA
C0079189|CYTOKINES
C0010813|CYTOKINESIS
C0010815|CYTOKININS
C0369080|CYTOMEGALOVIRUS IGG ANTIBODY
C0010825|CYTOMEGALOVIRUS, NOS
C0180140|CYTOMETERS, MANUAL, DIFFERENTIAL
C0010834|CYTOPLASM
C0521449|CYTOPLASMIC
C1333198|CYTOPLASMIC PROTEIN
C0010843|CYTOSINE
C1511632|CYTOSKELETAL MODELING
C0010852|CYTOSKELETAL PROTEINS
C0010853|CYTOSKELETON
C1744635|CYTOSOLIC PHOSPHOLIPASE A2
C4521706|CYTOTOXIC
C0596402|CYTOTOXICITY
C0010868|CYTOTOXIN
C1529457|D(4) DOPAMINE RECEPTOR
C0663182|DACLIZUMAB-CONTAINING PRODUCT
C0871707|DAILY ACTIVITIES
C0969677|D-ALPHA-TOCOPHEROL
C0634829|DAPT
C0993637|DATABASES
C0150098|DATA SET
C1706074|DATA TABLE
C0057161|DAURICINE
C0541854|DAYTIME SLEEPINESS
C1539224|DCHS2 GENE
C0239162|DDT EXPOSURE
C1333261|DEACETYLASE
C0011053|DEAFNESS, NOS
C1413906|DEATH-ASSOCIATED PROTEIN KINASE 1
C1413908|DEATH-ASSOCIATED PROTEIN KINASE 3
C0007465|DEATH DIAGNOSIS
C0541030|DEATH DOMAIN-ASSOCIATED PROTEIN 6
C0870392|DEBATES
C1549464|DECEASED
C0679006|DECISION
C0049065|DECITABINE-CONTAINING PRODUCT
C0547047|DECREASE
C1295676|DECREASED INSULIN LEVEL
C1371714|DECREASED MELATONIN SECRETION
C0002793|DEDIFFERENTIATION
C0394162|DEEP BRAIN STIMULATION THERAPY
C1457869|DEFECT, NOS
C1880266|DEFENSE
C0057256|DEFENSINS
C0679190|DEFENSIVENESS
C0043832|DEFERIPRONE-CONTAINING PRODUCT
C0180309|DEFIBRILLATORS, EXTERNAL, AUTOMATED
C1392205|DEFICIENCY; CENTRAL NERVOUS SYSTEM
C2987487|DEFICIT
C0439544|DEFINITE
C1704788|DEFINITION
C0443196|DEFINITIVE
C0266449|DEFORMITY; BRAIN
C0154671|DEGENERATIVE BRAIN DISORDER
C1285162|DEGENERATIVE DISORDER
C0699900|DEGRADATION
C3539688|DEGS1 WT ALLELE
C0011177|DEHYDROASCORBIC ACID
C0011198|DELAWARE
C0205421|DELAYED
C1511760|DELETION MUTATION
C0011206|DELIRIUM, UNSPECIFIED
C0308779|DELIVER
C0140057|DELTA OPIOID RECEPTOR (DOR)
C0011251|DELUSIONAL DISORDERS
C0006895|DELUSIONAL MISIDENTIFICATION SYNDROME
C0441516|DEMAND
C0860630|DEMENTED
C0262687|DEMENTIA MANAGEMENT
C0451074|DEMENTIA RATING SCALE
C0683970|DEMOGRAPHIC CHARACTERISTICS
C0011298|DEMOGRAPHY
C1563732|DENDRIMERS
C0011306|DENDRITIC CELLS
C0872341|DENDRITIC SPINE APPARATUS
C0011307|DENERVATION - ACTION
C1511770|DENSE CONNECTIVE TISSUE
C0178587|DENSITY
C1265608|DENSITY, DECREASED
C0011343|DENTAL CEMENTUM
C0011365|DENTAL HEALTH SERVICE
C0011331|DENTAL TREATMENT
C1414174|DENTIN SIALOPHOSPHOPROTEIN
C0011443|DENTITION
C0011503|DEOXYGUANOSINE
C0444245|DEOXYRIBONUCLEIC ACID SAMPLE
C0086126|DEOXYTHYMIDINE
C1395184|DEPOLARIZATION
C0086130|DEPRENYL
C0679604|DEPRESSION SCALE
C0086133|DEPRESSIVE SYNDROME
C0205125|DEPTH
C1527240|DERIVATIVE
C1511780|DERIVATIVE CHROMOSOME
C1441547|DERIVED
C0162820|DERMATITIS; CONTACT, ALLERGIC
C0011624|DERMATOGLYPHICS
C0406778|DERMATOPATHIA PIGMENTOSA RETICULARIS
C0599871|DESATURASE
C0680043|DESCENT
C0678257|DESCRIPTION
C2983265|DESIGN
C0011684|DESIGNER DRUGS
C0011685|DESIPRAMINE-CONTAINING PRODUCT
C0871633|DESIRE
C0113218|DESMOGLEIN II
C1531217|DESMOPLAKIN
C0011710|DESOXYCORTONE
C0011529|DESOXYRIBONUCLEOTIDE
C1948029|DESTRUCTION
C0233520|DESTRUCTIVENESS
C0442726|DETECTED
C0868945|DETERIORATION
C0870407|DETERMINISM
C1180419|DETRUSOR
C1157996|DEUBIQUITINATION
C0282613|DEVELOPED COUNTRY
C0011750|DEVELOPING COUNTRY
C0008073|DEVELOPMENTAL DISORDER, NOS
C1511806|DEVELOPMENTAL PROCESS
C1522647|DEVELOPMENTAL THERAPEUTICS PROGRAM
C0699733|DEVICE, NOS
C0077973|DEXAMETHASONE/DOXORUBICIN/VINCRISTINE
C0011777|DEXAMETHASONE PREPARATION
C0565699|DEXTERITY
C0011816|DEXTROMETHORPHAN-CONTAINING PRODUCT
C1707730|DHEKELIA
C0011847|DIABETES
C0011849|DIABETES MELLITUS NOS DIAGNOSED
C0422587|DIABETES MONITORING CHECK DONE
C1171304|DIABETES RISK
C0241863|DIABETIC
C0025945|DIABETIC MICROANGIOPATHY
C0369114|DIACETATE
C0011900|DIAGNOSIS
C0598285|DIAGNOSTIC ACCURACY
C0524922|DIAGNOSTIC EQUIPMENT
C0358514|DIAGNOSTIC SUBSTANCE
C0086143|DIAGNOSTIC TESTS
C0011946|DIALYSIS THERAPY
C1301886|DIAMETER
C0008838|DIAMINEDICHLOROPLATINUM
C0521532|DIAPHRAGM MUSCLE WEAKNESS
C2750737|DIARRHEA 5, WITH TUFTING ENTEROPATHY, CONGENITAL
C0849784|DIARRHOEA;BACTERIAL
C0012000|DIASTOLE, NOS
C0520863|DIASTOLIC DYSFUNCTION
C0428883|DIASTOLIC PRESSURE
C0012010|DIAZEPAM PRODUCT
C1425932|DICARBONYL/L-XYLULOSE REDUCTASE
C0600203|DICHLOROACETIC ACID
C0011037|DICHLORODIPHENYLDICHLOROETHANE (DDD)
C0011038|DICHLORODIPHENYL DICHLOROETHYLENE (DDE)
C0011041|DICHLORODIPHENYLTRICHLOROETHANE
C0012091|DICLOFENAC-CONTAINING PRODUCT
C0012141|DIELDRIN
C0012151|DIESEL EXHAUST
C0008395|DIETARY CHOLESTEROL
C0425440|DIETARY FAT INTAKE
C0556106|DIETARY FIBRE SUPPLEMENTATION
C2348265|DIETARY FLAVONOID
C0086152|DIETARY HABITS
C1286104|DIETARY INTAKE
C0376520|DIETARY IRON
C0425424|DIETARY PROTEIN INTAKE
C0743195|DIET CONTROLLED
C0011134|DIETHYL TOLUAMIDE
C0086153|DIET MODIFICATIONS
C0012155|DIETS
C1705242|DIFFERENCE
C1705241|*DIFFERENCE
C0011906|DIFFERENTIAL DIAGNOSIS
C1511934|DIFFERENTIATING NEUROBLASTOMA
C0947509|DIFFICULTY CONCENTRATING
C0235162|DIFFICULTY SLEEPING
C0205219|DIFFUSE
C1265896|DIFFUSE ATROPHY
C3899378|DIFFUSION COEFFICIENT
C1136216|DIFFUSION MRI
C1537007|DIFFUSION TENSOR MRI
C0598801|DIFFUSION WEIGHTED MRI
C0012228|DIFLUNISAL-CONTAINING PRODUCT
C0012238|DIGESTIVE TRACT FUNCTION, NOS
C0582802|DIGIT STRUCTURE
C0220821|DIHYDROPYRIDINE
C0262967|DIHYDROSTREPTOMYCIN-CONTAINING PRODUCT
C0058129|DIHYDROXYACETONE SULFATE (DHAS)
C0596448|DIMER
C0376525|DIMERIZATION
C0301360|DIMETHOXYAMPHETAMINE (DMA)
C1413939|DIMETHYLARGININE DIMETHYLAMINOHYDROLASE 1
C0058217|DIMETHYL ETHER
C0058218|DIMETHYL FUMARATE-CONTAINING PRODUCT
C0012466|DINITROPHENOL
C0058347|DIOXYGEN
C0599874|DIOXYGENASE
C0012512|DIPEPTIDE
C1447020|DIPEPTIDYL PEPTIDASE 4
C0012515|DIPEPTIDYLPEPTIDE HYDROLASE
C0012544|DIPHOSPHONATES
C1825848|DIPHTHAMINE BIOSYNTHESIS 6
C0012559|DIPHTHERIA+TETANUS+PERTUSSIS VACCINE
C1947931|DIRECT
C4522152|DIRECTED BLOOD PRODUCT DONATION
C1550500|DIRECT TARGET
C2827624|DISABILITIES OF THE ARM SHOULDER AND HAND OUTCOME MEASURE
C0231170|DISABILITY, NOS
C0596452|DISABLING DISEASE
C0012611|DISACCHARIDES
C0237070|DISCIPLINE
C1880354|DISCONNECTION
C1444662|DISCONTINUED
C1880355|DISCOVER
C4553050|DISCREPANCY
C1290905|DISCREPANCY
C2987623|DISCRIMINATION
C0557061|DISCUSSION
C0595961|DIS-EASE
C0741975|DISEASE;CAROTID
C0560175|DISEASE CARRIER STATE
C0544688|DISEASE COMPLICATION
C0920467|DISEASE CONTROL
C0683509|DISEASE DETECTION
C0679238|DISEASE FACTOR
C0684309|DISEASE MODEL
C0007775|DISEASE (OR DISORDER); CEREBROVASCULAR, ARTERIOSCLEROTIC
C0679250|DISEASE OUTCOME
C0679698|DISEASE PREVENTION
C1511984|DISEASE QUALIFIER
C0012644|DISEASES--ANIMAL MODELS
C0699749|DISEASE STAGE
C3714751|DISEASE STEPS QUESTIONNAIRE
C1265875|DISINTEGRATION
C0900627|DISKS LARGE HOMOLOG 4
C0002726|DISORDER; AMYLOID
C0003469|DISORDER;ANXIETY
C0544464|DISORDER OF AGING
C0005940|DISORDER OF BONE, UNSPECIFIED
C0007222|DISORDER OF CARDIOVASCULAR SYSTEM
C0007273|DISORDER OF CAROTID ARTERY
C1956346|DISORDER OF CORONARY ARTERY
C0012634|DISORDERS
C0009782|DISORDERS OF CONNECTIVE TISSUE
C0332624|DISPERSION, NOS
C1705417|DISPLAY
C1414054|DISRUPTED IN SCHIZOPHRENIA 1
C0518083|DISRUPTED SLEEP
C0870433|DISSATISFACTION
C0002949|DISSECTION OF ARTERY
C0086168|DISSOCIATION - MENTAL DEFENSE MECHANISM
C0192440|DISTAL SUBTOTAL GASTRECTOMY
C0442750|DISTANCE VISION 6/6
C0442751|DISTANCE VISION 6/9
C0443203|DISTANT
C0233415|DISTRACTIBLE
C0180482|DISTRACTORS
C0231303|DISTRESS, NOS
C0424621|DISTRIBUTION OF BODY FAT
C2699787|DISTURBANCE
C0012771|DISULFIDES
C0012780|DITERPENES
C0012789|DITHIOTHREITOL
C0012798|DIURETICS
C0886883|DIVALPROEX SODIUM
C0443204|DIVERGENCE
C1880371|DIVERSITY
C0332849|DIVIDED
C1414057|DKK1 GENE
C1333226|DLG4 GENE
C0012403|DMSO
C0200898|DNA ANALYSIS, NOS
C0950398|DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE
C0140145|DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE
C1148673|DNA BINDING
C0012940|DNA-BINDING PROTEINS
C1143167|DNA DC TO DU-EDITING ENZYME APOBEC-3G
C0212694|DNA-DEPENDENT PROTEIN KINASE
C1504769|DNA FRAGMENTATION FACTOR SUBUNIT BETA
C0012860|DNA, INJURY TO
C1158478|DNA INTEGRATION
C1423023|DNAJ/HSP40 HOMOLOG, SUBFAMILY A, MEMBER 2
C1424111|DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 5
C0376452|DNA METHYLATION
C0012873|DNA METHYLTRANSFERASE
C1511682|DNA METHYLTRANSFERASE INHIBITORS
C0600596|DNA MICROARRAY CHIP
C0012854|DNA MOLECULE
C1310127|DNA POLYMERASE DELTA CATALYTIC SUBUNIT
C0012899|DNA, REPAIR
C0268134|DNA REPAIR DISORDER
C0162326|DNA SEQUENCE
C0058610|DNAS PROTEIN
C0872150|DNA STRAND BREAK
C0598312|DNA SYNTHESIS
C0376613|DNA VACCINES
C0011318|DNK
C1333242|DNMT3B GENE
C0012968|DOCOSAHEXAENOIC ACID
C0058624|DOCOSAPENTAENOIC ACID
C0566001|DOES COMMUNICATE
C0553654|DOES STEER
C0600108|DOES WALK
C0012984|DOG
C0004611|DOMAIN BACTERIA
C0683222|DOMINANT ALLELE
C0017342|DOMINANT GENES
C0013014|DOMINICAN REPUBLIC
C0527316|DONEPEZIL-CONTAINING PRODUCT
C0013018|DONOR
C1413916|DOPAMINE BETA-HYDROXYLASE, PLASMA
C0013032|DOPAMINE-BETA-MONOOXYGENASE
C0058698|DOPAMINE D2 RECEPTOR
C0282151|DOPAMINE HYDROCHLORIDE
C1154437|DOPAMINE METABOLISM
C0013030|DOPAMINE PREPARATION
C0242702|DOPAMINE RECEPTOR ANTAGONIST-CONTAINING PRODUCT
C0034798|DOPAMINE RECEPTOR SITE
C0013036|DOPAMINERGIC AGENTS
C0178601|DOPAMINERGIC DRUGS USED IN PARKINSONISM
C0114838|DOPAMINE TRANSPORTER (DAT) PROTEIN
C0596458|DORSAL MOTOR NUCLEUS
C4019080|DORSOLATERAL PREFRONTAL CORTEX
C2986497|DOSAGE
C0678790|DOSE-RESPONSE RELATIONSHIP
C0013072|DOUBLE-BLIND STUDY
C0870444|DOUBT
C0013081|DOWN-REGULATION
C0013089|DOXORUBICIN-CONTAINING PRODUCT
C0013090|DOXYCYCLINE-CONTAINING PRODUCT
C1366555|DPYD GENE
C0013113|DRAWING
C1333251|DRD2 1 ALLELE
C1333254|DRD4 GENE
C1413922|DREBRIN E
C0684271|DRINKING
C0452428|DRINKS
C4683688|DRIVEN
C0588437|DRIVING ASSESSMENT
C0870446|DRIVING BEHAVIOR
C0013135|DROPOUTS
C0013138|DROSOPHILA
C0013139|DROSOPHILA MELANOGASTER
C0006935|DRUG CAPSULE
C0013161|DRUG CARRIERS (PHARMACY)
C0683151|DRUG CLEARANCE
C0013162|DRUG COMBINATIONS
C0815266|DRUG COMPANY
C0085104|DRUG DELIVERY SYSTEMS
C0025516|DRUG DETOXIFICATION
C0872152|DRUG DEVELOPMENT
C4684648|DRUG DEVELOPMENT PROCESS
C0920472|DRUG DISCOVERY
C0743284|DRUG EXPOSURE
C0154327|DRUG-INDUCED DEMENTIA
C0683140|DRUG METABOLISM
C0683154|DRUG RESPONSE
C0678800|DRUG SAFETY
C0002932|DRUGS CAUSING LOSS OF SENSATION
C0694536|DRUG SEEKING BEHAVIOUR
C1154689|DRUG TRANSPORT PROCESS
C0242510|DRUG USE
C1260959|DRUSEN
C3542417|DSSOUT
C0520511|DSTRBN
C1824983|DTL GENE
C1554184|DUAL
C0700319|DUAL DIAGNOSIS
C1824986|DUAL OXIDASE MATURATION FACTOR 1
C1539317|DUAL-SPECIFICITY PHOSPHATASE 26
C3146286|DUE
C0205173|DUPLICATE
C0332597|DUPLICATION
C0013314|DURABLE MEDICAL EQUIPMENT
C0013313|DURA MATER STRUCTURE
C2826775|DURATION OF USE
C0347984|DURING
C1333257|DUSP1 GENE
C0679228|DXCRIT
C0870454|DYADS
C1539322|DYMECLIN
C1423548|DYNACTIN SUBUNIT 4
C1414119|DYNAMIN 1-LIKE
C1119970|DYNAMIN D100
C1414204|DYRK1A GENE
C0013363|DYSAUTONOMIA
C3658208|DYSBIOSIS
C0234979|DYSDIADOCHOKINESIS
C0262405|DYSFUNCTION; CEREBRAL
C0013384|DYSKINESIA
C0242339|DYSLIPIDEMIA
C0011304|DYSMYELINATION
C0235287|DYSOSMIA
C0233477|DYSPHORIC MOOD
C0700201|DYSSOMNIA, NOS
C1851920|DYSTONIA, DOPA-RESPONSIVE
C0010036|DYSTROPHY; CORNEA
C0333606|DYSTROPHY, NOS
C0002037|DZA
C0146462|E2F TRANSCRIPTION FACTOR FAMILY
C1311470|E3 UBIQUITIN-PROTEIN LIGASE PARKIN
C1279919|EARLY
C0680085|EARLY ADULTHOOD
C0010278|EARLY CLOSURE OF CRANIAL SUTURES
C0596473|EARLY DIAGNOSIS
C0814120|EARLY DISEASE ONSET
C0349530|EARLY GASTRIC CANCER
C1447045|EARLY GROWTH RESPONSE PROTEIN 1
C0814435|EARLY IDENTIFICATION
C0393706|EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY WITH SUPPRESSION BURSTS
C1266864|EATING HABIT
C0424421|EATING PROBLEM
C0392339|EATING ROUTINE
C1426003|EBF TRANSCRIPTION FACTOR 3
C0042172|E-CADHERIN
C1512163|ECONOMIC BURDEN
C0150099|ECONOMIC EVALUATION
C0699914|ECONOMIC SUPPLY
C0162358|ECOSYSTEM
C0012359|ECTASIA
C0013574|ECTODERM STRUCTURE
C1512167|ECTOPIC EXPRESSION
C1553373|ECUADORIAN
C0070694|EDARAVONE-CONTAINING PRODUCT
C2975435|EDOXABAN-CONTAINING PRODUCT
C0010478|EDUCATIONAL CURRICULUM
C0281163|EDUCATIONAL INTERVENTION
C0150562|EDUCATIONAL PROGRAMS
C0595938|EFFECT INCREASED
C1704419|EFFECTIVE
C1280519|EFFICACY
C0013682|EFFICIENCY
C0013687|EFFUSION, NOS
C1095795|EGB 761
C0556195|EGG INTAKE
C0013710|EGGS (EDIBLE)
C1414314|EGR1 GENE
C0299417|EICOSANOIC ACID
C0082226|EIF-5A-DEOXYHYPUSINE SYNTHASE
C0302131|EJECTION
C0489482|EJECTION FRACTION (EF)
C1567656|ELACRIDAR
C0142580|ELAFIN
C1414369|ELASTASE, NEUTROPHIL-EXPRESSED
C0013765|ELASTIN
C0230899|ELASTIN FIBER
C0524337|ELDERLY MAN
C0001792|ELDERLY PERSON, NOS
C0337037|ELECTRIC FIELD
C0013786|ELECTRIC STIMULATION
C0344434|ELECTROCARDIOGRAM: ATRIAL FIBRILLATION
C0013798|ELECTROCARDIOGRAM (EKG, ECG)
C0180600|ELECTROCARDIOGRAPHS
C0013812|ELECTRODES, (E.G., APNEA MONITOR), PER PAIR
C0151611|ELECTROENCEPHALOGRAM; ABNORMAL
C1304879|ELECTROENCEPHALOGRAPHIC MONITORING REGIME
C0013819|ELECTROENCEPHALOGRAPHY (EEG)
C0854632|ELECTROLYTE REPLACEMENT
C0013838|ELECTROMAGNETIC
C0013850|ELECTRONICS
C0026019|ELECTRON MICROSCOPY
C0013846|ELECTRON TRANSPORT
C0206691|ELECTROPORATION
C1705248|ELEMENT
C0013879|ELEMENT, CHEMICAL
C0449265|ELICITED BY
C1427926|ELL-ASSOCIATED FACTOR 2
C1427925|ELONGATION FACTOR RNA POLYMERASE II
C1610768|EMAPUNIL
C0007780|EMBOLISM; CEREBRAL ARTERY
C1414372|EMBRYONIC LETHAL, ABNORMAL VISION, DROSOPHILA, HOMOLOG-LIKE 2
C0920502|EMBRYONIC TISSUE
C0013935|EMBRYOS
C0013835|EMF
C0233929|EMISSION, NOS
C0849912|EMOTIONAL
C0001721|EMOTIONAL AFFECT
C0011546|EMOTIONAL DEPENDENCY
C0700361|EMOTIONAL DISTRESS
C0013985|EMOTIONAL DISTURBANCE
C0013987|EMOTIONS
C0013990|EMPHYSEMA, NOS
C0557351|EMPLOYED
C0599987|EMPLOYEE
C0014003|EMPLOYMENT
C0562342|EMPOWERED
C1880497|EMPTY
C0014025|ENALAPRIL-CONTAINING PRODUCT
C0006104|ENCEPHALON
C0014099|ENDARTERECTOMY OF CAROTID ARTERY
C1172779|ENDOCANNABINOID
C1568245|ENDOCRINE DISRUPTING COMPOUND
C3538926|ENDOCRINE SYSTEM FINDINGS DOMAIN
C0259863|ENDOCRINOLOGISTS
C0444746|ENDOCYTE
C0014139|ENDOCYTOTIC PROCESS
C0887883|ENDOCYTOTIC VESICLE
C0205227|ENDOGENOUS
C0011573|ENDOGENOUS; DEPRESSION
C0014175|ENDOMETRIOSIS, UNSPECIFIED
C1166837|ENDOPLASMIC RETICULUM CISTERN
C0014239|ENDOPLASMIC RETICULUM, NOS
C0014245|ENDOSCOPY PROCEDURE
C0034850|ENDOSOMES
C0225336|ENDOTHELIAL CELLS
C0856169|ENDOTHELIAL DYSFUNCTION
C1447747|ENDOTHELIAL LIPASE
C1414260|ENDOTHELIN 1
C0079281|ENDOTHELIN-1
C1414244|ENDOTHELIN-CONVERTING ENZYME 1
C0079284|ENDOTHELINS
C0014264|ENDOTOXINS
C0424589|ENERGY
C0597987|ENERGY BALANCE
C0542479|ENERGY IN PHYSICS
C0489460|ENERGY REQUIREMENT
C2945645|ENERGY SUPPLY
C0006080|ENGAGED IN BOXING
C0336924|ENGAGED IN CONTACT TYPE PHYSICAL SPORT
C2937292|ENGAGEMENT
C0086222|ENHANCER OF DNA TRANSCRIPTION
C0014298|ENKEPHALINS
C1414402|ENOLASE 1
C1414404|ENOLASE 2
C1414408|ENPP2 GENE
C1516879|ENROLLMENT
C0165921|ENTACAPONE-CONTAINING PRODUCT
C1269010|ENTIRE AORTIC ARCH
C1282826|ENTIRE ARTERIOLE
C1269881|ENTIRE BASILAR ARTERY
C0229960|ENTIRE BODY AS A WHOLE
C1266909|ENTIRE BONY SKELETON
C1278940|ENTIRE BRACHIAL ARTERY
C1269537|ENTIRE BRAIN
C1269580|ENTIRE CAUDATE NUCLEUS
C1289620|ENTIRE CENTRUM SEMIOVALE
C1284087|ENTIRE CEREBELLAR CORTEX
C1289511|ENTIRE CEREBRAL CINGULUM
C1283832|ENTIRE CEREBRAL VESSELS
C1284115|ENTIRE CEREBRAL WHITE MATTER
C1280704|ENTIRE CHOROID PLEXUS
C1281025|ENTIRE CINGULATE GYRUS
C1281361|ENTIRE CRIBRIFORM PLATE
C1281026|ENTIRE DENTATE GYRUS
C1289526|ENTIRE ENTORHINAL CORTEX
C1281591|ENTIRE FACE
C1281590|ENTIRE HEAD
C1284077|ENTIRE HIPPOCAMPUS
C1279075|ENTIRE HUMERUS
C1289512|ENTIRE INFERIOR LONGITUDINAL FASCICULUS
C1281016|ENTIRE INFERIOR TEMPORAL GYRUS
C1284114|ENTIRE INFRATENTORIAL BRAIN
C1281019|ENTIRE INSULA
C1280107|ENTIRE INTRACRANIAL ARTERY
C1282824|ENTIRE LARGE ARTERY
C1268982|ENTIRE LATERAL VENTRICLE
C1281955|ENTIRE LEFT FRONTAL LOBE
C1278590|ENTIRE LEFT INTERNAL CAROTID ARTERY
C1267299|ENTIRE LEFT MIDDLE CEREBRAL ARTERY
C1281971|ENTIRE LEFT TEMPORAL LOBE
C1280206|ENTIRE LENS CAPSULE
C1280090|ENTIRE LIMB
C1278911|ENTIRE LIP
C1269079|ENTIRE LOWER LIMB
C1280997|ENTIRE MIDBRAIN
C1269012|ENTIRE MIDDLE CEREBRAL ARTERY
C1281015|ENTIRE MIDDLE TEMPORAL GYRUS
C1280541|ENTIRE NERVE
C1269560|ENTIRE NERVOUS SYSTEM
C1281094|ENTIRE OLFACTORY BULB
C1282858|ENTIRE PERIVASCULAR SPACE
C1281335|ENTIRE PUTAMEN
C1283878|ENTIRE RENAL TUBULE
C1281954|ENTIRE RIGHT FRONTAL LOBE
C1278588|ENTIRE RIGHT INTERNAL CAROTID ARTERY
C1267298|ENTIRE RIGHT MIDDLE CEREBRAL ARTERY
C1281970|ENTIRE RIGHT TEMPORAL LOBE
C1278851|ENTIRE SCIATIC NERVE
C1282822|ENTIRE SMALL ARTERY
C1269578|ENTIRE SUBSTANTIA NIGRA
C1281008|ENTIRE SUPERIOR FRONTAL GYRUS
C1289509|ENTIRE SUPERIOR LONGITUDINAL FASCICULUS
C1281074|ENTIRE SUPERIOR TEMPORAL SULCUS
C1279118|ENTIRE TIBIA
C1280198|ENTIRE TRIGEMINAL GANGLION
C1280632|ENTIRE TRUNK
C1289510|ENTIRE UNCINATE FASCICULUS
C1282680|ENTIRE VIRCHOW-ROBIN SPACE
C1551338|ENTITY
C0014394|ENURESIS, NOS
C0007091|ENVIRONMENTAL CARCINOGEN
C0871974|ENVIRONMENTAL EFFECTS
C0456156|ENVIRONMENTAL EVENTS
C0871732|ENVIRONMENTAL STRESS
C3494751|ENVIRONMENT - ORIGIN
C0014406|ENVIRONMENTS
C0243102|ENZYME ACTIVITY
C2717977|ENZYME ASSAYS
C1333402|ENZYME GENE
C0086231|ENZYME IMMUNOASSAY TECHNIQUE
C1524081|ENZYME INHIBITION
C0014441|ENZYME-LINKED IMMUNOSORBENT ASSAY
C0920508|ENZYME LINKED IMMUNOSPOT ASSAY
C0014442|ENZYMES
C0596529|ENZYME SUBSTRATE COMPLEX
C0014440|ENZYME TESTS
C1880519|ENZYME UNIT
C1516314|ENZYMOLYSIS
C0520572|ENZYMOPATHY, NOS
C0538075|EOTAXIN-2
C0228092|EPENDYMAL CELL
C0014472|EPENDYMA OF NEURAXIS
C4284622|EPHA5 WT ALLELE
C0812262|EPHRIN RECEPTOR EPHA1
C1333338|EPHRIN RECEPTOR EPHA4
C1333340|EPHRIN RECEPTOR EPHB2
C1370509|EPHRIN TYPE-A RECEPTOR 1
C0121258|EPHRIN TYPE A RECEPTOR 3 (EPHA3)
C3849574|EPHRIN TYPE-B RECEPTOR 2
C0014507|EPIDEMIOLOGY
C0002783|EPIDEMIOLOGY RESEARCH
C0242275|EPIDERMAL GROWTH FACTOR
C1414313|EPIDERMAL GROWTH FACTOR RECEPTOR
C0034802|EPIDERMAL GROWTH FACTOR-UROGASTRONE RECEPTOR SITE
C0059438|EPIGALLOCATECHIN GALLATE
C1655731|EPIGENETICS
C1516924|EPIGENETICS
C0504096|EPIMYSIUM
C0349217|EPISODE; DEPRESSIVE
C0332189|EPISODES
C4552000|EPISODIC KINESIGENIC DYSKINESIA 1
C0561843|EPISODIC MEMORY
C0743553|EPISTASIS
C0014597|EPITHELIAL CELLS
C1523298|EPITHELIAL-TO-MESENCHYMAL TRANSITION
C1516506|EPITHELIUM OF CHOROID PLEXUS
C0003316|EPITOPE
C0242831|EPITOPE MAPPING
C3887850|EPOCH REGIMEN
C0014653|EQUILIBRIUM, NOS
C0014654|EQUILIN
C0276356|EQUINE INFLUENZA
C0205163|EQUIVALENT
C3810541|ER
C1414444|ERN1 GENE
C0743559|ERRORS
C1423697|ERYTHROBLAST MEMBRANE ASSOCIATED PROTEIN (SCIANNA BLOOD GROUP)
C0014780|ERYTHROCYTE MEMBRANES
C0014819|ERYTHROPOIESIS
C2976467|ERYTHROPOIETIN
C0014822|ERYTHROPOIETIN PRODUCT
C1552150|ES
C0870509|ESCAPE
C0014834|ESCHERICHIA COLI (E COLI) BACTERIA
C2742136|E-SELECTIN
C0002525|ESSENTIAL AMINO ACIDS
C0015686|ESSENTIAL FATTY ACIDS
C0750572|ESTIMATED
C0680844|ESTIMATION
C0401805|ESTIMATOR
C0014908|ESTONIA
C0059672|ESTROGEN BINDING PROTEIN
C0720298|ESTROGENIC
C1158342|ESTROGEN METABOLIC PROCESS
C1521863|ESTROGEN RECEPTOR
C1414461|ESTROGEN RECEPTOR 1
C0665341|ESTROGEN RECEPTOR ALPHA
C0529099|ESTROGEN RECEPTOR BETA
C1414462|ESTROGEN RECEPTOR BETA
C0752229|ESTROGEN RECEPTOR MODULATOR
C0239301|ESTROGEN USE
C0717758|ETANERCEPT-CONTAINING PRODUCT
C0014963|ETHACRYNIC ACID PRODUCT
C0086264|ETHICAL ISSUE
C0015011|ETHINYLOESTRADIOL PRODUCT
C0682076|ETHNIC DIFFERENCES
C0015031|ETHNICITY
C0059747|ETHYL ACETATE
C0001962|ETHYL ALCOHOL-CONTAINING PRODUCT
C0972314|ETORICOXIB-CONTAINING PRODUCT
C0812270|ETV3 GENE
C0684063|EUKARYOTES
C0015161|EUKARYOTIC CELLS
C1539341|EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 2
C1414326|EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3
C1414334|EUKARYOTIC TRANSLATION INITIATION FACTOR 2 SUBUNIT ALPHA
C1414351|EUKARYOTIC TRANSLATION INITIATION FACTOR 4E
C0683983|EUROPEAN AMERICAN
C0425355|EUROPEAN ORIGIN
C0015179|EUROPEAN UNION
C0015180|EUROPIUM
C0948853|EUTHYMIA
C0282171|EVENT-RELATED POTENTIALS
C0441471|EVENTS
C3541888|EVENTS
C0332181|EVERY YEAR
C3887511|EVIDENCE
C0332120|EVIDENCE OF
C0015219|EVOLUTION
C1444749|EXACERBATED
C0849872|EXAM;COMPLETE
C4321457|EXAMINATION
C0332128|EXAMINED FOR
C1707959|EXAMPLE
C1705847|EXCEPTION
C0694563|EXCESSIVE DAYTIME SOMNOLENCE
C0683357|EXCESSIVE; DRINKING
C1333356|EXCISION REPAIR, COMPLEMENTING DEFECTIVE, IN CHINESE HAMSTER, 2
C0235169|EXCITABILITY
C0549255|EXCITATION
C0295921|EXCITATORY AMINO ACID TRANSPORTER 2
C1516988|EXCITATORY SYNAPSE
C0332196|EXCLUDE
C0680251|EXCLUSION CRITERIA
C0504085|EXCRETION
C0221102|EXCRETORY PROCESS
C0589089|EXECUTIVE COGNITIVE FUNCTIONS
C2748208|EXECUTIVE DYSFUNCTION
C0935584|EXECUTIVE FUNCTION
C0871735|EXECUTIVES
C0167117|EXENATIDE-CONTAINING PRODUCT
C0239313|EXERCISE INDUCED
C1831738|EXERCISE INTERVENTION
C0015260|EXERCISE TOLERANCE TEST
C0178629|EXHAUST
C0015283|EXOCYTOSIS
C0205228|EXOGENOUS
C0015295|EXON
C0117059|EXOPEPTIDASE
C1539372|EXOSOME COMPONENT 10
C0679138|EXPECTATIONS
C0015316|EXPENDITURE
C0596545|EXPERIENCE
C0304229|EXPERIMENTAL DRUG, NOS
C0086272|EXPERIMENTAL MODEL
C2825142|EXPERIMENTAL RESULT
C0009932|EXPERIMENT CONTROLS
C0011065|EXPIRED
C0681841|EXPLANATION
C0561766|EXPLICIT MEMORY
C1280903|EXPLORATION PROCEDURE
C1704625|EXPOSURE DOMAIN
C0014412|EXPOSURE ENVIRONMENTAL
C0870527|EXPOSURE THERAPY
C0332157|EXPOSURE TO
C0003948|EXPOSURE TO ASBESTOS
C0302826|EXPRESSED EMOTION
C3854321|EXPRESSION
C1274025|EXTENDED FAMILY MEMBER
C0231448|EXTENSION
C1184148|EXTENSOR
C0152345|EXTERNAL CAPSULE
C0079321|EXTERNAL FIXATOR
C0521119|EXTRACELLULAR
C0015349|EXTRACELLULAR FLUID
C0079323|EXTRACELLULAR MATRIX PROTEINS
C1333498|EXTRACELLULAR PROTEIN
C0015353|EXTRA CHROMOSOMAL INHERITANCE
C4554138|EXTRACOMPARTMENTAL TUMOR
C2828366|EXTRACT
C0234133|EXTRAPYRAMIDAL SYMPTOMS
C0015382|EXTRAVERSION
C0205403|EXTREME
C0008520|EYE, CHOROID
C0314719|EYES DRY
C1366449|F2R GENE
C0871740|FACE PERCEPTION
C0870537|FACE RECOGNITION
C0015450|FACIAL
C1547538|FACILITY
C1521761|FACTOR
C1304558|FAGOPYRUM ESCULENTUM
C2911689|FAIR
C0150223|FALL PREVENTION
C1532976|FALL RISK ASSESSMENT
C0000921|FALLS (ACCIDENTS)
C0205237|FALSE
C1880718|FALSE ALARM
C1880720|FALSE DISCOVERY RATE
C0011394|FALSE TEETH
C0209227|FAMCICLOVIR PRODUCT
C0276496|FAMILIAL ALZHEIMER DISEASE
C1843013|FAMILIAL ALZHEIMER'S DISEASE, TYPE 3
C0694546|FAMILIAL HYPERLIPIDEMIA
C0600269|FAMILIARITY
C0949933|FAMILY BURSERACEAE
C0086279|FAMILY CAREGIVERS
C0003455|FAMILY FORMICIDAE
C0262479|FAMILY HISTORY RISK FACTORS
C0424909|FAMILY HISTORY WITH EXPLICIT CONTEXT PERTAINING TO FATHER
C0241889|FAMILY MEDICAL HISTORY
C0015576|FAMILY, NOS
C0199236|FAMILY STUDY
C1825236|FAMILY WITH SEQUENCE SIMILARITY 107 MEMBER B
C0216736|FANCONI ANEMIA GROUP C PROTEIN
C1425722|FAS APOPTOTIC INHIBITORY MOLECULE
C1539477|FAS GENE
C1539478|FAS LIGAND
C0428568|FASTING BLOOD GLUCOSE TEST
C0015663|FASTING STATE
C1366532|FASTK GENE
C0443214|FAT ABSORPTION
C0206042|FATAL FAMILIAL INSOMNIA
C0012171|FAT - DIETARY
C0015671|FATHERS
C0015677|FATS
C0259753|FAT SOLUBLE VITAMINS
C0812278|FAT TUMOR SUPPRESSOR, DROSOPHILA, HOMOLOG OF, 1
C1333527|FATTY ACID-BINDING PROTEIN 4
C1312696|FATTY ACID-BINDING PROTEIN, HEART
C0015684|FATTY ACIDS
C0333574|FATTY DEPOSITION, NOS
C0309049|FAVOR
C1422079|FBXO5 GENE
C0034805|FC RECEPTOR SITE
C3641247|FDG-POSITRON EMISSION TOMOGRAPHY
C0877040|FEAR OF FALLING
C0015730|FEASIBILITY STUDY
C0015744|FEEDBACK
C0085631|FEELING AGITATED
C0522165|FEELING OF RELAXATION
C1527305|FEELINGS
C0325089|FELIDS
C0007450|FELIS CATUS
C0015770|FELLOWSHIP
C0015799|FEMINIZED MALE
C1539533|FERM DOMAIN-CONTAINING PROTEIN 4A
C0015852|FERMENTATION
C1423716|FERMT2 GENE
C0015879|FERRITIN
C0007841|FERROXIDASE
C0015895|FERTILITY, NOS
C2343853|FESOTERODINE-CONTAINING PRODUCT
C0440731|FETAL BRAIN
C0002210|FETUIN
C0242291|FETUS
C0015965|FETUS
C0205388|FEW
C1304649|FIBER
C0012173|FIBER
C0225326|FIBER-CONTAINING PRODUCT
C1948066|FIBRIL
C1180307|FIBRILLAR ACTIN
C0004238|FIBRILLATION; ATRIAL OR AURICULAR
C0244756|FIBRILLIN-1 (FBN1)
C0225328|FIBRIL, NOS
C0016006|FIBRINOGEN
C0016017|FIBRINOLYSIS, NOS
C1333536|FIBROBLAST GROWTH FACTOR 1
C0962301|FIBROBLAST GROWTH FACTOR 23
C0380603|FIBROBLAST GROWTH FACTOR 2 (FGF-2)
C0527057|FIBROBLAST GROWTH FACTOR RECEPTOR 3
C0016055|FIBRONECTINS
C1185705|FIBROUS LAYER
C0016059|FIBROUS THICKENING
C1521738|FIELD
C0016094|FILING
C3889645|FINAL REPORT
C0149692|FINANCES
C1287361|FINDING OF FEMALE SEX HORMONES - SERUM LEVEL
C3539655|FINDINGS
C0562229|FINE MOTOR FUNCTIONS
C0556281|FINE MOTOR IMPAIRMENT
C0870564|FINGER TAPPING
C0337803|FINNS
C0218501|FIPRONIL
C0205233|FIRM
C1279901|FIRSTLY
C1273976|FIRST MYOCARDIAL INFARCTION
C3826338|FISHERY PRODUCTS
C0556216|FISH INTAKE
C0016163|FISH, NOS
C0948110|FISTULA; CEREBROSPINAL
C0011253|FIXED BELIEFS CONTRADICTED BY REALITY
C0729218|FK506
C1414627|FKBP PROLYL ISOMERASE 5
C0309093|FLAIR
C0016198|FLAME RETARDANTS
C0252912|FLAP ENDONUCLEASE 1
C0038925|FLAPS
C0016213|FLAVINS
C0060440|FLAVONE
C0016219|FLAVONE
C0596577|FLAVONOIDS
C0060444|FLAVONOL
C0242808|FLEXIBILITY
C4050619|FLEXIBILITY INDEX
C3714591|FLOOR
C2742211|FLORBETAPIR
C1414639|FLOTILLIN 2
C0806140|FLOW
C0016263|FLOW CYTOMETRY, NOS
C0330090|FLOWERS, NOS
C0231239|FLUCTUATION, NOS
C0870569|FLUENCY
C0016284|FLUID BALANCE
C0012621|FLUID DISCHARGE
C0429791|FLUIDS INTAKE
C0016315|FLUORESCENCE
C0597717|FLUORESCENCE RESONANCE ENERGY TRANSFER
C0037802|FLUORESCENCE SPECTROMETRY
C0242506|FLUORESCENCE SPECTROSCOPY
C0162789|FLUORESCENT IN SITU HYBRIDIZATION
C0026022|FLUORESCENT MICROSCOPY
C0016321|FLUORESCENT PROBES
C0303920|FLUORESCENT STAIN, NOS
C0016327|FLUORIDE SALT, NOS
C0598447|FLUOROPHORE
C0016365|FLUOXETINE-CONTAINING PRODUCT
C0016377|FLURBIPROFEN-CONTAINING PRODUCT
C0004239|FLUTTER;ATRIAL
C0082608|FLUVASTATIN-CONTAINING PRODUCT
C2348693|FLUX
C1565434|FOCAL ADHESION KINASE
C0059239|FOCAL ADHESION KINASE 1 (FAK-1)
C1265891|FOCAL ATROPHY
C0333542|FOCAL INFARCT
C0205234|FOCUS
C0016400|FOCUS GROUPS
C0178638|FOLATE
C0332462|FOLD, NOS
C0016412|FOLIC ACID DEFICIENCY DISEASE
C0564428|FOLIC ACID INTAKE
C1157079|FOLIC ACID METABOLIC PROCESS
C0556110|FOLIC ACID SUPPLEMENT AGENT
C1517284|FOLLICULAR B CELL LYMPHOMA OF THE MOUSE HEMATOLOGIC SYSTEM
C1522577|FOLLOW-UP
C3274571|FOLLOW-UP
C0016441|FOLLOW-UP STUDY
C0589121|FOLLOW-UP VISIT
C0420338|FOLLOW-UP VISIT IN ONE YEAR
C0729311|FOOD ANTIOXIDANT
C0003618|FOOD APPETITE, NOS
C2983605|FOOD CONSUMPTION
C0016502|FOOD INDUSTRY
C3494174|FOOD INSECURITY
C0013470|FOOD INTAKE
C0920297|FOOD PREPARATION
C0681562|FOOD PRODUCT
C0016517|FOOTBALL GAME
C1306036|FORCED EXPIRATORY VOLUME
C0598976|FOREIGN LANGUAGES
C0016542|FOREIGN MATERIAL
C0430449|FORENSIC EXAMINATION
C0020498|FORESTIER'S DISEASE
C0542476|FORGETFULNESS
C0598853|FORGETTING
C0016564|FORMALDEHYDE PRODUCT
C0016576|FORMIC ACID
C1539521|FORMIN 1
C0152334|FORNIX OF FOREBRAIN
C0070895|FOSCARNET-CONTAINING PRODUCT
C0596588|FOS FAMILY PROTEIN
C0016613|FOSSIL FUELS
C0016617|FOUNDATIONS
C0263541|FOUNDER
C0205450|FOUR
C0812250|FOXN3 GENE
C1333572|FOXO1 GENE
C0016640|FRACTIONATION
C1264633|FRACTIONS OF
C0015806|FRACTURE OF NECK OF FEMUR
C0016658|FRACTURE(S)
C0302113|FRAGILITY, NOS
C1708096|FRAGMENT
C0185061|FRAGMENTATION PROCEDURE, NOS
C0486805|FRAGMENTS
C0871754|FRAIL
C0079377|FRAIL ELDERLY
C4075886|FRAILTY INDEX
C0180979|FRAMES
C0596235|FREE CALCIUM
C0678591|FREE ENERGY
C1517312|FREE RADICAL FORMATION
C0079381|FREE RADICAL SCAVENGER
C0016693|FREE RADICALS (CHEMISTRY)
C0370097|FREE TRIIODOTHYRONINE
C0079382|FRIENDS
C0205123|FRONTAL
C1260405|FRONTAL DEMENTIA
C0149554|FRONTAL HORN
C0016733|FRONTAL LOBE STRUCTURE
C3496374|FRONTAL WHITE MATTER
C0338451|FRONTOTEMPORAL DEMENTIA
C0060765|FRUCTOSAMINE
C0016767|FRUIT
C1970415|FTO GENE
C1555016|FTP
C0388088|FTY720
C1550543|FULFILL
C0001288|FUNCTIONAL ABILITY
C3827007|FUNCTIONAL ACTIVITIES QUESTIONNAIRE
C0558024|FUNCTIONAL BEHAVIOURAL ASSESSMENT
C0333234|FUNCTIONAL CONGESTION
C0872173|FUNCTIONAL DISABILITY
C0278372|FUNCTIONAL EVALUATION
C0598132|FUNCTIONAL GROUP
C0940836|FUNCTIONAL MEASUREMENT
C0581601|FUNCTIONAL MODIFICATION
C0376335|FUNCTIONAL MRI
C0598463|FUNCTIONAL STATUS
C4552744|FUNCTIONS
C0542341|FUNCTIONS
C0243098|FUNDING
C0740422|FUNDUS
C0016829|FUNGAL PROTEINS
C0016832|FUNGUS, NOS
C0287990|FURIN
C0332466|FUSION, NOS
C1293131|FUSION PROCEDURE
C0162768|FUSION PROTEIN-CONTAINING PRODUCT
C0016884|FUTURE
C3714541|FVC
C0812303|FYN PROTO-ONCOGENE, SRC FAMILY TYROSINE KINASE
C0060926|GABAPENTIN-CONTAINING PRODUCT
C0206518|GABA--RECEPTORS
C1517378|GAIN
C1510417|GAIT APRAXIA
C0744248|GAIT FUNCTIONAL
C2009910|GAIT SPEED
C0016928|GAIT TYPE
C0060993|GALANIN
C0016967|GALANTHAMINE
C0607430|GALECTIN
C0245382|GALECTIN-3
C0016976|GALLBLADDER STRUCTURE
C0016979|GALLIC ACID
C0008350|GALLSTONE(S)
C1333658|GALR2 GENE
C0150593|GAMES
C0016904|GAMMA-AMINOBUTYRIC ACID (GABA)
C1422662|GAMMA-AMINOBUTYRIC ACID TYPE A RECEPTOR THETA SUBUNIT
C1412791|GAMMA-CARBOXYGLUTAMIC ACID PROTEIN, BONE
C0017011|GAMMA RAYS
C0379528|GAMMA SECRETASE
C2678557|GAMMA-SECRETASE-ACTIVATING PROTEIN
C0017066|GANCICLOVIR PRODUCT
C0017082|GANGLIOSIDES
C2982066|GANTENERUMAB
C3887622|GAP
C0335454|GARDENERS
C0868963|GARDENING
C1009574|GARDEN MUM
C0008555|GAS CHROMATOGRAPHY MEASUREMENT, NOS
C0017110|GAS, NOS
C0017119|GASTRIC ACID
C1517454|GASTRIC TISSUE
C0017182|GASTROINTESTINAL HORMONES
C1427996|GASTROKINE 1
C0559221|GASTROSTOMY FEEDING
C1435727|GASTROTROPIN
C3539624|GATA-TYPE ZINC FINGER PROTEIN 1
C1398078|GAUCHER'S
C3537453|GBA WT ALLELE
C0024868|GC/MS
C1457885|GDNF FAMILY RECEPTOR ALPHA-2
C0172537|GELATINASE-A (MMP-2)
C0017237|GELATIN PRODUCT
C0061179|GELDANAMYCIN
C0596607|GEL ELECTROPHORESIS
C0017243|GELS (PHARMACY)
C0079399|GENDER
C0017255|GENE ACTIVATION
C0017258|GENE CLUSTER
C1442161|GENE DELETION ABNORMALITY
C0017260|GENE DELETION MUTATION
C0178655|GENE DOSAGE
C0596609|GENE-ENVIRONMENT INTERACTION
C0017262|GENE EXPRESSION
C1517488|GENE FAMILY
C0596610|GENE INTERACTION
C0596611|GENE MUTATION
C0678951|GENE POLYMORPHISM
C0002915|GENERAL ANESTHETIC
C0017302|GENERAL ANESTHETICS
C3714634|GENERAL BODY FUNCTION
C0424575|GENERAL HEALTH
C0451182|GENERAL HEALTH QUESTIONNAIRE
C0020008|GENERAL HOSPITAL
C4684594|GENERALIZABILITY
C0205246|GENERALIZED
C0270549|GENERALIZED; ANXIETY DISORDER
C0683971|GENERAL POPULATION
C0086343|GENERAL PRACTICE
C0079411|GENERATION
C0085155|GENERIC DRUGS
C0017337|GENES
C1708225|GENE SIGNATURE
C0598496|GENE SILENCING
C0017296|GENETIC
C0314603|GENETIC
C0002085|GENETIC ALLELES
C0796344|GENETIC ANALYSIS
C0007294|GENETIC DISORDER CARRIER
C0017261|GENETIC DUPLICATION PROCESS
C0014290|GENETIC ENHANCER ELEMENT
C0242960|GENETIC HETEROGENEITY
C0178659|GENETIC MANIPULATION
C0033413|GENETIC PROMOTOR REGION
C0017263|GENETIC REGULATION
C1517512|GENETIC RISK
C0017398|GENETICS
C0036576|GENETIC SELECTION
C1136352|GENETIC STRUCTURE
C0314657|GENETIC SUSCEPTIBILITY
C0678922|GENETIC TRAIT
C0061202|GENISTEIN
C0729552|GENITAL INFECTION
C0017428|GENOMES
C0919532|GENOMIC INSTABILITY
C2986505|GENOMIC PROFILE
C0887950|GENOMICS RESEARCH
C0598309|GENOTOXICITY
C1257899|GENOTOXIC STRESS
C0017431|GENOTYPES
C1285573|GENOTYPING
C3854019|GENTAMICINS
C1265549|GENUS CAPRA
C0017446|GEOGRAPHIC SITE
C0017462|GERBILS
C0451184|GERIATRIC DEPRESSION SCALE QUESTIONNAIRE
C0870602|GERIATRIC PATIENTS
C0017469|GERIATRICS
C0017463|GERIATRIC SCREENING
C0586872|GERONTOLOGISTS
C0424015|GETTING LOST
C1333672|GFRA2 GENE
C0017040|GGTP
C0000503|GHB
C0911014|GHRELIN
C3539617|GI
C0061267|GINGEROL
C0330206|GINKGO BILOBA PLANT
C0772125|GINKGO BILOBA PREPARATION
C1119918|GINSENG PRODUCT
C0061278|GINSENOSIDES
C1333675|GIPR GENE
C0870604|GIRL
C1550718|GIVEN
C0289884|GLATIRAMER ACETATE
C0207072|GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR (GDNF)
C1512195|GLIAL DIFFERENTIATION
C0017626|GLIAL FILAMENT
C0017638|GLIOMA; UNSPECIFIED SITE
C0017639|GLIOSIS, NOS
C0935987|GLIVEC
C0281858|GLOBAL ASSESSMENT
C1510610|GLOBALIZATION
C0017645|GLOBIN
C0178663|GLOBULAR PROTEIN
C0232809|GLOMERULAR FILTRATION, NOS
C0017654|GLOMERULAR FILTRATION RATE, NOS
C0772088|GLUCAGON
C0014361|GLUCAGON-LIKE PEPTIDE
C0061355|GLUCAGON-LIKE PEPTIDE 1
C1415105|GLUCAGON-LIKE PEPTIDE 1 RECEPTOR
C0034809|GLUCOCORTICOIDS--RECEPTORS
C3272933|GLUCOSE CLEARANCE MEASUREMENT
C0596620|GLUCOSE METABOLISM
C1257958|GLUCOSE METABOLISM DISORDERS
C0017757|GLUCOSEPHOSPHATE DEHYDROGENASE
C0017725|GLUCOSE PRODUCT
C0178666|GLUCOSE TRANSPORT
C0017742|GLUCOSE TRANSPORTER
C1159527|GLUCOSE UPTAKE
C0017765|GLUCOSIDES
C0017768|GLUCOSYLCERAMIDASE
C1414998|GLUCOSYLCERAMIDASE BETA
C0017770|GLUCOSYLCERAMIDE
C0017780|GLUE
C0220839|GLUTAMATE
C0017789|GLUTAMATE
C1415119|GLUTAMATE-AMMONIA LIGASE
C0067685|GLUTAMATE CARBOXYPEPTIDASE II
C1414925|GLUTAMATE DECARBOXYLASE 1
C0017786|GLUTAMATE DEHYDROGENASE, NOS
C0242910|GLUTAMATE RECEPTOR ANTAGONIST-CONTAINING PRODUCT
C1415287|GLUTAMATE RECEPTOR, IONOTROPIC, AMPA 1
C1415288|GLUTAMATE RECEPTOR, IONOTROPIC, AMPA 2
C1424528|GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE 3A
C1415303|GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE, ASSOCIATED PROTEIN
C0061465|GLUTAMATE RECEPTORS
C0061467|GLUTAMATE TRANSPORTER
C0004002|GLUTAMIC-OXALOACETIC TRANSAMINASE
C0001899|GLUTAMIC-PYRUVIC TRANSAMINASE
C0017801|GLUTAMINE SYNTHETASE
C0245636|GLUTAMINYL-TRNA CYCLOTRANSFERASE
C0061506|GLUTARIC ACID
C0017817|GLUTATHIONE, NOS
C0017822|GLUTATHIONE PEROXIDASE
C0017824|GLUTATHIONE REDUCTASE (NAD(P)H)
C1421933|GLUTATHIONE S-TRANSFERASE, OMEGA-1
C1427885|GLUTATHIONE S-TRANSFERASE, OMEGA-2
C0017837|GLUTATHIONE TRANSFERASE
C0061700|GLYCATED ALBUMIN
C0598528|GLYCATION
C1136206|GLYCEMIC INDEX
C0017854|GLYCERALDEHYDE
C1414968|GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE
C0017889|GLYCEROPHOSPHORYLCHOLINE
C0017890|GLYCINE PRODUCT
C0017911|GLYCOGEN, NOS
C1415377|GLYCOGEN SYNTHASE 1
C0017932|GLYCOGEN SYNTHETASE
C0017952|GLYCOLYSIS
C0017968|GLYCOPROTEINS
C0017970|GLYCOPYRROLATE
C0017976|GLYCOSIDASES
C0017977|GLYCOSIDES
C0017978|GLYCOSPHINGOLIPIDS
C0017853|GLYCOSYLATED HEMOGLOBIN
C0017982|GLYCOSYLATION
C1414988|GLYCYL-TRNA SYNTHETASE
C0017992|GLYOXAL
C0268274|GM2 GANGLIOSIDOSIS, UNSPECIFIED
C0150598|GOAL SETTING
C1510458|GOATS
C1424728|GOLGI-ASSOCIATED, GAMMA-ADAPTIN EAR-CONTAINING, ARF-BINDING PROTEIN 3
C0018042|GOLGI COMPLEX, NOS
C0301819|GONADAL HORMONES
C0034811|GONADOLIBERIN RECEPTOR SITE
C0205170|GOOD
C1415181|GOT1 GENE
C0018099|GOUT, UNSPECIFIED, SITE UNSPECIFIED
C0018104|GOVERNMENT
C1333690|GPI GENE
C1415223|G PROTEIN-COUPLED ESTROGEN RECEPTOR 1
C1415206|G PROTEIN-COUPLED RECEPTOR 1
C0682972|G PROTEIN COUPLED RECEPTORS
C1415275|GPX1 GENE
C0017636|GRADE IV ASTROCYTOMA
C0812409|GRADIENT
C0441800|GRADING
C0010055|GRAFT;CORONARY ARTERY BYPASS
C0086369|GRAIN
C0061860|GRAMINE
C0337471|GRANDPARENTS
C0596630|GRANULE CELL
C0079459|GRANULOCYTE COLONY-STIMULATING FACTOR
C0079460|GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR
C0333454|GRANULOVACUOLAR DEGENERATION
C1313497|GRANZYME A
C1415382|GRANZYME K
C0018208|GRAPES
C0772454|GRAPE SEED EXTRACT
C0018220|GRAY MATTER OF NEURAXIS
C1333653|GRB2-ASSOCIATED BINDING PROTEIN 2
C0387800|GRB2-ASSOCIATED-BINDING PROTEIN 2
C0018226|GREECE
C0337806|GREEKS
C0120285|GREEN FLUORESCENT PROTEIN
C1384640|GREEN TEA
C1415299|GRIN2A GENE
C1415300|GRIN2B GENE
C0429271|GRIP STRENGTH
C1366490|GRK2 GENE
C1415311|GRN GENE
C0677549|GROSS MOTOR FUNCTIONS
C0150375|GROUP INSTRUCTION
C1367452|GROUP-SPECIFIC COMPONENT
C1428913|GROWTH ARREST- AND DNA DAMAGE-INDUCIBLE GADD45G-INTERACTING PROTEIN
C1415032|GROWTH/DIFFERENTIATION FACTOR 11
C1431343|GROWTH/DIFFERENTIATION FACTOR 15
C0018273|GROWTH DISORDERS
C0206454|GROWTH FACTOR RECEPTOR
C1333707|GROWTH FACTOR RECEPTOR-BOUND PROTEIN 2
C0018284|GROWTH FACTORS
C1415063|GROWTH HORMONE RECEPTOR
C1154417|GROWTH HORMONE SECRETION
C0010454|GROWTH MEDIUM
C0244989|GSK-3
C1415320|GSK3A GENE
C1415321|GSK3B GENE
C0919534|GSTM1 GENE
C0919451|GSTP1 GENE
C0537086|GST-PI
C1333715|GSTT1 GENE
C1427594|GTP BINDING PROTEIN 4
C0763637|GTP-BINDING PROTEIN DI-RAS3
C0018301|GUADELOUPE ISLAND
C0018321|GUANINE
C1415157|GUANINE NUCLEOTIDE-BINDING PROTEIN, GAMMA-4
C0120465|GUANINE NUCLEOTIDE EXCHANGE FACTOR
C0018338|GUANOSINE CYCLIC 3',5'-(HYDROGEN PHOSPHATE)
C0018296|GUANOSINETRIPHOSPHATASE
C0061928|GUANOSINETRIPHOSPHATASE ACTIVATING PROTEIN
C0018353|GUANOSINE TRIPHOSPHATE (GTP)
C0018358|GUANYLATE CYCLASE
C0086376|GUANYL NUCLEOTIDE BINDING PROTEIN
C1123034|GUARANA
C1274041|GUARDIAN
C0016703|GUF
C0162791|GUIDELINES
C0302614|GUIDE, SURGICAL, INSTRUMENT
C0018387|GUINEA-BISSAU
C0999699|GUINEA PIG
C0085979|GUINEA PIGS
C0017562|GUMS
C0699819|GUT
C0018417|GYNECOLOGY
C0062739|H3 RECEPTOR
C0018464|HABITS
C0018517|HALF-LIFE
C0233762|HALLUCINATIONS AUDITORY
C0018524|HALLUCINATIONS, UNSPECIFIED
C0018546|HALOPERIDOL-CONTAINING PRODUCT
C0814942|HAN CHINESE
C1293900|HAND GRIP
C0018563|HAND, NOS
C0018591|HAPLOTYPE
C0018595|HAPTOGLOBINS
C0062124|HARMAN
C0679771|HARM REDUCTION
C1292721|HAS PROPERTY
C0598697|HAZARDS
C0440288|HAZELNUT, UNSPECIFIED
C0018670|HEAD STRUCTURE
C0018684|HEALTH
C0814098|HEALTH BELIEFS
C0086388|HEALTHCARE ACTIVITY
C0018696|HEALTH CARE SYSTEM
C0475309|HEALTH CENTRE
C1171307|HEALTH DISPARITY
C0018701|HEALTH EDUCATION
C0175637|HEALTH EVALUATION
C2362527|HEALTH LITERACY
C1550208|HEALTH OUTCOMES
C0237121|HEALTH-RELATED BEHAVIOUR
C4279947|HEALTH-RELATED QUALITY OF LIFE (HRQOL)
C0018747|HEALTH SERVICES
C1456613|HEALTH SYSTEMS
C0452415|HEALTHY DIET
C1708335|HEALTHY VOLUNTEER
C0175841|HEARING LEVELS
C0919661|HEART ALTERNATION
C0152021|HEART; DISEASE, CONGENITAL
C0010068|HEART; DISEASE, CORONARY
C1113667|HEART DISEASE RISK
C0018802|HEART FAILURE; CONGESTIVE
C0232197|HEART; FIBRILLATION
C0232164|HEART FUNCTIONS, UNSPECIFIED
C0007202|HEART/LUNG BYPASS
C0489835|HEART STUDY
C0018851|HEATING
C0018837|HEAT, NOS
C1415757|HEAT SHOCK PROTEIN FAMILY A (HSP70) MEMBER 1 LIKE
C1415764|HEAT SHOCK PROTEIN FAMILY A (HSP70) MEMBER 8
C1537388|HEAT SHOCK PROTEIN FAMILY B (SMALL) MEMBER 6
C1451001|HEAT-STABLE ENTEROTOXIN RECEPTOR
C0687132|HEAVY DRINKING
C1154714|HEAVY METAL CHELATION
C0347988|HEAVY METALS
C0489786|HEIGHT
C0018873|HELA CELLS
C0079487|HELICOBACTER INFECTIONS
C0085115|HELPER SUPPRESSOR RATIO DETERMINATION
C0018896|HELPING BEHAVIOR
C0206734|HEMANGIOBLASTOMA
C0018944|HEMATOMA, NOS
C1332710|HEMATOPOIETIC PROGENITOR CELL ANTIGEN CD34
C0018966|HEME GROUP
C2348951|HEME IRON
C0538674|HEME OXYGENASE 1
C0744741|HEME PROFILE
C2825407|HEMI
C1881036|HEMIZYGOSITY
C0019000|HEMOCYTE
C0019009|HEMODILUTION
C0019010|HEMODYNAMICS
C0019016|HEMOGLOBIN A
C0019018|HEMOGLOBIN A1C
C0019047|HEMOGLOBIN, ABNORMAL
C1314664|HEMOGLOBIN LEVEL
C0019046|HEMOGLOBINS
C4551514|HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1
C0018956|HEMOPOIETIC STEM CELL
C0018974|HEMOPROTEINS
C0019080|HEMORRHAGE, UNSPECIFIED
C0553692|HEMORRHAGIC STROKE
C0019113|HEMOSIDERIN
C0005779|HEMOSTATIC FUNCTION, ABNORMAL
C0062503|HEPARAN SULFATE PROTEOGLYCAN
C0272285|HEPARIN-INDUCED THROMBOCYTOPENIA (HIT)
C0019143|HEPARITIN SULFATE
C1453952|HEPATIC TRIACYLGLYCEROL LIPASE
C0001306|HEPATITIS; ACUTE, ALCOHOLIC
C0856706|HEPATITIS B POSITIVE
C0220847|HEPATITIS C VIRUS (HCV)
C0276623|HEPATITIS; VIRUS, CHRONIC
C0524909|HEPATITIS; VIRUS, CHRONIC, TYPE B
C0019186|HEPATITIS VIRUSES
C0966897|HEPCIDIN
C1739039|HER1
C3146288|HERBAL
C1360419|HERBAL DRUGS
C0949854|HERBAL PREPARATIONS
C0019236|HERBICIDES
C0019240|HERBS
C0019247|HEREDITARY DISORDER, CONGENITAL
C0534369|HEREDITARY HEMOCHROMATOSIS PROTEIN
C0599986|HEREDITY; COUNSELING
C0019270|HERNIATION
C0019340|HERPES
C0019342|HERPES GENITALIS
C1318711|HERPES SIMPLEX TYPE 1 INFECTION
C0276226|HERPESVIRAL ENCEPHALITIS
C0019369|HERPESVIRUSES
C1825523|HETEROCHROMATIN PROTEIN 1-BINDING PROTEIN 3
C1512424|HETERODIMERIZATION
C1415634|HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A1
C0019425|HETEROZYGOUS GENOTYPE
C0019472|HEXOKINASE
C0019475|HEXOKINASE-2
C0019477|HEXOSAMINE
C0005270|HEXOSAMINIDASE
C1415537|HHEX GENE
C1299351|HIGH
C0238617|HIGH ALTITUDE
C0062708|HIGH DENSITY LIPOPROTEIN SUBFRACTION 1
C0596701|HIGH ENERGY COMPOUND
C1512456|HIGH PREVALENCE
C0684030|HIGH-RISK GROUP
C0870646|HIGH RISK POPULATIONS
C0425441|HIGH SATURATED FAT DIET
C3827339|HIGH SENSITIVITY TROPONIN T ASSAY
C1445913|HIGH SUGAR DIET
C0019557|HIP; FRACTURE
C4315130|HIPPOCAMPAL ATROPHY
C1504404|HIPPOCAMPAL SCLEROSIS
C0019564|HIPPOCAMPUS (BRAIN)
C3887642|HIPPOCAMPUS PROPER
C0596706|HIP SURGERY
C0019573|HIRUDIN
C0086409|HISPANICS
C0019593|HISTAMINE H2 RECEPTOR ANTAGONIST-CONTAINING PRODUCT
C1415801|HISTATIN 3
C0344441|HISTOLOGY (AS PURPOSE OF BIOPSY)
C1156200|HISTONE ACETYLATION
C1336632|HISTONE ACETYLTRANSFERASE KAT5
C1530358|HISTONE ACETYLTRANSFERASE P300
C0062773|HISTONE ACETYLTRANSFERASES (HAT)
C0019643|HISTONE DEACETYLASE
C1333891|HISTONE DEACETYLASE 1
C1334032|HISTONE DEACETYLASE 1
C1333893|HISTONE DEACETYLASE 4
C1333895|HISTONE DEACETYLASE 6
C1512474|HISTONE DEACETYLASE INHIBITOR-CONTAINING PRODUCT
C0019647|HISTONE H3
C3898882|HISTONE H3 ACETYL LYS27
C3829683|HISTONE H3 TRIMETHYL LYS4
C0019648|HISTONE H4
C1156199|HISTONE MODIFICATION
C0019652|HISTONES
C0677043|HISTOPATHOLOGY
C0199182|HISTORY TAKING, NOS
C0596020|HITS
C0162714|HIV PROTEASE INHIBITORS
C0001849|HIV-RELATED DEMENTIA
C0744979|HIV RISK
C4082587|HLA CLASS II HISTOCOMPATIBILITY ANTIGEN GAMMA CHAIN
C4049595|HLA COMPLEX
C0122020|HLA-DQB1
C0019796|HMGB1
C0047420|HMG-COA
C1415615|HMGCR GENE
C1333912|HMGN1 GENE
C1415636|HNRNPA2B1 GENE
C0424337|HOARDING
C0475647|HOME EXERCISE PROGRAMME
C0019855|HOME HEALTH CARE
C0425241|HOMELESS FAMILY
C0019863|HOMELESS PERSONS
C0555052|HOMEMAKERS
C1384665|HOMEOSTATIC IRON REGULATOR
C1561987|HOMEOSTATIC MECHANISM
C0019868|HOMEOSTATIC PROCESS
C3495426|HOMOCYSTEINEMIA
C0751202|HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY
C0019880|HOMOCYSTINURIA, NOS
C0450127|HOMOGRAFTS
C1334043|HOMOLOGOUS GENE
C1512488|HOMOLOGOUS PROTEIN
C0019898|HOMOSEXUALS
C0178681|HOMOVANILLATE
C0019904|HOMOZYGOUS GENOTYPE
C0870663|HONESTY
C0323351|HONEY BEE
C0392347|HOPE
C0458083|HORMONAL
C1134488|HORMONAL CHANGES
C0599750|HORMONE DEFICIENCY
C0312426|HORMONE PRODUCTION
C0019932|HORMONES
C0279025|HORMONE TREATMENT
C0019939|HORNS
C0184673|HOSPITAL ADMISSION, EMERGENCY, NOS
C0184666|HOSPITAL ADMISSION, NOS
C0020003|HOSPITAL AND COMMUNITY
C0587906|HOSPITAL CLINIC
C0870668|HOSPITALIZED PATIENTS
C0085556|HOSPITAL MORTALITY
C0019994|HOSPITALS
C0019988|HOSPITAL UNIT
C1167395|HOST
C0442519|HOUSE
C0557163|HOUSEHOLD INCOME
C0020052|HOUSEHOLDS
C0020056|HOUSING
C0008562|HPLC
C0079488|H. PYLORI
C0018810|HR
C0010343|HRV
C3715113|HSD11B1 WT ALLELE
C0018847|HSP27
C0243044|HSP90
C1825546|HSP90B1 GENE
C1415761|HSPA5 GENE
C1333928|HSPB1 GENE
C1424667|HSPH1 GENE
C0018510|HTI
C1415809|HTR2A GENE
C0001490|HUMAN ADENOVIRUS, NOS
C0027362|HUMAN AGE GROUP
C0242821|HUMAN BODY
C0682523|HUMAN CELL LINE
C0427861|HUMAN CELLS
C0020119|HUMAN DEVELOPMENT
C0318598|HUMAN ENTERIC CALICIVIRUS
C0314604|HUMAN GENE, NOS
C0017429|HUMAN GENOME
C1366514|HUMAN GROWTH FACTOR-REGULATED TYROSINE KINASE SUBSTRATE
C0206679|HUMAN HERPESVIRUS 1
C0014644|HUMAN HERPESVIRUS 4
C0149678|HUMAN HERPESVIRUS 4 INFECTION
C0019682|HUMAN IMMUNODEFICIENCY VIRUS, NOS
C0019733|HUMAN LEUCOCYTE ANTIGEN A2
C0248450|HUMAN LEUCOCYTE ANTIGEN A23(9)
C0062802|HUMAN LEUCOCYTE ANTIGEN A24(9)
C0019721|HUMAN LEUCOCYTE ANTIGEN (HLA)
C0440470|HUMAN MATERIAL
C0596728|HUMAN OLD AGE (65+)
C1148523|HUMAN PARTURITION, FUNCTION
C0544357|HUMAN PLASMA
C0304925|HUMAN SERUM ALBUMIN PREPARATION
C2349001|HUMAN SUBJECT
C0440744|HUMAN TISSUE
C0199798|HUMAN VACCINATION
C0178694|HUMAN VERY OLD AGE (85+)
C0020166|HUMIC ACID
C1155229|HUMORAL IMMUNE RESPONSE
C0020967|HUMORAL IMMUNITY
C0330544|HUMULUS LUPULUS / COMMON HOP
C0872896|HUMULUS LUPULUS EXTRACT
C0020179|HUNTINGTONS DISEASE
C0063033|HUPERZINE A
C0333438|HYALINOSIS
C0020205|HYBRIDS (BIOLOGY)
C0020223|HYDRALAZINE-CONTAINING PRODUCT
C0682951|HYDRAZIDES
C0020235|HYDRAZONES
C0020255|HYDROCEPHALY
C1512523|HYDROCHLORIDE SALT
C0982446|HYDROGENATED VEGETABLE OIL
C0020281|HYDROGEN PEROXIDE PRODUCT
C0020282|HYDROGEN SULPHIDE
C0020289|HYDROLASES
C0020291|HYDROLYSIS
C0122759|HYDRON
C0475370|HYDROPHILICITY
C0678607|HYDROPHOBIC INTERACTION
C0220853|HYDROXIDE ION (OH)
C0020317|HYDROXY ACIDS
C0020339|HYDROXYCHOLESTEROL
C0020361|HYDROXYINDOLEACETIC ACID (HIAA)
C0700307|HYDROXYL GROUP (OH) - THAT CONSISTS OF AN OXYGEN ATOM JOINED TO A HYDROGEN ATOM
C0063146|HYDROXYL RADICAL
C1415597|HYDROXYMETHYLBILANE SYNTHASE
C0207262|HYDROXYMETHYLGLUTARYL-COA REDUCTASE (NADPH) KINASE
C0020374|HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASES
C1825528|HYDROXYSTEROID 17-BETA DEHYDROGENASE 10
C0398353|HYPERCAPNIC RESPIRATORY FAILURE
C0020440|HYPERCARBIA
C0020443|HYPERCHOLESTEROLEMIA, NOS
C0001622|HYPERCORTISOLISM
C0856984|HYPEREXCITABILITY
C0814034|HYPEREXCITABILITY
C0017687|HYPERGLYCEMIC-GLYCOGENOLYTIC FACTOR PREPARATION
C0020459|HYPERINSULINISM SYNDROME
C0342952|HYPERMETABOLISM
C1512554|HYPERMETHYLATION
C0085681|HYPERPHOSPHATEMIA
C0014173|HYPERPLASIA;ENDOMETRIUM
C0268528|HYPERPROLINEMIA, NOS
C0235222|HYPERTENSION, DIASTOLIC
C0751892|HYPERTENSIVE INTRACEREBRAL HEMORRHAGE
C0203597|HYPERTHERMIA TREATMENT, NOS
C0020557|HYPERTRIGLYCERIDEMIA
C1383860|HYPERTROPHY; HEART
C0020564|HYPERTROPHY, NOS
C0020591|HYPNOTICS
C0151718|HYPOCHOLESTEROLEMIA, NOS
C1415502|HYPOCRETIN RECEPTOR 2
C0268070|HYPOCUPREMIA, NOS
C0679221|HYPOFUNCTION
C0405580|HYPOFUNCTION; ADRENOCORTICAL
C0020616|HYPOGLYCEMIC DRUG, NOS
C0745153|HYPOGLYCEMIC EPISODE
C0020619|HYPOGONADOTROPISM
C2748055|HYPOINSULINAEMIA
C0342892|HYPOLIPIDEMIA
C0347938|HYPOMETABOLISM
C0544820|HYPOMYELINATION
C0442856|HYPOPERFUSION
C0016395|HYPOPLASIA; FOCAL DERMAL
C0857353|HYPOTENSIVE
C0003364|HYPOTENSIVE AGENTS
C0520541|HYPOTENSIVE EPISODE
C0301821|HYPOTHALAMIC INHIBITORY FACTOR (HIF)
C0597719|HYPOTHALAMIC PITUITARY ADRENAL (HPA) AXIS
C0678897|HYPOTHALAMIC PITUITARY AXIS
C0020663|HYPOTHALAMUS, NOS
C1836672|HYPOTRICHOSIS 7
C0020684|HYPOXANTHINE
C0700292|HYPOXEMIA
C0215848|HYPOXIA-INDUCIBLE FACTOR-1
C0020699|HYSTERECTOMY, NOS
C3813126|IAPP WT ALLELE
C0020738|IBOTENIC ACID
C0123047|IBUDILAST
C0745212|IBUPROFEN TREATMENT
C0020746|ICE
C0020748|ICE HOCKEY
C0337808|ICELANDERS
C0239849|ICHTHYOSIS; FETALIS
C1123005|ICI 182780
C1550748|ICV
C1512612|IDEAL
C1550043|IDENTIFIED
C0277553|IDIOPATHIC DISEASE, NOS
C0140080|IGF1R
C1446147|IGG INDEX
C0663914|I-KAPPA-B KINASE
C0020898|ILLINOIS
C0020899|ILLITERATE
C1704922|IMAGE
C0200765|IMAGE ANALYSIS, NOS
C2697663|IMAGE REGISTRATION
C0011923|IMAGING
C1275506|IMAGING - ACTION
C0203860|IMAGING OF BRAIN
C0079595|IMAGING TECHNIQUES
C0935989|IMATINIB-CONTAINING PRODUCT
C0939537|IMATINIB MESYLATE
C1397014|IMBALANCE
C0342579|IMBALANCE; ELECTROLYTE
C0020934|IMIPRAMINE-CONTAINING PRODUCT
C0231441|IMMOBILITY
C0439662|IMMUNE
C4330475|IMMUNE CELL
C0301889|IMMUNE DEFECT, NOS
C0001175|IMMUNE DEFICIENCY SYNDROME ACQUIRED <AIDS>
C0312740|IMMUNE EFFECTOR CELL
C0301872|IMMUNE RESPONSE, UNSPECIFIED
C0020964|IMMUNITY
C0205991|IMMUNIZATION, ACTIVE
C0020980|IMMUNOASSAY METHOD
C0020985|IMMUNOBLOTTING
C0242349|IMMUNOCYTOCHEMISTRY TEST
C0079835|IMMUNOELECTRON MICROSCOPY
C0016318|IMMUNOFLUORESCENCE TECHNIQUE
C0079603|IMMUNOFLUORESCENCE TECHNIQUE
C0003320|IMMUNOGENS
C0202087|IMMUNOGLOBULIN G MEASUREMENT
C0020856|IMMUNOGLOBULIN IGG2
C0020860|IMMUNOGLOBULIN IGG4
C0020852|IMMUNOGLOBULIN IGG, NOS
C1512661|IMMUNOGLOBULIN-LIKE V-TYPE DOMAIN
C0021027|IMMUNOGLOBULIN STRUCTURE
C0205470|IMMUNOLOGIC
C0021053|IMMUNOLOGIC DISORDERS
C1817756|IMMUNOLOGIC FUNCTION
C0034817|IMMUNOLOGIC RECEPTOR SITE
C0021054|IMMUNOLOGIC SUBSTANCE
C0020963|IMMUNOLOGIC UNRESPONSIVENESS
C1527392|IMMUNOMODULATOR-CONTAINING PRODUCT
C1963758|IMMUNOMODULATORY THERAPY
C0079611|IMMUNOPHENOTYPING
C0021069|IMMUNOPRECIPITATION
C0020971|IMMUNOPROPHYLAXIS
C0597879|IMMUNOREACTIVITY
C0596761|IMMUNOSENESCENCE
C0001551|IMMUNOSTIMULANTS
C0005525|IMMUNOTHERAPEUTIC AGENT
C0876248|IMMUNOTHERAPEUTIC AGENT
C0021083|IMMUNOTHERAPY, NOS
C0159069|IMPAIRED GLUCOSE TOLERANCE TEST
C0338656|IMPAIRMENT;COGNITIVE
C0011373|IMPLANTABLE DENTAL PROSTHESIS
C0021102|IMPLANT, NOS
C1881145|IMPRECISION
C0596764|IMPRESSION
C2986411|IMPROVEMENT
C0021125|IMPULSIVITY
C0003537|INABILITY TO UNDERSTAND OR EXPRESS LANGUAGE
C4524801|INACCURATE INFORMATION
C0544461|INACTIVATION
C0205412|INADEQUATE
C0021144|INBREEDING
C1551358|INCIDENT
C0332257|INCLUDING
C0007637|INCLUSION BODY
C0021162|INCOME (ECONOMIC)
C1629507|INCONCLUSIVE
C0021167|INCONTINENCE, NOS
C0205217|INCREASED
C0442805|INCREASED
C1372180|INCREASED CELLULAR DEATH
C1372273|INCREASED CYTOKINE PRODUCTION
C0277889|INCREASED DIASTOLIC ARTERIAL PULSE PRESSURE
C0301590|INCREASED ENERGY DIET
C0521974|INCREASED FAT DIET
C0017747|INCREASED GLUCOSE LEVEL
C1372517|INCREASED PHAGOCYTOSIS
C1705117|INCREMENT
C1562292|INCRETIN HORMONE
C0085862|INDEPENDENCE (PERSONALITY)
C0021189|INDEPENDENT LIVING
C0681367|INDEPENDENT STUDY
C0918012|INDEX
C0021201|INDIA
C1524069|INDIAN SUB-CONTINENT (NMO)
C0021212|INDICATOR
C0079891|INDIGENOUS POPULATIONS
C0237401|INDIVIDUAL
C0021228|INDIVIDUALITY
C0021236|INDOLE
C0596771|INDOLEAMINE
C1416433|INDOLEAMINE 2,3-DIOXYGENASE 1
C1268819|INDUCED PLATELET AGGREGATION
C0205263|INDUCTION
C0857127|INDUCTION PROCEDURE
C0021267|INDUSTRY
C0007439|INDWELLING CATHETER
C0231184|INEFFICIENCY
C0021270|INFANTS
C0333548|INFARCT, ACUTE
C0333556|INFARCT, CYSTIC
C0007785|INFARCTION; CEREBRAL
C0021308|INFARCT, NOS
C3714514|INFECTION
C0004623|INFECTION; BACTERIAL
C0006015|INFECTION; BORDETELLA
C0012546|INFECTION DUE TO CORYNEBACTERIUM DIPHTHERIAE
C0314732|INFECTIOUS AGENT, NOS
C0019191|INFECTIOUS CANINE HEPATITIS
C1541923|INFECTIVE ENDOCARDITIS
C0729584|INFECTIVE MENINGITIS
C0679201|INFERENCE
C0582740|INFERIOR FRONTAL CORTEX
C0011560|INFILTRATE; AMYLOID
C0014038|INFLAMMATION; CEREBRAL
C0021368|INFLAMMATION, NOS
C0014118|INFLAMMATION OF THE HEART VALVE
C0333348|INFLAMMATORY
C0003864|INFLAMMATORY ARTHROPATHY
C0021390|INFLAMMATORY BOWEL DISEASES
C0333361|INFLAMMATORY CELL INFILTRATION, ACUTE
C0021376|INFLAMMATORY CELL INFILTRATION, CHRONIC
C0178264|INFLAMMATORY DISEASE OF THE CENTRAL NERVOUS SYSTEM, NOS
C1290884|INFLAMMATORY DISORDER
C4054723|INFLUENCE
C0021400|INFLUENZA, NOS
C0021403|INFLUENZA VIRUS VACCINE, UNSPECIFIED FORMULATION
C1550484|INFORMANT
C1533716|INFORMATION
C0012625|INFORMATION DISCLOSURE
C0700301|INFORMATION PROCESSING
C2986490|INFORMATIVE
C0204032|INFRARED THERAPY
C1998546|INFRASTRUCTURE
C0441939|INFRATENTORIAL
C0677874|IN FULL REMISSION
C0574032|INFUSION TECHNIQUE
C0232478|INGESTION
C1372955|INGRD
C1550600|INGREDIENT
C1179837|INHALED AIR
C0439660|INHERITED
C1999216|INHIBITOR
C0682694|INHIBITORY INTERNEURON
C0205265|INITIAL
C0589507|INITIATION
C0424093|INITIATIVE
C1272883|INJECTION DEVICE
C0199779|INJECTION OF ANTIBIOTIC
C0560612|INJURY BY MECHANISM
C0270611|INJURY; CEREBRAL
C0751814|INJURY; CEREBRAL VESSELS
C0005700|INJURY DUE TO EXPLOSION
C0274281|INJURY DUE TO EXPOSURE TO EXTERNAL CAUSES
C0230840|INNER MITOCHONDRIAL MEMBRANE
C0021516|INNERVATION
C0021521|INORGANIC COMPOUNDS
C0063593|INOSITOL-1,4,5-TRISPHOSPHATE 5-PHOSPHATASE
C1428845|INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR INTERACTING PROTEIN
C0021562|INPATIENT
C0019993|INPATIENT CARE
C1708517|INPUT
C0221503|INSANITY
C0021576|INSECTICIDES
C1512796|INSERTION MUTATION
C0233820|INSIGHT (PSYCHOTHERAPEUTIC PROCESS)
C0162788|IN-SITU HYBRIDIZATION
C0004048|INSPIRATION
C0021622|INSTITUTE
C0868975|INSTITUTIONAL CARE
C0021629|INSTITUTIONALIZATION
C0562359|INSTITUTIONALIZED
C0302828|INSTRUCTION
C1290928|INSTRUMENTAL ACTIVITY OF DAILY LIVING
C1415875|INSULIN-DEGRADING ENZYME
C0858734|INSULIN; HYPOGLYCEMIA
C0123256|INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1
C0123257|INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2
C0123707|INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3
C0123259|INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 5
C1415932|INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 7
C1456383|INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN, ACID-LABILE SUBUNIT
C0074825|INSULIN-LIKE GROWTH FACTOR-BINDING PROTEINS
C0140079|INSULIN-LIKE GROWTH FACTOR RECEPTOR
C1448132|INSULIN RECEPTOR
C0034818|INSULIN RECEPTOR SITE
C0123658|INSULIN RECEPTOR SUBSTRATE 1
C1334191|INSULIN RECEPTOR SUBSTRATE 2
C0021655|INSULIN RESISTANCE
C1256369|INSULIN SECRETION
C0920563|INSULIN SENSITIVITY
C1512804|INSULIN SIGNALING PATHWAY
C0430191|INSULIN SUPPRESSION TEST
C0745343|INSULIN TREATMENT
C0021669|INSULYSIN
C0021675|INSURER
C0205266|INTACT
C1512806|INTAKE
C1416512|INTEGRAL MEMBRANE PROTEIN 2B
C0309311|INTEGRATOR
C1706057|INTEGRATOR DEVICE
C1701032|INTEGRIN ALPHA-M
C3714756|INTELLECTUAL FUNCTIONING DISABILITY
C0392334|INTELLECTUAL FUNCTIONS
C0423900|INTELLIGENCE, AVERAGE (I.Q.....)
C0423898|INTELLIGENCE LEVELS
C0021704|INTELLIGENCE, NOS
C1863535|INTELLIGENCE QUANTITATIVE TRAIT LOCUS 1
C1319010|INTELLIGENCE QUOTIENT ASSESSMENT
C0085559|INTENSIVE CARE
C0021708|INTENSIVE CARE UNITS
C0162425|INTENTION
C1704675|INTERACTION
C0021717|INTERCALATOR
C0242565|INTERCELLULAR CELL ADHESION MOLECULE (ICAM)
C1154413|INTERCELLULAR COMMUNICATION PROCESS
C0015352|INTERCELLULAR SPACE, NOS
C4316843|INTERDISCIPLINARY RESEARCH
C0021729|INTEREST GROUPS
C0543488|INTERESTS
C0521102|INTERFERES WITH
C0733470|INTERFERON
C0002199|INTERFERON ALPHA
C1568204|INTERFERON ALPHA/BETA RECEPTOR 1
C1415887|INTERFERON-ALPHA-INDUCIBLE PROTEIN 27
C0254119|INTERFERON BETA-1A-CONTAINING PRODUCT
C0015980|INTERFERON BETA-CONTAINING PRODUCT
C1334085|INTERFERON, GAMMA
C0021745|INTERFERON GAMMA-CONTAINING PRODUCT
C3710914|INTERFERON-INDUCED, DOUBLE-STRANDED RNA-ACTIVATED PROTEIN KINASE
C0021747|INTERFERONS
C1334098|INTERLEUKIN 10
C0085295|INTERLEUKIN-10
C0123759|INTERLEUKIN-12
C1099914|INTERLEUKIN-12 SUBUNIT BETA
C0254610|INTERLEUKIN-15
C1334106|INTERLEUKIN 16
C0384648|INTERLEUKIN-17
C0383327|INTERLEUKIN-18
C3849701|INTERLEUKIN-18
C1334111|INTERLEUKIN 1-ALPHA
C0600251|INTERLEUKIN-1-ALPHA
C1334112|INTERLEUKIN 1-BETA
C0021753|INTERLEUKIN-1 BETA
C0021755|INTERLEUKIN-1 (IL-1)
C0963088|INTERLEUKIN-23
C1537403|INTERLEUKIN 23 RECEPTOR
C1872104|INTERLEUKIN-23 RECEPTOR
C1423526|INTERLEUKIN 23 SUBUNIT ALPHA
C0021757|INTERLEUKIN-3
C1423575|INTERLEUKIN 37
C1334119|INTERLEUKIN 4
C0021758|INTERLEUKIN-4 (IL-4)
C1334122|INTERLEUKIN 6
C0021760|INTERLEUKIN-6
C1325331|INTERLEUKIN 6 SIGNAL TRANSDUCER
C0021761|INTERLEUKIN-7
C1366571|INTERLEUKIN 8
C1698756|INTERLEUKIN-8
C1334205|INTERLEUKIN GENE
C0021764|INTERLEUKINS
C2827755|INTERMEDIATE
C0205267|INTERMITTENT
C0205102|INTERNAL
C0007276|INTERNAL CAROTID ARTERY STRUCTURE
C1180561|INTERNAL ELASTIC LAMINA
C0871786|INTERNALIZATION
C0021792|INTERNEURONS
C0237519|INTERPERSONAL COMPATIBILITY
C0235744|INTERRUPTED BREATHING
C0225319|INTERSTITIAL SPACE, NOS
C0162385|INTERTROCHANTERIC FRACTURE OF FEMUR
C3274035|INTERVENTIONAL STUDY
C0599917|INTERVENTION PROGRAM
C1273869|INTERVENTION REGIME
C3542921|INTERVENTIONS
C0021822|INTERVIEWS
C0021826|INTESTINAL ABSORPTION, NOS
C0021838|INTESTINAL MOTILITY, NOS
C0459471|INTP
C0347985|INTRA
C0599814|INTRACELLULAR TRANSPORT
C0021870|INTRACEREBRAL HEMATOMA
C0007766|INTRACRANIAL ANEURYSMS
C0349604|INTRACRANIAL MENINGIOMA
C0021880|INTRACRANIAL PRESSURE
C0459922|INTRACRANIAL VESSEL
C0205708|INTRACYTOPLASMIC INCLUSION BODIES
C1512943|INTRAEPITHELIAL ROUTE OF ADMINISTRATION
C0021493|INTRAPERITONEAL INJECTIONS
C0085297|INTRAVENOUS IMMUNOGLOBULIN THERAPY
C0596795|INTRAVITAL MICROSCOPY
C1293116|INTRODUCTION PROCEDURE
C0021920|INTRONS
C1333210|INTS6 GENE
C0021936|INULIN
C2699153|INVASION
C1301757|INVASIVENESS
C1292732|INVESTIGATES
C1552578|INVESTIGATION
C0220825|INVESTIGATION
C1517586|INVESTIGATIONAL
C0013230|INVESTIGATIONAL NEW DRUG
C0949266|INVESTIGATIONAL TREATMENT
C1261322|INVESTIGATIONS
C0021953|INVESTMENTS
C1515655|IN VIVO
C0013421|INVOLUNTARY TWISTING MOVEMENTS
C0333953|INVOLUTION, NOS
C1314939|INVOLVING
C0021966|IODIDE SALT, NOS
C0021978|IODOCHLORHYDROXYQUIN
C0034538|IONIZING RADIATION
C1179928|IONOTROPIC RECEPTOR
C0022023|IONS
C0162585|ION TRANSPORT
C1019118|IPS BEETLES
C0022065|IRN
C1135611|IRON-BINDING PROTEINS
C1517598|IRON CHELATION
C0240066|IRON DEFICIENCY, NOS
C0060282|IRON(II) SULFATE
C0518043|IRON INTAKE
C0337439|IRON MEASUREMENT, NOS
C0596803|IRON METABOLISM
C0282193|IRON OVERLOAD, NOS
C0302583|IRON PRODUCT
C0018995|IRON; STORAGE DISORDER
C1159668|IRON TRANSPORT
C0022107|IRRITABLE MOOD
C1334140|IRS1 GENE
C0917798|ISCHEMIA CEREBROVASCULAR
C0022116|ISCHEMIA, NOS
C0007786|ISCHEMIC ENCEPHALOPATHY
C0376466|ISCHEMIC PRECONDITIONING
C0022122|ISCHIUM, NOS
C0205911|I SERIES PROSTAGLANDIN-CONTAINING PRODUCT
C0022130|ISLANDS
C0201519|ISLET CELL (PANCREAS) ANTIBODY MEASUREMENT
C0022179|ISOFLAVONES
C0022180|ISOFLURANE-CONTAINING PRODUCT
C1548221|ISOLATED
C0205409|ISOLATION
C0022202|ISOMERASES
C0682996|ISOPRENOID
C0949860|ISOPROSTANES
C0206359|ISOTHIOCYANATE
C0124209|ISOTHIOCYANATES
C0022265|ISOTRETINOIN-CONTAINING PRODUCT
C0021017|ISOTYPE
C1706387|ISSUE
C0022277|ITALY
C4554251|ITEM
C1854293|ITERATION
C1416487|ITGA4 GENE
C1366562|ITGAM GENE
C1552713|IVL
C0022326|IVORY COAST
C0597721|JANUS KINASE FAMILY
C0022389|JEWS
C0178443|JEWS
C0248813|JNK MITOGEN-ACTIVATED PROTEIN KINASES
C0240083|JOINT ABNORMALITY
C0022341|JPN
C0022423|JUDGMENTS
C1268568|JUICE
C3829443|JUNE
C0598744|JUVENILE ANIMAL
C1825635|JUXTAPOSED WITH ANOTHER ZINC FINGER GENE 1
C0064280|KAEMPFEROL
C0022471|KAINIC ACID
C0006100|KALLIDIN I
C0022478|KALLIKREIN
C1416679|KALLIKREIN-RELATED PEPTIDASE 8
C0004352|KANNER
C1832386|K ATP ASSOCIATED TRANSIENT NEONATAL DIABETES MELLITUS
C0022558|KENYAS
C0876060|KEPPRA
C0022575|KERATOCONJUNCTIVITIS SICCA
C0022614|KETAMINE-CONTAINING PRODUCT
C0022618|KETOACID, NOS
C0220982|KETOACIDOSIS, NOS
C0259972|KETOGENIC DIET
C0022631|KETONE BODY ANALYTE
C3821794|KETONE BODY METABOLISM
C0022634|KETONES
C0011880|KETOSIS, DIABETIC
C0022638|KETOSIS, NOS
C0006797|KHM
C0450663|KI3
C0019004|KIDNEY; DIALYSIS
C1150423|KINASE ACTIVITY
C1171350|KINASE INHIBITOR
C1334306|KINASE INSERT DOMAIN RECEPTOR
C0600169|KINEMATICS
C0085139|KINESIN
C1537485|KINESIN FAMILY MEMBER 21B
C1537482|KINESIN FAMILY MEMBER 7
C0003062|KINGDOM ANIMALIA
C1097812|KISS-1 RECEPTOR
C1366480|KIT LIGAND
C0064332|KLH
C1366489|KLK3 GENE
C1416656|KLOTHO
C0022686|K LYMPHOCYTE
C1522225|KNOCK-OUT
C0206745|KNOCK-OUT MOUSE
C0205309|KNOWN
C1708601|K PRIME
C0665301|KREV INTERACTION TRAPPED PROTEIN 1
C1416659|KRUPPEL-LIKE FACTOR 2
C1416663|KRUPPEL-LIKE FACTOR 8
C0022802|KURU; DISEASE
C0022816|KYNURENIC ACID
C0022818|KYNURENINE
C1416769|L1 CELL ADHESION MOLECULE
C4522130|LABEL
C0022877|LABORATORY
C0003064|LABORATORY ANIMALS
C1416808|LACTASE
C0376261|LACTATE
C0022925|LACTATION, NOS
C0064582|LACTIC ACID, UNSPECIFIED FORM
C0022940|LACTOBACILLUS CASEI
C0022942|LACTOFERRINS
C0016957|LACTOSYL CERAMIDE BETA-GALACTOSIDASE
C1435815|LACTOTRANSFERRIN
C0333559|LACUNAR INFARCTION
C0241970|LACUNE
C1609818|LADOSTIGIL
C0001898|L-ALANINE
C0051066|L-ALANOSINE
C0524904|LAMIACEAE
C0022984|LAMININ
C0064634|LAMININ RECEPTOR
C0064636|LAMOTRIGINE-CONTAINING PRODUCT
C0023015|LANGUAGE IMPAIRMENT
C0023008|LANGUAGES
C0023016|LANGUAGE TEST
C0050940|LANSOPRAZOLE-CONTAINING PRODUCT
C0023038|LAPAROTOMY, NOS
C4083076|LARGE HEAD
C0009368|LARGE INTESTINE, COLON
C0443228|LARGEST
C0225990|LARGE VESSELS, NOS
C1416798|LARGE XYLOSYL- AND GLUCURONYLTRANSFERASE 1
C0003765|L-ARGININE
C1449707|LASER SCANNING CYTOMETRY
C0850168|LASER TREATMENT
C0003995|L-ASPARAGINE
C0125323|LASSO
C0205087|LATE
C0205275|LATENT
C0872054|LATENT INFECTION
C0870784|LATENT INHIBITION
C0857345|LATE ONSET EPILEPSY
C1562670|LATE ONSET SCHIZOPHRENIA
C3829315|LATE PRETERM BIRTH
C0949335|LATINA
C1553378|LATIN AMERICAN
C0086528|LATINOS
C0058188|LATREPIRDINE
C0023133|LAUGHTER
C0023139|LAURIC ACID
C0023150|LAWS
C0282090|LAXATIVES,OTHER
C0303231|LEAD COMPOUNDS
C0023175|LEAD, NOS
C0181586|LEADS
C0015376|LEAKAGE
C0023182|LEAK; CEREBROSPINAL FLUID
C0424678|LEAN BODY MASS
C0013621|LEARNING
C0233832|LEARNING ABILITY, NOS
C1154338|LEARNING AND/OR MEMORY
C0751265|LEARNING DISABILITY
C0582590|LEARNING PERFORMANCE
C0031617|LECITHIN PRODUCT
C0023206|LECTINS
C2323804|LEFT PRECUNEUS
C0149721|LEFT VENTRICULAR HYPERTROPHY
C0455825|LEFT VENTRICULAR MASS
C0225897|LEFT VENTRICULAR STRUCTURE
C0242538|LEGACY
C1550438|LEGAL
C0728724|LEGAL SYSTEMS
C0104398|LEGUMAIN
C0023292|LEISURE ACTIVITY
C0336910|LEISURE PHYSICAL ACTIVITY
C0086542|LEISURE TIME
C0885571|LEMON BALM
C1444754|LENGTHS
C0079679|LENTIVIRUSES
C0023343|LEPROSY, UNSPECIFIED
C0051981|LEPROSY VACCINE
C0299583|LEPTIN
C0385463|LEPTIN RECEPTOR
C0521401|LEPTOMENINGEAL
C0221505|LESION OF BRAIN
C0246421|LETROZOLE-CONTAINING PRODUCT
C1428072|LEUCINE-RICH REPEAT, IMMUNOGLOBULIN-LIKE, AND TRANSMEMBRANE DOMAINS-CONTAINING PROTEIN 1
C1426227|LEUCINE-RICH REPEAT TRANSMEMBRANE PROTEIN 3
C0268576|LEUCINOSIS
C0023418|LEUKEMIA, UNSPECIFIED, WITHOUT MENTION OF REMISSION
C0948163|LEUKOARAIOSIS
C1326500|LEUKOCYTE TRAFFICKING
C0023520|LEUKODYSTROPHY, NOS
C3711381|LEUKOENCEPHALOPATHY, HEREDITARY DIFFUSE, WITH SPHEROIDS
C0023546|LEUKOTRIENE B4
C0700596|LEUPROLIDE ACETATE
C0023556|LEVAMISOLE-CONTAINING PRODUCT
C0456079|LEVEL
C1319226|LEVEL OF DEPRESSION
C0424090|LEVEL OF INTEREST
C0377265|LEVETIRACETAM-CONTAINING PRODUCT
C0087163|LEVOCARNITINE-CONTAINING PRODUCT
C0023570|LEVODOPA-CONTAINING PRODUCT
C0016745|LEVULOSE
C0085200|LEWY BODY
C0022828|L FORMS
C0061472|L-GLUTAMIC ACID
C0017797|L-GLUTAMINE
C0019602|L-HISTIDINE
C0019878|L-HOMOCYSTEINE
C0019879|L-HOMOCYSTINE
C0020388|L-HYDROXYPROLINE
C0023621|LIBRARY
C0023668|LIECHTENSTEIN
C0557155|LIFE EVENTS
C0023671|LIFE EXPECTANCY
C0162402|LIFE EXTENSION
C0005495|LIFE--ORIGIN
C0870809|LIFE SPAN
C2960841|LIFESTYLE CHANGE
C0023676|LIFESTYLES
C1517878|LIFETIME RISK
C0242210|LIGAND BINDING PROTEIN
C0023688|LIGANDS
C1416853|LIGASE III, DNA, ATP-DEPENDENT
C1562562|LIGHT CHAIN LEVEL
C1517883|LIGHT EXERCISE
C0023693|LIGHT - RADIATION
C0392223|LIGHTS
C0458337|LIMBIC LOBE
C0015385|LIMB STRUCTURE
C2746078|LINAGLIPTIN-CONTAINING PRODUCT
C2982391|LINCRNA
C0005038|LINDANE PRODUCT
C1402998|LINDAU
C0205132|LINEAR
C0023741|LINGUISTICS
C0023745|LINKAGE (GENETICS)
C0023749|LINOLEIC ACID
C1311738|LINTUZUMAB
C1416867|LIPC GENE
C1416870|LIPG GENE
C0019345|LIP; HERPES
C0023768|LIPID BILAYER MEMBRANE
C1148636|LIPID BINDING
C0023775|LIPID PEROXIDATION
C0023776|LIPID PEROXIDES
C1167250|LIPID RAFT
C0023779|LIPIDS
C0549634|LIPIDS ABNORMAL
C0598783|LIPIDS--METABOLISM
C0065031|LIPID TRANSFER PROTEIN
C0596846|LIPID TRANSPORT
C0206131|LIPOCYTE
C0023789|LIPOFUSCINS
C0020473|LIPOIDEMIA
C0023796|LIPOLYSIS
C1825916|LIPOLYSIS-STIMULATED LIPOPROTEIN RECEPTOR
C0023810|LIPOPOLYSACCHARIDE, NOS
C0023816|LIPOPROTEIN LIPASE
C0023820|LIPOPROTEINS
C0023821|LIPOPROTEINS, HDL
C0023822|LIPOPROTEINS, HDL CHOLESTEROL
C0023827|LIPOSARCOMA, NOS
C0023828|LIPOSOMES
C0023832|LIPOTROPIN
C0023837|LIPOXYGENASE
C0023759|LIP STRUCTURE
C0872318|LIQUID CHROMATOGRAPHY MASS SPECTROMETRY
C0008565|LIQUID CHROMATOGRAPHY MEASUREMENT, NOS
C0302908|LIQUID SUBSTANCE, NOS
C0086555|LIQUORICE
C1456408|LIRAGLUTIDE-CONTAINING PRODUCT
C0022192|L-ISOLEUCINE
C0745732|LIST
C0023864|LITERACY
C0282441|LITERATURE REVIEW
C0085217|LITHIUM CARBONATE-CONTAINING PRODUCT
C0065088|LITHIUM CHLORIDE PREPARATION
C0023870|LITHIUM PRODUCT
C0302213|LITHIUM SALTS
C0542463|LITHIUM USE
C0208940|LITHOSTATHINE-1-ALPHA
C0343081|LIVEDOID VASCULITIS
C0279000|LIVER CANCER
C0227525|LIVER CELLS
C0023890|LIVER; CIRRHOSIS
C0151763|LIVER; DAMAGE
C0341439|LIVER; DISEASE (CHRONIC) (ORGANIC)
C0019209|LIVER; ENLARGEMENT
C0239946|LIVER; FIBROSIS
C0086565|LIVER FUNCTION, ABNORMAL
C0085605|LIVER FUNCTION FAILURE
C0015695|LIVER; INFILTRATE, FATTY
C0019158|LIVER; INFLAMMATION
C0160390|LIVER; INJURY
C1373178|LIVER METABOLISM
C4288814|LIVER X RECEPTOR-LIKE FAMILY
C0042211|LIVE VACCINE
C4551704|LIVING
C0022917|L-LACTATE DEHYDROGENASE
C0023919|LLAMAS
C0023401|L-LEUCINE
C2939773|L-METHYLFOLATE
C1550025|LOAD
C1522010|LOBAR
C0333667|LOBAR ATROPHY
C0796494|LOBE
C0021640|LOBULE OF INSULA
C0205276|LOCAL
C0450429|LOCATION
C1708726|LOCUS
C1708728|LOG
C0206031|LOGISTIC REGRESSION
C1136323|LOINC
C0048852|LOMETREXOL
C0023974|LONELY
C0205166|LONG
C0522095|LONG CHAIN FATTY ACID, NOS
C0205127|LONGITUDINAL
C0443252|LONG-TERM
C0023977|LONG TERM CARE
C1517942|LONG-TERM FOLLOW-UP
C0423909|LONG-TERM MEMORY PERFORMANCE
C0206249|LONG-TERM POTENTIATION (LTP)
C0206193|LONG-TERM SURVIVOR
C0354100|LOOP DIURETICS
C0181687|LOOPS
C0939237|LOPINAVIR/RITONAVIR
C0024002|LORAZEPAM-CONTAINING PRODUCT
C0126174|LOSARTAN-CONTAINING PRODUCT
C1517945|LOSS
C0011175|LOSS OF BODY WATER
C0178417|LOSS OF PLEASURE FROM USUAL ACTIVITIES
C0745777|LOST
C0024027|LOVASTATIN-CONTAINING PRODUCT
C0745779|LOVASTATIN TREATMENT
C0024028|LOVE
C0020649|LOW;BLOOD PRESSURE
C0007166|LOW CARDIAC OUTPUT
C0452360|LOW COPPER DIET
C0023824|LOW DENSITY LIPOPROTEIN CHOLESTEROL
C0034821|LOW DENSITY LIPOPROTEIN RECEPTOR
C3493221|LOW-DENSITY LIPOPROTEIN RECEPTOR
C1366529|LOW DENSITY LIPOPROTEIN RECEPTOR GENE
C1422751|LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 10
C1416920|LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-ASSOCIATED PROTEIN 1
C0023823|LOW DENSITY LIPOPROTEINS
C1548802|LOWER
C2003888|LOWER
C0268696|LOWER URINARY TRACT DISEASE IN CATS
C0242970|LOW FAT DIET, NOS
C0205213|LOW FREQUENCY
C0456892|LOW INTRACRANIAL PRESSURE
C4321351|LOW LEVEL
C0019139|LOW MOLECULAR WEIGHT HEPARINS
C0279027|LOW POWER LASER THERAPY
C1416912|LRP1 GENE
C1416914|LRP2 GENE
C3811119|LRP2 WT ALLELE
C1416918|LRP6 GENE
C1416919|LRP8 GENE
C1425650|LRRK2 GENE
C1556111|LS
C0439092|LT (LESS THAN)
C0023879|LTU
C1334435|LUC GENE
C0024075|LUCIFERASES
C4553228|LUGANO LYMPHOMA RESPONSE CLASSIFICATION PROGRESSIVE DISEASE BY CT
C1305431|LUMBAR DISC
C0231953|LUNG VOLUME, NOS
C0043328|LUTEIN
C0065264|LUTEOLIN
C0023610|LUTEOTROPIN-RELEASING FACTOR
C0012691|LUXATED
C0428772|LVEF
C0065331|LYCOPENE
C0024198|LYME DISEASE, UNSPECIFIED
C0125272|LYMPHOCYTE ANTIGEN CD107B
C0080092|LYMPHOCYTE ANTIGEN CD115
C0079091|LYMPHOCYTE ANTIGEN CD11A
C0063717|LYMPHOCYTE ANTIGEN CD126
C0167627|LYMPHOCYTE ANTIGEN CD154
C0056182|LYMPHOCYTE ANTIGEN CD35
C0108793|LYMPHOCYTE ANTIGEN CD55
C0115305|LYMPHOCYTE ANTIGEN CD62E
C1619635|LYMPHOCYTE ANTIGEN CD71
C0004561|LYMPHOCYTE B CELLS
C0021756|LYMPHOCYTE MITOGENIC FACTOR
C0024297|LYMPHOKINES
C0301896|LYMPHOLYSIS, CELL MEDIATED
C1333931|LYSINE ACETYLTRANSFERASE 5
C0024337|LYSINE-CONTAINING PRODUCT
C1428785|LYSINE-SPECIFIC DEMETHYLASE 1A
C0024360|LYSOPHOSPHATIDYLCHOLINE
C0521450|LYSOSOMAL
C0391845|LYSOSOMAL ENZYMES
C1416788|LYSOSOME-ASSOCIATED MEMBRANE PROTEIN 1
C1416790|LYSOSOME-ASSOCIATED MEMBRANE PROTEIN 2
C0024369|LYSOSOMES
C1416898|LYSYL OXIDASE-LIKE 1
C0024399|MACACA FASCICULARIS
C0024398|MACAQUES
C0024403|MACAU
C0376284|MACHINE LEARNING
C1096293|MACROANGIOPATHY
C0301641|MACROMOLECULAR ALTERATION, NOS
C0178735|MACROMOLECULES
C2346926|MACRONUTRIENT
C1096155|MACROPHAGE ACTIVATION SYNDROME
C0079784|MACROPHAGE COLONY-STIMULATING FACTOR (M-CSF)
C0024432|MACROPHAGES
C0024426|MACROPHAGES--ACTIVATION
C0450295|MACULA LUTEA STRUCTURE
C0024437|MACULAR DEGENERATION SYNDROME
C0730285|MACULAR EDEMA DUE TO DIABETES MELLITUS
C0332573|MACULE, NOS
C0024473|MAGNESIUM; DEFICIENCY
C0024467|MAGNESIUM, NOS
C1096534|MAGNESIUM SUPPLEMENT THERAPY
C0563533|MAGNETIC FIELDS
C0024487|MAGNETIC RESONANCE SPECTROSCOPY (MRS)
C0024489|MAGNETOENCEPHALOGRAPHY (MEG)
C0449286|MAGNITUDE
C1269683|MAJOR DEPRESSIVE DISORDER
C2239682|MAJOR FACILITATOR SUPERFAMILY DOMAIN CONTAINING 11
C1415572|MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DQ BETA-1
C0024518|MAJOR HISTOCOMPATIBILITY COMPLEX, NOS
C0679637|MAJOR SURGERY
C0011109|MAKING UP MIND
C0233532|MALADAPTIVE BEHAVIOR ASSOCIATED WITH PHYSICAL ILLNESS
C0024534|MALARIAL ENCEPHALITIS
C0870221|MALE CHILD
C0232984|MALE CLIMACTERIC
C0021364|MALE INFERTILITY, UNSPECIFIED
C0236099|MALE REPRODUCTIVE SYSTEM DISORDER
C0302142|MALFORMATION
C0001418|MALIGNANT ADENOMATOUS NEOPLASM
C0442867|MALIGNANT DISEASE
C2930980|MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 1
C0685938|MALIGNANT NEOPLASM OF GASTROINTESTINAL TRACT, NOS
C0006142|MALIGNANT TUMOUR OF BREAST
C0007102|MALIGNANT TUMOUR OF COLON
C0346627|MALIGNANT TUMOUR OF INTESTINE
C0024643|MALONDIALDEHYDE
C0057889|MALONONITRILE
C1825950|MALONYL-COA-ACYL CARRIER PROTEIN TRANSACYLASE
C0002272|MALTASE
C0024658|MALTOSE, UNSPECIFIED FORM
C0024660|MAMMALS
C0024671|MAMMOGRAPHY, NOS
C0086418|MAN
C0376636|MANAGEMENT
C0871652|MANAGEMENT OF ANXIETY
C0024705|MANEB-CONTAINING PRODUCT
C0268090|MANGANESE; DEFICIENCY
C0024706|MANGANESE, NOS
C0338831|MANIC
C0349208|MANIC EPISODE, UNSPECIFIED
C0205319|MANIFESTATION OF
C0181722|MANIFOLDS
C0947647|MANIPULATION PROCEDURE
C0065661|MANNOSE-BINDING PROTEIN
C0369637|M ANTIBODY
C0026456|MAO-B
C1366909|MAP KINASE-ACTIVATING DEATH DOMAIN
C0967777|MAPK/MAK/MRK OVERLAPPING KINASE
C0024808|MARIJUANA
C0678449|MARIJUANA
C0006870|MARIJUANA DEPENDENCE
C0524645|MARINE
C0181736|MARKERS, MAGNETIC RESONANCE IMAGING (MRI)
C0024841|MARRIAGE, NOS
C0555047|MARRIED STATE
C0376152|MARROW
C0024264|MARROW LYMPHOCYTE
C0812372|MAS1 PROTO-ONCOGENE, G PROTEIN-COUPLED RECEPTOR
C0150108|MASKED
C0024861|MASKS
C1306372|*MASS
C0024875|MASSAGE NOS
C2316341|MASSAGE OF ABDOMEN
C0742078|MASS LESION OF BRAIN
C0005938|MASS OF BONE
C0037813|MASS SPECTROMETRY MEASUREMENT, NOS
C0175648|MAT
C0336766|MATCHES, NOS
C0559473|MATERNAL HISTORY
C0024923|MATERNAL MORTALITY
C1260875|MATING
C1417041|MATRILIN 1
C0331858|MATRIX
C0282597|MATRIX-ASSISTED LASER DESORPTION IONIZATION MASS SPECTROMETRY
C0623362|MATRIX METALLOPROTEINASE
C0671550|MATRIX METALLOPROTEINASE-14
C4553629|MATRIX REGIMEN
C0678723|MATURATION
C1254042|MATURATION
C0205286|MATURE
C0596888|MATURE ANIMAL
C0806909|MAXIMUM
C0340978|MAY HEGGLIN SYNDROME
C0083355|MAZE CHEMOTHERAPY PROTOCOL
C1417054|MBL2 GENE
C0024443|MDG
C1998602|MEAL
C0876919|MEANING
C2986844|MEAN LIFE
C0079809|MEASURE
C0201943|MEASUREMENT OF PROTEIN IN CEREBROSPINAL FLUID SPECIMEN
C0025017|MEAT
C0441712|MECHANISMS
C1513044|MEDIA INTERVENTION
C2939193|MEDIAN
C0127400|MEDIATOR
C1332782|MEDIATOR COMPLEX SUBUNIT 23
C0243042|MEDIATOR OF INFLAMMATION, NOS
C0025071|MEDICAID COVERAGE
C0205476|MEDICAL
C3536832|MEDICAL AIR
C0496675|MEDICAL CARE, UNSPECIFIED
C0565990|MEDICAL CENTRE
C0541653|MEDICAL CHART REVIEW
C0025080|MEDICAL DEVICE, NOS
C0871813|MEDICAL DIAGNOSIS
C0013560|MEDICAL ECONOMICS
C0582103|MEDICAL EXAMINATIONS
C0025086|MEDICAL IMAGING
C0680606|MEDICAL LAWS
C0018724|MEDICAL PERSONNEL
C2347098|MEDICAL PRODUCT STABILITY
C0008971|MEDICAL PROTOCOLS
C0036378|MEDICAL SCHOOL
C0418981|MEDICAL THERAPY
C0018717|MEDICARE
C0687133|MEDICATION INTERACTION
C0849166|MEDICATIONS;CARDIOVASCULAR
C0240320|MEDICATION USE
C0018026|MEDICINAL GOLD, NOS
C0025125|MEDICINAL HERBS
C0032100|MEDICINAL PLANTS
C0025118|MEDICINE
C0025123|MEDICINE, CHINESE
C0025119|MEDICINE IN ART
C0150277|MEDITATION
C0240321|MEDITERRANEAN
C1138412|MEDITERRANEAN DIET
C0522094|MEDIUM CHAIN FATTY ACID, NOS
C0724624|MEDIUM CHAIN TRIGLYCERIDES
C0065864|MEDROXYPROGESTERONE ACETATE PREPARATION
C1305694|MEDULLA
C0025148|MEDULLA OBLONGATA STRUCTURE
C0556656|MEETINGS
C0002888|MEGALOBLASTIC ANEMIA, NOS
C0065879|MEGESTROL ACETATE
C0025175|MEGESTROL-CONTAINING PRODUCT
C1417061|MELANOCORTIN 1 RECEPTOR
C0025202|MELANOMA SYNDROME
C0025219|MELATONIN-CONTAINING PRODUCT
C0065911|MELATONIN RECEPTOR
C1417449|MELATONIN RECEPTOR 1A
C0025235|MELKERSSON'S SYNDROME
C0083381|MELOXICAM-CONTAINING PRODUCT
C1881775|MELTING POINT
C0025242|MEMANTINE-CONTAINING PRODUCT
C0771988|MEMANTINE HYDROCHLORIDE
C0680022|MEMBER OF
C2698041|MEMBER ORGANIZATION
C0596897|MEMBRANE ACTIVITY
C0009545|MEMBRANE ATTACK COMPLEX (MAC)
C0004799|MEMBRANE, BASEMENT
C0022009|MEMBRANE CHANNEL
C0025245|MEMBRANE FLUIDITY
C0025249|MEMBRANE LIPIDS
C0025251|MEMBRANE POTENTIAL
C0230664|MEMBRANE RECEPTOR
C0025255|MEMBRANES
C1421956|MEMBRANE-SPANNING 4-DOMAINS, SUBFAMILY A, MEMBER 4A
C1422542|MEMBRANE-SPANNING 4-DOMAINS, SUBFAMILY A, MEMBER 4E
C1421960|MEMBRANE-SPANNING 4-DOMAINS, SUBFAMILY A, MEMBER 6A
C0596901|MEMBRANE STRUCTURE
C0406599|MEMBRANOUS LIPODYSTROPHY
C0312737|MEMORY CELLS
C0679057|MEMORY CONSOLIDATION
C0025261|MEMORY DISORDERS
C3887551|MEMORY DYSFUNCTION
C0557932|MEMORY LAPSES OR LOSS
C0002622|MEMORY LOSS
C0751295|MEMORY; LOSS
C0025260|MEMORY, NOS
C0700327|MEMORY OBSERVATIONS
C1285654|MEMORY PERFORMANCE
C0679052|MEMORY PROCESS
C0679063|MEMORY RECALL
C0598851|MEMORY RETENTION
C0025266|MEN
C0127516|MENADIONE SODIUM BISULFITE
C0065936|MENATETRENONE
C0025286|MENINGIOMA, NOS
C0025289|MENINGITIS, UNSPECIFIED
C0025309|MENINGOENCEPHALITIS
C0282402|MENOPAUSAL HORMONE THERAPY
C0236075|MENOPAUSAL SYMPTOMS
C0600142|MENOPAUSAL SYNDROME (HOT FLASHES)
C0004083|MENTAL ASSOCIATION
C0086045|MENTAL CONCENTRATION
C1263839|MENTAL; DEVELOPMENTAL DISORDER
C0542296|MENTAL HEALTH COUNSELING INDIVIDUAL EACH 15 MINUTES
C0025355|MENTAL HEALTH SERVICES, NOT OTHERWISE SPECIFIED
C0079822|MENTALLY RETARDED
C0850338|MENTAL STATE EXAMINATION
C1306341|MENTAL SUBNORMALITY
C0025365|MENTAL TEST
C0025424|MERCURY, NOS
C1257975|MESENCHYMAL STEM CELLS
C0380162|MESOTHELIN
C0025500|MESOTHELIOMA; UNSPECIFIED SITE
C0470166|MESSAGES
C0169911|MESSENGER PROTEIN
C0920317|META-ANALYSIS
C0311400|METABOLIC
C1513158|METABOLIC CONTROL
C0850673|METABOLIC DISORDER; CONGENITAL
C0012715|METABOLIC DISORDER; IRON
C0870882|METABOLIC RATES
C0524620|METABOLIC SYNDROME X
C0025519|METABOLISM
C1291081|METABOLISM
C1524026|METABOLISM
C1328813|METABOLOMICS
C0206529|METABOTROPIC GLUTAMATE RECEPTORS
C1178976|METABOTROPIC RECEPTOR
C0589513|METACOGNITION
C1323274|METAL ION BINDING
C1522552|METALLOPROTEINASE INHIBITOR 1
C0025543|METALLOPROTEINASES
C0025545|METALLOTHIONEIN
C1417392|METALLOTHIONEIN 1D, PSEUDOGENE
C0025552|METALS
C0025558|METAMORPHOSIS
C0860594|METASTATIC MALIGNANT MELANOMA
C0025598|METFORMIN-CONTAINING PRODUCT
C0025611|METHAMPHETAMINE PREPARATIONS
C0025627|METHAQUALONE
C0025637|METHEMOGLOBINEMIA, UNSPECIFIED
C0025638|METHENAMINE-CONTAINING PRODUCT
C1537982|METHIONINE SULFOXIDE REDUCTASE B3
C0039676|METHIONINE SYNTHASE
C3713294|METHIONINE SYNTHASE
C0025663|METHOD
C3266812|METHODOLOGY
C0746574|METHYLATE
C0025723|METHYLATION
C2347112|METHYLATION SITE
C0054666|METHYLENE
C0025750|METHYLENEBIS(CHLOROANILINE)
C0025746|METHYLENE BLUE STAIN-CONTAINING PRODUCT
C1417504|METHYLMALONYL-COA MUTASE
C0025810|METHYLPHENIDATE-CONTAINING PRODUCT
C0000097|METHYLPHENYLTETRAHYDROPYRIDINE
C0025831|METHYLTRANSFERASES
C0699680|METRIC
C0677647|MEVALONATE
C0025879|MEVALONIC ACID
C0056170|MEVASTATIN
C0240339|MEXICAN
C0025884|MEXICAN AMERICANS
C0019630|MHC CLASS II PROTEIN
C1417166|MHC CLASS I POLYPEPTIDE-RELATED SEQUENCE E (PSEUDOGENE)
C0025912|MIANSERIN-CONTAINING PRODUCT
C0721704|MICARDIS
C0730345|MICROALBUMINURIA
C0333101|MICROANEURYSMS
C0155765|MICROANGIOPATHY, NOS
C1449575|MICROARRAY TECHNOLOGY
C1136254|MICROBICIDES
C1003301|MICROCEBUS MURINUS
C0206056|MICRODIALYSIS
C0333227|MICROEMBOLUS
C0025958|MICROENCEPHALY
C0025979|MICROFILAMENT
C1257867|MICROFLUIDICS
C0521398|MICROGLIAL
C3686874|MICROGLIOSIS
C0025991|MICROINJECTIONS
C0026006|MICRONUCLEUS ASSAY
C0282575|MICRONUTRIENTS
C0445623|MICRO-ORGANISMS
C0230653|MICROPINOCYTOTIC VESICLE, NOS
C2743231|MICRORNA 124
C4321279|MICRORNA 16
C1537815|MICRORNA 181C
C0054943|MICROSOMAL AMINOPEPTIDASE
C1417147|MICROSOMAL GLUTATHIONE S-TRANSFERASE 3
C1313880|MICROTRAUMA
C1417033|MICROTUBULE AFFINITY REGULATING KINASE 1
C1422048|MICROTUBULE AFFINITY REGULATING KINASE 4
C3540600|MICROTUBULE-ASSOCIATED PROTEINS 1A/1B LIGHT CHAIN 3
C3642279|MICROTUBULE-ASSOCIATED PROTEINS 1A/1B LIGHT CHAIN 3-II
C0026045|MICROTUBULE-ASSOCIATED PROTEINS (MAP)
C1454489|MICROTUBULE-ASSOCIATED PROTEIN TAU
C1446659|MICROTUBULE-ASSOCIATED PROTEIN TAU
C1156032|MICROTUBULE POLYMERIZATION PROCESS
C0026046|MICROTUBULES
C0026056|MIDAZOLAM-CONTAINING PRODUCT
C0026062|MIDDLE-AGE
C0683973|MIDDLE-AGED ADULT
C3825963|MIDDLE-AGED MEN
C0205847|MIDDLE AGES
C1513295|MIDDLE INFERIOR FRONTAL CONVOLUTION
C1417167|MIDLINE 1
C0026018|MIEXAM
C0026088|MIFEPRISTONE PRODUCT
C2945599|MILD
C1270972|MILD; COGNITIVE IMPAIRMENT
C3494623|MILD DEMENTIA
C0588006|MILD DEPRESSION
C2347129|MILESTONE
C0237945|MILITARY VETERANS
C0560005|MILLICURIE(S)
C0920591|MIMETICS
C0006660|MINERALIZATION
C3254418|MINERALOCORTICOID RECEPTOR
C0026160|MINERALOCORTICOIDS
C0026162|MINERALS
C0240346|MINERS
C0445542|MINI
C1291708|MINIMAL COGNITIVE IMPAIRMENT
C0751699|MINIMALLY CONSCIOUS STATE
C0242827|MINISATELLITE REPEATS
C0026187|MINOCYCLINE-CONTAINING PRODUCT
C0026192|MINORITY GROUPS
C0040616|MINOR TRANQUILIZERS
C2825955|MIR144 WT ALLELE
C1826002|MIR146A GENE
C2826007|MIR203A WT ALLELE
C1537860|MIR222 GENE
C1537870|MIR320A GENE
C1537745|MIR34A GENE
C4284916|MIR574 WT ALLELE
C1428927|MIR7-3 HOST GENE
C4519306|MIRIDESAP
C1101610|MIRNA
C0049506|MIRTAZAPINE-CONTAINING PRODUCT
C1275957|MISALIGNMENT
C0679838|MISDIAGNOSIS
C0599155|MISSENSE MUTATION
C1551393|MISSING
C0544926|MITOCHONDRIAL ALTERATION
C0751651|MITOCHONDRIAL DISEASES
C0948444|MITOCHONDRIAL DNA MUTATION
C1537986|MITOCHONDRIALLY ENCODED CYTOCHROME C OXIDASE II
C1537995|MITOCHONDRIALLY ENCODED NADH:UBIQUINONE OXIDOREDUCTASE CORE SUBUNIT 6
C0596952|MITOCHONDRIAL MEMBRANES
C0949610|MITOCHONDRIAL PROTEIN
C1096176|MITOCHONDRIAL TOXICITY
C0230871|MITOCHONDRION IN DIVISION
C0026237|MITOCHONDRION, NOS
C1424611|MITOFUSIN 2
C1366876|MITOGEN-ACTIVATED PROTEIN KINASE 14
C1456380|MITOGEN-ACTIVATED PROTEIN KINASE 14
C1366765|MITOGEN-ACTIVATED PROTEIN KINASE 3
C0082529|MITOGEN-ACTIVATED PROTEIN KINASE-3 (MAPK3)
C1367731|MITOGEN-ACTIVATED PROTEIN KINASE 8
C1442512|MITOGEN-ACTIVATED PROTEIN KINASE KINASE 5
C1456387|MITOGEN-ACTIVATED PROTEIN KINASE KINASE 7
C0752312|MITOGEN-ACTIVATED PROTEIN KINASES
C0026255|MITOTIC CYCLE
C0026258|MITOTIC SPINDLE, NOS
C0205430|MIXED
C0813872|MK-801
C1417200|MMP10 GENE
C1619831|MMP3
C1366358|MMP3 GENE
C0165519|MMP-9
C1334523|MMP9 GENE
C0451306|MMSE
C0026327|MNS BLOOD GROUP SYSTEM
C0425258|MOBILITY POOR
C0066677|MODAFINIL-CONTAINING PRODUCT
C0695347|MODALITY-A THERAPEUTIC METHOD OR AGENT, SUCH AS SURGERY, CHEMOTHERAPY, OR ELECTROTHERAPY, THAT INVOLVES THE PHYSICAL TREATMENT OF A DISORDER
C3853906|MODEL
C3161035|MODEL
C0920595|MODEL DEVELOPMENT
C0870071|MODELING
C0026336|MODELS
C0026339|MODELS, BIOLOGICAL
C1513375|MODERATE EXERCISE
C0392747|MODIFY
C0443264|MODULATION
C1031041|MODULUS
C1521991|MOLECULAR
C0314678|MOLECULAR AGGREGATION
C0243041|MOLECULAR CHAPERONES
C0026377|MOLECULAR CONFORMATION, NOS
C1513388|MOLECULAR DIAGNOSIS
C1167622|MOLECULAR INTERACTION PROCESS
C1704259|MOLECULAR PATHWAY
C1513403|MOLECULAR TARGET
C0064830|MOL LEUKOCYTE ADHESIVE PROTEIN
C0563597|MOMENTUM
C0997448|MONASCUS
C1139730|MONITORING SYSTEMS
C0181904|MONITORS
C0026447|MONKEYS
C0026455|MONOAMINE OXIDASE A
C0595265|MONOAMINE OXIDASE B INHIBITOR-CONTAINING PRODUCT
C0026457|MONOAMINE OXIDASE--INHIBITORS
C0008225|MONOCHLOROACETIC ACID
C0003250|MONOCLONAL ANTIBODY-CONTAINING PRODUCT
C0279694|MONOCLONAL ANTIBODY THERAPY
C0128897|MONOCYTE CHEMOATTRACTANT PROTEIN 1
C0553698|MONOCYTE COUNT INCREASED
C0026473|MONOCYTES
C1442515|MONOGLYCERIDE LIPASE
C0596973|MONOMER
C0647210|MONOOXYETHYLENE TRIMETHYLOLPROPANE TRISTEARATE
C0066776|MONOPHOSPHORYL LIPID A
C0016895|MONOSIALOTETRAHEXOSYLGANGLIOSIDE
C0682997|MONOTERPENES
C0439231|MONTHS
C4721272|MONTREAL COGNITIVE ASSESSMENT SCORE
C3889585|MOOD
C0235146|MOOD EUPHORIC
C0233492|MOOD EXPANSIVE
C0026516|MOOD, NOS
C0026531|MORALITY
C0026538|MORBIDITY
C0066801|MORIN
C0344315|MOROSE MOOD
C0026549|MORPHINE-CONTAINING PRODUCT
C0332447|MORPHOLOGICALLY ABNORMAL STRUCTURE
C1260954|MORPHOLOGICALLY ALTERED STRUCTURE
C0085089|MORPHOLOGIC ARTIFACT
C0332437|MORPHOLOGY
C0021278|MORTALITY;INFANT
C0026565|MORTALITY RATE
C0026578|MOSAICISM
C0392053|MOSAICISM, NOS
C0026591|MOTHERS
C0026597|MOTION
C0026605|MOTIVATION, NOS
C0026607|MOTOR CORTEX
C0234393|MOTOR CORTICAL FUNCTION
C1705994|MOTOR DEVICE
C0221163|MOTOR; DISORDER
C0282617|MOTOR EVOKED POTENTIAL
C0234130|MOTOR FUNCTION, NOS
C1334804|MOTOR MANIFESTATIONS
C0026609|MOTOR NEURONS
C0085084|MOTOR NEURONS--DISEASES
C0870921|MOTOR PERFORMANCE
C1179106|MOTOR PROTEIN
C0426980|MOTOR SYMPTOMS
C0403130|MOTOR VEHICLE DRIVER
C0181909|MOUNTS
C1522730|MOUSE CENTRAL NERVOUS SYSTEM
C1334805|MOUSE PROTEIN
C1522259|MOUSE STRIATED SKELETAL MUSCLE
C1269909|MOVED FROM
C0558189|MOVEMENT; ABNORMAL
C0026650|MOVEMENT DISORDERS
C0026649|MOVEMENTS
C0560560|MOVING
C0026652|MOXIBUSTION TECHNIQUES
C0007591|M PHASE PROCESS
C0700271|M PROTEIN
C0412675|MRI OF BRAIN AND BRAIN STEM
C0412692|MRI OF HEART
C1515670|MRNA EXPRESSION
C3714939|MRS
C1367466|MSMB GENE
C1334534|MT3 GENE
C1425005|MTCH2 GENE
C0012929|MTDNA
C1538020|MTHFD1L GENE
C0066357|MTHFR
C0919427|MTHFR GENE
C3888046|MTORC1
C1515673|MTOR SIGNALING PATHWAY BIOCARTA
C0024853|MTQ
C1417458|MTRR GENE
C1612111|MUCIN-1
C1421967|MUCIN 3B, INTESTINAL
C0017973|MUCOPOLYSACCHARIDES
C1578559|MUCOSA, BUCCAL
C0017136|MUCOSA OF STOMACH
C0026724|MUCOUS MEMBRANE STRUCTURE
C0010674|MUCOVISCIDOSIS
C0687670|MULLERIAN DUCT INHIBITING SUBSTANCE (MIS)
C1562585|MULTIBACILLARY LEPROSY
C0206012|MULTICENTER TRIALS
C3463911|MULTICILIATE DIFFERENTIATION AND DNA SYNTHESIS-ASSOCIATED CELL CYCLE PROTEIN
C0242479|MULTIDISCIPLINARY
C0729737|MULTIDISCIPLINARY ASSESSMENT
C1144866|MULTI-DISCIPLINARY TEAM
C0026741|MULTIENZYME COMPLEXES
C0376478|MULTIMEDIA
C1513743|MULTIMODAL IMAGING
C0009429|MULTIMODALITY TREATMENT
C1535889|MULTIMORBIDITY
C0026751|MULTIPAROUS
C0314632|MULTIPLE ALLELES
C0026753|MULTIPLE BIRTHS
C3266262|MULTIPLE CHRONIC DISEASES
C0577305|MULTIPLE LESIONS
C3276432|MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1
C0026766|MULTIPLE ORGAN FAILURE, NOS
C0679225|MULTIPLE PATHOLOGIES
C0033972|MULTIPLE THERAPY
C1265815|MULTIPLE ULCERS
C1704444|MULTIPLICATIVE PRODUCT
C0393571|MULTISYSTEM ATROPHY
C0559758|MULTISYSTEM DISORDERS
C0230825|MULTIVESICULAR BODY, NOS
C0268659|MULTI-VITAMIN DEFICIENCY
C0441995|MURAL
C0337440|MURAMIDASE DETERMINATION
C0026794|MURAMIDASE (LYSOZYME)
C0026809|MUS
C0231491|MUSCLE ACTION, ANTAGONIST
C0596981|MUSCLE CELLS
C0026820|MUSCLE CONTRACTIONS
C0009917|MUSCLE; CONTRACTURE
C0011980|MUSCLE, DIAPHRAGM
C0240417|MUSCLE MASS
C0596984|MUSCLE METABOLISM
C0358430|MUSCLE RELAXANTS
C0026821|MUSCLE(S) CRAMP(S)
C0517349|MUSCLE STRENGTH
C0026845|MUSCLE TISSUE
C0851647|MUSCLE TONE; DISORDER
C0225358|MUSCULARIS PROPRIA, NOS
C2334362|MUSCULATURE OF BODY WALL
C1334531|MUSCULIN
C0026857|MUSCULOSKELETAL SYSTEM DISORDER
C0870929|MUSIC EDUCATION
C0026868|MUSIC THERAPY
C0026879|MUTAGENS
C0596988|MUTANT
C0678941|MUTANT GENE
C1564139|MUTANT PROTEIN
C1513776|MUTATE
C0796357|MUTATION ANALYSIS
C0026882|MUTATIONS
C0006416|MYANMAR
C0026896|MYASTHENIA GRAVIS, NOS
C1428063|MYCBP2 GENE
C0026955|MYCOTOXINS
C0080065|MYC PROTO-ONCOGENE PROTEIN
C1416989|MYELIN AND LYMPHOCYTE PROTEIN
C0596991|MYELINATION
C1567500|MYELIN BASIC PROTEIN
C0014063|MYELIN BASIC PROTEIN
C0026969|MYELIN, NOS
C1417248|MYELIN PROTEIN ZERO
C0026973|MYELIN SHEATH STRUCTURE
C1513787|MYELOID CELL ACTIVATION PROCESS
C0887899|MYELOID CELLS
C3491277|MYELOID CELL SURFACE ANTIGEN CD33
C0027030|MYIASIS, UNSPECIFIED
C0596995|MYOBLASTS
C3810814|MYOCARDIAL INFARCTION ECG ASSESSMENT
C0027051|MYOCARDIAL INFARCTIONS
C0878544|MYOCARDIUM DISORDER
C0746730|MYOCARDIUM; INJURY
C0151744|MYOCARDIUM; ISCHEMIC
C0751783|MYOCLONIC EPILEPSY OF LAFORA
C0014550|MYOCLONUS EPILEPSY
C0027066|MYOCLONUS; JERKS
C0016053|MYOFASCIAL PAIN SYNDROME
C0027078|MYOGLOBIN
C1417048|MYOGLOBIN
C0021547|MYO-INOSITOL
C0001497|MYOKINASE
C0026848|MYOPATHY, UNSPECIFIED
C0027120|MYOSIN LIGHT CHAIN KINASE, SMOOTH MUSCLE
C1427370|MYOSIN REGULATORY LIGHT CHAIN-INTERACTING PROTEIN
C0067067|MYRICETIN
C0024974|MYT
C0556124|N-3 FATTY ACID INTAKE
C0561929|N-3 FATTY ACID SUPPLEMENTATION
C0067518|N-(4-AMINOPHENETHYL)SPIROPERIDOL (NAPS)
C1879645|NA
C1452654|N-ACETYLCYSTEINE AMIDE
C0001056|N-ACETYL GLUCOSAMINE
C0067684|N-ACETYL-L-ASPARTATE
C0001047|N-ACETYL-L-CYSTEINE
C1417631|NADH:UBIQUINONE OXIDOREDUCTASE SUBUNIT AB1
C0027310|NADPH-FERRIHEMOPROTEIN REDUCTASE
C0068355|NADPH OXIDASE
C0474824|NAEVUS;HALO
C0027329|NAFTIDROFURYL
C0027365|NAMES
C0233735|NAMING, NOS
C1328814|NANOMEDICINE
C1450054|NANOPARTICLES
C0872323|NANOTECHNOLOGY
C0870935|NAPPING
C0027404|NARCOLEPTIC SYNDROME
C0068451|NARINGIN
C0001560|NASAL ADMINISTRATION
C0027442|NASOPHARYNX, NOS
C1172734|NATALIZUMAB-CONTAINING PRODUCT
C1555720|NATION
C1955974|NATIONAL INSTITUTE ON AGING
C0027473|NATIONALITY
C0027470|NATIONAL LIBRARY OF MEDICINE
C0681817|NATIONAL SURVEY
C0302891|NATIVE
C0282204|NATIVE AMERICANS
C1144709|NATRIURETIC PEPTIDE
C0205296|NATURAL
C0020969|NATURAL IMMUNITY
C0856856|NATURAL MENOPAUSE
C1566558|NATURAL PRODUCT
C0751363|NATURAL REMEDIES
C0086685|NATURAL SELECTION
C0349590|NATURE
C1521808|NCI CLINICAL TRIALS COOPERATIVE GROUP
C1706276|NEAR
C0376519|NEAR-INFRARED SPECTROSCOPY
C0475806|NEAR VISION
C0429541|NEAR VISUAL ACUITY
C0027530|NECK STRUCTURE
C0027551|NEEDLES
C0027552|NEEDS
C1518422|NEGATION
C1262620|NEGATIVE ATTITUDE
C0013852|NEGATIVE BETA PARTICLE
C1513916|NEGATIVE FINDING
C1516019|NEGATIVE REGULATION OF INFLAMMATORY RESPONSE PROCESS
C1709157|NEGATIVE SURGICAL MARGIN
C1553702|NEIGHBOR
C0027569|NEIGHBORHOODS
C0175173|NEOCORTEX
C0027608|NEON, NOS
C0005684|NEOPLASM MALIG;BLADDER
C0242379|NEOPLASM MALIG;LUNG
C0085136|NEOPLASM OF CENTRAL NERVOUS SYSTEM
C1263885|NEOPLASM OF CEREBRUM
C0068527|NEOPTERIN
C0596087|NEOVASCULARIZATION INHIBITORS
C0337579|NEPHEW
C0011881|NEPHROPATHY;DIABETIC
C0025250|NEPRILYSIN
C3887624|NEPRILYSIN
C1514121|NERVE CELL SURVIVAL
C0027754|NERVE GROWTH FACTOR
C1571151|NERVE GROWTH FACTOR
C0161479|NERVE INJURY, NOS
C0027740|NERVE STRUCTURE
C0003125|NERVOSA; ANOREXIA
C3542961|NERVOUS SYSTEM
C0004388|NERVOUS SYSTEM, AUTONOMIC
C0598282|NERVOUS SYSTEM DEVELOPMENT
C0007682|NERVOUS SYSTEM; DISORDER, CENTRAL
C0597037|NERVOUS SYSTEM DISORDER DIAGNOSIS
C0597039|NERVOUS SYSTEM INFECTIOUS DISORDER
C0054015|NESIRITIDE-CONTAINING PRODUCT
C0870949|NEST BUILDING
C1442814|NETRIN-1
C1882071|NETWORK
C3714606|NEURAL
C0282587|NEURAL CELL ADHESION MOLECULE (NCAM)
C0027746|NEURAL DEGENERATION
C0598941|NEURAL NETWORK
C0870951|NEURAL NETWORK SIMULATION
C0027792|NEURAL PATHWAYS
C1417664|NEURAL PRECURSOR CELL EXPRESSED, DEVELOPMENTALLY DOWNREGULATED 9
C1113654|NEURAL STEM CELLS
C0027794|NEURAL TUBE DEFECTS
C0752253|NEUREGULIN
C1437978|NEUREGULIN-1
C0665692|NEUREGULIN-3
C0085103|NEURITE
C1425210|NEURITIN 1
C0027817|NEUROBIOLOGY
C0814005|NEUROBLAST
C0027819|NEUROBLASTOMA; UNSPECIFIED SITE
C0518895|NEUROCOGNITIVE
C0270724|NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A
C0524851|NEURODEGENERATIVE DISORDER
C0011615|NEURODERMATITIS; DISSEMINATED
C0599855|NEURODEVELOPMENT
C1535926|NEURODEVELOPMENTAL DISORDER
C0027912|NEUROENDOCRINE SYSTEM
C0085400|NEUROFIBRILLARY TANGLES
C0085418|NEUROFILAMENT PROTEIN
C1417668|NEUROFILAMENT PROTEIN, LIGHT POLYPEPTIDE
C0814002|NEUROGENESIS
C1422393|NEUROGLOBIN
C1417847|NEUROGRANIN
C0679575|NEUROIMAGING
C0040615|NEUROLEPTICS
C1422548|NEUROLIGIN 1
C0205494|NEUROLOGICAL
C0848771|NEUROLOGICAL DISABILITY
C0751792|NEUROLOGICAL INJURY
C0234143|NEUROLOGICAL MUSCLE WEAKNESS
C0521654|NEUROLOGIC DEFICIT
C0027853|NEUROLOGIC EXAMINATION
C0027767|NEUROLOGIC FUNCTION
C0027854|NEUROLOGIC MANIFESTATIONS OF GENERAL DISEASES
C0746866|NEUROLOGIC STATUS
C0237426|NEUROLOGISTS
C0027855|NEUROLOGY
C0587475|NEUROLOGY DEPARTMENT
C0949370|NEUROMODULATORS
C0454448|NEUROMUSCULAR STIMULATION
C0027868|NEUROMYOPATHY
C0521390|NEURONAL
C0027877|NEURONAL CEROID LIPOFUSCINOSIS (CLN)
C3670500|NEURONAL DEGENERATION
C1518294|NEURONAL DIFFERENTIATION
C0022797|NEURONAL LIPOFUSCINOSIS, ADULT
C0178766|NEURONAL TRANSPORT
C0027882|NEURONS
C0682678|NEURON STRUCTURE
C0392776|NEUROPATHIC ATROPHY
C1518296|NEUROPATHOGENESIS
C0876934|NEUROPATHOLOGY
C1540677|NEUROPATHOLOGY
C0442874|NEUROPATHY
C0011882|NEUROPATHY;DIABETIC
C1334960|NEUROPEPTIDE GENE
C0027895|NEUROPEPTIDES
C0027893|NEUROPEPTIDE Y
C0700630|NEUROPHYSIOLOGY
C0228081|NEUROPIL
C0521175|NEUROPIL THREAD
C0027880|NEUROPLASTICITY
C0598958|NEUROPROTECTION
C0242912|NEUROPROTECTIVE AGENTS
C4285807|NEUROPSYCHIATRIC SYMPTOMS
C0334912|NEUROPSYCHIATRIST
C0027902|NEUROPSYCHOLOGICAL TESTS
C0027910|NEUROSCIENCES
C0011581|NEUROSIS; DEPRESSIVE
C0815278|NEUROSTEROIDS
C0521307|NEUROSTIMULATION PROCEDURE, NOS
C1842981|NEUROTICISM
C0597059|NEUROTOXICOLOGY
C0027934|NEUROTOXINS
C0598964|NEUROTRANSMITTER RELEASE
C0027908|NEUROTRANSMITTERS
C0132298|NEUROTROPHIC FACTOR
C0597065|NEUROTROPIC VIRUS
C1518304|NEUROTROPISM
C1570403|NEUTRAL CERAMIDASE
C0215955|NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN
C0079633|NEUTROPHILIC CHEMOTACTIC FACTOR
C0312860|NEUTROPHIL MIGRATION
C0205314|NEW
C0021289|NEWBORN INFANTS
C4528280|NEW TARGET LESION IDENTIFICATION
C0683887|NEW TECHNOLOGY
C2936622|NEXT GENERATION SEQUENCING
C1313359|N-GLYCOSYLASE/DNA LYASE
C0068008|N-HEXANE
C1074110|NIA FUNGUS
C1538050|NICASTRIN
C0086707|NICOTIANA, NOS
C0027270|NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD)
C1571622|NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE
C0028043|NICOTINE; DEPENDENCE
C0573225|NICOTINE OVERDOSE
C0238311|NICOTINE POISONING
C0028040|NICOTINE PRODUCT
C0034830|NICOTINIC RECEPTOR SITE
C0337578|NIECE
C0268242|NIEMANN-PICK DISEASE, TYPE A
C1843366|NIEMANN-PICK DISEASE, TYPE C2
C0028066|NIFEDIPINE-CONTAINING PRODUCT
C0028067|NIFLUMIC ACID
C0028084|NIGHTMARES
C1697238|NIH STROKE SCALE
C0442734|NIL
C0132512|NILVADIPINE
C0028094|NIMODIPINE-CONTAINING PRODUCT
C0028101|NIOBIUM
C0028125|NITRATE SALT, NOS
C0028127|NITRENDIPINE
C0028128|NITRIC OXIDE-CONTAINING PRODUCT
C0600437|NITRIC OXIDE DONORS
C0907533|NITRIC OXIDE SYNTHASE, BRAIN
C0669365|NITRIC OXIDE SYNTHASE, ENDOTHELIAL
C0669372|NITRIC OXIDE SYNTHASE, INDUCIBLE
C0132555|NITRIC OXIDE SYNTHETASE
C0028137|NITRITE SALT, NOS
C0028156|NITROFURANTOIN-CONTAINING PRODUCT
C0017887|NITROGLYCERINE
C0028197|NITROSAMINE, NOS
C0028215|NITROUS OXIDE GAS
C1826435|NLRP1 GENE
C1424250|NLRP3 GENE
C0598695|NMDA RECEPTOR ANTAGONIST-CONTAINING PRODUCT
C2916808|NMDA RECEPTOR ANTAGONISTS
C0079883|N-METHYL-D-ASPARTATE
C0080093|N-METHYL-D-ASPARTATE RECEPTOR
C0027183|N,-N-DIMETHYLTRYPTAMINE
C0012200|N-NITROSODIETHYLAMINE
C0012431|N-NITROSODIMETHYLAMINE
C0068235|N-NITROSOPIPERIDINE
C0027253|N-NITROSOPYRROLIDINE
C0028237|NOBELIUM
C0234194|NOCICEPTION
C0746922|NODE
C0445079|NODE STAGE N2A
C0233698|NOESIS
C1417753|NOGGIN, MOUSE, HOMOLOG OF
C0028263|NOISE
C0028296|NONAGENARIAN
C0400966|NONALCOHOLIC FATTY LIVER DISEASE
C0722138|NON-ASPIRIN
C4505065|NON-COMMUNICABLE DISEASE
C1536085|NONEXUDATIVE MACULAR DEGENERATION
C0271083|NONEXUDATIVE SENILE MACULAR RETINAL DEGENERATION
C1273529|NON-FAMILY MEMBER
C0349390|NON-FLUENT DYSPHASIA
C0729627|NON-HDL CHOLESTEROL
C0521118|NON-INFECTED
C0442743|NONINFLAMMATORY
C0205303|NON-INVASIVE
C0023467|NON-LYMPHOBLASTIC LEUKEMIA ACUTE
C0086692|NONMALIGNANT NEOPLASM
C1513853|NON MOUSE
C0233419|NONPERSISTENCE
C0020740|NON-PRESCRIPTION IBUPROFEN
C0027396|NON-PRESCRIPTION NAPROXEN
C0007131|NON SMALL CELL LUNG CARCINOMA
C0337672|NON-SMOKER
C0151583|NONSPECIFIC ABNORMAL FINDINGS IN CEREBROSPINAL FLUID
C1518388|NON-SURGICAL
C0242913|NOOTROPICS
C0332124|NO PAST HISTORY OF
C0599861|NORADRENERGIC
C0520868|NORMAL CARDIAC INDEX
C1268443|NORMAL CELL
C0314761|NORMAL FLORA
C0234725|NORMAL HEARING, NOS
C0358321|NORMAL IMMUNOGLOBULIN HUMAN-CONTAINING PRODUCT
C0578863|NORMAL INTRAOCULAR PRESSURE STATE
C0848894|NORMAL PATIENT
C0020258|NORMAL PRESSURE HYDROCEPHALUS SYNDROME
C0152136|NORMAL TENSION GLAUCOMA
C0544712|NORMAL VARIATION
C2712122|NORMOTENSIVE
C0239310|NORTHERN EUROPEAN
C0282245|NORTHERN MARIANA ISLANDS
C1417759|NOS1 GENE
C1328053|NOS3 GENE
C1235660|NOTCH
C0085632|NOTHING MATTERS
C1518424|NOT HISPANIC OR LATINO
C1273937|NOT SIGNIFICANT
C1417771|NOX4 GENE
C1417776|NPC INTRACELLULAR CHOLESTEROL TRANSPORTER 1
C1422736|NPC INTRACELLULAR CHOLESTEROL TRANSPORTER 2
C0118522|NRF-2
C1334903|NRG3 GENE
C1417853|NRXN3 GENE
C0003211|NSAIDS
C1417599|NSF ATTACHMENT PROTEIN ALPHA
C0919487|NTRK1 GENE
C1334909|NTRK2 GENE
C0752246|N-TYPE CALCIUM CHANNELS
C1449832|NUCHAL TRANSLUCENCY SCREEN
C0544910|NUCLEAR ACCUMULATION
C1179920|NUCLEAR DNA
C1431185|NUCLEAR FACTOR 1 B-TYPE
C1417700|NUCLEAR FACTOR, ERYTHROID 2 LIKE 1
C1565078|NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2
C0069116|NUCLEAR FACTOR-I
C1417706|NUCLEAR FACTOR, INTERLEUKIN 3-REGULATED
C0079904|NUCLEAR FACTOR KAPPA B (NF-KB)
C0214222|NUCLEAR FACTOR (NF)-KAPPA B P65
C0024485|NUCLEAR MAGNETIC RESONANCE IMAGING
C0949374|NUCLEAR PROTEIN
C1743596|NUCLEAR RECEPTOR COACTIVATOR 1
C0206588|NUCLEAR RECEPTORS
C1417824|NUCLEAR RECEPTOR SUBFAMILY 1, GROUP H, MEMBER 3
C1334899|NUCLEAR RECEPTOR SUBFAMILY 3, GROUP C, MEMBER 1
C1417838|NUCLEAR RECEPTOR SUBFAMILY 5, GROUP A, MEMBER 1
C1417839|NUCLEAR RECEPTOR SUBFAMILY 5, GROUP A, MEMBER 2
C0008546|NUCLEAR SAP
C1518440|NUCLEAR TRANSLOCATION
C0597094|NUCLEASE
C1180059|NUCLEATED CELL
C0014762|NUCLEATED RED CELLS
C0028606|NUCLEIC ACID SUBSTANCE
C1417756|NUCLEOLAR PROTEIN 3
C0069155|NUCLEOSIDE-DIPHOSPHATASE
C0524550|NUCLEOTIDE EXCISION REPAIR
C0028630|NUCLEOTIDES
C0004793|NUCLEOTIDE SEQUENCE
C0028633|NUCLEUS ACCUMBENS
C0175392|NUCLEUS DORSALIS RAPHAE
C0025932|NUDE MOUSE
C0456148|NULL
C1518469|NUMBER OF FIRST DEGREE RELATIVES (AFFECTED)
C0028643|NUMBNESS
C0028682|NURSING CARE, NOS
C0872103|NURSING & CUSTODIAL CARE FACILITIES; ASSISTED LIVING FACILITY
C0260062|NURSING HOME CARE
C0682287|NURSING HOME RESIDENT
C0028688|NURSING HOMES
C0886296|NURSING INTERVENTIONS
C0028663|NURSING SERVICE RELATED PROVIDERS; NURSE'S AIDE
C1518478|NUTRACEUTICAL
C0006777|NUTRIENT INTAKE
C0015745|NUTRIENT INTAKE ACTIVITY
C0678695|NUTRIENTS
C0242296|NUTRIENT SUPPLEMENTATION
C1521739|NUTRITIONAL
C0242739|NUTRITIONAL SUPPORT
C1556156|NUTRITION, CALORIES
C3536818|NUTRITIONIST
C0028719|NUTRITION--REQUIREMENTS
C0392209|NUTRITION:STATUS
C0028723|NUTS
C0311277|OBESITY;ABDOMINAL
C0028754|OBESITY, UNSPECIFIED
C0018017|OBJECTIVE
C4552789|OBJECTIVE
C0599621|OBJECT RECOGNITION
C1706279|OBJECT RELATIONSHIP
C1518527|OBSERVATIONAL STUDY
C0236018|OBSERVATION OF AURA
C0005612|OBSERVATION OF BIRTH WEIGHT
C0578022|OBSERVATION OF BODY MASS INDEX
C0600104|OBSESSIVE-COMPULSIVE BEHAVIOR
C0028778|OBSTRUCTIONS
C0865791|OBSTRUCTIVE; BRONCHITIS
C0520679|OBSTRUCTIVE SLEEP APNOEA SYNDROME
C1184145|OCCIPITAL
C3811911|OCCIPITAL CORTEX
C0028785|OCCIPITAL LOBE STRUCTURE
C0230005|OCCIPUT
C0740391|OCCLUSION; MIDDLE CEREBRAL ARTERY
C2827063|OCCUPANCY
C0521127|OCCUPATIONAL
C0028798|OCCUPATIONAL EXPOSURE
C0026126|OCCUPATION: MILITARY PERSONNEL
C1709305|OCCUR
C0028816|OCHRATOXINS
C0133660|OCTANOATE
C0999710|OCTODON DEGUS
C0028829|OCTOGENARIANS
C1282359|OCULAR CICATRICIAL PEMPHIGOID
C0015413|OCULAR MOTILITY, NOS
C1557335|OCULAR SURFACE DISEASE
C1519551|ODONTOGENIC TISSUE
C0006114|OEDEMA CEREBRAL
C0014927|OESTRIOL PRODUCT
C0853662|OESTROGEN DEFICIENCY
C0474186|OESTROGEN HORMONE THERAPY
C0877035|OESTROGENIC EFFECT
C0034804|OESTROGEN RECEPTOR
C0014935|OESTROGEN REPLACEMENT THERAPY
C0279494|OESTROGEN THERAPY
C0014942|OESTRONE
C0332183|OFTEN
C1335081|OGG1 GENE
C0028908|OIL, NOS
C0069389|OKADAIC ACID
C1457872|OKRA
C0171023|OLANZAPINE-CONTAINING PRODUCT
C0580836|OLD
C3826770|OLDER PEOPLE
C1518563|OLDER POPULATION
C0001795|OLDEST OLD
C0025914|OLD WORLD MOUSE
C0996956|OLEA
C0220884|OLEATE
C0133788|OLEATE
C0028928|OLEIC ACID
C0439826|OLFACTORY
C0028939|OLFACTORY PATHWAY STRUCTURE
C1418072|OLFACTORY RECEPTOR FAMILY 4 SUBFAMILY G MEMBER 1 PSEUDOGENE
C0599332|OLFACTORY SENSORY EPITHELIUM
C0069426|OLIGOCLONAL BANDS
C0028944|OLIGODENDROGLIA
C4330852|OLIGOMERIC PROCYANIDIN COMPLEX
C0028953|OLIGONUCLEOTIDES
C0028959|OLIGOSACCHARIDES
C1417945|O-LINKED N-ACETYLGLUCOSAMINE TRANSFERASE
C0069449|OLIVE OIL-CONTAINING PRODUCT
C0349382|OLIVES
C0015689|OMEGA-3-FATTY ACIDS
C0133860|OMEGA-6 FATTY ACIDS
C0028978|OMEPRAZOLE-CONTAINING PRODUCT
C0812383|ONCOGENE FPS-FES
C1417123|ONCOGENE MET
C0288472|ONCOPROTEIN P21
C0061851|ONDANSETRON-CONTAINING PRODUCT
C0549178|ONGOING
C0681318|ONLINE SEARCHING
C0277793|ONSET OF ILLNESS, NOS
C0578998|ON TREATMENT FOR HYPERTENSION
C1510497|OPACITY; LENS
C0029053|OPAQUE
C0189745|OPEN HEART SURGERY, NOS
C0547049|OPENNESS
C0038902|OPERATION ON FEMALE GENITAL ORGANS, NOS
C0018821|OPERATIVE PROCEDURE ON HEART, NOS
C0015392|OPHTHALMIC
C0180093|OPHTHALMIC CONFORMERS
C0015399|OPHTHALMIC SOLUTION DOSAGE FORM
C0029090|OPHTHALMOSCOPY, NOS
C0871010|OPINION
C0242402|OPIOID RECEPTOR AGONIST
C1417963|OPIOID RECEPTOR, KAPPA-1
C0002772|OPIOIDS
C0034801|OPIOIDS--RECEPTORS
C0524662|OPIOID TYPE DRUG DEPENDENCE
C0240602|OPIOID USE
C0422389|OPPORTUNISTIC SCREENING
C1417965|OPRM1 GENE
C1415024|OPSIN 1, MEDIUM-WAVE-SENSITIVE
C0278233|OPTIC DISC CUP
C0029127|OPTIC NERVE HEAD
C0029130|OPTIC NERVE STRUCTURE
C0027873|OPTIC; NEUROMYELITIS
C2698651|OPTIMUM
C1424774|OPTN GENE
C0354604|ORAL ANTICOAGULANTS
C0597134|ORAL BACTERIA
C0226896|ORAL CAVITY STRUCTURE
C0026636|ORAL DISORDER
C0029161|ORAL GLUCOSE TOLERANCE TEST
C0029164|ORAL HYGIENE
C0360482|ORAL IBUPROFEN
C0555971|ORAL INFECTION
C0069590|ORALIT ELECTROLYTE SOLUTION
C0175795|ORAL MEDICATION
C0001563|ORAL MEDICATION ADMINISTRATION EACH TREATMENT
C0026639|ORAL MUCOUS MEMBRANE STRUCTURE
C0153381|ORAL NEOPLASM MALIGNANT
C0351437|ORAL SUPPLEMENT
C1705178|ORDER
C0001774|ORDER AGARICALES
C0012578|ORDER DIPTERA
C1527908|OREXIN
C1113688|OREXIN
C1318453|ORGAN DONATION
C0029219|ORGANELLE STRUCTURE
C0683324|ORGANIC DISEASE
C0014898|ORGANIC ESTER
C0029235|ORGANISMS
C0029246|ORGANIZATIONS
C0392143|ORGANOCHLORINE PESTICIDE
C0029250|ORGANOID
C0360429|ORGANOPHOSPHATE PESTICIDE
C0029254|ORGANOPHOSPHORUS COMPOUNDS
C0178784|ORGANS (ANATOMY)
C0439659|ORIGINS
C0029279|ORNITHINE CARBAMOYLTRANSFERASE (OCT)
C0430533|ORODENTAL TEST
C0178782|OROFACIAL PAIN
C0521367|OROPHARYNX, NOS
C0029297|OROSOMUCOID
C1418187|OROSOMUCOID 2
C1335144|ORTHOLOGOUS GENE
C0029341|ORTHOMYXOVIRUSES
C0149746|ORTHOSTASIS
C0268004|OSMOLALITY DISTURBANCE, NOS
C0029393|OSMOTIC PRESSURE
C0432214|OSTEOARTHRITIS WITH MILD CHONDRODYSPLASIA
C0029408|OSTEOARTHROSIS (OA)
C0409959|OSTEOARTHROSIS OF KNEE
C0029418|OSTEOBLASTS
C0029431|OSTEOCLASTS
C0029433|OSTEOGENESIS
C0029442|OSTEOMALACIA, UNSPECIFIED
C0877342|OSTEOPOROSIS PROPHYLAXIS
C0747079|OSTEOPOROSIS RISK
C0029434|OSTEOPSATHYROSIS
C0009566|OTHER COMPLICATION
C0017394|OTHER GENETIC SCREENING
C0029713|OTHER PRETERM INFANTS, UNSPECIFIED [WEIGHT]
C0278321|OTHER REMOVAL OF BOTH OVARIES AT SAME OPERATIVE EPISODE
C1427896|OTU DOMAIN-CONTAINING UBIQUITIN ALDEHYDE-BINDING PROTEIN 1
C0029904|OUABAIN-CONTAINING PRODUCT
C0012652|OUTBREAK
C0086749|OUTCOME MEASURES
C1167331|OUTER MEMBRANE
C0230839|OUTER MITOCHONDRIAL MEMBRANE
C0004271|OUTLOOK
C0002423|OUTPATIENT CARE
C0002424|OUTPATIENT CLINICS
C0029921|OUTPATIENTS
C0205065|OVARIAN
C0678879|OVARIAN FUNCTION
C4521988|OVARIAN HORMONE
C0029939|OVARY, NOS
C0878773|OVERACTIVE; BLADDER
C0020550|OVERACTIVE THYROID
C1536696|OVERACTIVITY
C0424295|OVERACTIVITY; BEHAVIOR
C1561607|OVERALL
C0814466|OVERDIAGNOSIS
C0029944|OVERDOSE
C0017359|OVERLAPPING GENE
C1257763|OVERNUTRITION
C0013231|OVER THE COUNTER PRODUCTS
C0497406|OVERWEIGHT (BMI <30)
C0029976|OVUM; IMPLANTATION
C0029981|OWNERSHIP
C0069751|OXCARBAZEPINE-CONTAINING PRODUCT
C1418206|OXIDASE, CYTOCHROME C, ASSEMBLY 1-LIKE
C0242417|OXIDASES
C2266999|OXIDATION ACTIVITY
C0311404|OXIDATIVE
C0030013|OXIDATIVE PHOSPHORYLATION PATHWAY
C0242606|OXIDATIVE STRESS
C0028167|OXIDE OF NITROGEN
C0030015|OXIDES
C0030011|OXIDIZE
C0597152|OXIDIZED LIPID
C0348035|OXIDIZED LOW DENSITY LIPOPROTEIN
C0085403|OXIDIZING AGENTS
C0085196|OXIDOPAMINE
C0061516|OXIGLUTATIONE
C0051395|OXOGLURIC ACID
C0030031|OXOLINIC ACID
C0242184|OXYGEN; DEFICIENCY
C0178645|OXYGEN FREE RADICAL
C0030054|OXYGEN, NOS
C0429622|OXYGEN SUPPLY
C0003130|OXYGEN SUPPLY ABSENT
C0030106|OZONE (O3)
C0525037|P16
C0257535|P38 MAPK
C0071163|PACAP
C0013194|PACKAGING
C3814046|PAD REGIMEN
C0234238|PAIN ACHING
C1298685|PAIN CHRONIC SYNDROME
C0018681|PAIN; HEAD
C4086721|PAIN INTERFERENCE SUBORDINATE DOMAIN
C0026858|PAIN;MUSCULOSKELETAL
C0007859|PAIN; NECK
C0002771|PAIN RELIEVING DRUGS
C0597162|PAIRED HELICAL FILAMENT
C1426911|PAIRED IMMUNOGLOBULIN-LIKE TYPE 2 RECEPTOR, ALPHA
C0150103|PAIRING
C0753678|PALIPERIDONE-CONTAINING PRODUCT
C0069964|PALMIDROL
C0030234|PALMITIC ACID
C0030266|PANAMA
C0086767|PANAX
C0949314|PANAX GINSENG
C1179517|PANCREATIC ACINAR CELLS
C0235974|PANCREATIC CARCINOMA
C0232786|PANCREATIC FUNCTIONS
C0030292|PANCREATIC HORMONES
C0030298|PANCREATIC POLYPEPTIDE (PP)
C1418858|PANCREATIC POLYPEPTIDE RECEPTOR 1
C0376670|PANCREATITIS ALCOHOLIC
C0030305|PANCREATITIS, NOS
C0015625|PANCYTOPENIA; CONGENITAL
C1706365|PANEL DEVICE
C0324855|PAN PANISCUS
C0023756|PANTHERA LEO
C0369773|P ANTIBODY
C0315232|PANTOEA AGGLOMERANS
C0008111|PAN TROGLODYTES
C0682730|PAPEZ CIRCUIT
C0000970|PARACETAMOL PRODUCT
C0597170|PARACRINE
C0525011|PARACRINE COMMUNICATION
C0681797|PARADIGM
C0205310|PARADOXICAL
C1519524|PARAFFIN EMBEDDED TISSUE
C1418262|PARALEMMIN
C0015469|PARALYSIS; FACIAL NERVE
C0018378|PARALYSIS; LANDRY
C0522224|PARALYSIS, UNSPECIFIED
C0449381|PARAMETERS
C0349398|PARANOID DELUSIONS
C0052451|PARAOXONASE
C0030482|PARAPHILIC DISORDER
C0030493|PARAQUAT
C0030498|PARASITIC
C0030499|PARASITIC DISORDERS
C1419086|PARATHYMOSIN
C0020063|PARATHYROID HORMONE
C0020502|PARATHYROID; HYPERFUNCTION
C0231519|PARATONIA
C0933845|PARENCHYMA
C0682552|PARENCHYMAL CELL
C0524342|PARENTAL DEATH
C0030551|PARENTS
C0030554|PARESTHESIAS
C0249582|PARICALCITOL-CONTAINING PRODUCT
C0442030|PARIETAL
C0030560|PARIETAL LOBE STRUCTURE
C0230004|PARIETAL REGION STRUCTURE
C0582422|PARKINSONIAN FEATURES
C0242422|PARKINSONISM, NOS
C0070122|PAROXETINE-CONTAINING PRODUCT
C0235480|PAROXYSMAL ATRIAL FIBRILLATION
C0011017|PARTIAL HOSPITALIZATION
C0679646|PARTICIPANT
C0679823|PARTICIPATION
C0597177|PARTICLES
C0010851|PART OF CYTOSKELETON
C0005615|PARTURITION, NOS
C0439799|PASSAGE
C0344329|PASSING OUT
C3686820|PASSIVE
C0281176|PASSIVE ANTIBODY THERAPY
C0020974|PASSIVE IMMUNIZATION
C0600249|PASSIVE IMMUNOTHERAPY
C0175566|PATENT
C0683963|PATH ANALYSIS
C0699748|PATHOGENESIS
C1136169|PATHOGENICITY
C0450254|PATHOGENIC ORGANISM
C3495932|PATHOLOGIC INTIMAL THICKENING
C0030660|PATHOLOGIC PROCESS
C0596962|PATHOLOGY, MOLECULAR
C0277785|PATHOPHYSIOLOGY
C0679830|PATIENT ASSESSMENT
C0017313|PATIENT CARE
C0239966|PATIENT CURRENTLY IN HOSPITAL
C0439857|PATIENT DEPENDENCE ON
C1306577|PATIENT DIED
C0030685|PATIENT DISCHARGE, NOS
C0204934|PATIENT EDUCATION ABOUT NUTRITION
C0730543|PATIENT EDUCATION - LIFESTYLE
C1269815|PATIENT IDENTIFICATION
C0085393|PATIENT IMMUNOSUPPRESSED
C0701159|PATIENT IN HOSPITAL
C0150905|PATIENT IS FEMALE
C0030695|PATIENT MONITORING
C2987124|PATIENT-REPORTED OUTCOME (PRO)
C0030705|PATIENTS
C1113679|PATIENT SAFETY
C1290922|PATIENT'S BASELINE STATE
C0242802|PATIENT SELECTION
C0683521|PATIENT STATE
C1317600|PATIENT SYMPTOMS
C1518918|PATTERN RECOGNITION
C0449774|PATTERNS
C0009649|PAVLOVIAN CONDITIONING
C0687080|PAW, NOS
C0085262|PC12 CELLS
C2987167|PDE5A WT ALLELE
C1427812|PDZ AND LIM DOMAIN PROTEIN 7
C1538595|PDZ-BINDING KINASE
C1826563|PDZ DOMAIN-CONTAINING 2
C0023263|PEA FAMILY
C0030736|PEANUT
C0030738|PEAS
C0450063|PEDESTRIANS
C0679739|PEERS
C0740268|PELVIC PROLAPSE
C0210657|PEMETREXED-CONTAINING PRODUCT
C0030805|PEMPHIGOID, UNSPECIFIED
C0164815|PENCICLOVIR-CONTAINING PRODUCT
C0751795|PENETRATING HEAD TRAUMA
C0030827|PENICILLIN G, NOS
C0220892|PENICILLIN (ORAL)
C1427759|PENTATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 1
C0030892|PENTOSE PHOSPHATE SHUNT
C0070317|PENTOSIDINE
C1417813|PENTRAXIN II, NEURONAL
C1417812|PENTRAXIN I, NEURONAL
C0030903|PENTYLENETETRAZOLE
C1539110|PEPTIDASE A
C1335528|PEPTIDASE GENE
C2239827|PEPTIDASE M20 DOMAIN-CONTAINING PROTEIN 1
C0597192|PEPTIDE HORMONES
C1417375|PEPTIDE METHIONINE SULFOXIDE REDUCTASE
C0030956|PEPTIDES
C1327133|PEPTIDE SYNTHESIS
C0599934|PEPTIDE VACCINE
C0022709|PEPTIDYL DIPEPTIDASE A
C0136073|PEPTIDYLPROLYL ISOMERASE
C0439168|PERCENT AGGREGATION
C1264641|PERCENTILE
C0439175|PERCENT OF TOTAL
C0030971|PERCEPTUAL FUNCTIONS, UNSPECIFIED
C1532338|PERCUTANEOUS CORONARY INTERVENTION
C0176751|PERCUTANEOUS GASTROSTOMY (PROCEDURE)
C0597198|PERFORMANCE
C0871060|PERFORMANCE TESTS
C0879554|PERFUSION MAGNETIC RESONANCE IMAGING
C0031001|PERFUSION, NOS
C0031039|PERICARDIUM; EFFUSION
C0598800|PERICYTE OF ROUGET
C0002913|PERIDURAL ANESTHESIA
C0331303|PERILLA, NOS
C0070421|PERILLA SEED OIL
C0332182|PERIODIC
C0236023|PERIODONTAL DESTRUCTION
C0747479|PERIODONTAL; INFECTION
C0031094|PERIODONTAL POCKETS
C0031099|PERIODONTITIS, NOS
C0031090|PERIODONTIUM DISORDER
C0205100|PERIPHERAL
C1704436|PERIPHERAL ARTERIAL DISORDER
C0229664|PERIPHERAL BLOOD
C0005773|PERIPHERAL BLOOD CELL
C1518997|PERIPHERAL BLOOD LYMPHOCYTE
C1321301|PERIPHERAL BLOOD MONONUCLEAR CELLS
C0425710|PERIPHERAL CIRCULATION
C0031119|PERIPHERAL NERVE STRUCTURE
C0027813|PERIPHERAL; NEURITIS
C0085649|PERIPHERAL OEDEMA
C0446881|PERIPHERAL RETINA
C0031139|PERITONEAL DIALYSIS, NOS
C0442165|PERIVASCULAR
C0228157|PERIVENTRICULAR WHITE MATTER, NOS
C0136134|PERLECAN
C3642217|PER LITER
C0281945|PERMANENT PACEMAKER
C0031164|PERMEABILITY
C0007959|PERONEAL MUSCULAR ATROPHY
C0031179|PEROXIDASE
C0027021|PEROXIDASE
C0031180|PEROXIDES
C0536221|PEROXISOMAL MULTIFUNCTIONAL ENZYME TYPE 2
C1452082|PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA COACTIVATOR 1-ALPHA
C0166418|PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR (PPAR)
C2917405|PEROXISOME PROLIFERATOR RECEPTOR GAMMA AGONIST
C0600434|PEROXISOME PROLIFERATORS
C0752063|PEROXISOMES
C0136157|PEROXYNITRITE
C0871062|PERSECUTION
C0233651|PERSEVERATIONS
C0546816|PERSISTENCE
C0001973|PERSISTENT ALCOHOL ABUSE
C0013415|PERSISTENT DEPRESSIVE DISORDER (DYSTHYMIA)
C1264606|PERSISTENT INFECTION
C1265824|PERSISTENT INFLAMMATION
C0870281|PERSISTENT MENTAL ILLNESS
C0683314|PERSONAL HEALTH
C0009595|PERSONALITY DISORDER OBSESSIVE COMPULSIVE
C0029233|PERSONALITY DISORDER; ORGANIC
C0031208|PERSONALITY, NOS
C0233849|PERSONALITY TRAITS
C0262926|PERSONAL MEDICAL HISTORY
C0242352|PERSONHOOD
C0086282|PERSON IN THE FAMILY
C2347489|PERSON OBSERVER
C0027361|PERSONS
C0018576|PERSON WITH DISABILITY
C0020731|PERTUSSIS TOXIN
C0524528|PERVASIVE DEVELOPMENTAL DISORDER, UNSPECIFIED
C0031246|PESSARY, VAGINAL
C0031253|PESTICIDES
C0031268|PETS
C1738970|P-GLYCOPROTEIN
C0242643|P-GLYCOPROTEIN
C0031307|PHAGOCYTIC CELL, NOS
C0031308|PHAGOCYTOSIS, NOS
C0013227|PHARMACEUTICAL / BIOLOGIC PRODUCT
C3815179|PHARMACOGENOMICS FINDINGS DOMAIN
C0441694|PHARMACOLOGICAL STIMULATION
C0150270|PHARMACOLOGIC MANAGEMENT
C0031330|PHARMACOLOGY
C0013216|PHARMACOTHERAPY
C0031336|PHARMACY
C0031323|PHARMACY SERVICE PROVIDERS; PHARMACIST
C0205390|PHASE
C0282461|PHASE III TRIAL
C0585064|PHASES
C1418527|PHD FINGER PROTEIN 1
C0031364|PHENACETIN
C0070559|PHENETHYLAMINE
C0031404|PHENFORMIN PREPARATION
C0031412|PHENOBARBITONE PRODUCT
C0031428|PHENOLS
C1882365|PHENOMENON
C0031437|PHENOTYPIC EXPRESSION
C0031441|PHENOXYBENZAMINE-CONTAINING PRODUCT
C0031453|PHENYLALANINE-CONTAINING PRODUCT
C0281398|PHENYLBUTYRATE
C0170531|PHENYLBUTYRIC ACID-CONTAINING PRODUCT
C0031469|PHENYLEPHRINE-CONTAINING PRODUCT
C0070689|PHENYLMERCURIC CHLORIDE
C0312359|PHENYLPYRUVATE TAUTOMERASE
C0597217|PHOSPHATASE INHIBITOR
C1367456|PHOSPHATASE, PROSTATE-SPECIFIC ACID
C0991865|PHOSPHATE BUFFER
C0302950|PHOSPHATE SALTS
C0031610|PHOSPHATIDIC ACID
C1450468|PHOSPHATIDYLETHANOLAMINE
C0070788|PHOSPHATIDYLETHANOLAMINE N-METHYLTRANSFERASE
C0031619|PHOSPHATIDYLGLYCEROL
C0031614|PHOSPHATIDYL GLYCEROL
C0089793|PHOSPHATIDYLINOSITOL 4-KINASE BETA
C1418591|PHOSPHATIDYLSERINE DECARBOXYLASE
C0031623|PHOSPHATIDYLSERINES
C0031634|PHOSPHOCREATINE
C0757672|PHOSPHODIESTERASE-5
C1318700|PHOSPHODIESTERASE 5 INHIBITOR-CONTAINING PRODUCT
C1418435|PHOSPHODIESTERASE 9A
C0031638|PHOSPHODIESTERASE INHIBITOR-CONTAINING PRODUCT
C0251211|PHOSPHOENOLPYRUVATE CARBOXYKINASE (ATP)
C0031642|PHOSPHOENOLPYRUVATE (PEP)
C0162448|PHOSPHOGLYCERIDE
C1418520|PHOSPHOGLYCOLATE PHOSPHATASE
C0031621|PHOSPHOINOSITIDES
C0031672|PHOSPHOLIPASE A
C0031667|PHOSPHOLIPASE A2 ENZYME FAMILY
C0536678|PHOSPHOLIPASE A2, MEMBRANE ASSOCIATED
C0031669|PHOSPHOLIPASE C
C1424784|PHOSPHOLIPASE D FAMILY, MEMBER 3
C0031671|PHOSPHOLIPASES
C1158419|PHOSPHOLIPID METABOLISM
C0085078|PHOSPHOLIPIDOSIS
C0031676|PHOSPHOLIPIDS
C2744579|PHOSPHOLIPID-TRANSPORTING ATPASE IB
C0031684|PHOSPHOPEPTIDE
C0031686|PHOSPHOPROTEIN PHOSPHATASES
C0031640|PHOSPHORIC DIESTER HYDROLASE
C0031701|PHOSPHORIC ESTER
C0031678|PHOSPHORIC MONOESTER HYDROLASES
C1615057|PHOSPHORUS
C0202178|PHOSPHORUS MEASUREMENT, NOS
C0031705|PHOSPHORUS PREPARATIONS
C0031715|PHOSPHORYLATION PROCESS
C0031716|PHOSPHORYLCHOLINE
C0031721|PHOSPHOSERINE
C0031727|PHOSPHOTRANSFERASES
C0031752|PHOTOMETRY
C1882368|PHOTON CORRELATION SPECTROSCOPY
C0086805|PHOTONS
C0031760|PHOTORECEPTORS
C0031765|PHOTOTHERAPY, NOS
C1301988|PHYSICAL ACTIVITY ASSESSMENT
C0474395|PHYSICAL ACTIVITY, INCREASED
C1442065|PHYSICAL ADDRESS
C0476644|PHYSICAL AND EMOTIONAL EXHAUSTION STATE
C0516977|PHYSICAL CONDITIONING
C0015259|PHYSICAL EXERCISES
C0031812|PHYSICAL FITNESS
C0018270|PHYSICAL GROWTH PROCESS
C0520817|PHYSICAL HANDICAP
C0015264|PHYSICAL HARD WORK
C3714565|PHYSICAL HEALTH
C0683323|PHYSICAL ILLNESS
C0231171|PHYSICAL IMPAIRMENT
C3463820|PHYSICAL INHIBITION
C0556453|PHYSICALLY ACTIVE
C0028708|PHYSICAL/NUTRITIONAL ASSESSMENT
C0700329|PHYSICAL SHAPE
C2347509|PHYSICAL SHIFT
C0679309|PHYSICAL SYMPTOM
C0679543|PHYSICAL THERAPY ASSESSMENT PHYSICAL PERFORMANCE TESTING
C0028654|PHYSICIAN ASSISTANTS & ADVANCED PRACTICE NURSING PROVIDERS; CLINICAL NURSE SPECIALIST
C1518579|PHYSICIAN ASSISTANTS & ADVANCED PRACTICE NURSING PROVIDERS; CLINICAL NURSE SPECIALIST; ONCOLOGY
C0031831|PHYSICIANS
C0017319|PHYSICIANS (GENERAL PRACTICE)
C0259831|PHYSICIANS; PHYSICIAN/OSTEOPATH; DERMATOLOGY
C0334903|PHYSICIANS; PHYSICIAN/OSTEOPATH; NEUROPATHOLOGY
C0237427|PHYSICIANS; PHYSICIAN/OSTEOPATH; SURGERY, NEUROLOGICAL
C0237466|PHYSIOLOGICAL AGING
C0237476|PHYSIOLOGICAL AROUSAL
C0031845|PHYSIOLOGICAL VALUES
C1254359|PHYSIOLOGIC FUNCTION
C0031849|PHYSOSTIGMINES
C0031855|PHYTIC ACID
C0577749|PHYTOCHEMICALS
C0071011|PHYTOESTROGENS
C0251991|PI3K/BET INHIBITOR LY294002
C0044602|PI3-KINASE
C1423544|PICALM GENE
C0031886|PICORNAVIRUS GROUP, NOS
C0441468|PICTURE
C2982836|PIECE UNIT
C1426219|PIGGYBAC TRANSPOSABLE ELEMENT DERIVED 1
C0333629|PIGMENTATION, HEMOSIDERIN
C0440745|PIGMENT CELLS
C1519082|PIGMENT EPITHELIUM
C0031916|PIGMENTS
C0473169|PILOT - AIRCRAFT
C0812214|PIM-1 PROTO-ONCOGENE, SERINE/THREONINE KINASE
C0031935|PIMOZIDE-CONTAINING PRODUCT
C1418582|PIN1 GENE
C0031939|PINEAL STRUCTURE
C1418715|PININ, DESMOSOME ASSOCIATED PROTEIN
C0071097|PIOGLITAZONE-CONTAINING PRODUCT
C0071109|PIPERAZINE-N N'-BIS(2-ETHANESULFONIC ACID) (PIPES)
C0031959|PIPERIDINE
C0031977|PIRACETAM-CONTAINING PRODUCT
C0031978|PIRENZEPINE-CONTAINING PRODUCT
C0031979|PIRIBEDIL
C1101838|PITAVASTATIN-CONTAINING PRODUCT
C0031995|PITCAIRN ISLANDS
C0032022|PITUITARY ADRENAL AXIS
C0017547|PITUITARY; GIGANTISM
C0017963|PITUITARY GLYCOPROTEIN HORMONE, ALPHA SUBUNIT
C0032005|PITUITARY STRUCTURE
C0683286|PITY
C1956352|PIWI-INTERACTING RNA
C0031327|PK
C0071174|PK11195
C0058980|PKR
C3540622|PLA2G1B WT ALLELE
C0441587|PLACEMENT
C0021107|PLACEMENT OF DEVICE
C0059249|PLACENTAL PROTEIN 4
C0032074|PLANNING
C0032081|PLANT EXTRACTS
C0032088|PLANT PRODUCT, NOS
C0032098|PLANTS
C0031866|PLANT STEROL
C0332461|PLAQUE, NOS
C1278144|PLASMA APOLIPOPROTEIN A-I MEASUREMENT
C1278103|PLASMA CAFFEINE MEASUREMENT
C0026764|PLASMA CELL NEOPLASM
C0858034|PLASMA CHOLESTEROL TEST
C0008429|PLASMA CHOLINESTERASE
C1281899|PLASMA CORTISOL MEASUREMENT
C0455280|PLASMA GLUCOSE
C0202042|PLASMA GLUCOSE MEASUREMENT
C1278165|PLASMA HOMOCYSTEINE TEST
C0857690|PLASMA INSULIN
C0032133|PLASMALOGEN, NOS
C0007603|PLASMA MEMBRANE
C0032120|PLASMA PROTEIN
C0444263|PLASMA SPECIMEN
C1271648|PLASMA VITAMIN E LEVEL
C0032136|PLASMIDS
C0016016|PLASMIN
C0032140|PLASMINOGEN
C1620101|PLASMINOGEN ACTIVATOR INHIBITOR 1
C0030190|PLASMINOGEN ACTIVATOR INHIBITOR-1
C0032145|PLASMINOGEN INACTIVATOR, NOS
C0206524|PLASTIDS
C0032172|PLATELET ACTIVATING FACTOR (PAF)
C0032173|PLATELET ACTIVATION
C0032200|PLATELET DERIVED GROWTH FACTOR (PDGF)
C0071253|PLATELET-DERIVED GROWTH FACTOR RECEPTOR
C1335205|PLATELET-ENDOTHELIAL CELL ADHESION MOLECULE 1
C3887682|PLATELET GLYCOPROTEIN 4
C0370220|PLATELET-RICH PLASMA
C0085355|PLATELET-SPECIFIC ANTIGEN, NOS
C1562590|PLATELET VOLUME
C0005971|PLATES, BONE
C0032214|PLAY
C0600138|PLAY
C1335226|PLCG2 GENE
C1538735|PLECKSTRIN AND SEC7 DOMAIN CONTAINING 2
C0032221|PLETHYSMOGRAPHY, NOS
C1418662|PLEXIN A3
C1826602|PLEXIN A4
C1184808|PLEXUS
C1412234|PLIN2 GENE
C0032246|PLOIDY, NOS
C0439064|PLURAL
C0242397|PLW
C0540124|PN401
C1579319|PNEUMOCOCCAL CONJUGATE VACCINE
C0032290|PNEUMONIA; ASPIRATION
C0032300|PNEUMONIA; LOBAR
C0032285|PNEUMONIA, UNSPECIFIED
C0030375|PNG
C0032334|PODOPHYLLOTOXIN-CONTAINING PRODUCT
C1418724|PODXL GENE
C3714763|POINT
C0162735|POINT MUTATION
C2937256|POISE
C0677050|POISONING BY MANGANESE AND ITS COMPOUNDS
C0032343|POISONING, NOS
C0286382|POLAPREZINC
C0946292|POLARIZATION
C0032371|POLIOMYELITIS
C0220896|POLISH
C0032400|POLYADENYLATE
C1567710|POLY(ADP-RIBOSE) POLYMERASE-1
C0032433|POLYAMINES
C0032447|POLYCHLORINATED BIPHENYLS
C0032458|POLYCYCLIC AROMATIC HYDROCARBONS
C0022680|POLYCYSTIC RENAL DISEASE
C0032483|POLYETHYLENE GLYCOL, UNSPECIFIED
C1148552|POLYGENIC INHERITANCE
C0597268|POLYION
C1414861|POLYKARYOCYTOSIS PROMOTER
C0061145|POLY(L-GLUTAMIC ACID(60)-L-ALANINE(30)-L-TYROSINE(10)) (GAT)
C1335439|POLYMERASE
C0200931|POLYMERASE CHAIN REACTION ANALYSIS
C0032520|POLYMERASE CHAIN REACTION (PCR)
C0314672|POLYMERIZATION
C0032521|POLYMER SUBSTANCE
C0032529|POLYMORPHISM
C0796451|POLYMORPHISM ANALYSIS
C1167650|POLYNEUROPATHY CHRONIC
C0152025|POLYNEUROPATHY, UNSPECIFIED
C0077730|POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE
C1305923|POLYPEPTIDE, NOS
C0071649|POLYPHENOLS
C0949059|POLYP OF LARGE INTESTINE
C1504336|POLYPOIDAL CHOROIDAL VASCULOPATHY
C1419054|POLYPYRIMIDINE TRACT-BINDING PROTEIN 1
C0032594|POLYSACCHARIDES
C0032416|POLY T
C0556123|POLYUNSATURATED FATTY ACID INTAKE
C0032615|POLYUNSATURATED FATTY ACIDS
C1418754|PON1 GENE
C0032639|PONTINE STRUCTURE
C2349200|POOL
C0232462|POOR;APPETITE
C0683321|POOR HEALTH
C0580104|POOR VISUAL ACUITY
C0242444|POPULATION AT RISK
C1257890|POPULATION GROUPS
C0032671|POPULATION GROWTH
C3242284|POPULATION HEALTH
C2347634|POPULATION MEAN
C0771648|PORACTANT ALFA-CONTAINING PRODUCT
C0071728|PORIN
C0085478|PORPHYROMONAS GINGIVALIS
C0005767|PORTION OF BLOOD
C0005889|PORTION OF BODY FLUID
C0009780|PORTION OF CONNECTIVE TISSUE
C1383501|PORTION OF CYTOSOL
C0014609|PORTION OF EPITHELIUM
C0015350|PORTION OF EXTRACELLULAR MATRIX
C0026131|PORTION OF MILK
C0032105|PORTION OF PLASMA
C0439178|% POSITIVE CELLS
C1514241|POSITIVE FINDING
C1326205|POSITIVE REGULATION OF APOPTOSIS
C1516338|POSITIVE REGULATION OF CELL DEATH
C0032744|POSITRON
C0871103|POSSESSION
C0332149|POSSIBLE
C0175191|POSTERIOR CINGULATE GYRUS
C0228491|POSTERIOR LOBE OF THE CEREBELLUM
C0032009|POSTERIOR PITUITARY
C0032017|POSTERIOR PITUITARY HORMONES
C1299564|POSTHEMORRHAGIC HYDROCEPHALUS
C2347647|POST-INTERVENTION
C0029458|POSTMENOPAUSAL; OSTEOPOROSIS
C0206159|POST-MENOPAUSE
C0004398|POSTMORTEM EXAMINATION
C0444184|POSTMORTEM TISSUE SAMPLE
C0001779|POSTNATAL AGE
C0032786|POSTOPERATIVE CARE
C0032787|POSTOPERATIVE; COMPLICATIONS
C1319200|POSTOPERATIVE CONFUSION
C0400877|POSTOPERATIVE ILEUS
C0032790|POSTOPERATIVE (POST-OP)
C0080040|POSTPOLIO SYNDROME
C1514248|POST-TRANSCRIPTIONAL REGULATION
C0002623|POSTTRAUMATIC AMNESIA
C0020651|POSTURAL; HYPOTENSION
C0234987|POSTURAL LIGHTHEADEDNESS
C1262869|POSTURE, NOS
C0032768|POSTZOSTER NEURALGIA
C1416602|POTASSIUM CHANNEL, CALCIUM-ACTIVATED, LARGE CONDUCTANCE, SUBFAMILY M, ALPHA MEMBER 1
C1416604|POTASSIUM CHANNEL, CALCIUM-ACTIVATED, LARGE CONDUCTANCE, SUBFAMILY M, BETA MEMBER 2
C0032824|POTASSIUM CHANNELS
C0032821|POTASSIUM PRODUCT
C0304490|POTASSIUM-SPARING DIURETICS
C1416596|POTASSIUM TWO PORE DOMAIN CHANNEL SUBFAMILY K MEMBER 3
C1416614|POTASSIUM VOLTAGE-GATED CHANNEL SUBFAMILY Q MEMBER 2
C3245505|POTENTIAL
C0279023|POTENTIATION
C0032847|POTENTIOMETRY
C1426490|POU DOMAIN, CLASS 2, TRANSCRIPTION FACTOR 3
C0032854|POVERTY STATUS
C0032861|POWDERS
C0032863|POWER
C0063017|PP
C1418776|PPARA GENE
C1428918|PPARG COACTIVATOR 1 BETA
C1335238|PPARG GENE
C3245512|PRACTICE
C1709627|PRACTITIONER
C0032897|PRADER-WILLI SYNDROME (PWS)
C0011185|PRASTERONE
C0085542|PRAVASTATIN-CONTAINING PRODUCT
C0392356|PRAYER
C0032912|PRAZOSIN-CONTAINING PRODUCT
C1709634|PRECURSOR
C0271650|PREDIABETES
C0362046|PREDIABETIC STATE
C0681842|PREDICTION
C0683956|PREDICTIVE FACTOR
C0681898|PREDICTIVE VALIDITY
C1514307|PREDICTIVE VALUE
C2698872|PREDICTOR
C0521987|PRE-EXISTING DISEASE
C0558295|PREFERENCES
C0162783|PREFRONTAL LOBE
C0028840|PREGLAUCOMA OCULAR HYPERTENSION
C0747845|PREGNANCY EARLY
C0085207|PREGNANCY INDUCED DIABETES
C0687675|PREGNANCY LOSS
C0032961|PREGNANCY, NOS
C0033006|PREGNANE COMPOUND
C0033011|PREGNANT WOMEN
C1855073|PREMATURE DEATH
C0025322|PREMATURE OVARIAN FAILURE
C0993589|PREMENOPAUSE
C4321248|PREMORBID ADJUSTMENT SCALE
C0026661|PRE-MRNA
C1826706|PRE-MRNA PROCESSING FACTOR 6
C0678804|PRENATAL
C0678726|PRENATAL DEVELOPMENT
C0871124|PRENATAL EXPOSURE
C0162759|PRENYLATION
C1521827|PREPARATION
C0033074|PRESBYCUSIS, UNSPECIFIED EAR
C0008100|PRESCHOOL STUDENTS
C0304227|PRESCRIPTION DRUGS
C0033081|PRESCRIPTION OF DRUG
C0033080|PRESCRIPTION(S)
C0231341|PRESENILE; PREMATURE AGING
C0299212|PRESENILIN-1
C0528480|PRESENILIN-2
C0872078|PRESENILINS
C0449450|PRESENTATION
C0033085|PRESERVED
C0237795|PRESSORS
C0595921|PRESSURE IN EYE
C0033095|PRESSURE - PHYSICAL AGENT
C0206181|PRESYNAPTIC KNOB
C0151526|PRETERM DELIVERY
C0021294|PRETERM INFANT
C3539076|PRETREATMENT
C0309872|PREVENT
C0150638|PREVENTING INJURY
C0281206|PREVENTION OF CANCER
C0679716|PREVENTION STRATEGY
C1706420|PREVENTION STUDY
C0814861|PREVENTION TRIAL
C1552607|PREVIOUS
C0008312|PRIMARY BILIARY CIRRHOSIS
C2239176|PRIMARY CARCINOMA OF LIVER
C0033131|PRIMARY CARE PHYSICIAN
C4551720|PRIMARY CILIARY DYSKINESIA
C0079773|PRIMARY CUTANEOUS T-CELL NON-HODGKIN LYMPHOMA
C0750901|PRIMARY DEGENERATIVE DEMENTIA OF THE ALZHEIMER TYPE, PRESENILE ONSET
C0494463|PRIMARY DEGENERATIVE DEMENTIA OF THE ALZHEIMER TYPE, SENILE ONSET
C0277554|PRIMARY DISORDERS
C0033137|PRIMARY HEALTH CARE
C0392514|PRIMARY HEMOCHROMATOSIS
C3469186|PRIMARY HEMOCHROMATOSIS - TYPE 1
C0162823|PRIMARY IRRITANT DERMATITIS
C1384584|PRIMARY; POLYARTHROSIS
C0033144|PRIMARY PREVENTION
C0282513|PRIMARY PROGRESSIVE APRAXIA OF SPEECH
C0751964|PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS
C0151449|PRIMARY SJOGREN SYNDROME
C0236991|PRIMARY SLEEP DISORDERS
C1708063|PRIMARY TREATMENT
C0677930|PRIMARY TUMOR
C0085273|PRIMATE ERYTHROPARVOVIRUS 1 INFECTION
C0033147|PRIMATES
C0237798|PRIMATES (NONHUMAN)
C0422895|PRIMITIVE REFLEXES
C0205225|PRINCIPAL
C1882460|PRINCIPAL COMPONENT
C0429865|PRINCIPAL COMPONENTS ANALYSIS
C0033164|PRIONS
C0557972|PRIORITIZING PROBLEMS
C3890397|PRKAA1 WT ALLELE
C1418270|PRKN GENE
C1418941|PRNP GENE
C0033199|PROACTIVE INHIBITION
C0033204|PROBABLE
C0182400|PROBES
C0575081|PROBLEM;GAIT
C0850474|PROBLEM; GAMBLING
C1405458|PROBLEM; LANGUAGE
C1446377|PROBLEM;MENTAL HEALTH
C0221571|PROBLEM; NEUROLOGICAL
C0033213|PROBLEM, NOS
C3714509|PROBLEM;NUTRITIONAL
C1546466|PROBLEMS
C1303140|PROBLEM SOLVING THERAPY
C0015331|PROBLEMS RELATED TO EXPOSURE TO NOISE
C0009241|PROBLEMS WITH COGNITIVE/INTELLECTUAL FUNCTION
C0575090|PROBLEM WITH BALANCE
C0033215|PROBUCOL (DISCONTINUED)
C0033223|PROCARBAZINE-CONTAINING PRODUCT
C3539779|PROCEDUR
C0561782|PROCEDURAL MEMORY
C1547268|PROCEDURE ERROR
C0184661|PROCEDURE, NOS
C0430022|PROCEDURES;DIAGNOSTIC
C4521541|PROCESS
C1522240|PROCESS
C1709694|PROCESSING
C0589104|PROCESS TRAINING
C1292267|PROCOAGULANT
C0033384|PROCOLLAGEN-PROLINE DIOXYGENASE
C0240805|PRODROME, NOS
C3687582|PRODUCES MILK FOR HUMAN FOOD
C1254351|PRODUCT
C1514468|PRODUCT
C0011479|PRODUCT CONTAINING DEOXYCHOLIC ACID
C0679924|PROFESSIONAL
C0682271|PROFESSIONAL ATHLETE
C0402108|PROFESSIONAL BOXER
C0013647|PROFESSIONAL EDUCATION
C0028661|PROFESSIONAL NURSE (GENERAL)
C1522486|PROFESSIONAL ORGANIZATION OR GROUP
C0028811|PROFESSIONS
C0072074|PROFILIN
C0680063|PROGENY
C1418244|PROGESTAGEN-ASSOCIATED ENDOMETRIAL PROTEIN
C4082178|PROGESTERONE RECEPTOR
C1423971|PROGESTERONE RECEPTOR MEMBRANE COMPONENT 1
C0034833|PROGESTERONE RECEPTOR SITE
C0033325|PROGNOSIS, NOS
C0278252|PROGNOSIS POOR
C0086858|PROGRAMMED LEARNING
C1280477|PROGRESS
C0242656|PROGRESSION
C0242792|PROGRESSION-FREE SURVIVAL
C0338457|PROGRESSIVE APHASIA
C1265895|PROGRESSIVE ATROPHY
C0030442|PROGRESSIVE BULBAR PALSY
C0011989|PROGRESSIVE DIAPHYSEAL DYSPLASIA
C1335499|PROGRESSIVE DISEASE
C0023524|PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY
C0026850|PROGRESSIVE MUSCULAR DYSTROPHY
C0751778|PROGRESSIVE MYOCLONUS EPILEPSY
C0301817|PROHORMONE, NOS
C1709701|PROJECT
C0033371|PROLACTIN PREPARATION
C0072108|PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA)
C0033382|PROLINE
C0033385|PROLINE OXIDASE
C1418893|PROLINE-RICH PROTEIN, HAEIII SUBFAMILY, 2
C0425945|PROLONGED PERIODS
C0234452|PROLONGED SLEEP
C0072132|PROLYL ENDOPEPTIDASE (THIOL-DEPENDENT)
C0205402|PROMINENT
C0086860|PROMOTER
C0023487|PROMYELOCYTIC; LEUKEMIA
C0556981|% PROOF
C0072171|PROPENTOFYLLINE
C1839454|PROPERDIN DEFICIENCY, X-LINKED
C0033453|PROPERDIN FACTOR B
C0282515|PROPHYLACTIC CHEMOTHERAPY
C0033487|PROPOFOL-CONTAINING PRODUCT
C1553874|PROPOSED
C1426592|PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 GENE
C0085140|PROSENCEPHALON STRUCTURE
C0023981|PROSPECTIVE
C0589154|PROSPECTIVE MEMORY
C0033522|PROSPECTIVE STUDY
C0379214|PROSPERO PROTEIN
C1565830|PROSTAGLANDIN G/H SYNTHASE 1
C1565860|PROSTAGLANDIN G/H SYNTHASE 2
C0072261|PROSTAGLANDIN PGA1
C0033558|PROSTAGLANDIN PGD
C0012472|PROSTAGLANDIN PGE2
C0012471|PROSTAGLANDIN PGF2 ALPHA
C0072288|PROSTAGLANDIN PGH2
C0034835|PROSTAGLANDIN RECEPTOR SITE
C0033551|PROSTAGLANDIN SYNTHETASE
C0033567|PROSTAGLANDIN X
C0033554|PROSTANOID
C0376358|PROSTATE--CANCER
C0936223|PROSTATE CANCER METASTATIC
C0281413|PROSTATE CANCER PREVENTION
C0005001|PROSTATE HYPERTROPHY BENIGN
C1740167|PROSTATIC ACID PHOSPHATASE
C0600139|PROSTATIC CARCINOMA
C0033572|PROSTATIC STRUCTURE
C0175649|PROSTHETIC DEVICES
C0033607|PROTEASE INHIBITORS
C0208355|PROTEASOME
C1443643|PROTEASOME INHIBITOR-CONTAINING PRODUCT
C0246694|PROTEASOME INHIBITOR MG-132
C0033613|PROTECTIVE DRUGS
C1960806|PROTECTIVE EQUIPMENT USED
C0679688|PROTECTIVE FACTORS
C0033617|PROTEIN-ARGININE METHYLTRANSFERASE
C1826700|PROTEIN ARGININE METHYLTRANSFERASE 5
C0030946|PROTEINASES
C1436804|PROTEIN CAPICUA HOMOLOG
C0072348|PROTEIN C INHIBITOR
C0033621|PROTEIN C, NOS
C1180347|PROTEIN COMPLEX
C0427716|PROTEIN CONCENTRATION, TEST STRIP MEASUREMENT
C1623036|PROTEIN DEGRADATION PROCESS
C1514562|PROTEIN DOMAIN
C1171362|PROTEIN EXPRESSION
C0162847|PROTEIN FOLDING
C1527118|PROTEIN FUNCTION
C0751455|PROTEIN GENE PRODUCTS
C0376322|PROTEIN GLYCOSYLATION
C0489617|PROTEIN INTAKE
C0010531|PROTEIN KINASE A
C0243459|PROTEIN KINASE A INHIBITOR
C0164786|PROTEIN KINASE B
C0285558|PROTEIN KINASE B
C1418902|PROTEIN KINASE, CAMP-DEPENDENT, CATALYTIC, BETA
C1418913|PROTEIN KINASE C, BETA
C1514555|PROTEIN KINASE C INHIBITOR
C0033634|PROTEIN KINASE C (PKC)
C1335262|PROTEIN KINASE, DNA-ACTIVATED, CATALYTIC SUBUNIT
C0033640|PROTEIN KINASES
C0024375|PROTEIN-LYSINE 6-OXIDASE
C0597299|PROTEIN METABOLISM PROCESS
C1136348|PROTEIN MICROARRAYS
C0815043|PROTEIN, ORGANIZED BY FUNCTION
C1514559|PROTEIN OVEREXPRESSION
C0080055|PROTEIN P53
C1417581|PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 12A
C1418829|PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 3A
C1423073|PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 3B
C1704708|PROTEIN PHOSPHATASE 2A
C1335249|PROTEIN PHOSPHATASE 2 REGULATORY SUBUNIT B'EPSILON
C0054450|PROTEIN PHOSPHATASE 3
C1418848|PROTEIN PHOSPHATASE 3, REGULATORY SUBUNIT B, ALPHA
C1514560|PROTEIN PHOSPHATASE INHIBITOR
C0033665|PROTEIN PRECURSORS
C0033666|PROTEIN PROCESSING
C0444680|PROTEIN PROFILING
C0872079|PROTEIN-PROTEIN INTERACTIONS
C0598391|PROTEIN REPLACEMENT THERAPY
C0033684|PROTEINS
C0887837|PROTEIN SORTING
C1510464|PROTEIN STRUCTURE
C0599220|PROTEIN SUBUNIT
C0770246|PROTEIN SUPPLEMENTS
C0597295|PROTEIN SYNTHESIS
C0599895|PROTEIN TRANSPORT
C0597297|PROTEIN TURNOVER
C1430595|PROTEIN-TYROSINE KINASE 2-BETA
C0085536|PROTEIN-TYROSINE-PHOSPHATASE
C1419106|PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 4
C1419107|PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 5
C0033687|PROTEIN, URINE, ABNORMAL PRESENCE
C0033692|PROTEOGLYCANS
C0597304|PROTEOLYSIS
C0030940|PROTEOLYTIC ENZYMES
C1514570|PROTEOLYTIC PROCESSING
C0751973|PROTEOME
C0872252|PROTEOMICS
C0033706|PROTHROMBIN
C1418306|PROTOCADHERIN 11, X-LINKED
C2599718|PROTOCOL
C0178812|PROTONATION
C0260061|PROTON MAGNETIC RESONANCE
C0032743|PROTON MAGNETIC RESONANCE SPECTROSCOPIC IMAGING
C0018440|PROTON PUMP
C0358591|PROTON PUMP INHIBITORS
C0033727|PROTONS
C0072467|PROTO-ONCOGENE WNT-1
C0175996|PROTOPLASM
C0585171|PROTOZOAN PARASITE, NOS
C0242687|PROVISION OF EARLY INTERVENTION SERVICE FOR CHILD
C0205107|PROXIMAL
C0221629|PROXIMAL MUSCLE WEAKNESS
C0022677|PROXIMAL TUBULE
C0600420|PROXY
C0162373|PROZAC
C1141002|PRUNES
C0453309|PRUNES
C0053622|PRUNETIN
C0030428|PRY
C0199176|PRYLX
C0138741|PSA ANTIGEN
C0134835|P-SELECTIN
C1418985|PSEN1 GENE
C1418986|PSEN2 GENE
C3541303|PSENEN WT ALLELE
C0728810|PSEUDOCHOLINESTERASE
C1168443|PSEUDOCHOLINESTERASE TEST
C0851256|PSEUDOCOARCTATION
C0206368|PSEUDOEXFOLIATION GLAUCOMA
C0549150|PSEUDOFOLLICULITIS BARBAE
C0013264|PSEUDOHYPERTROPHIC PROGRESSIVE MUSCULAR DYSTROPHY
C1419034|PSMD4 GENE
C1419043|PSME3 GENE
C0033860|PSORIASIS, UNSPECIFIED
C3697468|PSQI
C0229992|PSYCHE, NOS
C0376338|PSYCHIATRIC DIAGNOSIS
C0004936|PSYCHIATRIC DISORDERS
C0748059|PSYCHIATRIC HISTORY
C0748061|PSYCHIATRIC HOSPITALIZATION
C0748064|PSYCHIATRIC PATIENTS
C0233401|PSYCHIATRIC SYMPTOMS
C0033872|PSYCHIATRISTS
C1510472|PSYCHOACTIVE SUBSTANCE DEPENDENCE, NOS
C0682880|PSYCHOACTIVE SUBSTANCES
C0815107|PSYCHOLOGICAL DISTRESS
C0849888|PSYCHOLOGICAL DISTURBANCE
C0025353|PSYCHOLOGICAL HEALTH
C0020792|PSYCHOLOGICAL IDENTIFICATION
C0848067|PSYCHOLOGICAL PROBLEMS
C0233397|PSYCHOLOGICAL SYMPTOMS
C0033908|PSYCHOLOGISTS
C0033909|PSYCHOLOGY
C0033920|PSYCHOMETRIC TESTING
C0033927|PSYCHOPATHOLOGY
C0430872|PSYCHOPHYSICAL TESTS
C0033954|PSYCHOSINE
C1456784|PSYCHOSIS; PARANOID
C0011265|PSYCHOSIS; PRESENILE
C0454041|PSYCHOSOCIAL INTERVENTION STRATEGY
C0015618|PSYCHOTHERAPY FAMILY EACH 15 MINUTES
C0033971|PSYCHOTHERAPY GROUP EACH 60 MINUTES
C0871189|PSYCHOTIC SYMPTOMS
C0033978|PSYCHOTROPIC DRUGS
C0033979|PSYLLIUM PREPARATIONS
C0033991|PTERIDINES
C0664965|PTEROSTILBENE
C1310550|PTEROYLPOLY-GAMMA-GLUTAMATE CARBOXYPEPTIDASE
C1367485|PTGS2 GENE
C1419072|PTH GENE
C1335273|PTK2B GENE
C1419100|PTPN2 GENE
C1335285|PTPRC GENE
C1335287|PTPRG GENE
C0206086|PUBLICATION BIAS
C0034036|PUBLICATIONS
C0681328|PUBLIC EDUCATION
C0034019|PUBLIC HEALTH
C0679898|PUBLIC HEALTH PROGRAM
C0020022|PUBLIC HOSPITALS
C0871194|PUBLIC TRANSPORTATION
C0034037|PUBLISHED
C1138432|PUBMED
C0034043|PUERTO RICAN
C0580846|PULLING ACTION
C0281169|PULMONARY COMPLICATIONS
C0024115|PULMONARY; DISORDER
C0231921|PULMONARY FUNCTION
C0577317|PULSATILITY
C0429863|PULSATILITY INDEX, ARTERIAL VELOCITY WAVEFORM
C0949236|PULSE PRESSURE
C0182537|PUMPS
C0149843|PUNCHDRUNK SYNDROME
C0026961|PUPIL DILATION
C0423300|PUPIL REACTION
C0220903|PURINE
C0920640|PURINE METABOLISM PATHWAY
C0034137|PURINE NUCLEOTIDES
C0001471|PURINERGIC P1 RECEPTOR
C1418215|PURINERGIC RECEPTOR P2X, LIGAND-GATED ION CHANNEL, 7
C1425330|PURINERGIC RECEPTOR P2Y, G PROTEIN-COUPLED, 12
C0034140|PURINES
C0034836|PURINES--RECEPTORS
C1882508|PURITY
C0034143|PURKINJE NEURON
C0139360|PUROMYCIN-SENSITIVE AMINOPEPTIDASE
C1285529|PURPOSE
C0034161|PUS, NOS
C0034170|PUTRESCINE
C3494431|PWV
C0072642|PYCNOGENOL
C0072662|PYRAZOLE
C0597329|PYRETHROIDS
C0034263|PYRIDOXAL-CONTAINING PRODUCT
C0034266|PYRIDOXAL PHOSPHATE
C0034268|PYRIDOXAMINE
C0034284|PYRIMIDINE, NOS
C0054858|PYROCATECHOL-CONTAINING PRODUCT
C2732543|PYROSEQUENCING
C0244104|PYRUVATE
C0034348|PYRUVATE KINASE
C1158861|PYRUVATE METABOLISM PATHWAY
C0332173|QD
C1419183|QPCT GENE
C0489625|QTC INTERVAL
C0860814|QTCUNS
C0429028|QT INTERVAL, NOS
C0151878|QT PROLONGED
C0949415|QUALITATIVE RESEARCH
C0332306|QUALITY
C0080071|QUALITY ADJUSTED LIFE YEARS
C0034378|QUALITY CONTROL (QC)
C0034380|QUALITY OF LIFE
C0518214|QUALITY OF LIFE SATISFACTION
C0424563|QUALITY OF SLEEP
C1709793|QUANTITATION
C0392762|QUANTITATIVE CONCEPT
C1510568|QUANTITATIVE METHODS
C1514628|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION
C0597336|QUANTITATIVE TRAIT LOCUS
C0034386|QUARANTINE
C0680226|QUARRELSOME BEHAVIOR
C0034392|QUERCETIN-CONTAINING PRODUCT
C0034394|QUESTIONNAIRES
C0123091|QUETIAPINE-CONTAINING PRODUCT
C0034414|QUINIDINE-CONTAINING PRODUCT
C1096793|QUINONE
C0034435|QUINONE COMPOUND
C0028351|(R)-4-(2-AMINO-1-HYDROXYETHYL)-1,2-BENZENEDIOL
C0684010|RABBIS
C0378482|RABEPRAZOLE-CONTAINING PRODUCT
C3853635|RACE OF MAN
C0078988|RACE: ORIENTAL
C0682075|RACIAL DIFFERENCES
C0034510|RACIAL GROUP
C0439807|RADICAL
C0302912|RADICAL, NOS
C0850292|RADIOFREQUENCY ABLATION
C0260194|RADIOLOGISTS
C0040398|RADIONUCLIDE EMISSION TOMOGRAPHY
C0182638|RADIOPHARMACEUTICALS
C0597354|RADIOTRACER
C0034629|RADON, NOS
C0034634|RAGE
C0497247|RAISED BLOOD PRESSURE
C0234708|RAISED INTRAOCULAR PRESSURE
C0020437|RAISED SERUM CALCIUM LEVEL
C0244404|RALOXIFENE-CONTAINING PRODUCT
C1565316|RAMELTEON-CONTAINING PRODUCT
C0072973|RAMIPRIL-CONTAINING PRODUCT
C0282440|RANDOMIZED CONTROLLED TRIAL
C0080078|RANGE OF MOTION
C0294869|RAN GTPASE-ACTIVATING PROTEIN 1
C0699794|RANKING
C1436337|RANTES
C1705641|RAP1A WT ALLELE
C1424450|RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 3
C0678236|RARE DISORDER
C1826758|RAS-ASSOCIATED PROTEIN RAB7
C0034678|RAS ONCOGENES
C1521828|RATE
C0871208|RATING
C1610540|*RATIOS
C0034721|RATTUS
C0034693|RATTUS NORVEGICUS
C0001884|RAW
C2584321|REACHING
C0020517|REACTION; HYPERSENSITIVITY
C0028768|REACTION; OBSESSIVE-COMPULSIVE
C0205332|REACTIVE
C0178824|REACTIVE HYPEREMIA
C0162772|REACTIVE OXYGEN SPECIES
C0443286|REACTIVITY
C1514743|READER
C1318963|READINESS
C0034754|READING, NOS
C0034760|REAGENT
C0684328|REASONING
C0069562|REBAMIPIDE
C0237816|RECALL (LEARNING)
C0332185|RECENT EPISODE
C0544683|RECEPTION
C1514758|RECEPTOR ACTIVATION PROCESS
C2987634|RECEPTOR AGONIST
C0597358|RECEPTOR BINDING
C0597359|RECEPTOR COUPLING
C0597360|RECEPTOR EXPRESSION
C0101725|RECEPTOR FOR ADVANCED GLYCATION ENDPRODUCTS (RAGE)
C0920644|RECEPTOR FUNCTION
C1335671|RECEPTOR GENE
C0597361|RECEPTOR MEDIATED ENDOCYTOSIS
C0683187|RECEPTOR OPERATED CHANNEL
C0597357|RECEPTORS
C1514762|RECEPTOR SIGNALING
C0005456|RECEPTOR SITES
C1870006|RECEPTOR-TYPE TYROSINE-PROTEIN PHOSPHATASE C
C0206364|RECEPTOR TYROSINE KINASE
C3853568|RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4
C0600194|RECIPES
C1709854|RECIPIENT
C0243043|RECOMBINANT 70-KD HEAT-SHOCK PROTEIN
C1522712|RECOMBINANT INTERFERON-ALPHA INDUCIBLE PROTEIN 10
C0034861|RECOMBINANT PROTEINS
C1514798|RECOMBINANTS
C0034862|RECOMBINANT VACCINES
C0597363|RECOMBINANT VIRUS
C0034865|RECOMBINATION
C0034866|RECOMMENDATION
C0150600|RECOMMENDATION TO
C0034869|RECORDS
C0034872|RECREATION
C2949735|RECRUITMENT (SUBJECTS)
C0221480|RECURRENT DEPRESSION
C0458990|RECURRENT FALLS
C0239998|RECURRENT INFECTIOUS DISEASE
C0034897|RECURRING
C0282114|RECYCLING
C0014792|RED BLOOD CELLS
C1277078|RED BLOOD CELLS PRODUCT
C0427460|RED CELL DISTRIBUTION WIDTH DETERMINATION
C0014779|RED CELL INDICES
C0740236|RED-CELL INDICES
C0014789|RED CELL VOLUME MEASUREMENT
C0452848|RED MEAT
C0030012|REDOX
C0424099|REDUCED CONCENTRATION
C0426597|REDUCED FLUID INTAKE
C0700572|REDUCED;MOBILITY
C0027289|REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (NADH)
C0030016|REDUCTASE
C0349371|RED WINE
C0763533|RED YEAST RICE
C1514811|REFERENCE
C0680399|REFERENCE GROUPS
C0584096|REFERRAL TO PALLIATIVE CARE SERVICE
C0558058|REFLECTING
C0151889|REFLEXES INCREASED
C0017168|REFLUX; GASTROESOPHAGEAL
C1096063|REFRACTORY EPILEPSY
C0034963|REGENERATION, NOS
C0205147|REGIONAL
C0034965|REGIONAL BLOOD FLOW
C0682132|REGIONAL DIFFERENCES
C0010346|REGIONAL ENTERITIS
C0031006|REGIONAL PERFUSION
C0013769|REGION OF ELBOW
C1514821|REGISTRATION
C0034975|REGISTRY
C0684321|REGRESSIVE BEHAVIOUR
C0582191|REGULAR EXERCISE
C0021641|REGULAR INSULIN
C0851285|REGULATION
C2265640|REGULATION OF AUTOPHAGY
C1704735|REGULATOR
C1414160|REGULATOR OF CALCINEURIN 1
C0034987|REGULATORY ELEMENT
C0017362|REGULATORY GENE
C1327622|REGULATORY PROCESS
C0815047|REGULATORY PROTEINS
C0039198|REGULATORY T CELL
C0034991|REHABILITATION THERAPY, NOS
C0035015|REJECTION (PSYCHOLOGY)
C0035016|REJUVENATION
C1314792|REL
C0035020|RELAPSE PHASE
C0439849|RELATIONSHIPS
C0080103|RELATIVE
C0028873|RELATIVE ODDS
C0425043|RELATIVES DIED
C2347946|RELEVANCE
C2347947|RELIABILITY
C3858758|RELIABLE
C0035039|RELIGIONS
C0681189|RELIGIOSITY
C0682141|RELIGIOUS AFFILIATION
C1419337|RELN GENE
C0034770|REMEMBERING
C0557033|REMINDING
C0871247|REMINISCENCE
C0150321|REMINISCENCE THERAPY
C0687702|REMISSION
C0185115|REMOVAL
C0185051|REMOVAL BY GRINDING
C0349707|REMOVAL BY SUCTION
C0029936|REMOVAL OF OVARIES
C0846764|REMOVAL OF PLAQUE OR STAIN
C0849355|REMOVED
C0751772|REM SLEEP BEHAVIOR DISORDER
C0022646|RENAL
C0194073|RENAL BIOPSY
C0553257|RENAL CELL
C1561643|RENAL DISEASE CHRONIC
C0022658|RENAL DISORDER
C0151650|RENAL FIBROSIS
C0232804|RENAL FUNCTION, NOS
C0312437|RENAL HORMONE, NOS
C1565489|RENAL INSUFFICIENCY
C0035094|RENIN
C0877206|RENIN-ANGIOTENSIN SYSTEM INHIBITION
C1419339|RENIN-BINDING PROTEIN
C0035100|RENNIN
C0185027|REPAIR BY IMBRICATION
C0185026|REPAIR BY PLICATION
C0871881|REPEATED MEASURES
C0035126|REPERFUSION INJURY
C0086908|REPETITIVE SEQUENCE
C0872259|REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION
C0003506|REPLACEMENT OF AORTIC VALVE, NOS
C0190173|REPLACEMENT OF UNSPECIFIED HEART VALVE
C0279033|REPLACEMENT THERAPY
C0035139|REPLANTATION PROCEDURE
C3273238|REPORT
C0335038|REPORTER (PRESS/RADIO/T.V.)
C0556030|REPOSITIONING
C1882932|REPRESENTATION
C1514863|REPRODUCIBILITY
C0035150|REPRODUCTIVE
C0017471|REPRODUCTIVE CELL
C0597375|REPRODUCTIVE DEVELOPMENT
C3889426|REQUIREMENT
C2347379|RES
C0035168|RESEARCH
C0242481|RESEARCH ACTIVITY
C0035172|RESEARCH INSTITUTES
C0086912|RESEARCH METHODS
C0683939|RESEARCH ORGANIZATION
C0376368|RESEARCH PRIORITIES
C0683954|RESEARCH RESULTS
C0681814|RESEARCH STUDY
C0080105|RESEARCH SUBJECTS
C0521210|RESECTION OF POLYP, NOS
C2347957|RESERVATION
C0237096|RESIDENCE
C0035182|RESIDENCY
C1709915|RESIDUE
C0035191|RESIN
C2699488|RESOLUTION
C0035201|RESOURCE
C0162297|RESPIRATORY ARREST
C0161818|RESPIRATORY; COMPLICATIONS
C2986904|RESPIRATORY DOMAIN
C0035245|RESPIRATORY FUNCTION
C0035203|RESPIRATORY FUNCTION, NOS
C1145670|RESPIRATORY INSUFFICIENCY/FAILURE
C0001883|RESPIRATORY; OBSTRUCTION
C0429702|RESPIRATORY QUOTIENT (R=VCO2/VO2)
C2362565|RESPIRATORY, REHABILITATIVE & RESTORATIVE; PHYSICAL THERAPIST
C0024117|RESPIRATORY TRACT; DISORDER, OBSTRUCTIVE, CHRONIC
C0149725|RESPIRATORY TRACT INFECTION LOWER
C0035243|RESPIRATORY TRACT INFECTION (RTI)
C0282122|RESPONDENTS
C1704632|RESPONSE
C0600508|RESPONSE ELEMENT
C0871261|RESPONSES
C0282498|RESPONSE TO HEAT
C0678341|RESPONSIBILITY
C1170584|RESTASIS
C0035253|RESTING
C0679218|RESTING STATE
C0035260|RESTRAINT
C0337184|RESTRAINTS, ANY TYPE (BODY, CHEST, WRIST OR ANKLE)
C0425422|RESTRICTED DIET
C0200930|RESTRICTION FRAGMENT-LENGTH POLYMORPHISM ANALYSIS
C0035268|RESTRICTION FRAGMENT LENGTH POLYMORPHISM (RFLP)
C0035269|RESTRICTION MAPPING
C1274040|RESULT
C0073096|RESVERATROL
C4331247|RETAILER
C0025362|RETARDATION;MENTAL
C0035280|RETENTION
C1698057|RETEST
C0024299|RETICULOLYMPHOSARCOMA
C1419770|RETICULON 3
C0035295|RETICULUM
C0530684|RETIGABINE-CONTAINING PRODUCT
C0035300|RETINAL ABNORMALITY
C0235272|RETINAL DAMAGE, NOS
C0035304|RETINAL DEGENERATION
C0035331|RETINALDEHYDE
C0151891|RETINAL DEPIGMENTATION, NOS
C0235972|RETINAL DEPOSITS
C0035316|RETINAL GANGLION CELLS
C0347602|RETINAL INJURY
C0278230|RETINAL SIGN, NOS
C0035298|RETINA, NOS
C0140278|RETINOIC ACID RECEPTOR
C1366536|RETINOIC ACID RECEPTOR, ALPHA
C0035339|RETINOIDS
C1438309|RETINOL-BINDING PROTEIN 4
C0035342|RETINOL BINDING PROTEIN FAMILY
C0011884|RETINOPATHY DUE TO DIABETES MELLITUS
C0339467|RETINOPATHY; PROLIFERATIVE
C0035345|RETIREMENT, NOS
C1514918|RETRIEVING
C0002624|RETROGRADE; AMNESIA
C0035363|RETROSPECTIVE STUDY
C0035369|RETROVIRUS INFECTIONS
C0035366|RETROVIRUS, NOS
C0332156|RETURN TO
C0599702|REUPTAKE
C2347961|REVEREND
C0282443|REVIEW
C0035400|REYE SYNDROME
C0748398|RF
C0024400|RHESUS MONKEY
C0003873|RHEUMATOID DISEASE
C0035439|RHEUMATOID HEART DISEASE
C0537670|RHIL-11
C0007815|RHINORRHEA; CEREBROSPINAL
C0949790|RHIZOME
C0812234|RHOA GENE
C4551438|RHO KINASE INHIBITOR
C0003811|RHYTHM, HEART; ABNORMAL
C0034580|RIA
C0015540|RIBOFLAVIN DINUCLEOTIDE (FAD)
C0035693|RIBONUCLEIC ACID, DOUBLE STRANDED
C1167298|RIBONUCLEOPROTEIN COMPLEX
C0035552|RIBOSOMAL PROTEIN
C0035561|RIBS
C0035567|RICE, NOS
C0453861|RICH FOOD
C0035608|RIFAMPIN-CONTAINING PRODUCT
C0034219|RIGGS' DISEASE
C0205090|RIGHT
C0238767|RIGHT AND LEFT
C0815007|RIGHT BRAIN
C0228175|RIGHT HEMISPHERE
C2334127|RIGHT POSTERIOR CINGULATE GYRUS
C1184320|RIGHT TEMPORAL PART OF HEAD
C2328150|RIGHT THALAMUS
C0225883|RIGHT VENTRICULAR STRUCTURE
C0026837|RIGOR
C0073378|RILMAZAFONE
C0073379|RILUZOLE-CONTAINING PRODUCT
C0333773|RIMMED VACUOLES
C1260969|RINGS
C0246719|RISEDRONATE
C0086930|RISK ASSESSMENT
C0679809|RISK ASSESSMENT
C0086931|RISK BEHAVIORS
C0850624|RISK FACTOR;CARDIOVASCULAR
C1281905|RISK FOR DISEASE
C1268740|RISK FOR FALLS
C0035648|RISK INDICATORS
C0035649|RISK MANAGEMENT
C0035647|RISK OF
C0242492|RISK RATIO
C1137094|RISK REDUCTION
C0035651|RISK TAKING
C0683303|RISK-TAKING BEHAVIOR
C0073393|RISPERIDONE-CONTAINING PRODUCT
C0728759|RITALIN
C0292818|RITONAVIR-CONTAINING PRODUCT
C0649350|RIVASTIGMINE-CONTAINING PRODUCT
C1837204|RNA BINDING MOTIF PROTEIN 45
C0085177|RNA BINDING PROTEIN
C4043426|RNA-BINDING PROTEIN FUS
C1136031|RNA INTERFERENCE (RNAI)
C0035696|RNA, MESSENGER (MRNA)
C1522002|RNA RECOGNITION MOTIF
C0035541|RNASE
C3469597|RNAX ADMINISTER MEDICATION TREATMENT
C1160858|RNAX ASSESS BEHAVIOR
C0009244|RNAX COGNITION TREATMENT ACTIONS
C0026426|RNAX MONITOR BLOOD PRESSURE
C0002766|RNAX PAIN ACTIONS
C1455743|RNAX PERFORM PSYCHOSOCIAL ASSESSMENT
C0700287|RNAX REPORTING ACTIONS
C0026606|RNDX ACTIVITY
C0184517|RNDX ACTIVITY ALTERATION
C0003467|RNDX ANXIETY
C0260662|RNDX AUDITORY ALTERATION
C0231353|RNDX BODY NUTRITION DEFICIT
C0018799|RNDX CARDIAC
C1998980|RNDX CAREGIVER ROLE STRAIN
C0184524|RNDX CEREBRAL ALTERATION
C0150055|RNDX CHRONIC PAIN
C0009460|RNDX COMMUNICATION IMPAIRMENT
C0009967|RNDX COPING
C0013146|RNDX DRUG ABUSE
C0015726|RNDX FEAR
C0018235|RNDX GRIEVING
C0018687|RNDX HEALTH BEHAVIOR
C0150041|RNDX HOPELESSNESS
C0020672|RNDX HYPOTHERMIA
C0009450|RNDX INFECTION UNSPECIFIED
C0233794|RNDX MEMORY IMPAIRMENT
C0027497|RNDX NAUSEA
C0184570|RNDX PERIPHERAL ALTERATION
C0518456|RNDX PHYSICAL MOBILITY IMPAIRMENT
C2922974|RNDX POLYPHARMACY
C0150155|RNRX BOWEL CARE
C0700431|RNRX CARDIAC REHABILITATION
C0010210|RNRX COUNSELING SERVICE
C0150544|RNRX DIABETIC CARE
C1527398|RNRX EMERGENCY CARE
C0579118|RNRX HOME SITUATION ANALYSIS
C0199782|RNRX INSULIN INJECTION
C0022100|RNRX IRRIGATION
C0184647|RNRX MENTAL HEALTH TREATMENT
C0031809|RNRX PHYSICAL EXAMINATION
C0034107|RNRX PULSE
C0442650|ROADS
C0221706|ROAD TRAFFIC ACCIDENT
C2986815|ROBUST
C1519106|RODENT MODEL OF DISEASE
C0035804|RODENTS
C1527027|ROMIDEPSIN-CONTAINING PRODUCT
C0162644|ROOT CARIES
C0242726|ROOTS
C0035854|ROSACEA, UNSPECIFIED
C0035857|ROSE BENGAL PRODUCT
C0019381|ROSEOLA VIRUS
C0035853|ROSES
C0289313|ROSIGLITAZONE-CONTAINING PRODUCT
C0073591|ROSOXACIN-CONTAINING PRODUCT
C3163631|ROSTRAL
C0965129|ROSUVASTATIN-CONTAINING PRODUCT
C0035868|ROTATION
C0035871|ROTENONE
C0230779|ROUGH ENDOPLASMIC RETICULUM (RER)
C0027581|ROUNDWORM
C0013153|ROUTE OF ADMINISTRATION VALUES
C1419748|RPS6KB1 GENE
C1335645|RPS6KB2 GENE
C1366527|RTN4 GENE
C0599161|RT-PCR
C0701303|RU-486
C0035920|RUBELLA, NOS
C0032027|RUBRA PILARIS; PITYRIASIS
C0035950|RUMINANTS
C0600140|RUN
C0035953|RUNNING ACTIVITY
C3203359|RUPTURE
C2937358|RUPTURE;BLOOD VESSEL;BRAIN
C0162869|RUPTURED ANEURYSM, NOS
C0018813|RUPTURE OF HEART
C0086944|RURAL COMMUNITIES
C0035962|RURAL POPULATIONS
C0035976|RUTIN-CONTAINING PRODUCT
C0035190|RV
C1419780|RYANODINE RECEPTOR 3
C1419778|RYR1 GENE
C1335796|S100 CALCIUM-BINDING PROTEIN A12
C0007004|SACCHARIDES
C0458232|SACROILIAC JOINT PAIN
C0036037|SACRUM, NOS
C4033447|SACUBITRIL
C4294492|SACUBITRILAT
C0036001|S-ADENOSYL HOMOCYSTEINE
C1412379|S-ADENOSYLMETHIONINE DECARBOXYLASE
C0036002|S-ADENOSYLMETHIONINE (SAME)
C3536794|SADNESS
C0036043|SAFETY
C0581560|SAFETY OBSERVATIONS
C0376238|SAFFRON
C0036075|SALICYLATE
C0036077|SALICYLATES
C0073202|SALIDROSIDE
C0443452|SALIVARY AMYLASE ISOENZYME
C0010823|SALIVARY GLAND; INCLUSION DISEASE
C0438730|SALIVA SPECIMEN
C0036111|SALMONELLA, NOS
C0195495|SALPINGO-OOPHORECTOMY, BILATERAL
C0237820|SALVAGE
C0331292|SALVIA, NOS
C0994408|SAMBUCUS
C0331055|SAMBUCUS, NOS
C3890731|SAMOA STANDARD TIME
C0242618|SAMPLE SIZE
C2348152|SAMPLE VARIANCE
C1511897|SANGER SEQUENCING
C0036172|SANITATION
C0392907|SAPHENOUS VEIN
C0520481|SAPONIN
C0036189|SAPONINS
C0286738|SAQUINAVIR PRODUCT
C1420006|SARCOGLYCAN, BETA
C1420009|SARCOGLYCAN, GAMMA
C0019829|SARCOMA;HODGKINS
C1261473|SARCOMA, NOS
C0598790|SARCOMA OF LUNG
C0872084|SARCOPENIA
C0036239|SATIETY
C0242428|SATISFACTION
C0556120|SATURATED FAT INTAKE
C0597423|SATURATED FATTY ACIDS
C0522534|SATURATION
C0004836|SAUNA EACH 15 MINUTES
C0349674|SCALE - RANK
C0596217|SCAN BRAIN
C0441633|SCANNING
C0026020|SCANNING ELECTRON MICROSCOPY
C0392288|SCANNING LASER OPHTHALMOSCOPE
C0183115|SCANNING SYSTEMS
C0262879|SCANNING/TRANSMISSION ELECTRON MICROSCOPE
C1413218|SCAVENGER RECEPTOR CLASS B, MEMBER 1
C1413219|SCAVENGER RECEPTOR CLASS B, MEMBER 2
C0074129|SCAVENGER RECEPTORS
C1003377|SCAVENGERS
C0683579|SCENARIO
C0141729|SCHISANDRA
C0221765|SCHIZOPHRENIA CHRONIC
C0036337|SCHIZOPHRENIA, SCHIZO-AFFECTIVE TYPE
C0684017|SCHOLAR
C0420160|SCHOOL CHILD HEALTH EXAMINATION
C0036375|SCHOOLS
C0036387|SCHWANN CELLS
C0085112|SCID MOUSE
C0036397|SCIENCES
C2827396|SCIENTIFIC EQUIPMENT
C0947630|SCIENTIFIC STUDY
C0402112|SCIENTISTS
C0034606|SCINTIGRAPHY
C0002395|SCLEROSIS; ALZHEIMER
C0010054|SCLEROSIS; CORONARY
C0023521|SCLEROSIS; GLOBOID BODY
C0154682|SCLEROSIS; LATERAL
C0026769|SCLEROSIS; MULTIPLE
C0036429|SCLEROSIS, NOS
C0000768|SCONG
C0036442|SCOPOLAMINE PREPARATIONS
C0449820|SCORES
C0663332|SCOURGE
C0036457|SCRAPIE
C1710032|SCREENING
C0871311|SCREENING TESTS
C1539732|SCRIB GENE
C0206208|SEAFOOD, NOS
C1706202|SEARCH
C0036497|SEASONS
C0856416|SECONDARY DEMENTIA
C0752205|SECONDARY DYSTONIA
C0021055|SECONDARY IMMUNE RESPONSE
C0153690|SECONDARY MALIGNANT NEOPLASM OF BONE, NOS
C0494165|SECONDARY MALIGNANT NEOPLASM OF LIVER, NOS
C0679699|SECONDARY PREVENTION
C0751965|SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS
C0162807|SECONDARY PROTEIN STRUCTURE
C0004457|SECOND CERVICAL VERTEBRA
C0029132|SECOND CRANIAL NERVE DISORDER OR SYNDROME
C0813971|SECONDHAND SMOKE
C1508748|SECOND MESSENGER
C0457385|SECOND (SEC)
C0036532|SECOSTEROIDS
C0171484|SECRETASE
C1335806|SECRETIN RECEPTOR
C0036537|SECRETIONS
C1822654|SECRETOGLOBIN, FAMILY 1D, MEMBER 4
C0334187|SECRETORY ENDOMETRIUM
C0036557|SEDATIVES
C0205254|SEDENTARY
C1532253|SEDENTARY LIFESTYLE
C1550099|SEDIMENT
C1705192|SEED
C0036563|SEEDS
C0080141|SEGREGATION
C0014547|SEIZURE DISORDER FOCAL
C1299590|SEIZURE FREE
C0149775|SEIZURE FREQUENCY
C0234533|SEIZURE, GENERALIZED
C0036572|SEIZURES
C0751495|SEIZURES, FOCAL
C0282651|SELECTINS
C0036577|SELECTION BIAS
C0242801|SELECTION CRITERIA
C0036579|SELEGILINE-CONTAINING PRODUCT
C1519229|SELENIUM AND VITAMIN E EFFICACY TRIAL
C0238421|SELENIUM; DEFICIENCY
C0036581|SELENIUM (SE)
C0074302|SELENOPROTEINS
C0036588|SELF
C3146223|SELF AWARENESS
C0036592|SELF-CARE INTERVENTIONS
C0237529|SELF-CONFIDENCE
C0162638|SELF DESTRUCTION OF THE CELL
C0600564|SELF-EFFICACY
C0425092|SELF-EMPLOYMENT
C0036605|SELF-HELP DEVICES
C0086969|SELF-MANAGEMENT
C0424359|SELF-NEGLECT
C0242498|SELF-PERCEPTION
C2700446|SELF-REPORTED
C1609861|SELICICLIB
C2713560|SEMAGACESTAT
C0338462|SEMANTIC DEMENTIA
C0454582|SEMANTIC IMPAIRMENT
C0542312|SEMANTIC MEMORY
C0561746|SEMANTIC MEMORY PERFORMANCE
C0036612|SEMANTICS
C4505788|SEMBRAGILINE
C1999167|SENESCENCE
C0392079|SENILE
C0011268|SENILE DEMENTIA, NOS
C0752347|SENILE DEMENTIA WITH LEWY BODIES
C0242383|SENILE MACULAR RETINAL DEGENERATION, NOS
C0333463|SENILE PLAQUE
C0231337|SENILITY
C1456594|SENIORS' HEALTH
C0036668|SENSITIVITY SPECIFICITY
C0183210|SENSORS
C0748618|SENSORY DEFICIT
C0234213|SENSORY DENERVATION, NOS
C0278134|SENSORY; LOSS
C0027883|SENSORY NEURONS
C0871340|SENTENCE COMPREHENSION
C0950580|SENTINEL
C0687118|SEPARATED
C0036679|SEPARATION, NOS
C0442004|SEPTAL
C0036687|SEPTAL NUCLEI
C1539749|SEPTIN 7
C0543419|SEQUELA OF DISORDER
C3889830|SEQUENCING
C0679085|SEQUENTIAL LEARNING
C1454337|SERINE/ARGININE-RICH SPLICING FACTOR 3
C0074375|SERINE PALMITOYLTRANSFERASE
C0036734|SERINE PROTEASES
C0036733|SERINE PROTEINASES--INHIBITORS
C3711796|SERINE-PROTEIN KINASE ATM
C0036720|SERINE (SER)
C0072402|SERINE/THREONINE PROTEIN KINASE
C0659150|SERINE/THREONINE-PROTEIN KINASE CHK1
C1259236|SERINE/THREONINE-PROTEIN KINASE CHK2
C1307407|SERINE/THREONINE-PROTEIN KINASE MTOR
C1449326|SERINE/THREONINE-PROTEIN KINASE TBK1
C1335545|SERINE/THREONINE-PROTEIN PHOSPHATASE 2A 56 KDA REGULATORY SUBUNIT EPSILON ISOFORM
C1511476|SERINE/THREONINE PROTEIN PHOSPHATASE 2B CATALYTIC SUBUNIT ALPHA ISOFORM
C1519255|SERIOUS ADVERSE EVENT (SAE)
C0732611|SERM
C0521143|SEROPOSITIVE
C0036751|SEROTONIN
C0034838|SEROTONIN RECEPTOR SITE
C0170657|SEROTONIN TRANSPORTER
C0162758|SEROTONIN UPTAKE INHIBITORS
C0036759|SEROTYPING PROCEDURE, NOS
C0021389|SEROUS INFLAMMATION, NOS
C1418556|SERPIN FAMILY B MEMBER 9
C1426527|SERPIN FAMILY H MEMBER 1 PSEUDOGENE 1
C1418544|SERPIN PEPTIDASE INHIBITOR, CLADE A, MEMBER 1
C3888213|SERPIN PEPTIDASE INHIBITOR, CLADE A, MEMBER 2, PSEUDOGENE
C1418252|SERPIN PEPTIDASE INHIBITOR, CLADE E (NEXIN, PLASMINOGEN ACTIVATOR INHIBITOR TYPE 1), MEMBER 1
C0074393|SERTRALINE-CONTAINING PRODUCT
C0229671|SERUM
C0036773|SERUM ALBUMIN
C0036774|SERUM ALBUMIN FROM COWS
C0443856|SERUM AMYLOID P
C0311444|SERUM AMYLOID PROTEIN, NOS
C0595929|SERUM CHOLESTEROL RAISED
C0858105|SERUM COPPER
C1277266|SERUM C REACTIVE PROTEIN LEVEL
C0583332|SERUM GLUCOSE LEVEL
C0202041|SERUM GLUCOSE TEST
C0428357|SERUM INSULIN MEASUREMENT
C0235430|SERUM KETONE CONCENTRATION ABOVE NORMAL RANGE
C0428462|SERUM LIPIDS NOS
C1257646|SERUM PARAOXONASE/ARYLESTERASE 1
C0487953|SERUM/PLASMA
C0036825|SERUM PROTEIN, NOS
C0455307|SERUM SEX HORMONE BINDING GLOBULIN MEASUREMENT
C0455272|SERUM URIC ACID TEST
C0557854|SERVICES
C0074405|SESAMIN
C0036847|SESQUITERPENES
C1883016|SESSION
C2985547|SESTAMIBI BREAST IMAGING
C0392905|SET OF ALL JOINTS
C0003842|SET OF ARTERIES
C1185744|SET OF ASSOCIATION FIBERS
C0729594|SET OF AXILLARY LYMPH NODES
C0004781|SET OF BASAL GANGLIA
C0546019|SET OF BASAL GANGLIA OF LEFT CEREBRAL HEMISPHERE
C0546018|SET OF BASAL GANGLIA OF RIGHT CEREBRAL HEMISPHERE
C0007301|SET OF CARTILAGES
C0007634|SET OF CELLS
C1185625|SET OF COMPARTMENTS
C0205042|SET OF CORONARY ARTERIES
C0015420|SET OF EYEBROWS
C0016129|SET OF FINGERS
C0162342|SET OF LENTIFORM NUCLEI
C0206116|SET OF MICROGLIAL CELLS
C0027836|SET OF NEUROGLIAL CELLS
C0028938|SET OF OLFACTORY NERVES
C0022131|SET OF PANCREATIC ISLETS
C0031093|SET OF PERIODONTIA
C0036622|SET OF SEMICIRCULAR CANAL SPACES
C0036665|SET OF SENSE ORGANS
C0036849|SET (PSYCHOLOGY)
C1822695|SETX GENE
C0443302|SEVERAL
C1175175|SEVERE ACUTE RESPIRATORY SYNDROME (SARS)
C0588008|SEVERE; DEPRESSION
C1443924|SEVERE DIARRHEA
C0028756|SEVERE OBESITY
C0278140|SEVERE PAIN
C0521117|SEVERITY OF ILLNESS, NOS
C0457451|SEVERITY SCORE
C0036866|SEX DIFFERENCES
C0086287|SEX FEMALE
C0205906|SEXISM
C0086582|SEX MALE
C0036883|SEX STEROID BINDING GLOBULIN
C0036884|SEX STEROID HORMONE
C0598095|SEXUAL DIMORPHISM
C0023618|SEXUAL DRIVE
C0278092|SEXUAL FUNCTION, NOS
C0242350|SEXUAL IMPOTENCE, NOS
C0423988|SEXUAL PREOCCUPATION
C0871356|SEXUAL SATISFACTION
C0723176|SFC
C1822703|SH2B ADAPTOR PROTEIN 1
C1822704|SH2B ADAPTOR PROTEIN 2
C1420017|SH2 DOMAIN PROTEIN 1A
C1438514|SH3 AND MULTIPLE ANKYRIN REPEAT DOMAINS PROTEIN 2
C2699243|SH3 AND MULTIPLE ANKYRIN REPEAT DOMAINS PROTEIN 3
C1822711|SH3PXD2A GENE
C0030567|SHAKING; PALSY
C0032042|SHAM THERAPY
C0348078|SHAPE
C0332479|SHAPES
C0965915|SHARPIN
C0027796|SHARP NERVE PAIN
C0202218|SHBG
C1366439|SHBG GENE
C0205013|SHEARING
C1123019|SHEEP
C0222041|SHELL, NOS
C0425104|SHIFT WORKER
C0020683|SHOCK; HYPOVOLEMIC
C0036983|SHOCK; SEPTIC
C0150768|SHOPPING
C1806781|SHORT
C0682884|SHORT-ACTING BENZODIAZEPINES
C2930586|SHORT HAIRPIN RNA
C0521525|SHORT NECK
C0013404|SHORTNESS OF BREATH (SOB)
C0425946|SHORT PERIOD
C0751509|SHORT-SLEEPER
C0701811|SHORT TERM MEMORY LOSS
C1547282|SHOW
C0237652|SHUTTLE BOXES
C0067762|SIALIC ACID, NOS
C0037047|SIBLINGS
C0002895|SICKLING DISORDER DUE TO HEMOGLOBIN S
C0221423|SICKNESS
C0441987|SIDE
C0041755|SIDE EFFECTS (DRUG)
C0162316|SIDEROPENIC; ANEMIA
C0037061|SIDEROSIS
C1417966|SIGMA NONOPIOID INTRACELLULAR RECEPTOR 1
C1710082|SIGNAL
C1519315|SIGNALING MOLECULE
C0935996|SIGNALING PATHWAY GENE
C1335962|SIGNALING PROTEIN
C0037080|SIGNAL PATHWAY
C1432814|SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 1-ALPHA/BETA
C1420452|SIGNAL-TRANSDUCING ADAPTOR MOLECULE 2
C0037083|SIGNAL TRANSDUCTION
C0086982|SIGNAL TRANSDUCTION PATHWAYS
C0005516|SIGNATURE MOLECULE
C0682323|SIGNIFICANT OTHER
C3887537|SIGNIFICANT OTHERS
C0311392|SIGN, NOS
C0037088|SIGN/SYMPTOM
C1277063|SIKHS
C1822725|SIL1, S. CEREVISIAE, HOMOLOG OF
C0529793|SILDENAFIL-CONTAINING PRODUCT
C0858952|SILENCE
C1519323|SILENT MUTATION
C0086983|SILICATE SALT, NOS
C0037105|SILICIC ACID
C0037098|SILICON DIOXIDE
C0037107|SILICON, NOS
C0037116|SILICOSIS
C0037125|SILVER, NOS
C0037135|SILYMARIN
C0205352|SIMPLE
C0017612|SIMPLE; GLAUCOMA
C0016399|SIMPLE PARTIAL SEIZURE WITH MOTOR DYSFUNCTION
C0019348|SIMPLEX; HERPES
C0206558|SIMPLEXVIRUS, NOS
C0284447|SIMULATE
C0521115|SIMULTANEOUS
C0074554|SIMVASTATIN-CONTAINING PRODUCT
C0751980|SINGLE CELL GEL ELECTROPHORESIS
C1883036|SINGLE-CHAIN VARIABLE FRAGMENT
C0024517|SINGLE EPISODE OF MAJOR DEPRESSIVE DISORDER
C1313913|SINGLETON
C0074565|SINGLET OXYGEN
C1883034|SINGLE-WALLED NANOTUBE
C0337201|SINKING
C0003813|SINUS ARRHYTHMIA BY ECG FINDING
C0037199|SINUSITIS, NOS
C0072980|SIROLIMUS-CONTAINING PRODUCT
C1136177|SIRTUINS
C0337514|SISTERS
C0205145|SITE
C0220914|SITOSTEROL
C0037215|SITOSTEROLS
C0205452|SIX
C0456389|SIZE
C0000739|SKELETAL MUSCLE STRUCTURE OF ABDOMEN
C0242692|SKELETAL MUSCLE TISSUE
C0816871|SKELETON
C0678856|SKILL
C0037271|SKIN--AGING
C0586537|SKIN BIOPSY SAMPLE
C0751676|SKIN CANCER BASAL CELL
C0007114|SKIN CANCERS
C0699893|SKIN CARCINOMA
C0016989|SKIN CONDUCTION
C0037274|SKIN DISORDERS
C1272578|SKIN FIBROBLAST
C0162835|SKIN HYPOPIGMENTED
C0011603|SKIN; INFLAMMATION
C0152030|SKIN; IRRITATION
C0015230|SKIN RASH
C0237849|SKIN SCALES
C1123023|SKIN STRUCTURE
C0586407|SKIN SYMPTOMS
C0814024|SKNCUDNC
C0037316|SLEEP DEPRIVATION
C0037317|SLEEP DISTURBANCE, UNSPECIFIED
C0424522|SLEEPING
C0917799|SLEEPING TOO MUCH
C0917801|SLEEPLESSNESS
C0235161|SLEEP LOSS
C0037313|SLEEP, NOS
C0871908|SLEEP ONSET
C0037322|SLEEP, PARADOXICAL
C0474396|SLEEP PATTERN
C0234451|SLEEP, SLOW
C0162701|SLEEP TESTING
C0871379|SLEEP WAKE CYCLE
C0851578|SLEEP-WAKE DISORDER
C0877792|SLEEP-WAKE SCHEDULE DISORDER, NOS
C0013144|SLEEPY
C1519355|SLICE
C0343755|SLIM DISEASE
C0807955|SLOPE
C0027544|SLOUGHING
C0015934|SLOW FETAL GROWTH, UNSPECIFIED
C0428977|SLOW HEART RATE
C0233565|SLOW PHYSICAL MOVEMENT
C0235546|SLOW SHALLOW BREATHING
C0013754|SLV
C1334468|SMAD FAMILY MEMBER 2
C0919432|SMAD FAMILY MEMBER 3
C0700321|SMALL
C0024305|SMALL CLEAVED CELL (DIFFUSE) NON-HODGKIN'S LYMPHOMA
C0679993|SMALL GROUPS
C1099354|SMALL INTERFERING RNA
C0013303|SMALL INTESTINE, DUODENUM
C0022378|SMALL INTESTINE, JEJUNUM
C1328819|SMALL MOLECULE
C1367790|SMALL NUCLEAR RIBONUCLEOPROTEIN F
C0748864|SMALL SIZE
C2733158|SMALL VESSEL CEREBROVASCULAR DISEASE
C2370955|SMELL FUNCTION
C0003126|SMELL; LOSS, COMPLETE (ANOSMIA)
C0037361|SMELL, NOS
C0037363|SMILING
C0175694|SMITH-LEMLI-OPITZ SYNDROME
C0037366|SMOKE
C0337664|SMOKER, NOS
C0037369|SMOKING
C1519386|SMOKING STATUS
C0302836|SMOKING TOBACCO, NOS
C1135918|SMOOTH MUSCLE CELL
C0304437|SMOOTH MUSCLE RELAXANTS
C1267092|SMOOTH MUSCLE (TISSUE)
C0036154|SMR
C0453863|SNACK FOODS
C0018882|SNAIL
C0635399|SNAKE VENOM FACTOR V ACTIVATOR
C4284285|SNAP25 WT ALLELE
C1548534|SNF
C1159123|S-NITROSYLATION
C0037384|SNORING SYMPTOMS
C0331658|SNOWDROPS
C0752046|SNP
C1260880|SNUFFLES
C1366586|SNW DOMAIN CONTAINING 1
C0037392|SOAPS
C0037393|SOCCER
C0728831|SOCIAL
C0419189|SOCIAL CARE
C0037402|SOCIAL CLASSES
C0037412|SOCIAL DISTANCE
C0237827|SOCIAL; EXCLUSION
C0037420|SOCIAL INTERACTION
C0237101|SOCIAL INTERACTION FINDING
C0037421|SOCIAL; ISOLATION
C3179002|SOCIAL NETWORKS
C0150775|SOCIAL NETWORKS
C0037431|SOCIAL PROBLEMS
C0679005|SOCIAL SKILLS
C0037438|SOCIAL SUPPORT NETWORK
C0037440|SOCIAL WELFARE ORGANIZATION
C0037455|SOCIETY
C0748878|SOCIOECONOMIC
C0037414|SOCIOENVIRONMENT
C0074721|SODIUM AZIDE
C1452369|SODIUM CHANNEL PROTEIN TYPE 9 SUBUNIT ALPHA
C0037492|SODIUM CHANNELS
C0037494|SODIUM CHLORIDE PRODUCT
C1439340|SODIUM-DEPENDENT DOPAMINE TRANSPORTER
C1456447|SODIUM-DEPENDENT NORADRENALINE TRANSPORTER
C1456457|SODIUM-DEPENDENT SEROTONIN TRANSPORTER
C0037473|SODIUM, NOS
C0037537|SODIUM OXYBUTYRATE
C0001479|SODIUM POTASSIUM PUMP
C0074765|SODIUM SELENATE
C1419867|SODIUM VOLTAGE-GATED CHANNEL ALPHA SUBUNIT 9
C2935150|SOLANEZUMAB
C1145678|SOLANUM TUBEROSUM
C0524647|SOLDIERS
C0280100|SOLID TUMOR, NOS
C0005937|SOLITARY; CYST BONE
C0037623|SOLOMON ISLANDS
C0037628|SOLUBILITY
C1948047|SOLUBLE
C1368111|SOLUBLE EPIDERMAL GROWTH FACTOR RECEPTOR
C4331302|SOLUBLE INTERCELLULAR ADHESION MOLECULE 1 MEASUREMENT
C3840403|SOLUBLE VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2
C1420089|SOLUTE CARRIER FAMILY 11 (PROTON-COUPLED DIVALENT METAL ION TRANSPORTER), MEMBER 2
C1420116|SOLUTE CARRIER FAMILY 18 (VESICULAR ACETYLCHOLINE), MEMBER 3
C1420118|SOLUTE CARRIER FAMILY 19 (THIAMINE TRANSPORTER), MEMBER 2
C1420120|SOLUTE CARRIER FAMILY 1 MEMBER 2
C1420138|SOLUTE CARRIER FAMILY 22 MEMBER 3
C1335837|SOLUTE CARRIER FAMILY 2 MEMBER 1
C1420180|SOLUTE CARRIER FAMILY 30 (ZINC TRANSPORTER), MEMBER 3
C1420184|SOLUTE CARRIER FAMILY 32 MEMBER 1
C1412113|SOLUTE CARRIER FAMILY 33 MEMBER 1
C3469826|SOLUTE CARRIER FAMILY 35, MEMBER G1
C1420192|SOLUTE CARRIER FAMILY 3 MEMBER 2
C1456396|SOLUTE CARRIER FAMILY 40 MEMBER 1
C1420193|SOLUTE CARRIER FAMILY 4 MEMBER 1 (DIEGO BLOOD GROUP)
C1420214|SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, SEROTONIN), MEMBER 4
C1420240|SOLUTE CARRIER FAMILY 9 MEMBER A6
C0037633|SOLUTION, NOS
C0525069|SOLUTIONS (PHARMACY)
C0599444|SOMA
C0544886|SOMATIC MUTATION
C0021665|SOMATOMEDIN C
C0037657|SOMATOMEDIN PREPARATION
C0015216|SOMATOSENSORY EVOKED POTENTIALS
C0037659|SOMATOTROPIN RELEASE INHIBITING FACTOR (SRIF)
C0373506|SOMATOTROPIN STIMULATION TEST
C0037663|SOMATROPHIC HORMONE
C0037658|SOMESTHETIC SENSORY CORTEX
C2830004|SOMNOLENCE
C1298942|SOMNOLENCE; EXCESSIVE
C0037683|SONS
C0037688|SORBITOL PREPARATION
C1420313|SORTILIN 1
C1307867|SORTILIN-RELATED RECEPTOR
C1420312|SORTILIN RELATED RECEPTOR 1
C1539803|SORTILIN RELATED VPS10 DOMAIN CONTAINING RECEPTOR 1
C1539804|SORTILIN RELATED VPS10 DOMAIN CONTAINING RECEPTOR 2
C1426661|SORTING NEXIN FAMILY MEMBER 27
C0018767|SOUND PERCEPTION
C0037709|SOUNDS
C0449416|SOURCE
C0238605|SOUTH AFRICAN
C1519427|SOUTH ASIAN
C0022773|SOUTH KOREA
C1262902|SOYBEAN
C1532456|SOY BEAN PRODUCT
C0037733|SOYBEANS
C0677666|SOY PROTEIN ISOLATE
C0074926|SOY PROTEINS
C1883067|SPACE
C0037747|SPAIN
C1711300|SPAN
C1420343|SPARC-LIKE PROTEIN 1
C0023882|SPASTIC; PARALYSIS, CEREBRAL INFANTILE
C0037772|SPASTIC PARAPLEGIA SYNDROME
C0679024|SPATIAL ABILITY
C0584950|SPATIAL AWARENESS
C0422893|SPATIAL DISORIENTATION
C0814087|SPATIAL MEMORY
C0871400|SPATIAL ORGANIZATION
C0087009|SPECIALISTS
C0597010|SPECIAL POPULATIONS
C1705920|SPECIES
C1552740|SPECIFIC
C0443640|SPECIFIC ANTIBODY
C0149676|SPECIFIC ENZYME DEFICIENCY
C3858709|SPECIFIC GROUP
C1515879|SPECIFIC IMMUNE CELL
C0037791|SPECIFICITY
C0449604|SPECIFIC SITE
C0700364|SPECIMEN APPEARANCE
C0436196|SPECTROMETRY
C0037805|SPECTROPHOTOMETRY
C0037812|SPECTRUM ANALYSIS
C0040399|SPECT SCAN
C0023009|SPEECH LANGUAGE DISORDER
C0037817|SPEECH, NOS
C0678536|SPEED
C0680968|SPENDING
C0037871|SPERMIDINE
C0037874|SPERMINE
C1822783|SPERM MITOCHONDRIA-ASSOCIATED CYSTEINE-RICH PROTEIN
C0812425|S-PHASE FRACTION (SPF)
C0381943|S-PHASE KINASE-ASSOCIATED PROTEIN 2
C0080129|S PHASE PROCESS
C0037889|SPHEROCYTOSIS HEREDITARY
C1519451|SPHINGOLIPID METABOLISM PATHWAY
C0037900|SPHINGOLIPIDS
C0037906|SPHINGOMYELIN
C0028064|SPHINGOMYELIN/CHOLESTEROL LIPIDOSIS, NOS
C0037903|SPHINGOMYELIN PHOSPHODIESTERASE
C3539580|SPHINGOMYELIN PHOSPHODIESTERASE 2
C0037907|SPHINGOSINE
C0074992|SPHINGOSINE 1-PHOSPHATE
C0074993|SPHINGOSINE KINASE
C1420357|SPHK1 GENE
C1425830|SPHK2 GENE
C0037910|SPICES
C0521329|SPINAL
C0037929|SPINAL CORD INJURY, NOS
C0037925|SPINAL CORD STRUCTURE
C0234112|SPINAL FACILITATION
C0007806|SPINAL FLUID
C0270697|SPINAL PUNCTURE; HEADACHE
C0016719|SPINAL; SCLEROSIS, HEREDITARY (FRIEDREICH'S ATAXIA)
C0002736|SPINAL; SCLEROSIS, LATERAL (AMYOTROPHIC)
C0682540|SPINDLE CELL
C0026847|SPINE MUSCLE ATROPHY
C0812377|SPINK1 GENE
C0037914|SPIN LABELS
C0087012|SPINOCEREBELLAR; ATAXIA
C0752120|SPINOCEREBELLAR ATAXIA TYPE 1
C0024408|SPINOCEREBELLAR ATAXIA TYPE 3
C0752121|SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS
C0037970|SPIROCHAETE
C0037973|SPIROCHETES
C0037974|SPIROCHETOSIS
C0919490|SPLEEN FOCUS FORMING VIRUS PROVIRAL INTEGRATION ONCOGENE SPI1
C0037993|SPLENIC STRUCTURE
C1519477|SPLENOCYTE
C0017205|SPLENOMEGALY; GAUCHER'S
C0035687|SPLICING
C0038111|SPM
C1855229|SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE
C0205359|SPONTANEOUS
C1321132|SPONTANEOUS HEMORRHAGE
C0338582|SPORADIC CEREBRAL AMYLOID ANGIOPATHY
C1852467|SPORADIC CREUTZFELDT-JAKOB DISEASE
C0277552|SPORADIC DISORDER, NOS
C0038039|SPORTS ACTIVITY, NOS
C0004161|SPORTS INJURY, NOS
C0331428|SPOTTED THISTLE
C0162409|SPOUSES
C2699239|SPRAGUE-DAWLEY
C0027627|SPREADING OF TUMOR
C1420393|SQSTM1 GENE
C0751688|SQUAMOUS CELL CANCER
C0413258|SQUEEZE
C1419989|SRSF1 GENE
C1420328|SRY-BOX 5
C0360105|SSRI
C1539862|ST3 BETA-GALACTOSIDE ALPHA-2,3-SIALYLTRANSFERASE 4
C1293130|STABILIZATION
C0920880|STABILIZER
C0340288|STABLE ANGINA
C0677946|STABLE DISEASE
C3272897|STACK
C0851286|STAFF
C0038122|STAFF ATTITUDES
C1704680|STAINING
C4288315|STAKEHOLDER
C0935572|STALKING
C2828392|STANDARD
C0871420|STANDARD DEVIATION
C0038136|STANDARDIZATION
C1255664|STANDARDIZED ASSESSMENTS
C0475411|STANDARDIZED TECHNIQUE
C0516711|STANDING BALANCE
C3642273|STANFORD CANCER INSTITUTE
C1547201|START UP
C0038187|STARVATION, NOS
C0333138|STASIS, NOS
C0253050|STAT3
C1367307|STAT3 GENE
C1514955|STAT3 SIGNALING PATHWAY
C0205548|STAT (DO IMMEDIATELY)
C1301808|STATE
C0233485|STATE; APPREHENSION
C0009676|STATE; CONFUSIONAL
C0011570|STATE; DEPRESSIVE
C0025320|STATE; MENOPAUSAL
C1710187|STATEMENT
C0027932|STATE; NEUROTIC
C0221099|STATE OF IMPAIRMENT
C0597240|STATE OF MATTER
C1419850|STATHMIN-LIKE 2
C0360714|STATINS
C0871424|STATISTICAL ANALYSIS
C0814897|STATISTICAL POWER
C0034980|STATISTICAL REGRESSION
C0005890|STATURE
C0424639|STATURE
C0038220|STATUS EPILEPTICUS, UNSPECIFIED
C0311335|STATUS; GRAND MAL
C0332152|STATUS PRE-
C0023252|STATUTES AND LAWS
C0075193|STAUROSPORINE
C0678587|STEADY-STATE
C0038229|STEARIC ACID
C0038250|STEM CELLS
C0872278|STEM CELL THERAPY
C0472699|STEM CELL TRANSPLANT
C0007282|STENOSIS;ARTERY;CAROTID
C0242231|STENOSIS; CORONARY
C0427126|STEP LENGTH
C0376211|STEREOISOMERS
C0038273|STEREOTYPY HABIT DISORDER
C0038302|STEROID 17ALPHA MONOOXYGENASE
C0301818|STEROID HORMONES
C0597513|STEROIDOGENESIS
C0393639|STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS
C0038317|STEROIDS
C0149783|STEROID TREATMENT
C1420399|STEROL REGULATORY ELEMENT-BINDING TRANSCRIPTION FACTOR 2
C0038323|STEROLS
C0906802|STI571
C0427008|STIFFNESS
C0038329|STIGMASTEROL
C0038333|STILBENE
C0595939|STILLBORN INFANT
C0304402|STIMULANT
C0175727|STIMULATORS (APPARATUS)
C0234402|STIMULUS, NOS
C0813171|ST. JOHN'S WORT
C0282380|ST. KITTS AND NEVIS
C0036056|ST. LUCIA
C1416797|STMN1 GENE
C0597526|STOICHIOMETRY
C0024623|STOMACH--CANCER
C0017127|STOMACH EMPTYING
C0038351|STOMACH, NOS
C0022650|STONE;RENAL
C0015733|STOOL
C0019116|STOPPING BLEEDING
C0815045|STORAGE PROTEINS
C2987481|STRAIN
C0301647|STRAND BREAKS
C0233514|STRANGE; BEHAVIOR
C1514983|STRATIFICATION
C0681879|STRATIFIED RANDOM SAMPLING
C0442540|STREAM
C1705922|STRENGTH
C0808080|STRENGTH
C0872279|STRENGTH TRAINING
C0038395|STREPTOCOCCUS INFECTION
C0075301|STREPTOLYSIN O
C0038432|STREPTOZOTOCIN
C0848237|STRESS;ACUTE
C0086209|STRESS; EMOTIONAL
C0016664|STRESS; FRACTURE
C0038444|STRESSFUL EVENTS
C0597530|STRESSOR
C0018850|STRESS PROTEIN
C0038443|STRESS, PSYCHOLOGICAL
C0149784|STRESS RESPONSE
C0038435|STRESS; STATE
C0038446|STRIATE CORTEX
C0162512|STRIATUM
C1261287|STRICTURE, NOS
C0038450|STRIDOR
C0038452|STRIKES
C0948008|STROKE, ISCHEMIC
C1277289|STROKE PREVENTION
C0927195|STROMA
C0218504|STROMAL CELL-DERIVED FACTOR 1
C0164371|STROMELYSIN 1
C0442821|STRONG
C0581602|STRUCTURAL MODIFICATION
C0582263|STRUCTURAL PROTEIN
C0678594|STRUCTURE
C0003847|STRUCTURE OF ARTERIOLE
C0222679|STRUCTURE OF ARTICULAR SURFACE OF BONE
C0085156|STRUCTURE OF BRUCH'S BASAL MEMBRANE
C0006901|STRUCTURE OF CAPILLARY BLOOD VESSEL (ORGAN)
C0007776|STRUCTURE OF CEREBRAL CORTEX
C0018427|STRUCTURE OF CINGULATE GYRUS
C0008812|STRUCTURE OF CIRCLE OF WILLIS
C0010090|STRUCTURE OF CORPUS CALLOSUM
C0010316|STRUCTURE OF CRIBRIFORM PLATE
C0014257|STRUCTURE OF ENDOTHELIUM TISSUE
C0175196|STRUCTURE OF ENTORHINAL CORTEX
C0016536|STRUCTURE OF FOREARM, UNSPECIFIED
C0228195|STRUCTURE OF FRONTAL LOBE GYRUS
C0017651|STRUCTURE OF GLOBUS PALLIDUS
C0018494|STRUCTURE OF HAIR
C0460004|STRUCTURE OF HEAD AND/OR NECK
C0018787|STRUCTURE OF HEART, UNSPECIFIED
C0175202|STRUCTURE OF HIPPOCAMPAL FORMATION
C0020962|STRUCTURE OF IMMUNE SYSTEM, UNSPECIFIED
C0152298|STRUCTURE OF INFERIOR FRONTAL GYRUS
C0226276|STRUCTURE OF INTERNAL THORACIC ARTERY
C0021853|STRUCTURE OF INTESTINE, UNSPECIFIED
C0447028|STRUCTURE OF INTRACRANIAL ARTERY
C0228243|STRUCTURE OF LATERAL OCCIPITOTEMPORAL GYRUS
C0023884|STRUCTURE OF LIVER
C0023951|STRUCTURE OF LOCUS CERULEUS
C0023216|STRUCTURE OF LOWER EXTREMITY, UNSPECIFIED
C0024109|STRUCTURE OF LUNGS, UNSPECIFIED
C0024204|STRUCTURE OF LYMPH NODE
C0025285|STRUCTURE OF MENINGES
C0149566|STRUCTURE OF MIDDLE CEREBRAL ARTERY
C0017067|STRUCTURE OF NERVOUS SYSTEM GANGLION
C0027757|STRUCTURE OF NERVOUS TISSUE
C0028429|STRUCTURE OF NOSE, UNSPECIFIED
C0004788|STRUCTURE OF NUCLEUS BASALIS OF MEYNERT
C0014876|STRUCTURE OF OESOPHAGUS
C0028936|STRUCTURE OF OLFACTORY BULB
C0228065|STRUCTURE OF OLFACTORY SYSTEM
C0152301|STRUCTURE OF ORBITAL GYRUS
C0030274|STRUCTURE OF PANCREAS
C0228249|STRUCTURE OF PARAHIPPOCAMPAL GYRUS
C0030797|STRUCTURE OF PELVIC REGION, UNSPECIFIED
C0228492|STRUCTURE OF POSTERIOR SEMILUNAR LOBULE
C0152306|STRUCTURE OF PRECUNEUS
C0034169|STRUCTURE OF PUTAMEN
C0035322|STRUCTURE OF RETINAL PIGMENT EPITHELIUM
C0230425|STRUCTURE OF RIGHT THIGH
C0021852|STRUCTURE OF SMALL INTESTINE
C0557651|STUDY
C0035173|STUDYINVESTIGATOR
C1521743|STUDY MONITOR
C4553760|STUDY VARIABLE
C0085628|STUPOR
C0035171|STYPE
C0762592|SU 5416
C0970963|SU 6668
C0002928|SUBARACHNOID BLOCK
C0038525|SUBARACHNOID HEMORRHAGE, UNSPECIFIED
C0038527|SUBARACHNOID SPACE STRUCTURE
C0007613|SUBCELLULAR PROCESS
C1159772|SUBCELLULAR PROTEIN TARGETING
C0271790|SUBCLINICAL; HYPOTHYROIDISM
C0275522|SUBCLINICAL INFECTION
C0815275|SUBCORTICAL
C0751014|SUBCORTICAL INFARCTION
C0018946|SUBDURAL HEMORRHAGE, NOS
C0018557|SUBFAMILY CRICETINAE
C1515021|SUBGROUP
C1079230|SUBGROUP
C0332282|SUBSEQUENT
C0038581|SUBSTANCE K
C0439861|SUBSTANCES
C0237123|SUBSTANCE USE
C0038586|SUBSTANCE USE DISORDERS
C0359916|SUBSTANCE WITH PHENOL STRUCTURE
C0175412|SUBSTANTIA NIGRA PARS COMPACTA
C1555721|SUBSTITUTION
C3891814|SUBSTRATE
C0162386|SUBTROCHANTERIC FRACTURE OF FEMUR
C0449560|SUBTYPE
C0887892|SUBUNIT VACCINES
C0597535|SUCCESS
C0012384|SUCCIMER-CONTAINING PRODUCT
C1420510|SUCCINATE-COA LIGASE, ADP-FORMING, BETA SUBUNIT
C0038636|SUCROSE PRODUCT
C0038642|SUDAN
C0011071|SUDDEN / INSTANTANEOUS DEATH
C0008489|SUDDEN, JERKY INVOLUNTARY MOVEMENTS
C0016382|SUDDEN REDNESS OF SKIN PRIMARILY INVOLVING FACE
C0143993|SUFENTANIL-CONTAINING PRODUCT
C0004044|SUFFOCATION
C0020456|SUGAR; BLOOD, HIGH
C0020615|SUGAR; BLOOD, LOW
C0556234|SUGAR INTAKE
C0242209|SUGARS
C1705535|SUGGESTION
C0038659|SUGGESTIONS
C0438696|SUICIDAL
C0424001|SUICIDAL PLAN
C0038663|SUICIDE ATTEMPT(S)
C0038661|SUICIDE, NOS
C0055966|SULFATED GLYCOPROTEIN 2
C0038739|SULFIDES
C0038727|SULFOGLYCOSPHINGOLIPID
C0038761|SULFONES
C0163159|SULFORAPHANE
C0038782|SULFUR OXIDES
C0038792|SULINDAC PRODUCT
C0038720|SULPHATES
C0038766|SULPHONYLUREA PRODUCT
C0038774|SULPHUR PRODUCT
C1515051|SUM
C0949898|SUMAC
C1705536|SUMMATION
C1142436|SUN DOWNING
C0241303|SUN LIGHT EXPOSURE
C0038817|SUNSHINE
C0022602|SUNSHINE; KERATOSIS
C0004923|SUPERFAMILY APOIDEA
C0152309|SUPERIOR TEMPORAL GYRUS
C1550101|SUPERNATANT
C1420307|SUPEROXIDE DISMUTASE 2
C0010461|SUPEROXIDE DISMUTASE [CU-ZN]
C0038838|SUPEROXIDE DISMUTASE (SOD)
C0038836|SUPEROXIDES
C0038842|SUPERVISION
C0038846|SUPINE POSITION
C4048877|SUPPER
C0242297|SUPPLEMENTATION
C0242295|SUPPLEMENTS
C1521721|SUPPORT
C0449436|SUPPORTING STRUCTURE
C0183683|SUPPORT, NOS
C0344211|SUPPORT THERAPY
C1337104|SUPPRESSION OF TUMORIGENICITY 13
C0038868|SUPRANUCLEAR PALSY PROGRESSIVE
C0699040|SURFACE OF CELL
C0597731|SURFACE PLASMON RESONANCE
C0025252|SURFACE PROTEINS
C0206058|SURGERY; ELECTIVE
C0441478|SURGICAL ADVANCEMENT - ACTION
C0023690|SURGICAL BINDING
C0007344|SURGICAL CASTRATION
C0221082|SURGICAL COMPLICATIONS
C0813207|SURGICAL CONSTRUCTION OF SHUNT
C0206078|SURGICAL CUTTING OF THE INTERVERTEBRAL DISK
C1442858|SURGICAL FISTULA
C0185111|SURGICAL MANIPULATION
C0740421|SURGICAL MENOPAUSE
C0200760|SURGICAL PATHOLOGY MORPHOMETRIC ANALYSIS
C0871463|SURGICAL PATIENTS
C0033061|SURGICAL PREPARATION
C0035110|SURGICAL PROCEDURE REPEATED
C0524865|SURGICAL RECONSTRUCTION PROCEDURE
C0728940|SURGICAL REMOVAL - ACTION
C0008320|SURGICAL REMOVAL OF THE GALLBLADDER
C0038944|SURINAME
C0086589|SURROGATE MARKER
C1282914|SURROUNDING
C0733511|SURVEILLANCE
C0038951|SURVEYS
C0664336|SURVIVIN ANTIGEN
C0206194|SURVIVORS
C0038952|SURVIVORSHIP
C0220898|SUSCEPTIBILITY
C1547045|*SUSCEPTIBILITY
C0012655|SUSCEPTIBILITY (DISORDERS)
C0919453|SUSCEPTIBILITY GENE
C0443318|SUSTAINED
C1710261|SUSTAINED RELEASE DOSAGE FORM
C0589099|SUSTAINING ATTENTION
C3897504|SUVR
C0038975|SV40 (VIRUS)
C0206579|SVK
C0740170|SWALLOWING
C0011168|SWALLOWING DISORDERS
C0038981|SWAYBACK OF SHEEP
C0038995|SWEDEN
C0013604|SWELLING DUE TO EXCESS FLUID
C0038999|SWELLING, NOS
C0039005|SWINE
C1707719|SWITCHES
C0039021|SWITZERLAND
C0036919|SYC
C1335892|SYK GENE
C0036939|SYMBIOTIC; PSYCHOSIS
C0039044|SYMPATHETIC NERVOUS SYSTEM STRUCTURE
C0231217|SYMPT/COMPLAINT;MULTIPLE
C0436331|SYMPTOM AGGRAVATING FACTORS
C0030569|SYMPTOMATIC PARKINSON'S DISEASE
C0231221|SYMPTOMLESS
C0030231|SYMPTOM MANAGEMENT
C1457887|SYMPTOMS
C0436345|SYMPTOM SEVERE
C1319166|SYMPTOM SEVERITY LEVEL
C0235031|SYMPTOMS; NERVOUS SYSTEM
C0086132|SYMPTOMS OF DEPRESSION
C0039062|SYNAPSE STRUCTURE
C0085252|SYNAPSIN
C0598501|SYNAPSIS
C0682685|SYNAPTIC CLEFT
C1178983|SYNAPTIC CONNECTIVITY
C0039063|SYNAPTIC MEMBRANE
C1515106|SYNAPTIC PROTEINS AT THE SYNAPTIC JUNCTION
C0234097|SYNAPTIC TRANSMISSION, CHOLINERGIC
C0027793|SYNAPTIC TRANSMISSION, NOS
C0039065|SYNAPTIC VESICLES
C0597545|SYNAPTOGENESIS
C1420550|SYNAPTOGYRIN 3
C0085255|SYNAPTOPHYSIN
C0039067|SYNAPTOSOMES
C0439580|SYNCHRONOUS
C1419891|SYNDECAN 1
C1419892|SYNDECAN 2
C0002962|SYNDROME; ANGINAL
C0085278|SYNDROME; ANTIPHOSPHOLIPID
C0024586|SYNDROME; CARCINOID
C0007286|SYNDROME; CARPAL TUNNEL
C0007760|SYNDROME; CEREBELLAR
C0003635|SYNDROME; DYSPRAXIA
C0014544|SYNDROME; EPILEPTIC
C0221060|SYNDROME; FACIAL DIPLEGIA, CONGENITAL
C0016667|SYNDROME; FRAGILE X
C0549117|SYNDROME; FRONTAL LOBE
C0393735|SYNDROME; HEADACHE
C0022104|SYNDROME; IRRITABLE BOWEL
C0024031|SYNDROME; LOW BACK
C0149931|SYNDROME; MIGRAINE
C0026141|SYNDROME; MILK-ALKALI
C0027341|SYNDROME; NAIL PATELLA
C0002625|SYNDROME; ORGANIC AMNESIC
C0236642|SYNDROME; PICK
C0546983|SYNDROME; POSTCONTUSIONAL
C0015674|SYNDROME; POSTVIRAL, FATIGUE
C0033300|SYNDROME; PREMATURE SENILITY
C0035258|SYNDROME; RESTLESS LEGS
C0039082|SYNDROMES
C0020625|SYNDROME; SALT, LOW
C0036202|SYNDROME; SCHAUMANN
C0032460|SYNDROME; SCLEROCYSTIC OVARY
C0038644|SYNDROME; SUDDEN INFANT DEATH
C1428377|SYNEMIN
C0599739|SYNERGISM
C0039097|SYNOVIAL FLUID
C0288881|SYNTAXIN
C1420506|SYNTAXIN-BINDING PROTEIN 1
C1420508|SYNTAXIN-BINDING PROTEIN 3
C0174878|SYNTEX ADJUVANT FORMULATION (SAF)
C0220781|SYNTHESIS
C0023689|SYNTHETASE
C0259849|SYNTHETIC DRUGS
C0033307|SYNTHETIC PROGESTOGEN
C0033306|SYNTHETIC PROGESTOGEN-CONTAINING PRODUCT
C0165073|SYNUCLEIN
C0027927|SYPHILIS; NERVOUS SYSTEM
C3888058|SYSTEM
C1955832|SYSTEMATIC REVIEW
C0205373|SYSTEMIC
C0268380|SYSTEMIC AMYLOIDOSIS, NOS
C1272641|SYSTEMIC BLOOD PRESSURE
C0749223|SYSTEMIC CHANGE
C0020538|SYSTEMIC HYPERTENSION
C0442893|SYSTEMIC ILLNESS
C0243026|SYSTEMIC INFECTION, NOS
C4049882|SYSTEMIC LUPUS INTERNATIONAL COLLABORATING CLINICS/AMERICAN COLLEGE OF RHEUMATOLOGY-DAMAGE INDEX
C0302339|SYSTEMIC POISON
C0024141|SYSTEM; LUPUS ERYTHEMATOSUS
C0039152|SYSTEMS ANALYSIS
C1450477|SYSTEMS BIOLOGY
C0036421|SYSTEM; SCLEROSIS
C0039155|SYSTOLE, NOS
C1306620|SYSTOLIC BLOOD PRESSURE
C0871470|SYSTOLIC PRESSURE
C0206136|TABLE SALT
C0039225|TABLETS (MEDICINE)
C0723595|TACE
C0039240|TACHYCARDIA; SUPRAVENTRICULAR
C0039231|TACHYCARDIA, UNSPECIFIED
C1420563|TACHYKININ PRECURSOR 1
C1420566|TACHYKININ RECEPTOR 2
C0039241|TACHYKININS
C0085149|TACROLIMUS-CONTAINING PRODUCT
C1139855|TAGS
C0376403|TAI-CHI
C0039259|TAIL STRUCTURE
C1515187|TAKE
C1423493|TALIN 2
C0231779|TANDEM GAIT
C0599748|TANDEM MASS SPECTROMETRY
C0075807|TANGERETIN
C0039292|TANGIER; DISEASE
C0302595|TANNING
C0039294|TANNINS
C0331409|TANSY
C0331408|TANSY
C0039297|TANTALUM, NOS
C0035334|TAPETORETINAL; DEGENERATION
C0037943|TAP;SPINAL CORD
C0686347|TARDIVE DYSKINESIA
C1420588|TAR DNA-BINDING PROTEIN
C1327754|TARENFLURBIL
C1521840|TARGET
C0221284|TARGET CELLS
C0599894|TARGETING
C0039309|TARGET STUDY POPULATION
C0813158|TARGRETIN
C3540678|TASK
C0949664|TAUOPATHY
C0085401|TAU PROTEIN
C0039350|TAURINE-CONTAINING PRODUCT
C0075857|TAUROURSODEOXYCHOLIC ACID
C1426037|TAU TUBULIN KINASE 1
C0162781|TBARS
C0034790|T CELLS--RECEPTORS
C1572543|TEA, BLACK EXTRACT
C0221457|TEACHERS
C0000872|TEACHING HOSPITAL
C0729377|TEACHING MEMORY TECHNIQUE
C1420679|TEA DOMAIN TRANSCRIPTION FACTOR 1
C0556161|TEA INTAKE
C0871489|TEAMS
C0039400|TEA, NOS
C0039411|TECHNETIUM, NOS
C0303611|TECHNETIUM TC-99M
C0378335|TECHNETIUM TC-99M BICISATE
C0145055|TECHNETIUM TC-99M EXAMETAZIME
C0683888|TECHNOLOGICAL INNOVATION
C0039421|TECHNOLOGY
C0205653|TEENAGER
C1521910|TEENAGERS
C0750862|TEETH; EXAMINATION
C0537147|TEGASEROD-CONTAINING PRODUCT
C0004135|TELANGIECTASIA; ATAXIA
C0039462|TELLURIUM (TE)
C0248719|TELMISARTAN-CONTAINING PRODUCT
C0087071|TELOMERASE
C1148756|TELOMERASE ACTIVITY
C1836777|TELOMERE LENGTH, MEAN LEUKOCYTE
C1155299|TELOMERE MAINTENANCE
C0754515|TELOMERE REVERSE TRANSCRIPTASE
C0085187|TELOMERES
C1515263|TELOMERE SHORTENING
C0076080|TEMOZOLOMIDE-CONTAINING PRODUCT
C0039475|TEMPERANCE
C0015967|TEMPERATURE; HIGH
C0039476|TEMPERATURE, NOS
C0442043|TEMPORAL ANATOMIC QUALIFIER
C0546015|TEMPORAL AND FRONTAL LOBES
C0439603|TEMPORAL FREQUENCY
C0230007|TEMPORAL REGION
C0039485|TEMPORAL REGION
C0428763|TEMPORAL RESOLUTION
C0814229|TEMPTATION AND RESTRAINT INVENTORY (TRI)
C0000379|TENAMFETAMINE
C1540034|TENOMODULIN
C0076096|TENOXICAM-CONTAINING PRODUCT
C0039526|TENSILE STRENGTH
C0233494|TENSION; MENTAL
C0027769|TENSION; NERVOUS
C0033893|TENSION TYPE HEADACHE, UNSPECIFIED
C0039536|TERATOGENS
C1366448|TERC GENE
C1705313|TERM
C0233324|TERM BIRTH OF NEWBORN, NOS
C0205088|TERMINAL
C0012881|TERMINAL DEOXYRIBONUCLEOTIDYL TRANSFERASE
C0679247|TERMINAL ILLNESS
C0039561|TERPENES
C0046563|TERT-BUTYLHYDROQUINONE-CONTAINING PRODUCT
C1367342|TERT GENE
C0679700|TERTIARY PREVENTION
C0871504|TEST ANXIETY
C0018941|TEST;BLOOD
C0201950|TEST;CHOLESTEROL
C0373607|TEST;FERRITIN
C0849974|TEST;FEV-1
C0337428|TEST;FIBRINOGEN
C0679560|TEST;GENETIC
C0019699|TEST; HIV, POSITIVE
C0151721|TESTICULAR HYPOGONADISM, NOS
C0039593|TESTING METHOD
C0202098|TEST;INSULIN
C0153594|TESTIS NEOPLASM MALIGNANT
C0039597|TESTIS STRUCTURE
C0022885|TEST; LABORATORY
C0202123|TEST;LH;F
C0034786|TESTOSTERONE RECEPTORS
C0039601|TESTOSTERONES
C0497100|TEST;PHYSICAL FUNCTION
C0202194|TEST;POTASSIUM
C0202202|TEST;PROTEIN
C0456984|TEST;RESULT(S)
C0392366|TESTS
C0037981|TEST;SPIROMETRY
C0523912|TEST;TESTOSTERONE
C0449900|TEST USING A CONSTRAST MEDIUM
C0039644|TETRACYCLINE, NOS
C0039245|TETRAHYDROAMINOACRIDINE
C0039663|TETRAHYDROCANNABINOL (THC)
C0048898|TETRAHYDROFOLIC ACID
C0039686|TETRAMERES, NOS
C1540098|TETRASPANIN 18
C0039725|THAILAND
C0195894|THALAMOTOMY
C0752050|THALAMUS, ANTEROVENTRAL NUCLEUS
C0039729|THALAMUS, NOS
C0039736|THALIDOMIDE-CONTAINING PRODUCT
C0076374|THAPSIGARGIN
C0007570|THAYSEN
C1515358|THEAFLAVINS
C0076380|THEANINE
C0008858|THE CITRIC ACID CYCLE
C0016993|THE GAMBIA
C1517941|THE IGF-1 RECEPTOR AND LONGEVITY
C2936411|T HELPER 17 CELL
C0006622|THEOBROMA CACAO
C0039763|THEOBROMINE
C0039771|THEOPHYLLINE PRODUCT
C0871935|THEORY
C0302350|THERAPEUTIC
C1611640|THERAPEUTIC AGENT, NOS
C0002844|THERAPEUTIC ANDROGEN
C0038148|THERAPEUTIC ANDROSTANOLONE
C0723712|THERAPEUTIC BRAND
C0010412|THERAPEUTIC COLD
C0001617|THERAPEUTIC CORTICOSTEROID
C0772289|THERAPEUTIC CORTICOTROPIN-RELEASING FACTOR
C1527144|THERAPEUTIC EFFECT
C0014563|THERAPEUTIC EPINEPHRINE
C0014912|THERAPEUTIC ESTRADIOL
C0014939|THERAPEUTIC ESTROGEN
C0017710|THERAPEUTIC GLUCOCORTICOID
C0020268|THERAPEUTIC HYDROCORTISONE
C0808232|THERAPEUTIC INTERVENTION
C0033308|THERAPEUTIC PROGESTERONE
C1276413|THERAPEUTIC REGIMEN
C0521982|THERAPEUTIC RESPONSE
C0039795|THERAPEUTIC USE
C0871525|THERAPISTS
C0879626|THERAPY ADVERSE EFFECT
C0013806|THERAPY;ELECTROCONVULSIVE
C0949766|THERAPY; PHYSICAL
C0178862|THERMOMETRY
C0036658|THE SENSES
C0039836|THIADIAZINE
C0039848|THIAMIN PYROPHOSPHATE
C0541746|THIAZIDE
C0012802|THIAZIDES/RELATED DIURETICS
C1257987|THIAZOLIDINEDIONES
C0205400|THICKNESS, INCREASED
C1120149|THIENOPYRIDINE
C0015811|THIGH BONE
C0424000|THINKING ABOUT SUICIDE
C0023791|THIOCTIC ACID
C0952039|THIOFLAVINE S STAIN
C0076466|THIOFLAVINE T STAIN
C1504637|THIOREDOXIN
C0039938|THIOREDOXIN
C1450344|THIOREDOXIN-INTERACTING PROTEIN
C1872943|THIOREDOXIN REDUCTASE 1, CYTOPLASMIC
C0039971|THIRST
C0039869|THOUGHT FUNCTIONS, UNSPECIFIED
C0025361|THOUGHT PROCESS
C0563664|THREATENING SUICIDE
C0205449|THREE
C0450363|THREE-DIMENSIONAL
C0040005|THREONINE (THR)
C0600388|THREONINE/TYROSINE PROTEIN KINASE
C0232269|THRILL
C0162578|THROMBECTOMY
C1373124|THROMBIN INHIBITORS
C0040018|THROMBIN PREPARATION
C0005821|THROMBOCYTE
C0398623|THROMBOPHILIA
C0221145|THROMBOPOIESIS
C0218227|THROMBOPOIETIN RECEPTOR
C0149871|THROMBOSIS;DEEP VENOUS
C0040053|THROMBOTIC DISORDER
C0302148|THROMBUS
C0040038|THROMBUS; EMBOLISM
C0087086|THROMBUS, NOS
C0040077|THYMIDINE
C1428114|THYMUS, BRAIN, AND TESTES ASSOCIATED
C1420709|THYROGLOBULIN
C0337445|THYROGLOBULIN (THYROID RELATED HORMONE) LEVEL
C0348024|THYROID DYSFUNCTION
C0740378|THYROID FUNCTION NORMAL
C0549473|THYROID GLAND CARCINOMA
C0919489|THYROID HORMONE RECEPTOR ALPHA
C0040135|THYROID HORMONES
C0279175|THYROID PREPARATIONS
C0040132|THYROID STRUCTURE
C0040165|THYROXINE (T4)
C0040180|TIAPRIDE
C1999375|TICAGRELOR-CONTAINING PRODUCT
C0242358|TIGHT JUNCTION
C0076681|TILMICOSIN
C0449247|TIME COURSE
C0233408|TIME DISORIENTATION
C0040223|*TIME (E.G. SECONDS)
C0206209|TIME MANAGEMENT
C1948053|TIME PERIODS
C0449243|TIMING
C0000545|TIMNODONIC ACID
C0991583|TINCTURE DOSAGE FORM
C0040264|TINNITUS, UNSPECIFIED EAR
C0015672|TIREDNESS
C0001511|TISSUE ADHESION
C0040284|TISSUE CULTURE, NOS
C0010957|TISSUE DAMAGE
C0027540|TISSUE DEATH
C0011164|TISSUE DEGENERATION
C0596171|TISSUE ENGINEERING
C4048299|TISSUE FACTOR
C0164707|TISSUE FACTOR PATHWAY INHIBITOR (TFPI)
C0162367|TISSUE FLUID
C0332448|TISSUE INFILTRATION
C1367459|TISSUE INHIBITOR OF METALLOPROTEINASE 1
C0145947|TISSUE INHIBITOR OF METALLOPROTEINASES 1
C0024348|TISSUE LYSIS
C1519522|TISSUE MICROARRAY
C0032143|TISSUE PLASMINOGEN ACTIVATOR-CONTAINING PRODUCT
C1373140|TISSUE PLASMINOGEN ACTIVATOR INHIBITORS
C0332550|TISSUE RAREFACTION
C0040300|TISSUES (BODY)
C1519516|TISSUE-SPECIFIC GENE EXPRESSION
C1292533|TISSUE SPECIMEN
C0444099|TISSUE SPECIMEN FROM SKIN
C0162621|TITRATION METHOD
C0475208|TITRE
C0040329|TOBACCO PRODUCTS
C0439994|TOBACCO SMOKE
C0453996|TOBACCO SMOKING BEHAVIOUR
C0543414|TOBACCO USE
C0050063|TOCLADESINE
C3255108|TOCOPHERYL
C3555502|TOCOPHERYLQUINONE
C0949647|TOCOTRIENOL
C0682053|TODDLER
C0040363|TOGO
C3274448|TOLERABILITY STUDY
C0076799|TOLFENAMIC ACID-CONTAINING PRODUCT
C0670896|TOLL LIKE RECEPTOR
C1336634|TOLL-LIKE RECEPTOR 2
C0754727|TOLL-LIKE RECEPTOR 2
C1336636|TOLL-LIKE RECEPTOR 4
C1336637|TOLL-LIKE RECEPTOR 5
C1308398|TOLL-LIKE RECEPTOR 5
C1336763|TOLL-LIKE RECEPTOR FAMILY GENE
C1140676|TOMATO
C0040395|TOMOGRAPHY
C0040405|TOMOGRAPHY
C0040408|TONGUE STRUCTURE
C3543842|TONICS
C0040442|TOOTH BUD
C0011334|TOOTH DECAY
C0325132|TOOTHED WHALE, NOS
C0877046|TOOTH; INFECTION
C0080233|TOOTH LOSS, NOS
C0011389|TOOTH PLAQUE
C0040426|TOOTH STRUCTURE
C0683174|TOPICAL APPLICATION
C0304604|TOPICAL CORTICOSTEROIDS
C0076829|TOPIRAMATE-CONTAINING PRODUCT
C0005898|TOPOGRAPHIC REGION, NOS
C0002812|TOPOLOGY
C0270173|TORCH SYNDROME CONGENITAL
C0076836|TOREMIFENE-CONTAINING PRODUCT
C0333076|TORTUOSITY, NOS
C0879399|TOSITUMOMAB-CONTAINING PRODUCT
C0443621|TOTAL APOLIPOPROTEIN E
C1265894|TOTAL ATROPHY
C0201925|TOTAL CALCIUM TEST
C0543421|TOTAL CHOLESTEROL
C0085758|TOTAL COLONIC AGANGLIONOSIS
C0473965|TOTAL INTRAVENOUS ANESTHESIA
C0029189|TOTAL ORCHIDECTOMY
C0555903|TOTAL PROTEIN MEASUREMENT
C0086511|TOTAL REPLACEMENT OF KNEE
C2964552|TOTAL SCORE
C0152054|TOUCH
C0013537|TOXEMIA; ECLAMPTIC
C1407029|TOXIC
C1256754|TOXIC ACTIONS
C0599787|TOXICANT
C0235032|TOXIC DISEASE OR SYNDROME OF NERVOUS SYSTEM
C0600688|TOXICITY
C0430054|TOXICOLOGY SCREEN, GENERAL, NOS
C0032346|TOXIC SUBSTANCE
C0004630|TOXIN, BACTERIAL
C0006055|TOXIN, BOTULINUM
C0012550|TOXIN, DIPHTHERIA
C0444622|TOXIN PRODUCTION
C0040549|TOXINS
C0040557|TOXOPLASMA GONDII
C0040556|TOXOPLASMA, NOS
C0040560|TOXOPLASMOSIS; CONGENITAL
C0040558|TOXOPLASMOSIS, UNSPECIFIED
C0103013|T-PROTEIN
C2827507|TPROTP
C0040577|TRACE ELEMENTS
C1522485|TRACER
C0006290|TRACHEOBRONCHIAL ENDOSCOPY
C1185740|TRACT
C0000932|TRAFFIC ACCIDENTS
C0599896|TRAFFICKING
C0040604|TRAIL MAKING TEST (TMT)
C0220931|TRAINING
C0013658|TRAINING LEVEL
C0599883|TRAIT
C0062961|TRAMIPROSATE
C0020592|TRANQUILIZER
C0001068|TRANSACETYLASE
C0040624|TRANSACTIVATION
C0040640|TRANSCOBALAMIN II
C0234523|TRANSCORTICAL APRAXIA
C3850024|TRANSCRANIAL DIRECT CURRENT STIMULATION
C0206077|TRANSCRANIAL DOPPLER ULTRASONOGRAPHY
C0436548|TRANSCRANIAL MAGNETIC STIMULATION (TMS)
C1519595|TRANSCRIPT
C0040646|TRANSCRIPTASE
C0040649|TRANSCRIPTION
C1158770|TRANSCRIPTIONAL REGULATION
C0920533|TRANSCRIPTIONAL REPRESSION
C1336776|TRANSCRIPTION COACTIVATOR
C1506928|TRANSCRIPTION FACTOR E2F1
C1448629|TRANSCRIPTION FACTOR EB
C0812327|TRANSCRIPTION FACTOR GENE
C0040648|TRANSCRIPTION FACTORS
C1335858|TRANSCRIPTION FACTOR SP1
C1158830|TRANSCRIPTION INITIATION
C3178810|TRANSCRIPTOME
C0597601|TRANSCYTOSIS
C1420754|TRANSDUCIN-LIKE ENHANCER OF SPLIT 3
C1257879|TRANS FATTY ACIDS
C0040669|TRANSFECTION
C0040676|TRANSFERASES
C0040671|TRANSFER OF TRAINING
C1442762|TRANSFERRIN
C0040679|TRANSFERRIN
C1420708|TRANSFERRIN RECEPTOR
C1420707|TRANSFERRIN RECEPTOR 2
C0034845|TRANSFERRIN RECEPTOR SITE
C1704256|TRANSFORMING GROWTH FACTOR BETA 1
C1515406|TRANSFORMING GROWTH FACTOR BETA-1
C0080222|TRANSFORMING GROWTH FACTOR BETA-1
C1366557|TRANSFORMING GROWTH FACTOR, BETA-1
C0040690|TRANSFORMING GROWTH FACTORS-BETA
C0005841|TRANSFUSION OF BLOOD PRODUCT
C0199960|TRANSFUSION PROCEDURE
C0278347|TRANSFUSIONS PLASMA
C0282641|TRANSGENES
C0003069|TRANSGENIC ANIMALS
C1519606|TRANSGENIC MODEL
C0025936|TRANSGENIC MOUSE
C0887838|TRANS-GOLGI NETWORK
C1273059|TRANSIENT EPILEPTIC AMNESIA
C0019151|TRANSIENT HEPATARGY SYNDROME
C0007787|TRANSIENT ISCHEMIC ATTACK (TIA)
C1421168|TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY C, MEMBER 1
C0962567|TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL SUBFAMILY V MEMBER 4
C0040707|TRANSISTORS
C2700061|TRANSITION
C0682906|TRANSITION METALS
C0339897|TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT [TIPS]
C0040710|TRANSLATING
C1519619|TRANSLATIONAL REPRESSION
C3494163|TRANSLATIONAL RESEARCH
C1519613|TRANSLATION INITIATION
C1519614|TRANSLATION PROCESS
C0040712|TRANSLATIONS
C0582119|TRANSLOCASE
C1427202|TRANSLOCASE OF OUTER MITOCHONDRIAL MEMBRANE 20, S. CEREVISIAE, HOMOLOG OF
C1425229|TRANSLOCASE OF OUTER MITOCHONDRIAL MEMBRANE 40, YEAST, HOMOLOG OF
C1823301|TRANSMEMBRANE P24 TRAFFICKING PROTEIN 10
C0021699|TRANSMEMBRANE PROTEIN
C1823367|TRANSMEMBRANE PROTEIN 106B
C1823439|TRANSMEMBRANE PROTEIN 175
C1336807|TRANSMEMBRANE PROTEIN GENE
C1519624|TRANSMEMBRANE TRANSPORT
C0022336|TRANSMISSIBLE VIRUS DEMENTIA
C0242781|TRANSMISSION
C0262880|TRANSMISSION ELECTRON MICROSCOPE (TEM)
C0522503|TRANSPARENT
C0040732|TRANSPLANT PROCEDURE
C0376387|TRANSPLANT RECIPIENT
C0022671|TRANSPLANT;RENAL
C0596902|TRANSPORTER
C1519628|TRANSPORT PROCESS
C0007292|TRANSPORT PROTEIN
C0040674|TRANSPOSITION PROCEDURE, NOS
C0032923|TRANSTHYRETIN
C0582456|TRAUMA RISK
C0236959|TRAUMATIC ENCEPHALOPATHY
C0876926|TRAUMATIC; ENCEPHALOPATHY
C0014557|TRAUMATIC; EPILEPTIC
C0038436|TRAUMATIC; NEUROSIS
C0038441|TRAUMATIC STRESS DISORDER
C0040805|TRAZODONE-CONTAINING PRODUCT
C0184069|TREADMILL
C0087110|TREADMILL TEST
C1321605|TREATMENT COMPLIANCE
C0087113|TREATMENT EFFICACY
C0557980|TREATMENT EVALUATION
C0018704|TREATMENT FACILITIES
C0935576|TREATMENT GUIDELINES
C0087111|TREATMENT METHOD
C1299575|TREATMENT MODIFICATION
C0376405|TREATMENT;NON COMPLIANCE
C0683525|TREATMENT OPTION
C0085415|TREATMENT OUTCOMES
C0679841|TREATMENT PROGRAM
C0040808|TREATMENT REGIMEN
C0282334|TREATMENT RESEARCH
C0749659|TREATMENT STATUS
C1292734|TREATS
C0072523|TREFOIL FACTOR 1
C1420701|TREFOIL FACTOR 2
C0040815|TREHALOSE
C0270736|TREMOR; ESSENTIAL
C0040822|TREMOR, UNSPECIFIED
C0318222|TREPONEMA DENTICOLA
C0040840|TREPONEMA PALLIDUM
C0039128|TREPONEMA PALLIDUM; INFECTION
C0023764|TRIACYLGLYCEROL LIPASE-CONTAINING PRODUCT
C3641234|TRIAL DESIGN
C0034656|TRIAL IS RANDOMIZED
C0040879|TRIAZOLAM-CONTAINING PRODUCT
C0040900|TRICHLOROACETIC ACID-CONTAINING PRODUCT
C0008238|TRICHLOROMETHANE
C0003290|TRICYCLIC ANTIDEPRESSANTS
C0040976|TRIETHYLENETETRAMINE
C0330783|TRIFOLIUM PRATENSE / RED CLOVER BLOSSOM
C0270868|TRIGEMINO-SYMPATHETIC SYNDROME
C1444748|TRIGGER
C0032930|TRIGGERING FACTOR
C1425066|TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1
C1143976|TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2
C1425067|TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2
C1426933|TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS-LIKE PROTEIN 1
C1540048|TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS-LIKE PROTEIN 2
C0041004|TRIGLYCERIDES
C0041014|TRIIODOTHYRONINE (T3)
C0519160|TRIIODOTHYRONINE T3; FREE
C0032982|TRIMESTERS
C1336673|TRIM FAMILY
C0041078|TRIOSEPHOSPHATE ISOMERASE
C1540056|TRIPARTITE MOTIF-CONTAINING PROTEIN 21
C2240119|TRIPARTITE MOTIF FAMILY LIKE 2
C0146894|TRIPHOSPHATE
C1336674|TRIPLE FUNCTIONAL DOMAIN
C0282537|TRIPLET REPEAT
C0041107|TRISOMY; SYNDROME
C0013080|TRISOMY; SYNDROME, 21
C0155017|TRITANOPIA
C0059256|TRITIRACHIUM ALKALINE PROTEINASE
C0035711|TRNA
C0041197|TROPOMYOSINS
C0077401|TROPONIN-I
C0178602|TRTDOS
C1718418|TRUNK RESTRAINT
C0041213|TRYPAN BLUE STAIN-CONTAINING PRODUCT
C0041228|TRYPANOSOMIASIS; AFRICAN
C0041234|TRYPANOSOMIASIS; TRYPANOSOMA CRUZI
C0041242|TRYPSIN INHIBITORS
C0041236|TRYPSIN, UNSPECIFIED FORM
C0041252|TRYPTOPHAN 5-MONOOXYGENASE
C0202230|TSH
C0040160|TSH
C1823521|TSPO GENE
C0014327|TUBE FEEDING
C0041281|TUBE FEEDING OF PATIENT
C0151332|TUBERCULOSIS ACTIVE
C0041290|TUBERCULOSIS SKIN TEST
C0041296|TUBERCULOUS
C1547937|TUBES
C0041345|TUBOCURARINE-CONTAINING PRODUCT
C0022672|TUBULAR NECROSIS ACUTE
C0041348|TUBULINS
C0151747|TUBULO-RENAL FUNCTION; IMPAIRED
C0598934|TUMOR GROWTH
C0007621|TUMORIGENESIS
C1519697|TUMORIGENICITY
C0036221|TUMOR; MAST CELL, MALIGNANT
C1448177|TUMOR NECROSIS FACTOR
C0812246|TUMOR NECROSIS FACTOR
C0041368|TUMOR NECROSIS FACTOR FAMILY PROTEIN
C1143949|TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 10
C1420817|TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 14
C0077503|TUMOR NECROSIS FACTOR--RECEPTORS
C1363982|TUMOR NECROSIS FACTOR RECEPTOR SUBFAMILY, MEMBER 1B
C0667477|TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 11A
C1435659|TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 16
C1420811|TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 19
C1456820|TUMOR NECROSIS FACTOR (TNF)
C0001430|TUMOR OF THE GLAND
C0178874|TUMOR PROGRESSION
C0079419|TUMOR PROTEIN P53
C1420865|TUMOR PROTEIN P53-BINDING PROTEIN 1
C1540040|TUMOR PROTEIN P53-INDUCIBLE NUCLEAR PROTEIN 2
C0079427|TUMOR SUPPRESSOR GENE
C0006826|TUMOR; UNCLASSIFIED, MALIGNANT
C0027651|TUMOUR
C0334227|TUMOUR CELLS, MALIGNANT
C0431085|TUMOUR CELLS, UNCERTAIN WHETHER BENIGN OR MALIGNANT
C0225342|TUNICA EXTERNA
C0162864|TUNICA INTIMA, NOS
C0162867|TUNICA MEDIA VASORUM
C0041385|TUNICAMYCIN
C0041388|TUNISIA
C1519630|TUR
C0549217|TURKISH
C0950101|TURMERIC
C0041356|TURMERIC
C0077524|TURMERIC EXTRACT
C0541749|TURNING ACTION
C0031227|TURNOVER
C0041427|TWIN SIBLING
C0041432|TWINS, MONOZYGOTIC
C1421245|TWISTED GASTRULATION HOMOLOG 1
C1421244|TWIST FAMILY BHLH TRANSCRIPTION FACTOR 1
C0533325|TWIST-RELATED PROTEIN 1
C0013860|TWO DIMENSIONAL GEL ELECTROPHORESIS
C1424661|TXNIP GENE
C0441729|TYPE 1
C0390423|TYPE-2 ANGIOTENSIN II RECEPTOR
C0030281|TYPE B CELL OF PANCREATIC ISLET
C2700185|TYPEI
C0750929|TYPE I CHIARI MALFORMATION
C0041455|TYPE I COLLAGEN
C0011854|TYPE I; DIABETES
C0205557|TYPE I ERRORS
C0009331|TYPE II COLLAGEN
C0011860|TYPE II; DIABETES
C0020445|TYPE II HYPERLIPIDAEMIA
C0020479|TYPE III HYPERLIPIDAEMIA
C0009333|TYPE IV COLLAGEN
C0543467|TYPE OF SURGERY
C0199801|TYPHOID VACCINATION
C1336693|TYRO PROTEIN TYROSINE KINASE BINDING PROTEIN
C1336692|TYRO PROTEIN TYROSINE KINASE-BINDING PROTEIN
C1268567|TYROSINE KINASE INHIBITOR
C1336653|TYROSINE KINASE, NONRECEPTOR, 1
C1519726|TYROSINE PHOSPHORYLATION
C1567665|TYROSINE-PROTEIN KINASE ITK/TSK
C1335056|TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE 1
C0755562|U-0126
C0600531|U937 CELLS
C1421304|UBIQUILIN 1
C0041536|UBIQUINONE
C0041538|UBIQUITIN
C1519751|UBIQUITINATION
C1421267|UBIQUITIN C
C1741097|UBIQUITIN-CONJUGATING ENZYME E2 T
C0077678|UBIQUITIN--PROTEIN LIGASE
C0164005|UBIQUITIN THIOLESTERASE
C1519740|UC01
C1421309|UCHL1 GENE
C1421319|UGCG GENE
C0333295|ULCER, ACUTE
C0009324|ULCERATIVE COLITIS, UNSPECIFIED
C0149745|ULCER; ORAL MUCOSA
C0030920|ULCER; PEPTIC
C0041582|ULCERS
C0011127|ULCER; SKIN, DECUBITUS
C0728475|ULTRA
C0041609|ULTRACENTRIFUGATION, NOS
C0013516|ULTRASONIC CARDIOGRAPHY
C0235198|UNABLE TO CONCENTRATE
C0021359|UNABLE (TO);GET PREGNANT
C0015732|UNABLE TO RESTRAIN BOWEL MOVEMENT
C0686905|UNAVAILABLE
C1421359|UNC-5 NETRIN RECEPTOR C
C0087130|UNCERTAINTY
C0041657|UNCONSCIOUS(NESS)
C0039070|UNCONSCIOUSNESS; ATTACK
C1421313|UNCOUPLING PROTEIN 1
C0542339|UNDER
C0391853|UNDERACTIVE
C0086439|UNDERACTIVITY
C0682177|UNDERGRADUATE
C0012613|UNDERPRIVILEGED
C0162340|UNDERSTANDING, NOS
C0038454|UNDETERMINED STROKE
C1408353|UNDIAGNOSED
C0334463|UNDIFFERENTIATED PLEOMORPHIC SARCOMA
C0242503|UNEQUAL
C0015688|UNESTERIFIED FATTY ACID
C1321037|UNEXPLAINED FALLS
C1155342|UNFOLDED PROTEIN RESPONSE
C0019134|UNFRACTIONATED HEPARIN
C3815933|UNINSURED MEDICAL EXPENSES
C0041696|UNIPOLAR DEPRESSION
C1710548|UNIQUE
C0439148|UNITS
C0041740|UNIVERSITY
C0041741|UNIVERSITY HEALTH SERVICES
C0020028|UNIVERSITY HOSPITALS
C0200896|UNLISTED CYTOGENETIC STUDY
C0524850|UNLISTED PROCEDURE, NERVOUS SYSTEM
C0041618|UNLISTED ULTRASOUND PROCEDURE (EG, DIAGNOSTIC, INTERVENTIONAL)
C0087136|UNMARRIED
C0037179|UNMARRIED PERSON
C0445356|UNRELATED
C0015690|UNSATURATED FATTY ACIDS
C0020676|UNSPECIFIED ACQUIRED HYPOTHYROIDISM
C0004245|UNSPECIFIED ATRIOVENTRICULAR BLOCK
C0349251|UNSPECIFIED BEHAVIOURAL SYNDROMES ASSOCIATED WITH PHYSIOLOGICAL DISTURBANCES AND PHYSICAL FACTORS
C0005586|UNSPECIFIED BIPOLAR DISORDER
C0085584|UNSPECIFIED BRAIN DISEASE
C0085932|UNSPECIFIED BULLOUS DERMATOSES
C0086543|UNSPECIFIED CATARACT
C0007820|UNSPECIFIED CEREBROVASCULAR DISEASE
C0008677|UNSPECIFIED CHRONIC BRONCHITIS
C0022661|UNSPECIFIED CHRONIC RENAL FAILURE
C0006111|UNSPECIFIED CONDITION OF BRAIN
C0009806|UNSPECIFIED CONSTIPATION
C4048158|UNSPECIFIED CONVULSIONS
C0041782|UNSPECIFIED DEFICIENCY ANEMIA
C0424605|UNSPECIFIED DELAY IN DEVELOPMENT
C0497327|UNSPECIFIED DEMENTIA
C0342257|UNSPECIFIED DIABETES MELLITUS WITH UNSPECIFIED COMPLICATIONS
C0035204|UNSPECIFIED DISEASE OF RESPIRATORY SYSTEM
C0018939|UNSPECIFIED DISEASES OF BLOOD AND BLOOD-FORMING ORGANS
C0010034|UNSPECIFIED DISORDER OF CORNEA
C0015397|UNSPECIFIED DISORDER OF GLOBE
C0154251|UNSPECIFIED DISORDER OF LIPOID METABOLISM
C0023895|UNSPECIFIED DISORDER OF LIVER
C0025517|UNSPECIFIED DISORDER OF METABOLISM
C0040128|UNSPECIFIED DISORDER OF THYROID
C0027765|UNSPECIFIED DISORDERS OF NERVOUS SYSTEM
C0149654|UNSPECIFIED DISTURBANCE OF CONDUCT
C0085580|UNSPECIFIED ESSENTIAL HYPERTENSION
C0260832|UNSPECIFIED FOLLOW-UP EXAMINATION
C0016807|UNSPECIFIED FUNCTIONAL DISORDER OF INTESTINE
C0017601|UNSPECIFIED GLAUCOMA
C1384666|UNSPECIFIED HEARING LOSS
C0019087|UNSPECIFIED HEMORRHAGIC CONDITIONS
C0019693|UNSPECIFIED HUMAN IMMUNODEFICIENCY VIRUS [HIV] DISEASE
C1263846|UNSPECIFIED HYPERKINETIC SYNDROME OF CHILDHOOD
C0021051|UNSPECIFIED IMMUNITY DEFICIENCY
C0018674|UNSPECIFIED INJURY OF HEAD
C0151699|UNSPECIFIED INTRACRANIAL HEMORRHAGE
C0022408|UNSPECIFIED JOINT DISORDER, SITE UNSPECIFIED
C0520966|UNSPECIFIED LACK OF COORDINATION
C0024530|UNSPECIFIED MALARIA
C0525045|UNSPECIFIED MOOD [AFFECTIVE] DISORDER
C0026946|UNSPECIFIED MYCOSIS
C0162429|UNSPECIFIED NUTRITIONAL DEFICIENCY
C0029456|UNSPECIFIED OSTEOPOROSIS, SITE UNSPECIFIED
C0521170|UNSPECIFIED OSTEOPOROSIS WITH PATHOLOGICAL FRACTURE
C0030193|UNSPECIFIED PAIN
C0032914|UNSPECIFIED PRE-ECLAMPSIA, UNSPECIFIED TRIMESTER
C0033975|UNSPECIFIED PSYCHOSIS
C0035078|UNSPECIFIED RENAL FAILURE
C1260922|UNSPECIFIED RESPIRATORY ABNORMALITY
C0035309|UNSPECIFIED RETINAL DISORDER
C0036341|UNSPECIFIED SCHIZOPHRENIA, UNSPECIFIED
C0036690|UNSPECIFIED SEPTICEMIA
C0149516|UNSPECIFIED SINUSITIS (CHRONIC)
C0007097|UNSPECIFIED SITE; CARCINOMA, UNSPECIFIED SITE
C0037315|UNSPECIFIED SLEEP APNEA
C1135191|UNSPECIFIED SYSTOLIC (CONGESTIVE) HEART FAILURE
C0917805|UNSPECIFIED TRANSIENT CEREBRAL ISCHEMIA
C0085633|UNSTABLE MOOD
C0600680|UNTRANSLATED REGIONS OF MRNA
C0887909|UNTRANSLATED RNA
C0558080|UNWILLING
C0446516|UPPER ARM STRUCTURE
C0018792|UPPER CHAMBERS OF THE HEART
C0041909|UPPER GI BLEEDING
C1140618|UPPER LIMB STRUCTURE
C1280388|UPPER LIP
C0458578|UPPER RESPIRATORY TRACT STRUCTURE
C0041904|UPREGULATION
C0231472|UPRIGHT BODY POSITION
C0522505|UPSTREAM
C0243144|UPTAKE
C0935936|URATE
C0729829|URATE LEVEL - FINDING
C2700386|URBAN
C0041938|URBANIZATION
C0041935|URBAN POPULATION
C0442507|URBAN RESIDENTIAL
C0856880|UREA HIGH
C0041942|UREA PRODUCT
C0343305|UREMIA; CONGENITAL
C0439609|URGENT
C4047660|URGENT HOSPITAL ADMISSION
C0041981|URIC ACID, INCREASED LEVEL
C0740394|URICEMIA
C0041984|URIDINE-CONTAINING PRODUCT
C0041986|URIDINE DIPHOSPHATE (UDP)
C0042002|URIDYLIC ACID
C0876271|URINARY ANTISPASMODICS
C0005682|URINARY BLADDER STRUCTURE
C0028734|URINARY FREQUENCY MORE THAN ONCE AT NIGHT
C1508753|URINARY TRACT
C0574785|URINARY TRACT SYMPTOM LOWER
C0042036|URINE
C1318330|URINE ALBUMIN:CREATININE RATIO
C0474662|URINE FREE CORTISOL MEASUREMENT
C0042025|URINE; INCONTINENCE, STRESS
C0150045|URINE; INCONTINENCE, URGE
C0042029|URINE; INFECTED
C1305628|URINE PROTEIN, NOS
C0080274|URINE; RETENTION
C0042014|URINE TESTS
C0032617|URINE VOLUME, INCREASED
C1421312|UROCORTIN
C3827687|UROLITHIN
C0042075|UROPATHY
C0042105|URSODIOL-CONTAINING PRODUCT
C0041703|USA
C0085756|U.S. BLACKS
C0001948|USE; ALCOHOL
C0238662|USE; ANTICOAGULANTS
C0476643|USE; DRUGS
C3827682|USEFUL
C1706077|USER
C0457083|USES
C0869040|USE STUDIES
C1421376|USF1 GENE
C4521534|US MILITARY ENLISTED E1
C4521398|US MILITARY ENLISTED E4
C1421395|USP18 GENE
C1421409|USP9X GENE
C0042124|UTAH
C0025874|UTERINE BLEEDING DYSFUNCTIONAL
C0007874|UTERINE CERVIX, NOS
C0042134|UTERUS; HEMORRHAGE
C0042133|UTERUS; LEIOMYOMA
C0582205|UTILITIES
C1823727|UTP25 SMALL SUBUNIT PROCESSOR COMPONENT
C1535578|UVULOPALATOPHARYNGOPLASTY
C0042196|VACCINATIONS
C1519887|VACCINE ANTIGEN
C0042210|VACCINES
C0042209|VACCINE THERAPY
C0042219|VACUOLES
C1293903|VAGAL STIMULATION
C1314687|VAGINAL INTERCOURSE
C0042232|VAGINA/VAGINAL
C0085166|VAGINOSIS NON SPECIFIC
C0231218|VAGUE ILL HEALTH
C0812228|V-AKT MURINE THYMOMA VIRAL ONCOGENE HOMOLOG 1
C0913246|VALDECOXIB-CONTAINING PRODUCT
C1519941|VALIDATION
C0681836|VALIDATION STUDY
C0042285|VALINE (VAL)
C0080356|VALPROATE PRODUCT
C0042291|VALPROIC ACID-CONTAINING PRODUCT
C0750121|VALPROIC ACID TREATMENT
C0216784|VALSARTAN-CONTAINING PRODUCT
C1522609|VALUE
C0042295|VALUES
C0018826|VALVE, CARDIAC
C0042306|VANADIUM (V)
C0042308|VANADYL
C0042317|VANILMANDELIC ACID (VMA)
C0025691|VANYLGLYCOL
C1569608|VARENICLINE-CONTAINING PRODUCT
C2827666|VARIABILITY
C0439828|VARIABLE
C0376329|VARIANT CREUTZFELDT-JAKOB DISEASE
C0205419|VARIATION
C0740380|VARICELLA ZOSTER
C3540763|VARIOUS
C0241657|VASCULAR ABNORMALITY
C0036974|VASCULAR; COLLAPSE
C0011269|VASCULAR DEMENTIA, UNSPECIFIED
C0004153|VASCULAR DISEASE ATHEROSCLEROTIC
C0085096|VASCULAR DISEASE PERIPHERAL
C1568520|VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 1
C3849882|VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2
C1256770|VASCULAR ENDOTHELIAL GROWTH FACTORS
C0014261|VASCULAR ENDOTHELIUM
C0232340|VASCULAR FLOW, ABNORMAL
C0232342|VASCULAR FLOW, DECREASED
C0232341|VASCULAR FLOW, INCREASED
C0232338|VASCULAR FLOW, NOS
C0854443|VASCULAR FRAGILITY
C0232337|VASCULAR FUNCTION
C0546783|VASCULAR IMAGING
C0947751|VASCULAR INFLAMMATIONS
C0178324|VASCULAR INJURY
C0232352|VASCULAR INSUFFICIENCY, NOS
C0027686|VASCULARIZATION
C1402315|VASCULAR; LESION
C0700221|VASCULAR LINE
C0429854|VASCULAR MEASUREMENTS
C1096458|VASCULAR; OCCLUSION
C0026844|VASCULAR SMOOTH MUSCLE
C0489903|VASCULAR SYSTEM
C0042373|VASCULAR SYSTEM DISORDERS
C0042384|VASCULITIS; SYNDROME
C0042396|VASOCONSTRICTION
C0042401|VASODILATION
C0042402|VASODILATORS
C2825502|VASOGENIC EDEMA
C0597640|VASOMOTION
C0265110|VASOSPASM; CEREBRAL
C0085616|VASOSPASTIC; SYNDROME
C0078056|VCAM-1
C0012656|VECTOR
C0556223|VEGETABLE INTAKE
C0042440|VEGETABLES
C1171892|VEGF
C1823619|VEGFA GENE
C0388911|VEGF-C
C0148199|VEGF RECEPTOR
C0684312|VEHICLE DRIVER
C0004380|VEHICLE EMISSION
C0683911|VEHICULAR ACCIDENT
C1547053|*VELOCITY
C0036916|VENEREAL DISEASE, UNSPECIFIED
C0042469|VENEZUELA, BOLIVARIAN REPUBLIC OF
C0241664|VENEZUELAN
C0042479|VENOMS
C0042449|VENOUS STRUCTURE
C0042487|VENOUS THROMBOSIS, NOS
C0235522|VENOUS VASCULAR DISEASE OR SYNDROME
C0231940|VENTILATION, ALVEOLAR (V)
C0199470|VENTILATION MECHANICAL
C0018827|VENTRICLES
C0018790|VENTRICULAR ASYSTOLE
C2675972|VENTRICULAR ENLARGEMENT
C0240059|VENTRICULAR; HEMORRHAGE
C0040479|VENTRICULAR TACHYCARDIA, POLYMORPHIC WITH Q-T PROLONGATION
C0042514|VENTRICULAR TACHYCARDIA (V-TACH)
C0750200|VENTRICULOPERITONEAL SHUNT PLACEMENT
C0042520|VENULES
C0439824|VERBAL
C1145677|VERBAL ABILITY
C0150820|VERBAL COMMUNICATION
C0871945|VERBAL FLUENCY
C0566027|VERBAL IMPAIRMENT
C0042531|VERBAL LEARNING
C0561770|VERBAL MEMORY OBSERVABLE
C0812265|V-ERB-B2 AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG 3
C0037949|VERTEBRAL COLUMN, NOS
C0080179|VERTEBRAL FRACTURE
C0549207|VERTEBRA, NOS
C0042567|VERTEBRATES
C0242648|VERTICAL TRANSMISSION
C4307343|VERUBECESTAT
C0442804|VERY HIGH
C0450093|VERY LARGE
C0542549|VERY LONG CHAIN FATTY ACID
C0023825|VERY LOW DENSITY LIPOPROTEIN (VLDL)
C1622418|VESICLE
C0333262|VESICLE
C0148339|VESICLE-ASSOCIATED MEMBRANE PROTEIN 1
C0039010|VESICULAR DISEASE OF PIGS
C0005847|VESSEL, BLOOD
C0229889|VESSEL, LYMPHATIC
C0035330|VESSEL OF RETINA
C0682674|VESTIBULAR SYSTEM
C1321513|VESTIBULE
C0042606|VESTIBULE
C0042610|VETERANS
C0443348|VIABLE
C4318462|VIABLE CELLS
C0663448|VIAGRA
C0680681|VICTIM
C0682306|VIETNAM VETERAN
C0449911|VIEW
C0554101|VILLOUS ATROPHY
C1519988|VILLUS
C0042670|VINBLASTINE-CONTAINING PRODUCT
C0059752|VINPOCETINE
C0042693|VIOLENCE
C0424323|VIOLENT BEHAVIOUR
C0876768|VIOXX
C0206298|VIPERA BERUS
C0521026|VIRAL
C0343363|VIRAL; GASTROENTERITIS, ROTAVIRAL
C0017376|VIRAL GENE
C0376705|VIRAL LOAD
C1160185|VIRAL TRANSDUCTION
C0009443|VIRAL UPPER RESPIRATORY INFECTION
C0042742|VIRAL VACCINES
C1520007|VIRAL VECTOR
C0042760|VIRION
C1136170|VIRULENCE FACTORS
C0042721|VIRUS; HEPATITIS
C0019196|VIRUS; HEPATITIS, NON-A, NON-B
C0019163|VIRUS; HEPATITIS, TYPE, B
C0042776|VIRUS, NOS
C0042736|VIRUS PROTEIN
C0034848|VIRUS RECEPTOR SITE
C1421472|VISININ-LIKE 1
C0042798|VISION, SUBNORMAL
C1512346|VISIT
C0000936|VISUAL ACCOMMODATION, NOS
C0042817|VISUAL CORTEX
C0015217|VISUAL EVOKED RESPONSE
C0036454|VISUAL FIELD SCOTOMA
C0042789|VISUAL FUNCTION
C0233763|VISUAL HALLUCINATIONS
C0582587|VISUAL LEARNING
C0542316|VISUAL MEMORY
C0042829|VISUAL PATHWAYS
C0042830|VISUAL PERCEPTION
C0589087|VISUAL PROCESSING
C0587900|VISUAL STRUCTURE
C3536733|VISUAL SYSTEM
C0814069|VISUOSPATIAL ABILITY
C0872011|VISUOSPATIAL MEMORY
C0042834|VITAL CAPACITY (VC)
C0040845|VITAMIN A ACID
C0087161|VITAMIN A COMPOUND
C0042839|VITAMIN A PRODUCT
C0039840|VITAMIN B1
C0042845|VITAMIN B12 PREPARATION
C0028027|VITAMIN B3
C0087162|VITAMIN B-6
C0016410|VITAMIN B COMPLEX
C0042849|VITAMIN B PRODUCT
C0853988|VITAMIN C DECREASED
C0003968|VITAMIN C PREPARATION, NOS
C0014695|VITAMIN D2 (ERGOCALCIFEROL)
C0008318|VITAMIN D3 (CHOLECALCIFEROL)
C3657722|VITAMIN D3 RECEPTOR
C1520059|VITAMIN D ANALOG
C0919766|VITAMIN D DECREASED
C0035579|VITAMIN D DEFICIENCY DISEASE
C0042842|VITAMIN; DEFICIENCY, A
C0003969|VITAMIN; DEFICIENCY, C
C0042870|VITAMIN; DEFICIENCY, D
C0042850|VITAMIN; DEFICIENCY, GROUP B
C1510471|VITAMIN DEFICIENCY, UNSPECIFIED
C0564439|VITAMIN D INTAKE
C0042866|VITAMIN D PRODUCT
C0108082|VITAMIN D RECEPTOR
C0919430|VITAMIN D RECEPTOR
C0242154|VITAMIN D TOXICITY
C0042874|VITAMIN E PREPARATION, NOS
C0005575|VITAMIN H
C0086605|VITAMIN K>2<
C1096489|VITAMIN K ANTAGONIST
C0042880|VITAMIN K DEFICIENCY DISEASE
C0042878|VITAMIN K PRODUCT
C0056077|VITAMIN Q10
C1533658|VITAMIN THERAPY
C0302837|VITAMIN THERAPY
C0202252|VITB12
C0035527|VITB2
C0919758|VITD
C0344320|VIVID DREAMS
C1537502|V-KI-RAS2 KIRSTEN RAT SARCOMA VIRAL ONCOGENE HOMOLOG
C1421455|VLDLR GENE
C0086661|V-MYC MYELOCYTOMATOSIS VIRAL ONCOGENE HOMOLOG (MYC) GENE
C0042939|VOICE, NOS
C1287298|VOIDED URINARY VOLUME
C0028910|VOLATILE OIL-CONTAINING PRODUCT
C0814022|VOLTAGE-GATED CALCIUM CHANNEL (VGCC)
C0597675|VOLTAGE GATED CHANNEL
C0449468|*VOLUME
C0449972|VOLUME CONTROL
C2986837|VOLUME OF INTEREST
C0445383|VOLUMETRIC
C0436188|VOLUMETRY
C0042960|VOLUNTEERS
C0038013|VON BECHTEREW
C0299505|VON HIPPEL-LINDAU DISEASE TUMOR SUPPRESSOR
C0672708|VORINOSTAT-CONTAINING PRODUCT
C0042978|VOTING
C1422017|VPS35 RETROMER COMPLEX COMPONENT
C0040210|VT
C0001144|VULGARIS; ACNE
C1562367|VULNERABLE ADULT
C0577651|VULNERABLE PERSONALITY
C0949366|VULNERABLE POPULATIONS
C1336938|VWF GENE
C0078433|VX NERVE GAS
C0796195|WAISMAN SYNDROME
C0205682|WAIST TO HIP RATIO
C0043010|WAITING LISTS
C0814636|WAITING TIME
C0585034|WAKE
C0043012|WAKEFULNESS
C0442696|WAKING
C0080331|WALKING
C0004134|WALK IS WOBBLY OR UNSTEADY
C0043020|WALLERIAN DEGENERATION
C0230770|WALL OF ENDOPLASMIC RETICULUM
C0230812|WALL OF LYSOSOME
C0507618|WALL OF VENTRICLE
C0330971|WALNUT
C0233569|WANDERING
C0871597|WANDERING BEHAVIOR
C0043031|WARFARIN-CONTAINING PRODUCT
C4303340|WARFARIN THERAPY
C0871599|WARNINGS
C0022603|WART(S);SENILE
C1421479|WAS PROTEIN FAMILY, MEMBER 1
C0043045|WASTE PRODUCTS
C0026846|WASTING;MUSCLE(S)
C0700325|WATCHFUL WAITING
C0871498|WATCH TELEVISION
C0599638|WATER
C0599635|WATER CHANNEL
C0043047|WATER PRODUCT
C0020311|WATER THERAPY
C0013123|WC
C0042024|WEAK; BLADDER
C0457435|WEAKNESS AFFECTING ENTIRE RIGHT SIDE
C3714552|WEAKNESS GENERALIZED
C0018801|WEAKNESS;HEART
C0151786|WEAKNESS;MUSCLE(S)
C0750865|WEBBING
C0039445|WEBER-OSLER
C0038505|WEBER SYNDROME
C0204456|WECHSLER ADULT INTELLIGENCE SCALE (WAIS)
C0204457|WECHSLER INTELLIGENCE SCALE FOR CHILDREN
C0451575|WECHSLER MEMORY SCALE
C0425152|WEDDING ENGAGEMENT
C1305866|WEIGHT
C0043094|WEIGHT INCREASING
C1262477|WEIGHT LOSS ON EXAM
C1456587|WEIGHT LOSS SURGERY
C0041667|WEIGHT OF PATIENT TOO LOW
C0336106|WELDER
C0686750|WELL ADULT
C3813622|WELL BEING
C3853142|WELL CONTROLLED
C0686753|WELL ELDER
C0424578|WELL IN SELF
C0388246|WERNER SYNDROME ATP-DEPENDENT HELICASE
C0349464|WERNICKE-KORSAKOV SYNDROME
C0043121|WERNICKES SYNDROME
C0238606|WEST AFRICANS
C0949466|WESTERN BLOT ASSAY
C0005863|WESTERN IMMUNOBLOTTING
C0271084|WET SENILE MACULAR DEGENERATION
C0023516|WHITE BLOOD CELL (WBC)
C0270612|WHITE MATTER DISEASE
C0682708|WHITE MATTER TISSUE
C0007457|WHITE RACE
C0043157|WHITES
C0370231|WHOLE BLOOD PRODUCT
C0444256|WHOLE BLOOD SAMPLE
C0444584|WHOLE BODY
C2350277|WHOLE GENOME ASSOCIATION STUDY
C0452717|WHOLE MILK
C0043167|WHOOPING COUGH DUE TO BORDETELLA PERTUSSIS [B. PERTUSSIS]
C0849867|WIDESPREAD DISEASE
C0043174|WIDOWERS
C0206275|WIDOWHOOD
C1510465|WIDOWS
C0003070|WILDLIFE
C0325628|WILD TURKEY, NOS
C1883559|WILD TYPE
C1520150|WILD TYPE MOUSE
C0600109|WILLING
C0019202|WILSON'S DISEASE
C1272706|WINDOW
C0559432|WINE INTAKE
C0043188|WINE, NOS
C0043189|WINGS
C0034716|WISTAR RAT
C1061163|WITHANIA SOMNIFERA
C2349954|WITHDRAW
C0237955|WITHDRAWAL (DEFENSE MECHANISM)
C0087169|WITHDRAWAL SYMPTOMS
C0857121|WITH HIGH BLOOD PRESSURE
C0028884|WITH ODOR
C0439793|WITH SEVERITY
C0332305|WITH STAGING
C0242665|WIVES
C0812233|WNT FAMILY MEMBER 1
C0043207|WOLFRAM SYNDROME
C4551693|WOLFRAM SYNDROME 1
C0042149|WOMB
C0043210|WOMEN
C0476254|WORD BLINDNESS
C0588438|WORK ASSESSMENT
C0025265|WORKING MEMORY
C0085122|WORK LOAD
C0814090|WORK STRESS
C0750430|WORK-UP
C2700280|WORLD
C0043234|WORLD BANK
C0043237|WORLD HEALTH ORGANIZATION (WHO)
C0018893|WORMS
C0018889|WORMS; INFESTATION
C0233481|WORRY
C0002965|WORSENING ANGINA
C0518645|WORSHIP
C0332798|WOUND OPEN
C0043240|WOUND REPAIR
C0043251|WOUNDS AND INJURIES
C0564444|WOUND;SKIN
C1337007|WRN GENE
C0455829|WSTCIR
C0694898|WT1 TRANSCRIPTION FACTOR
C1823863|WW, C2, AND COILED-COIL DOMAIN-CONTAINING 1
C1704666|WWW-LINKS
C0043317|XANTHINE OXIDASE
C0043318|XANTHINES
C0949636|XANTHOPHYLLS
C0004063|[X]ASSAULT BY UNSPECIFIED MEANS
C4083144|X-BOX BINDING PROTEIN 1
C0043292|X CHROMOSOME
C0043335|XENOBIOTICS
C1520166|XENOGRAFT MODEL
C0520484|XENOTRANSPLANTATION
C0043352|XEROSTOMIA
C0480203|[X]INTENTIONAL SELF HARM BY UNSPECIFIED MEANS, OCCURRENCE AT UNSPECIFIED PLACE
C0023374|X-LINKED HYPERURICEMIA
C1839730|X-LINKED MENTAL RETARDATION SYNDROME 2 (MRXS2)
C1306645|X-RAY
C0034575|X-RAY OF TEETH
C0002978|X-RAY OF THE BLOOD VESSEL
C0043299|X-RAYS
C1366475|XRCC1 GENE
C0085639|[X]UNSPECIFIED FALL
C1170735|XYREM
C1823882|YBX1 GENE
C0036025|YEAST
C0872306|YEAST PROTEIN
C0001527|YELLOW FAT
C0085036|YESSOTOXIN
C0528649|YKL-40
C0043419|YOGURT
C0332239|YOUNG
C0238598|YOUNG ADULTS
C0087178|YOUTH
C0439234|YYYY
C0043444|ZAIRE
C0078752|ZEAXANTHIN
C0043457|ZEBRAFISH
C0078755|ZEOLITES
C0081408|ZILEUTON-CONTAINING PRODUCT
C0149368|ZINC ACETATE-CONTAINING PRODUCT
C0360686|ZINC-CONTAINING PRODUCT IN ORAL DOSE FORM
C0235950|ZINC DEFICIENCY DISORDER
C1428099|ZINC FINGER CW-TYPE AND PWWP DOMAIN CONTAINING 1
C1538172|ZINC FINGER FYVE TYPE-CONTAINING PROTEIN 9
C1824069|ZINC FINGER PROTEIN 804A
C1426391|ZINC FINGER PROTEIN, MULTITYPE 1
C0043481|ZINC PRODUCT
C1608304|ZINC TRANSPORTER
C0524981|ZINGIBERACEAE
C1879327|ZINGIBER OFFICINALE WHOLE
C1521842|ZIP CODE
C1425506|ZNF292 GENE
C0078839|ZOLPIDEM-CONTAINING PRODUCT
C1710706|ZONE
C0043528|ZOONOTIC INFECTION
C0019360|ZOSTER; HERPES
C0871421|Z-SCORE
